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Abstract 
 
Background:  
ESRD is a serious and irreversible condition. Understanding the impact of ESRD 
and its treatment on an individual's QoL is important. There are limited studies 
found that assess QoL and Health-related QoL in Arab Muslim patients, and 
Oman in particular.  
Method:  
A cross-sectional, correlational study was conducted in four phases. Phase One 
explored the conceptual basis of QoL and how that has been assessed in ESRD 
patients. Phase Two explored the understanding and acceptability of the 
concepts within Omani patients using cognitive interviewing and individualised 
QoL instrument. Phase Three tested the feasibility of the main study design.  
Phase Four assessed the level and predictors of QoL/HRQoL from 13 
haemodialysis units across Oman; and tested psychometric adequacy of key 
measures using exploratory and confirmatory factor analysis.  
Findings:  
Phase 1: showed inconsistencies and inappropriate us of the terms QoL and 
HRQoL in literature. A range of measures used to examine QoL/HRQoL. 
Phase 2: revealed some cultural sensitivities in two items of the SF36v2 and 
QoLI-D measures but generally were accepted.  The SEIQoL-DW instrument 
supported the finding that QoL is a meaningful concept but one significant 
difference was the importance and universality of religion/spirituality as a key 
aspect of QoL.   
Phase 3: showed that chosen study approach was feasible and acceptable.  Six 
nurses were identified and trained to support in patient recruitment and data 
collection.  
Phase 4: participants were 445 with mean age 46.59. Majority were male (56.3 
%), married (62.5%), and employed (37.5%). Significant impairment in HRQoL 
was found for most of SF36v2 scales: PF 52.24, RP 54.24, BP 56.72, GH 53.18, 
VT 52.90, SF 60.50, RE 56.25, MH 63.75, respectively. Anxiety and depression 
symptoms were the most significant predictors and fatigue and pruritus were next. 
Also Muslims patients with ESRD encounter difficulties in performing their religion 
obligations due to the disease.   
Psychometric testing revealed that SF-36 is a three-factor structure with the 
inclusion of a separate role functioning component; and HADS one and two factor 
solutions were supported. 
Conclusion: future studies should continue to identify factors that influence 
quality of life and determine interventions that enhance a person’s sense of well-
being. 
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Chapter 1- Introduction and overview 
 
1. Introduction 
This introductory chapter establishes the nature, severity and prevalence of End 
Stage Renal Disease (ESRD), and its subsequent consequence on patients’ 
lives.  The chapter will also critically discuss the rationale for the study focus of 
Quality of Life (QoL) in this patient group and will finish with a summary of the 
study aims and research questions.  
1.1. Nature and severity of problems in ESRD 
End Stage Renal Disease (ESRD) is a serious, irreversible condition that affects 
a significant number of people worldwide.  The Global View Report of ESRD 
Patients (2011) estimated the prevalence of ESRD to be between 100 to over 
2,000 patients per million population (p.m.p), with an annual increase of 
approximately 6-7% higher than world population growth. The estimated number 
of patients receiving renal replacement therapy (RRT) is around 2.5 million. In 
Oman, no studies have been conducted on identifying the prevalence of ESRD, 
however, Al-Ismaili et al (2017) reported that there were 2386 Omani patients on 
RRT, of whom 1206 (50.5%) were on haemodialysis, 1080 (45.3%) living with a 
transplanted kidney, and 100 (4.2%) on peritoneal dialysis. The incidence of 
ESKD on RRT was 21, 75, and 120 per million population in 1983, 2001, and 
2013, respectively. These figures clearly show the incidence of ESRD is 
increasing substantially which, as a result, means the impact of the condition and 
its treatment has widespread consequences for healthcare services, individuals, 
and society.  
ESRD occurs when the estimated Glomerular Filtration Rate (eGFR), is <10-15 
ml/min/1.73m2. Renal failure could result from any disease process affecting one 
or more parts of the kidney including blood vessels, the glomeruli, kidney tubules, 
and bladder or urethra.  The commonest causes of ESRD are: 1) chronic 
glomerulopathy which is basically an alteration in the immune system in patients 
in which antibodies damage capillary membranes in the glomerulus; 2) diabetes 
mellitus could also affect blood vessels of the kidney causing narrowing by 
arteriosclerosis, 3) ischemic nephropathy which is manifested by ischemia in the 
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kidney caused by hypertension and ageing; 4) hereditary renal disease such 
polycystic kidney disease and Alport’s Syndrome; and 5) obstructive uropathy.  
Indeed, conditions such as diabetes and hypertension are dominant causes of 
ESRD in the Middle Eastern countries (Hassanien et al, 2012). Around 40% of 
patients with diabetes are prone to develop diabetic nephropathy, although it can 
take around 15 to 20 years between the first sign of renal damage and need for 
dialysis. 
ESRD causes significant biochemical abnormalities leading to symptom groups 
such as the uremic syndrome (National Kidney Foundation, 2002) that may 
impact negatively on an individual’s quality of life (Trivedi, 2011). Usually the 
associated symptoms appear late when the renal function is less than 15 % of 
normal (DOQI Guidelines, 2014). The majority of patients present clinically very 
late where they require immediate dialysis at time of diagnosis to remove the 
accumulative waste product in their blood. Consequently, almost all body organs 
are affected by the accumulative waste product including the gastro-intestinal 
tract, central nervous system, cardiovascular system, musclo-skeletal system, 
haematological system, skin, and reproductive organs. Studies that measured 
the prevalence of symptoms in patients with ESRD reported that fatigue, pruritus, 
and pain were rated as the most distressing to ESRD patients. Fatigue, for 
instance, is consistently ranked as the highest debilitating symptom in HD 
patients (Jablonski, 2007), and pain has been identified as an independent 
predictor of HRQoL (Davison and Jhangri, 2009). Pruritus was associated with 
the most intense symptoms and correlated negatively with all HRQoL domains 
(Yong et al., 2009).  
The treatment of ESRD starts virtually when renal function deteriorates to around 
80% and kidneys become unable to remove waste products from blood (National 
Kidney Foundation Guideline, 2005). Although kidney transplantation is 
considered the gold standard for patients with ESRD, practically it is not easy due 
to the fact that demand for kidneys exceeds the available supply. Instead, renal 
replacement therapy is the best option available for ESRD or what is clinically 
called haemodialysis (HD). Haemodialysis usually commences when the 
remaining percentage of renal function is insufficient to excrete urea and other 
toxins from blood which usually leads to the emergence of severe symptoms. HD 
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is the most common renal replacement therapy worldwide. It is performed by 
filtering patients’ blood for three to five hours two to three times every week. Prior 
to commencing HD, patients are usually required to undergo a surgical procedure 
to create vascular access so that two needles can be connected to withdraw and 
return filtered blood. The main advantages of HD are its ability to amend the 
proportions of body fluids according to dialysis specifications, and efficient 
removal of body waste. Although HD is a safe procedure which can be performed 
in out-patients’ clinics or patients’ homes, complications may occur including 
hypotension, a sense of fatigue, and hardening of the arteries.  
Treating ESRD and its related symptoms has significant costs, not only for the 
healthcare system but also for the individuals. In the UK, where ESRD represents 
only 0.05% of the total population, the estimated total cost to the National Health 
Service (NHS) of managing renal failure patients comprises approximately 2% of 
its total budget (Kidney Disease Key factors & Figures, 2016, NHS). In countries 
that do not have a national health system, patients with ESRD may be 
responsible for the cost of their own treatment and such costs might have a 
significant and enduring impact on the financial status of patients’ families.  In 
Oman, The Ministry of Health (MoH) spends yearly around RO 7,000 (around £ 
11,917) on each patient with ESRD who is on regular dialysis (National Renal 
Statistics Report, 2012, Not Published).  The cost of caring for ESRD patients is 
likely to increase over time, and there are issues around long-term sustainability 
of these costs. 
1.2. Quality of Life, Health, and Health-related Quality of Life 
1.2.1. Quality of Life 
The notion of quality of life (QoL) in nephrology started appearing in literature in 
the 1970s. The majority of these studies were conducted in the UK, Canada, 
USA, and Netherlands. Since then, numerous studies using different designs 
including quantitative and qualitative approaches have been conducted. 
Qunatitative studies in particular have used different tools and measures to 
examine QoL. Similarly, these studies have used several clinical and 
sociodemographic variables to examine QoL among ESRD patients. Reviewing 
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the published studies that have examined QoL in this group of patients has 
helped in identifying the gap that exists in current literature and has informed this 
study design. To the researcher’s knowledge, this PhD study is among the few 
that have used a combination of an individualised QoL instrument, disease-
specific measure, HRQoL measure, and symptoms-specific measures. It is also 
the first known study that examines QoL and health-related quality of life (HRQoL) 
in patients with ESRD in Oman. Given the characteristics of the Omani population 
in relation to culture, and religion, it was essential to use different measures 
including religious and spiritual measures in this population. The measures used 
in this study were initially developed in western counties and had been translated 
into different languages including Arabic. 
QoL is a complex and scattered concept that makes a significant impact on 
research exploring patient experience and practice. It is often used to describe 
different physical and psychosocial variables (Cameron et al., 2010) including 
health status, functions, behaviours, life satisfaction, perceptions, and symptoms 
(Fink, 2009). In contemporary health care research, the term QoL has been linked 
and used interchangeably with different related concepts such as HRQoL and 
functional ability (Gehrmann et al., 2007). The interchangeable use of the terms 
‘health’, ‘functional ability’ and ‘QoL’, far from clarifying and providing exact 
meaning, might add additional confusion.  In spite of inconsistency and the 
complexity of defining QoL, there is a consistency in literature that QoL is a 
multidimensional concept (Hass, 2007; Bowling 2005). Due to cultural and 
religious beliefs that may influence patients’ perceptions about QoL, measuring 
QoL should be considered as an individualised concept. 
1.2.2. The relationship between QoL and Health 
There is an increased acceptance in the literature of using QoL as a critical 
endpoint in medical research. Yet, there is little consensus on how it differs from 
perceived health-status. The term ‘health’ is usually referred to as the absence of 
disease and illness, which might indicate a good level of quality of life on an 
individual level. Most of the measures of health status have considered health as 
a baseline for QoL (Hall, Krahn et al. 2011). However, a positive conception of 
health is difficult to measure due to the lack of agreement over its definition 
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(Kurpas, Mroczek et al. 2013). Also it is difficult to determine if the state of health 
has been achieved because of the absence of a unified operational definition for 
the term ‘health’. Clinicians’ judgment might focus on the absence of disease, 
whereas others professionals, and indeed patients, might see it as the ability to 
carry out normal everyday tasks, feeling strong and fit to carry out life.  
The WHO definition of ‘health’ as a state of complete physical, mental and social 
well-being provided a new focus to the borders of the meaning of health rather 
than a narrow (disease-based) focus (Holmes, 2005). This step was followed by 
the development of measures of positive health. Currently, there is broad 
agreement that the concept of positive health is more than the absence of disease 
or even disability, but is about full functioning, efficiency of mind and body and 
social adjustment (Kaasa and Loge 2003; Krethong et al., 2008). By reflecting on 
the concept of QoL, it can be realised that ‘health’ is a component of QoL with a 
kind of tautology and overlap existing between the concepts.  
1.2.3. Health-related QoL 
Because the majority of life domains are related to health, the term health-related 
quality of life ‘HRQoL’ is used to differentiate and specify health related issues 
from the general issues of quality of life. The term HRQoL was developed by 
psychological and sociological researchers primarily to help measure the health 
domains that influence an individual’s physical and mental health status (Cella et 
al., 2005). HRQoL as a concept, therefore, is more appropriate in that it can be 
measured within distinct components which can be interpreted separately 
(Kolotkin et al., 2003).  
Both QoL and HRQoL concepts represent patients’ own satisfaction with life and 
can be influenced by how they perceive the physical, mental, and social effects 
of ESRD on their daily living (Griva et al., 2009). This suggests that QoL and 
HRQoL are individualised concepts. That is, ESRD may be considered as an 
irritation for one patient but may be severely frustrating for others (Ferrans, 1996). 
Studies that examined QoL and HRQoL in ESRD patients with different ethnicities 
and religious beliefs found significant differences in their perceptions about 
factors that make up their overall QoL (Guillemin et al., 1993; Hallinen et al., 2009; 
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Hayashino et al., 2009; Abd Elhfeez et al., 2012). Assessing QoL and HRQoL, 
therefore, using measures that are able to capture patients’ individualised 
experiences of health becomes a vital and often required part of health outcomes 
appraisal (Anderson and Burckhardt, 2003).  
Measurement of HRQoL has the potential to provide important additional 
information about the wellbeing of individuals with ESRD which is not readily 
available from the clinical and laboratory assessments currently used to monitor 
patients (Soni et al, 2011). Various measures are used with different languages, 
including Arabic Language, to assess HRQoL and its predictors, such as generic 
and disease-specific instruments. Generic measures are the ones most 
commonly used to evaluate different aspects of HRQoL: physical, psychological 
and social as well as perceived well-being; and disease or condition-specific 
measures which evaluate the particular symptom or condition that might be 
associated with level of QoL.  Measuring such personal and complex theoretical 
concepts, therefore, is difficult, and, as a result, individualised QoL tools were 
developed. These tools allow respondents to nominate the areas of life which are 
most important, rate their level of functioning or satisfaction with each, and 
indicate the relative importance of each to their overall quality of life. However, 
there are very limited studies that have used a combination of generic QoL 
measures, disease-specific measures, and QoL individualised measures. This 
study has considered this gap in assessing QoL. 
1.3. HRQoL and dialysis patients 
The studies that examined HRQoL among ESRD patients revealed that their 
HRQoL is affected due to major physical, mental, and socioeconomic factors. 
Patients affected by ESRD have to receive dialysis for survival on a routine basis 
which creates uncertainty about their future, which may change their perception 
about their self and self-confidence, and sometimes bring about a reversal in 
family roles (George, 1998).  
Functional status, including physical functioning, role functioning, social 
functioning, and mental functioning as a result of disease symptoms and 
treatment regimens, is usually limited in patients with ESRD.  Studies that have 
used physical performance, health, and self-reported measures reported low 
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physical functioning in patients with ESRD (Fidan et al, 2013; Guney et al, 2010; 
and Morsch et al, 2005). Patients engaged in social activities reported better 
HRQoL, whereas social isolation and decreased social interactions were 
associated with worse HRQoL (Kao et al, 2008). This might suggest that patients 
who develop an appropriate adaptive strategy to manage the stress stemming 
from the disease and subsequent HD treatment might able to maintain a better 
QoL (Peruniak, 2008, Skevington, 2009, Welsch, 2009).  
Co-morbidities such as malnutrition, anaemia, and congestive heart failure (CHF) 
are strongly associated with HRQoL in individuals with ESRD.  Hypoalbuminemia 
(albumin <35g/L) influenced physical composite summary negatively by affecting 
physical functioning and general health and emotional well-being (Laws et al, 
2000). Anaemia has also been shown to impact on HRQoL in persons with 
ESRD. Anaemia severity (haematocrit <33%) is associated with poor physical 
function, whereas the effect on social function was modest. A pre-existing 
myocardial infarction was the most common observed predictor of decline in 
HRQoL influencing physical role-functioning, general health and emotional role-
functioning. Similarly, a history of congestive heart failure (CHF) was associated 
with decline of HRQoL in ESRD patients (Mujais et al, 2009). 
Demographic factors, such as gender, age, socioeconomic status, and marital 
status, correlate with HRQoL in ESRD patients. Female patients on HD 
consistently reported worse HRQoL when compared to men (Loos, 2003; Mujais 
et al, 2009; Fidan, 2013). They had lower scores for physical functioning, 
emotional well-being, social function, and increased fatigue. Elderly patients also 
reported lower HRQoL in most of the HRQoL measures, particularly on physical 
functioning. Employment and marital status were associated positively with score 
of QoL and HRQoL (Oren and Enc, 2013). Patients who were employed and were 
married or had a marriage-like relationship had higher mental health (Bohlke et 
al, 2008). Similarly, patients who had a higher level of education associated with 
better HRQoL (Fagerlind et al., 2010; Mellon et al., 2013). 
Healthcare providers including nephrologists and nephrology nurses are 
encouraged to deal with patients from various ethnicities and cultures and Oman 
is one of the countries that promotes the teaching of culturally safe practice and 
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meeting an individual’s needs for health care services on an equality basis (Oman 
Vision 2050 report). Nephrologists and nephrology nurses are the centre of care 
for ESRD patients, thus they should utilise cross cultural knowledge and culturally 
sensitive skills in providing and maximising good patient care outcomes. ESRD 
patients are close to the nephrology healthcare team because they spend around 
15 hours each week in dialysis units attending dialysis session. Thus, the 
healthcare providers need to understand that HRQoL is important in improving 
renal care services. In Oman as in other countries, nephrology nurses should 
focus on the development and application of clear concepts that that look into 
psychosocial aspects of care, like emotional status, and social involvement. 
1.4. Overview of Oman and dialysis services 
The Sultanate of Oman is located in the south-eastern corner of the Arabian 
Peninsula. The total area of the Sultanate is around 309.5 thousand square 
kilometres. According to the census and information centre (2017), the population 
of the Sultanate was around 3 million by end of March 2017. The Omani 
population is relatively young of which 12% and 34% of the population are under 
5 years and under 15 years, respectively; and only 3.8% are 60 years and above. 
The sex ratio is 102 males per 100 females; and the singulate mean age at first 
marriage is 25 years for females and 28 years for males (census and information 
centre, 2017).  
Oman has witnessed significant development over the past thirty years to 
become one of the wealthy countries in the Arab Gulf area. Health services have 
improved accordingly, including services for patients with chronic renal failure. 
However, this dramatic improvement in economic status has been accompanied 
by changes in the lifestyle of the Omanis which are assumed to contribute to 
increasing the incidence of ESRD. This dramatic change in lifestyle has 
challenged the healthcare system in Oman to meet the increase in non-
communicable diseases. Although no accurate figures of the prevalence of ESRD 
in Oman are available, the causes of renal failure are still mostly uncertain but 
assumed to be due to diabetes, hypertension, and chronic glomerulonephritis, 
since many cases present at an advanced stage. Diabetes mellitus in itself is 
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responsible for 14.5% of the causes of renal failure in this population (National 
Health Report, Oman, 2016).  
The delivery of treatment for ESRD presents significant costs and ethical 
challenges in all countries including Oman. The national dialysis services in 
Oman have expanded between 1985 and 2017 to include an additional private 
sector dialysis unit to meet the demands for dialysis treatment. Figure 1.1 shows 
the population of each region in Oman and numbers of patients on dialysis. Since 
the health services in Oman are provided by the national health system, the 
services for citizens with renal failure are fully paid for by the government. Despite 
the expansion of dialysis services of HD and peritoneal dialysis, kidney 
transplantation is limited within Oman, which could be a factor that may challenge 
the sustainability of the health services.  
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Figure 1. 1 Total population of Omani and number of ESRD patients per regions 
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1.5. Justification and study relevance to clinical and policy change 
The interaction between symptom burden, physical, psychological and socio-
demographical factors is important in understanding HRQoL in ESRD. The 
majority of studies that assessed QoL of patients with ESRD mainly focused on 
health-related QoL, and no studies were found which comprehensively assessed 
biological function, symptoms, functional status, general health perceptions, and 
various characteristics of the individuals and their environment.  Even with studies 
that used more than one measure of QoL, the researchers did not articulate a 
holistic conceptual framework to guide their study, thus limiting the independent 
variables used to explain QoL.  In addition, most studies were conducted within 
Western culture, with only two found that examined QoL and HRQoL aspects in 
ESRD patients in the Arab world. The results of these studies showed a low 
HRQoL among Arab patients with ESRD, with a significant score variation evident 
within the different subdomains of HRQoL that were assessed. As in other Arab 
countries, no studies were found that had been conducted in Oman to assess 
QoL in this group of patients, or on how these patients perceived their QoL.  As 
a result, this study is needed to fill these gaps in knowledge. 
The results of this PhD can create an evidence base upon which future health 
care services can be developed within the nephrology care services in Oman. 
Identifying the factors that impact the level of QoL and HRQoL in this group of 
the population can help to design new strategies to improve their HRQoL in 
relation to: clinical factors, psychological issues, physical functioning, social 
support, symptom burden, and spiritual factors. It can, also, promote the use of 
HRQoL measures in clinical practice to monitor the patients’ condition and 
associated symptoms such as fatigue and pain. 
Validating the HRQoL measures in an Omani population will benefit clinical 
practice as it is likely to provide clinicians with specific validated tools to assess 
their patients which can greatly improve the integration of HRQoL data into 
clinical practice. A major benefit to integrating these measures into routine clinical 
practice is the potential for identifying symptoms and problems that may result in 
improved patient care and clinical outcomes over time. 
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This study will significantly contribute to the knowledge of understanding the 
issues around HRQoL among cultures. It will influence the nephrology services 
in Oman and help clinicians in developing intervention plans based on a holistic 
view of physical and psychosocial views. It is also anticipated to facilitate the 
understanding of the renal failure patients’ perceptions about their disease, which 
can be then tailored into their intervention plans. 
Assessing the perceptions of this patient group in Oman, using multi measures 
including an individualised QoL measure, would help to identify their predictors 
and measures so that they can be tackled to improve patients’ HRQoL; and 
support the shift of healthcare services from episodic treatment to a treatment 
that meets their ongoing needs. The intervention model suggested by this study 
will be presented to those making healthcare decisions, relevant stakeholders, 
and those providing nephrology services in Oman. This is in line with the aim of 
the long-term healthcare plan ‘Health Vision 2050’ developed by the Omani 
Ministry of Health which emphasises that quality of health is one of its target 
priorities (Al Mawali et al., 2017).  
1.6. Study Purpose, specific aims, and research questions   
The purpose of this PhD is to describe the QoL in Omani patients with ESRD and 
identify factors that predict their QoL and HRQoL.  
1.6.1. Study specific aims  
The specific aims of this study are: 
1. To explore the meaning of ‘QoL’ to an Omani population 
2. To assess the QoL and HRQoL perceptions of Omani patients with 
ESRD 
3. To explore and identify factors that predict QoL/HRQoL in this patient 
group 
4. To test the validity and reliability of common QoL and HRQoL measures 
within Omani population 
5. To test the practicality and feasibility of using the Revised Wilson and 
Clearly HRQoL model to explore factors associated with HRQOL within 
Omani patients with ESRD. 
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1.6.2. Study Questions 
1. What does QoL/HRQoL mean to an Omani population? 
2. What is the level of QoL/HRQoL for patients with ESRD on HD in Oman? 
3. To what extent do the following factors predict QoL/HRQoL in Omani patients 
with ESRD?  
a) Individual characteristics (age, gender, educational status, income, 
region, and marital status) measured by demographic. 
b) Treatment characteristics (duration of dialysis, dialysis adequacy, and 
length of time to get to dialysis) measured by clinical data 
c) Socio-environmental factors (family support, socio-economic, religious 
and spiritual), measured by disease-specific and generic instruments. 
d) Biological function (anaemia and malnutrition) measured by clinical data 
such as serum albumin, haematocrit and serum Hb 
e) Symptoms (fatigue, pain, mood, pruritus), measured by symptom-
specific instruments. 
f) Functional status and general health perceptions, measured by health 
status-instruments. 
3. What are the psychometric properties of the study measures in an Omani 
context in relation to its validity and reliability? 
4. What intervention model can be recommended for augmenting QoL and 
HRQoL for Omani patients with ESRD based on the study results?  
1.7. List of Definitions 
The following terms are defined for the purpose of this study: 
- Patient with end stage renal disease (ESRD):  the patient who has been 
diagnosed by a nephrologist to have the last stage of renal diseases and 
require renal replacement therapy. For this study, only patients with ESRD 
and on HD were included in the study. 
- Haemodialysis: A medical procedure in which the blood is cleaned outside 
the body using an artificial kidney or filter using a machine named a 
dialysis machine. Each dialysis session lasts for three to five hours, and 
sessions are usually needed three times a week. 
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- Dialysis hours: the amount of time of each HD session in hours. 
- Dialysis duration: the amount of time in years that patient has been on 
dialysis. 
- Time to reach dialysis: the amount of time in minutes required by the 
dialysis patient to reach dialysis unit for routine HD. 
- Urea reduction rate (URR): A lab test that compares the amount of blood 
urea nitrogen before and after haemodialysis to measure the effectiveness 
of the haemodialysis dose. 
- Dialysis adequacy: a measure, commonly expressed as a percentage, of 
how effectively a dialysis treatment removed urea from blood. According 
to the Kidney Disease Outcomes Quality Initiative (DOQI), the standard of 
adequate dialysis is a minimum of URR 65%. 
- Spiritual wellbeing: refers to the affirmation of an individual’s life in relation 
to God, self and community (Johnson et al., 2007). It falls very much in line 
with one’s personal values, standards of conduct and the spiritual beliefs 
that shape one’s life. The emphasis of this domain is on the importance of 
spiritual well-being as a dimension that may help to organise an 
individual’s values to maintain a better QoL.   
- Quality of Life (QoL): ‘A person’s sense of well-being that stems from 
satisfaction or dissatisfaction with the areas of life that are important to 
him/ her’ (Ferrans et al., 2005). 
- Health-related quality of life: refers to the subjective perception of the 
impact of an illness or its treatment on one’s health and QoL. 
- Kidney Disease Outcomes Quality Initiation (KDOQI): a recognised 
evidence-based clinical practice guideline for kidney disease and related 
complications produced by the National Kidney Foundation, USA. 
- University Research Ethics Committee (UREC): the responsible 
committee at University of Dundee for approving and monitoring 
research projects. 
- Research and Ethical Review & Approve Committee of Ministry of Health, 
Oman: the central committee at Ministry of Health, Oman, which is 
responsible for reviewing, approving, and monitoring research proposals 
and projects. 
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1.8. Assumptions 
A number of assumptions underlie the methods used in this study. First, the 
concept of QoL is a multidimensional construct. Second, the abstracts and 
concepts that are unobservable, for instance, symptom burden and health 
perception, can be assessed by specific-related measures and statistical 
analysis. This assumption addresses the belief that patients with ESRD will 
respond to study measures that assess symptom burden, functional status, 
general health perception, QoL, and individual and environmental characteristics 
in accurate and honest answers. Lastly, obtained clinical and medical data reflect 
reality. 
1.9. Thesis Outline 
 
Chapter 1- Introduction and overview 
Introduces the nature, severity and prevalence of ESRD, and its subsequent 
consequence on patients’ lives.  The chapter discusses also the rationale for the 
study focus of QoL in this patient group, presents a list of definitions of the terms 
used in this study, and will finish with a summary of the study aims and research 
questions. 
Chapter 2- Definitions and Conceptualisation of QoL and HRQoL (Literature 
Review One) 
 
It presents the narrative review that was conducted to analyse the conceptual 
and theoretical issues associated with QoL in general as well as the related 
concept of HRQoL and its measurement, which, in turn, informed the necessary 
review that was undertaken in the next stage of this study. The search questions 
formulated to guide this review, search strategy used to identify the relevant 
literature, data search results, quality of revealed literature, and characteristics 
of reviewed literature will be presented, respectively, under a section of 
‘literature review and selection of relevant articles’. The ‘discussion’ section of 
this chapter examines the definitions of QoL and HRQoL, conceptual and 
theoretical factors associated with QoL and HRQoL, common approaches to 
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measurement of QoL and HRQoL, and critique of the conceptualisation of QoL. 
Finally, a conclusion and recommendations were drawn to inform the next review 
(chapter 3). 
 
Chapter 3- QoL and HRQoL in patients undergoing haemodialysis (Literature 
Review Two) 
 
This chapter contributes to building up the understanding of QoL and HRQoL in 
ESRD patients. The search questions formulated to guide this review, search 
strategy used to identify the relevant literature, data search results, quality of 
revealed literature, and characteristics of reviewed literature were presented, 
respectively, under the section of literature review and selection of relevant 
articles. The ‘discussion’ section examines the factors and predictors of HRQoL 
in ESRD patients; common measures of QoL and HRQoL in ESRD; and the 
psychometric properties of the identified measures. Finally, a summary was 
drawn to inform the chapter of empirical work of this PhD. 
 
Chapter 4- Methodology 
The methodology chapter presents justification for the philosophical paradigm, 
the methodological approach and details of the theoretical framework that are 
adopted in this study for the three phases to answer the proposed research 
questions. It also justifies the use of the research design, the population and 
sampling, and clinical settings; as well as an overview of the three study phases 
in relation to procedures for data collection, recruitment strategy, ethical 
approval process and ethical consideration, and data analysis strategies.  
 
Chapter 5– Testing the concept of QoL and measures assessing HRQoL in 
Omani ESRD patients. 
This chapter critically discusses and justifies the approach used to answer the 
research question-1 (What does QoL/HRQoL mean to an Omani population?). 
The ‘method’ section presents the details of the two methods which were used 
to validate and check the understanding of the concept of QoL and HRQoL in an 
17 
 
Omani context. Ethical approval, sampling and recruiting strategies were 
implemented for both methods and the results are discussed under this section. 
Finally, the discussion and recommendations related to this stage were 
discussed at the end of the chapter to inform the pilot study and the survey 
phase. 
 
Chapter 6- Health-related QoL of Omani patients with ESRD: a pilot study. 
 
This chapter critically discusses and justifies the pilot study that was conducted 
to test the feasibility of recruiting research assistants (nephrology nurses) to help 
in recruiting patients and administering study measures; develop and test the 
response rate; and 6) develop and test the proposed analytical syntax. The 
chapter is presented in a format that includes the method utilised, findings, 
discussion of the findings, and, finally, recommendations that were drawn to 
inform the main study 
 
Chapter 7- Exploratory and confirmatory factor analysis of the Arabic version 
SF36v2 and HADS within an Omani context. 
 
This chapter answers the research question–What are the psychometric 
properties of the study measures in an Omani context in relation to its validity 
and reliability?–by evaluating the psychometric properties of the Short Form- 
36v2 (SF36v2) and Hospital Anxiety Depression (HADS) measures within the 
Omani context. The methods, in details, that were used in conducting the factor 
analysis were discussed under relevant measure. Likewise, main findings were 
identified, and discussion of main findings presented under relevant sections. 
Finally, a conclusion and recommendation were drawn to inform the analysis of 
the main study 
 
Chapter 8- Main study results. 
This chapter presents the results from the cross-sectional survey (main study) 
analysis. It answers research RQ2 and RQ4 by presenting the details related to 
the response rate, level of missing data, and description of the characteristics of 
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the participants. It also presents the findings from the scores of study measures 
and their subscales scores; findings from the comparisons of the independent 
variables and the total scores. The results of the degree of association and 
regression analyses were presented according to the study outcomes. 
Chapter-9 Discussion and recommendations 
 
This chapter critically discusses the key findings of the PhD according to the 
research questions. The chapter also discusses the strengths and limitations of 
the study, the recommendations for future research that might be conducted in 
this area; and recommendations for practice and future research. 
1.10. Summary 
The aim of this study was to explore QoL and HRQoL and its predicting factors 
in patients with ESRD in an Omani context. The revised version of Wilson and 
Cleary’s Model for HRQoL (Ferrans et al., 2005) was used to guide this study. It 
is anticipated that the results of this study will inform the health care strategies of 
MoH, the 2050 vision in particular, to allocate necessary resources and future 
plans related to providing nephrology services. It will also assist nephrologists, 
nephrology nurses, and researchers in Oman to begin a research trajectory of 
evaluating QoL and HRQoL and to determine intervention plans to enhance it by 
targeting influencing factors. 
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Chapter-2: Conceptual and Theoretical Issues Associated with 
Quality of Life: Literature review-one 
Background: Quality of life (QoL) and health-related quality of life (HRQoL) are 
multidimensional concepts. Several tools have been developed to measure these 
concepts. The aim of this narrative review is to gain a general understanding 
about QoL concepts, track its theoretical development, and identify the theoretical 
framework underpinning the concept. 
Method: SCOPUS, Cochrane Library, ProQuest (ASSIA) and EBSCO (CINAHL 
and Medline) were the main databases searched. Secondary internet resources 
(ScienceDirect and PubMed), and non-electronically published relevant articles 
were also searched. English was the only language used in the search. Joined 
and separate keywords were used to find the published literature that discussed 
QoL generally across all disciplines. 
Result: A total of 85 articles met the inclusion criteria: 27 empirical studies and 
58 discussion articles (7 HRQoL, 18 concept analyses, 21 QoL definitions and 12 
papers were related to different factors of QoL and HRQoL). No standard 
definition was provided for the concepts of QoL and HRQoL. The QoL concept 
was best described by the WHO definition. Possible factors that might influence 
QoL definitions are the different use of the term “QoL” at a multidisciplinary level 
and the ambiguity of which aspects of life are more important in determining QoL. 
Five substantial areas were identified which related to the concepts of QoL and 
HRQoL: physical wellbeing, psychological wellbeing, spiritual wellbeing, cognitive 
wellbeing and social-environmental wellbeing. Three main approaches are being 
used to assess QoL and HRQoL: generic, disease-specific and individualised 
measurement measures.  
Recommendations: to use the WHO definition of QoL as well as the Revised 
Wilson and Clarey model of HRQoL by Ferrans et al. (2005) to guide this PhD 
project. Individualised QoL instrument and cognitive debriefing method can be 
used to explore the meaning of QoL and test the readability of HRQoL measures 
within the Omani population.  
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1. Introduction 
Patients affected by the end-stage renal disease (ESRD) might experience 
deteriorated quality of life due to the imposed limitations in most of life domains. 
Dialysis procedure may also impose changes in their normal way of living 
because it requires recurrent dialysis unit visits, usually three times a week. As a 
result, advancement in medical sciences, for instance, advances in diagnostic 
procedures, treatments, medications, surgical procedures and primary health 
care services traditionally have been directed towards improving patients’ overall 
health and increased their life expectancy. However, simply increasing life 
expectancy without considering a good quality of life might not be sufficient. 
Considering and assessing quality of life of patients affected by ESRD can be a 
predictive indicator of the outcome of the disease as well as a valuable research 
tool in assessing the effectiveness of therapeutic intervention, patients’ survival 
and hospitalisations. 
The term ‘QoL’, however, is a multi-dimensional concept and can have several 
meanings (Sousa et al., 2006) since several factors related to social and 
economic aspects must be taken into account when attempting to define the 
concept of QoL (Kao et al., 2009). Several definitions are available in current 
literature that define the concept of QoL.  Generally, the term “QoL” refers to a 
wide range of individual experiences related to the individual’s overall wellbeing 
(Revicki et al., 2000). With the existing numerous definitions of QoL, researchers, 
and clinicians, need to be clear about the conceptual definition of QoL so as not 
to confuse it with the disease process and complications or with treatment side-
effects. As with the definitions of QoL, several tools have been developed to 
measure QoL. Most of these tools, however, as Fayers et al. (1997) say, are 
causal indicators of QoL rather than QoL itself.  
To narrow and focus on the concept of QoL, the term HRQoL evolved to reflect 
the value of health states. HRQoL is determined by the manner in which changes 
in health and treatment-related symptoms affect the dimensions of one’s well-
being (Huber, Sillick et al. 2010). This description might indicate that HRQoL is 
entirely constructed by a patient’s individual perceptions and that others cannot 
make judgments about what is best for the patient. Patient perceptions about QoL 
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have been found to have poor correlation with, and wide discrepancies between, 
practitioners’ assessments (Krethong, Jirapaet et al. 2008). Health providers tend 
to overestimate or underestimate the effects of symptoms on a patient’s QoL. 
Although care providers believe that they know what patients want, patients’ 
feelings, preferences and perceptions cannot be assumed (Painter, Krasnoff et 
al. 2012).  
Despite the extensive research carried out in trying to conceptualise and 
operationalise QoL and HRQoL, these concepts remain ambiguous. That may be 
because the concept of HRQoL overlaps with the terms QoL and health concept. 
It is crucial therefore to have a clear definition of QoL and HRQoL prior to 
exploring and measuring the factors that could worsen the QoL and HRQoL of 
patients with ESRD. The aim of this narrative review, therefore, is to analyse the 
conceptual and theoretical issues associated with QoL in general as well as the 
related concept of HRQoL and its measurement, which, in turn, informed the 
focused review related to QoL and HRQoL of patients with ESRD, undertaken in 
the next chapter of this research. 
2. Method 
The method section highlights the strategy used to search for relevant literature 
concerning issues around QoL and HRQoL conceptualisation. It was performed 
by formulating focused search questions, inclusion and exclusion criteria, 
keywords, and finally a search in the appropriate databases. 
2.1. Search questions 
The following are the questions that were formulated prior to conducting the 
search for relevant articles containing evidence related to the conceptualisation 
of QoL and HRQoL: 
1. What are QoL and HRQoL? 
2. How are QoL and HRQoL defined? 
3. What concepts are related to QoL and HRQoL? 
4. What is the relation between QoL and health? 
5. How are QoL and HRQoL assessed? 
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2.2. Search strategy 
The search for articles relevant to this review was initiated by a comprehensive 
search using four electronic literature databases [SCOPUS, Cochran Library, 
ProQuest (ASSIA) and EBSCO (CINAHL and Medline)]. The search also covered 
secondary internet resources (ScienceDirect and PubMed), as well as non-
electronically published relevant articles to gain a full view of the relevant 
information published without specific dates. EBSCO, which consists of CINAHL 
and Medline, was the initial database accessed as it is known to contain regularly 
updated evidence-based healthcare literature. For articles not published in an 
electronic format, the University of Dundee Library Catalogue was consulted to 
identify this type of article.   
The literature search was not limited to any specific date in order to obtain the 
most applicable and relevant evidence. English was the only language used in 
the search because of the inability to interpret non-English published articles. All 
searches were conducted in the second half of December 2013 and updated in 
April 2017. 
Joined and separate keywords were used to find the published literature that 
discussed quality of life generally across all disciplines: “Quality of life” – “health-
related quality of life” – “integrative quality of life” – “QOL” or “QoL” – “QoL” or 
“HRQoL definition” – “QoL” or “HRQoL concept” or “HRQoL conceptualisation” – 
“QoL” or “HRQoL theory” – “QoL” or “HRQoL operationalisation” – “well-being”. 
The inclusion and exclusion criteria are summarised in table 2.1.  
Table 2.1.  Inclusion and exclusion criteria 
Inclusion Exclusion 
1. published in English 
2. pertained to QoL and HRQoL 
concepts and theories 
3. included an adult population (>18 
years of age) 
4. were forms of published evidence 
5. were articles with findings derived 
from QoL and HRQoL concepts. 
 
1. did not pertain to the QoL of 
humans 
2. published in a non-English 
language 
3. published as general information, 
dissertations, editorials and clinical 
opinions 
4. included a paediatric population 
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Data were retrieved from empirical studies and discussion articles and were 
extracted using relevant extraction methods. The results of the “empirical studies 
articles” were reported based on a modified data-extraction form suggested by 
the Joanna Briggs Institute (JBI); whereas the results of the “discussion articles” 
were reported on three different themes (QoL definitions, conceptualisation of 
QoL and theoretical factors) in a tabular form based on data-extraction tables 
using criteria suggested by Garrard’s (2007) Matrix Method. The Matrix Method 
is both a structure and a process for systematically reviewing literature. 
Consistent with Garrard’s approach, the review matrix table, a place to record 
notes about papers using columns and rows, provides a standard structure for 
creating order. Each of the “discussion articles” was evaluated in ascending 
alphabetical order, using a structured abstracting form with seven columns: 
author’s name, publication year, country, paper type, paper purpose and context, 
participants (if any) and study findings (Appendix 2.3). The synthesis method 
employed in the Matrix Method is a critical-analysis and review process of the 
literature on a specific topic. Results were then tabulated and presented using 
the following headings: author and year of publication, country, design, sample 
size, outcome measures and key results. 
3. Result  
The inclusive search revealed a total of 4,658 articles. The identified articles were 
screened against titles in order to match inclusion and exclusion criteria, which 
then resulted in the exclusion of 4,144 articles. The remaining 514 articles were 
then checked for duplication using the EndNote X4 reference management 
software programme in which 148 articles were identified as duplicates and were 
excluded. Checking the remaining articles against inclusion and exclusion 
criteria, 193 articles were removed for not meeting inclusion criteria, which left a 
remaining sum of 173 articles to be screened. No articles were included out of 
the manual search of the University of Dundee Library Catalogue (this revealed 
a total of 1,147 different resources: 19 conference papers, two e-books, eight 
textbooks and one dissertation thesis, with the remaining 1,117 being electronic 
resources). Of these, 1,054 did not meet the inclusion criteria and 93 were 
duplicates found in different databases. Figure 2.1 shows the flow of literature 
identified. 
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After excluding duplicate articles and those articles fitting the exclusion criteria 
(Appendix 2.1), two reviewers (the PhD student and the study supervisor) sorted 
out the list of the potential articles (173 articles) for inclusion independently by 
reviewing each article’s title and abstract. The aim was to maintain a rigorous 
selection process and minimise selection bias. A table was created to compare 
the ratings of both reviewers of articles to be included in the review that met the 
inclusion and exclusion criteria. Agreement between reviewers was reached in 
70 articles. Disagreement occurred in 55 articles and on those occasions, a third 
reviewer (study supervisor) reviewed.   This resulted in 85 full-text papers to be 
reviewed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  1 Flow of literature identified through database searching 
Cochran 
Library = 63 
ProQuest (ASSIA) 
= 233 
EBSCO (CINAHL & 
MEDLINE) 
 = 2,061 
SCOPUS = 2,301 
All databases: 4,658 
Abstracts retrieved: 336   
Duplicates and were 
excluded 
N= (148) 
Full-text obtained: 173 
Articles included in the 
review: 85 
Articles excluded after 
application of inclusion 
criteria by two 
reviewers against titles 
and abstracts 
N = (88) 
Articles excluded after 
application of inclusion 
criteria against titles by 
the principal reviewer  
N = (4,144) 
Articles were removed for 
not meeting inclusion 
criteria N= (193) 
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3.1. Summary of search and quality appraisal of articles 
A final total of 85 articles met the inclusion criteria and are included in this 
narrative review: 27 empirical studies and 58 discussion articles (seven HRQoL; 
18 concept analyses; 21 QoL definitions; and 12 papers related to different 
factors of QoL and HRQoL). The quality of the “empirical study papers” was 
assessed using the quality appraisal forms of the Critical Appraisal Skills 
Programme (CASP) criteria; and for “discussion articles”, the Joanna Briggs 
Institute (JBI) critical appraisal checklist was used (Appendix 2.2). 
Figure 2. 1  Example of data extraction 
Author Country 
Methodology 
Results 
Design 
Size and 
characteristics 
of sample 
Measure 
Abdel-
Kader et 
al (2009) 
USA 
Cross-sectional 
design 
151 patients 
undergoing 
peritoneal or 
haemo-dialysis. 
SEiQoL-
DW 
Family and health were 
the most common 
domain for patients. No 
significant differences in 
SEiQoL-DW scores 
between subgroups.  
SEiQoL-DW scores 
correlated mental 
wellbeing (r= -.22, p 
<0.010). 
Bailey et 
al (2007) 
USA Cross-sectional 
332 psychology 
and business 
students from 
Baylor 
University. 
Trait Hope 
Scale and 
Quality of 
life 
Inventory 
(QoLI) 
The internal reliabilities 
of both scales were 
above 0.70. Alphas for 
the scales were: Hope 
scale = 0.79 and QoLI = 
0.73. 
Fagerlind 
et al 
(2009) 
Sweden 
Phenomenographic 
qualitative design 
Semi structured 
interviews of 22 
patients with 
rheumatoid 
arthritis. 
Interviews 
analysed 
by using 
QSR 
NUD*IST 
VIVO 
Two concepts, “being 
healthy” and “being 
able to function 
normally”, overlapped 
with respondents’ 
understanding of QoL. 
Garratt et 
al (1993) 
UK 
Observational 
study, postal 
questionnaire to 
check if SF36 is a 
suitable measure 
for routine use 
within the NHS. 
1,700 patients 
with one of four 
conditions (low 
back pain, 
menorrhagia, 
suspected 
peptic ulcer, 
varicose veins). 
SF36 
The SF36 satisfied 
rigorous psychometric 
criteria for validity and 
internal consistency.  
Internal consistency 
(0.55-0.78). 
Validity (factor analysis 
identified five relevant 
factors with eigenvalues 
12.8 to 1.3) 
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3.2. Characteristics of reviewed articles 
The 85 articles included in this review addressed the both concepts of QoL and 
HRQoL as the main outcomes. The publishing period was from 1990 (Hoernquist 
J, 1990) until 2016 (Ravenek et al, 2014). Thirty-two papers were published ≤ 
2000, and 53 were published after 2000. Only one study assessed QoL in the 
Arab world (Abdel-Kader et al, 2009) and the rest were: Europe, 32 papers; USA, 
31; Canada, 10; and Asia, six papers. A summary of the empirical studies results 
are shown in Appendix 2.3. 
For discussion articles, the purpose was clearly reported in the introduction 
section of each article. Two articles (Koller et al, 2005; Carr et al, 2001) did not 
clearly report the title and field of expertise of the authors, whereas the rest of the 
articles clearly indicated the author’s background and field of expertise, all of 
which were relevant to the particular areas of studying QoL throughout the 
various fields. Patients were the central focus of the discussion of these articles. 
However, Hass et al (1999), Meeberg (1992), George and Bearon (1980), Gladis 
et al (1999) and Vitterso J (2003) all provided a general discussion around the 
concept of QoL without any focus on a particular group of individuals. The 
arguments and discussion around the concepts of QoL and HRQoL and the 
underpinning factors were developed analytically and supported by relevant 
references in all the articles included in this review. 
The majority of the 27 studies involved common features for quality research 
including: detailed reporting on study aims; participant demographics and 
contexts; study design; analytic methods; and a precise description of study 
procedures. However, only three articles explicitly reported the use of a QoL 
conceptual framework (Koller et al, 2005; Krethong et al, 2008; Sousa and Kwok, 
2006). With regard to study design, one study had a longitudinal design (Rudolf 
and Priebe, 1999) and the rest used cross-sectional design. As the majority of 
studies were cross-sectional in design, it is difficult to make causal inference with 
factors that might contribute to the outcome over time because, in this case, data 
are collected only at one point in time. Also, when data are collected at one point 
in time, differing results might have been found if another point in time had been 
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chosen (Bland, 2001). Such methodological limitations in cross-sectional design 
might affect the generalisability of the results of the studies.  
3.3. SQ1:  What are QoL and HRQoL? 
Tracking the meaning of QoL and HRQoL, it was notable that these two terms 
are used interchangeably in literature.  Despite this, it can be observed that each 
term has its own meaning. The term ‘QoL’ can be seen as a broader concept that 
covers all aspects of life; whereas ‘HRQoL’ is a concept that focuses on the 
effects which disease and its related treatment may have on QoL. QoL is 
therefore is broader than HRQoL because it includes evaluation of non-health 
related features of life whereas HRQoL is connected to a patient’s health or 
disease status. The term “HRQoL”, therefore, is determined by the manner in 
which changes in health- and treatment-related symptoms affect the dimensions 
of a patient’s well-being (Huber, Sillick et al, 2010). Hence, it can be argued that 
QoL and HRQoL are two distinct but related constructs. 
The WHO definition of QoL has been found to be consistent with studies that 
explore the factors comprising QoL, such as physical health, psychological state 
and socio-environmental factors (Testa et al., 1996; Oort et al., 2005; Brush et 
al., 2011). Currently, there is broad agreement that the concept of positive health 
is more than the absence of disease or even disability, but is about having a fully 
functioning efficiency of mind and body and social adjustment (Kaasa and Loge, 
2003; Fleck et al, 2011). Health-related QoL, in turn, is the more appropriate term 
to be used when describing and assessing the concept of QoL within patients 
with chronic health issues. That is because it encompasses a broad, 
multidimensional concept that usually includes self-reported measures of 
physical and mental health (Debout, 2011). Nonetheless, there is no standard 
definition available for the term “HRQoL”, the common agreement across the 
literature being that it is the functional effect of an illness status and/or its 
consequent therapy on a patient and the encompassing physical and 
psychological status (Cella, 1995; Guyatt et al., 1993; Fagerlind et al., 2010; 
Dyess, 2011). 
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3.4. SQ2: How are QoL and HRQoL defined? 
Despite several definitions existing that define both concepts, QoL and HRQoL, 
no consensus on one standard definition was identified. Different approaches can 
be found that refer to the meaning of QoL and HRQoL. These approaches are 
based on an individual’s needs (Huber et al., 2010), subjective wellbeing 
(Kitayama and Markus, 2000), expectations and phenomenological viewpoints 
(Johnson et al., 2007).  
In the literature, a number of factors can be identified that might contribute 
towards influencing the definition of QoL. First, the different use of the term “QoL” 
at a multidisciplinary level has led to a multitude of definitions that reflect the 
biases of each discipline (Hajiran 2006). For instance, healthcare researchers 
focus on issues pertaining to quality and healthcare outcomes, while economics 
researchers interested in measuring QoL focus on issues related to QoL and cost 
per quantum. Ambient cultural setting is a second factor that might be considered 
as influencing QoL definition (Bergland and Narum, 2007). The differences in 
cultural settings may depend on factors such as age, gender, social class and 
generation. For example, a study that examined racial and ethnic differences in 
the QoL of cancer patients suggested specific differences in symptomology 
across cultures (Rao, Debb et al., 2008). Third, a statement of the operational 
definitions of QoL might also have an influence on understanding the concept of 
QoL. Operational definitions provide meaning to any concept by describing the 
operations required to assess that concept (Fink, 2009).  
Another possible factor which reflects the difficulty in providing a universal 
definition of QoL is the decision about which particular aspects of life are more 
important in determining QoL and how these aspects should be measured (Read, 
Quinn et al, 1987). Definitions of QoL might provide different meanings with 
different constructions of that meaning between individuals (Rosenberg, 1995). 
Regardless of the commonly used aspects of life in measuring QoL, the selection 
of items to represent aspects identified by any one researcher does not always 
ensure their relevance to individuals (Antaki and Raply, 1996). The choice of 
aspects of life raises concerns that might significantly affect the value of data 
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obtained from participants. Thus, whatever instrument is used to assess QoL it 
should include different aspects of life including health. 
Despite these possible factors that might contribute to defining QoL, the common 
agreement between all the definitions of QoL is that it is a subjective term and 
depends on one’s present and past experiences and on one’s dreams and 
ambitions (Bonner et al., 2013; Camfield and Skevington, 2008).  Since QoL 
depends on a person’s perceptions and experiences of life, it should be 
considered to be dynamic, changing and constantly developing as new 
knowledge and a range of different experiences are gained (Pastrana, Juenger 
et al, 2008). That is, the timing of QoL measurement might influence an 
individual’s levels of QoL. Happy moments usually stimulate individuals to 
express a positive life satisfaction and, in contrast, sad moments might reflect 
dissatisfaction with life. Patients affected by chronic conditions, such as ESRD, 
pain and long-life treatment procedures, might not be able to provide one exact 
meaning of the definition of QoL as their perception may change according to the 
disease status. 
Because the majority of life domains are related to health, the term “HRQoL” is 
used to specify health-related issues and to differentiate them from general 
issues of quality of life. Perhaps the World Health Organisation (WHO, 1995) can 
be seen as providing an inclusive definition of HRQoL. It is about “an individual’s 
perception of their position in life in the context of the culture and value systems 
in which they live and in relation to their goals, expectations, standards and 
concerns; it is a broad ranging concept affected in a complex way by the person's 
physical health, psychological state, personal beliefs, social relationships and 
their relationship to salient features of their environment” (The WHO QoL Group, 
1995). This definition goes beyond the direct measure of health and refers to a 
multidimensional concept that includes aspects of life related to physical, 
psychological and social functioning. 
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Figure 2. 2 Examples of structured definitions of QoL   
Examples of QoL and HRQoL definitions 
“Quality of life is a feeling of overall life satisfaction, as determined by the mentally alert individual 
whose life is being evaluated. Other people, preferably those from outside that person’s living 
situation, must also agree that the individual’s living conditions are not life-threatening and are 
adequate in meeting that individual’s basic needs”. (Meeberg, 1993, p. 37). 
“… the degree of satisfaction or dissatisfaction felt by people with various aspects of their lives”. 
(Bond et al., 2004, p. 4). 
“… a person’s sense of well-being that stems from satisfaction or dissatisfaction with the areas 
of life that are important to him/her”. (Ferrans, 1990, p. 33). 
“'Quality of life' and more specifically, 'health-related quality of life' refer to the physical, 
psychological, and social domains of health, seen as distinct areas that are influenced by a 
person's experiences, beliefs, expectations and perceptions (which we refer to here collectively 
as 'perceptions of health'). Each of these domains can be measured in two dimensions: objective 
assessments of functioning or health status, and more subjective perceptions of health." (Testa 
et al., 1996, p. 835). 
“QoL is seen, in relation to health, as ‘a positive state, a desirable outcome of healthcare 
interventions’.” (Holmes, 2005, p 496). 
“… an individual’s perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and concerns. 
It is a broad ranging concept affected in a complex way by the person's physical health, 
psychological state, personal beliefs, social relationships and their relationship to salient 
features of their environment.” (The WHO QoL Group, 1995).  
“… quality of life should be defined as what the individual determines it to be.” (O'Boyle, 1997, 
p. 1875) 
 
3.5. SQ3: What concepts are related to QoL and HRQoL? 
There is a substantial overlap between the concepts of QoL and HRQoL 
throughout the literature. Five areas were identified to correlate the concepts of 
QoL and HRQoL, though mainly related to HRQoL. These areas were grouped 
under relevant aspects of life and are shown in Table 2.4. For purposes of clarity, 
the term “aspects of life” refers to the set of factors that combine to determine the 
related concepts of QoL and HRQoL. These aspects are: physical wellbeing, 
psychological wellbeing, spiritual wellbeing, cognitive wellbeing and social-
environmental wellbeing. The results of the articles analysed QoL concept are 
shown in Appendix 2.4. 
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Table 2.2. Reported conceptual and theoretical factors associated with QoL under relevant 
aspects (n= 85 articles) 
QoL aspects and related factors 
Physical well-
being 
Psychological 
well-being 
Cognitive well-
being 
Spiritual well-being  
Socio-
environmental 
well-being 
-Illness and 
disability 
-Physical fitness 
-Accessibility of 
service 
-Emotional/ 
mental health 
-Coping 
abilities 
-Life 
acceptance 
-Achievement 
of personal 
goals 
-Autonomy/ 
independence 
-Thinking 
process 
-Management 
skills 
-Problem-
solving 
skills/decision-
making 
-Personal values 
-Personal beliefs 
-Sense of life 
purpose 
-Sense of 
wholeness 
-Socio-economic 
factors 
-Social 
relationships 
-Housing 
conditions 
-Privacy/ 
confidentiality 
-Safety 
 
Physical wellbeing is one of the main determinants of HRQoL (Tsilika et al., 1999; 
McKevitt et al, 2003; Chang et al, 2005; Brutt et al., 2008). The importance of 
physical wellbeing as a determinant of HRQoL was highlighted by most of the 
measures of health status which considered physical health as a predictor of 
HRQoL (Hall, Krahn et al., 2011). However, physical functioning and functional 
status are terms that are used interchangeably in studies that also examine QoL. 
Liedy (1994) provided a basic definition of functional status as “the ability to 
perform normal daily activities to meet basic needs and maintain health including 
physical health” (page 66). It might be difficult to determine if the state of health 
has been achieved solely by a patient’s ability to carry out daily life activities. 
Understanding the effects of patients’ health conditions on their ability to perform 
basic tasks and participate in life situations could help in improving their HRQoL. 
Psychological well-being is the second concept found to be related to HRQoL. 
Psychological well-being is a comprehensive term for different personal aspects, 
including emotional and mental health and general well-being (Peruniak 2008, 
Skevington 2009, Welsch, 2009). Individuals with a high ability to face and 
manage life stresses, and a high experience of this, are able to maintain a better 
HRQoL (Ramirez et al., 2012a). These components of psychological well-being 
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interact with stressful life situations including disease status. Siegrist (2001) 
argued that individuals depend on their ability to identify and draw upon internal 
and external resources to face up to their needs, for instance informational and 
emotional support, which, consequently, might improve their HRQoL. 
Despite the high emphasis on psychological factors associated with HRQoL, 
particularly within a health context (Debout, 2011), there is a need to view each 
patient as a unique individual and to treat them based on an individualised plan 
(Mitchell 1990; Lopez, Eng et al, 2005). Certainly, each individual is unique and 
has unquestionable value. The behavioural changes occurring within the 
individual who has been diagnosed with a long-term illness, for instance ESRD, 
might alter that patient’s behavioural and cognitive process (Barclay-Goddard, 
2012; Oort et al., 2005). This change could be the result of the internal standards, 
values and conceptualisation of HRQoL which that patient develops to 
accommodate the new health status. 
This view, however, should not overlook the fact that individuals cannot function 
separately from their socio-environmental interaction, which means that all 
individuals’ lives are interdependent and interconnected. To assess the balance 
between interpersonal issues and external factors, a comprehensive framework 
is required which does not exist at present (Chwalisz, 2008; Giordano, Björk et 
al, 2012; Eckersley, 2013).   
Cognitive wellbeing was the third important determinant for HRQoL (Downie, 
2000; Hendry and McVittie, 2004; Huber et al., 2010; Kurpas et al., 2013). Self-
dependence is linked to patients having control over their own lives and making 
decisions that they see as the most satisfying and appropriate for them based on 
their health status. A good level of HRQoL can be determined by a patient’s ability 
to manage life activities such as financial management, performing within a job 
and learning new skills (Vitterso 2004). Because this is about patients’ ability and 
capacity to make choices and to have control over their lives, patients should 
therefore have intellectual ability so that they can be self-dependent and can look 
after their own lives. Cognitive well-being involves the thinking processes and 
skills needed to manage life situations (Hermann 1995). It includes intellectual 
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capacity and the ability to make decisions that are reasonable and based on 
rational thought processes (Kaasa and Loge, 2003).  
Spiritual wellbeing is the fourth determinant of HRQoL which can also be seen as 
a determinant of QoL. It refers to the affirmation of an individual’s life in relation 
to God, self and community (Piderman et al, 2007). It falls very much in line with 
one’s personal values, standards of conduct and the spiritual beliefs that shape 
one’s life. The importance of this aspect has often been noted in the literature. 
Recently, more attention has been given to spiritual well-being as a factor that 
might improve one’s wellbeing (Fleming and Evans 2008; Dyess 2011; Gall, 
Malette et al, 2011). The emphasis in this aspect of life might be on the 
importance of spiritual well-being as a dimension that may help to organise an 
individual’s values so as to maintain a better QoL and HRQoL. This was 
highlighted by the literature that examined the influence of religiousness on 
HRQoL (Ramirez et al., 2012; Gall et al., 2011; Moreira and Koenig, 2006). 
Socio-environmental wellbeing was reported in the literature as being an 
imperative determinant of both QoL and HRQoL. It refers to a person’s ability to 
interact positively and successfully with the surrounding environment and within 
the community and its cultural contexts (Carr, Gibson et al, 2001; Camfield and 
Skevington 2008; Fagerlind, Ring et al., 2010). It is essential for individuals to 
have a role in their community and to have good links with their social networks 
in order to maintain a satisfactory level of QoL and HRQoL. The effects of social 
well-being can, through an interaction between socio-economic factors that might 
support the individual, bring about an easy life, which ultimately influences their 
perceptions of their HRQoL. Farsides and Dunlop (2001) argue that relationships 
of love and friendship, or even of enmity and competition, make life worth living. 
Community interactions, family and social networks and support, including 
positive interaction and emotional support, are generally indicators of good levels 
of social well-being and determinants of social well-being (Huber et al., 
2010).This might indicate that the complexity of life dimensions is a multi-faceted 
element and necessitates the use of a multiple focus-assessment framework 
when assessing QoL (Flynn, Greenhalgh et al, 2005; Ghylin, Green et al, 2008).  
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Lastly, the concept of spirituality must also be considered as a possible drive for 
providing the purpose of life for some individuals (Fleming and Evans, 2008). It 
is a kind of connectedness and it describes a way of being that is characterised 
by certain identifiable values in regard to self, others and life (Malette et al., 2011). 
Religiosity is often understood as an individual’s involvement in a set of beliefs 
and social activities as a means of spiritual expression and this may include 
adherence to religious practices and traditions, such as Christmas, fasting during 
Ramadan, or adhering to specific dietary regimens such as avoiding alcohol and 
being vegetarian. The interplay between the two concepts of spirituality and 
religiosity may affect how individuals live and may also affect their moral 
decisions (Malette et al., 2011). These consequently affect their day-to-day 
choices. In Islam, for instance, being religious is considered an essential element 
of happiness. Muslims perceive life satisfaction to be connected with (Allah’s or 
God’s) satisfaction through the dialogue and performance of worship, which 
results in the belief of having a pleasant and satisfied life (Al-Zamel et al., 2010). 
3.6. SQ4:  What is the relation between QoL and HRQoL? 
The need to have a measure to rely on to allocate the resources for health care 
services may have provided the impetus to introduce and relate QoL and HRQoL 
as a health outcome measure (Brekke et al., 2014).  QoL has been discussed in 
medical literature since 1960s (Karimi and Brazier, 2016). Since development in 
medical care enabled the prolongation of patients’ lives, traditional measures of 
health, such as death rate, were no longer enough to measure the output of 
health care systems. The definition of the WHO of HRQoL therefore reflects the 
relationship between QoL and health (Carr et al. 2001). The term ‘HRQoL’ was 
developed by health researchers as a way to measure QoL within health domain 
(Claes et al., 2012) and to differentiate between QoL as an overall sense of 
wellbeing and HRQoL as a satisfaction with health status (Debout, 2011). As a 
result, QoL research has shifted towards considering good HRQoL as a primary 
goal and outcome of effective health care (Painter, Krasnoff et al. 2012). 
However, there are no exhaustive aspects of measurement for HRQoL presented 
in the literature and therefore its measurement should consider both personal 
perceptions and socio-environmental conditions alongside health factors. The 
35 
 
five aspects that correlate the concepts of QoL and HRQoL discussed earlier 
might provide a theoretical framework to assessing HRQoL as a health measure, 
which are: physical well-being, psychological well-being, cognitive well-being, 
spiritual well-being and socio-environmental well-being. These aspects are 
similar to the conceptual model of HRQoL by Ferrans et al. (2005) that highlights 
four main domains: biological functioning, symptoms, functional status, and 
general health perception. The components of this conceptual model 
acknowledge that health exists in a continuum from simple to complex outcomes 
with four determinants, each having multiple variables (Peterson and Bredow, 
2009). These determinants, as well as the overall quality of life, are ultimately 
affected by the characteristics of the individual and by the environment (Ferrans 
et al., 2005; Kring, 2008).  
3.7. RQ5: How are QoL and HRQoL assessed? 
Three main approaches are used to assess QoL and HRQoL: generic, disease-
specific and individualised measures. Many of the measures that have been 
developed are currently widely used and have been translated into different 
languages including Arabic. 
Generic instruments, sometimes referred to as health measures, for instance the 
Short Form-36 (SF36), attempt to measure a broad range of life aspects related 
to HRQoL. These measures cover a range of areas and can be used across 
different populations. The perceived strength of these instruments is their ability 
to allow comparisons of outcomes to be made between the different groups 
measured (Bowden and Fox-Rushby, 2003). Additionally, they provide the ability 
to monitor and screen large populations within different age spectrums. However, 
the use of such measures to assess impairment-specific populations, such as 
those people with chronic diseases, should be verified in order to ensure their 
appropriateness (Krahn et al., 2011). The success of these tools is likely to 
depend on group characteristics and these tools are more susceptible to the 
influence of general life factors other than illness severity, unlike measurement 
tools that are disease-specific.  
The measures that are condition- or disease-specific are designed to address 
areas of life that are particularly pertinent for patients with a specific condition or 
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disease in a predefined list of items which must be rated in a particular manner 
(Bergland and Narum, 2007). The limitations of this method of measurement lie 
in the difficulty of interpreting the responses and its relevance across different 
diseases. Despite these tools being criticised for having a narrow focus, they 
have been credited with being more sensitive to changes in health status 
compared with generic instruments (Krahn et al., 2011). 
Individualised measurement tools were developed as an attempt to explore the 
aspects of life that the individual perceives to be most important and to assess 
the level of functioning or satisfaction within each aspect (Totten et al, 2011). A 
number of such measures have been developed, such as the Schedule for the 
Evaluation of Individual Quality of Life, based on direct weighting procedure 
(SEiQoL-DW), by McGee et al (1991) and O’Boyle et al (1992); and the Quality 
of Life Index (QoLI) by Ferrans and Powers (1985). The main advantage of this 
type of measure of QoL is the ability to address individuals’own concerns about 
their lives rather than impose standard questions which might be less relevant 
(Malette et al., 2011).  
There are five main reasons for measuring QoL and HRQoL identified in the 
literature: (a) it provides an understanding of the causes and consequences of 
the difference in QoL and HRQoL among individuals and groups (Chang et al., 
2005; Gehrmann et al., 2007); (b) it helps in assessing the impact of social and 
environmental factors on QoL and HRQoL (Bullinger et al., 2008; Krahn et al., 
2011); (c) it estimates the needs of a target population; (d) it evaluates the 
effectiveness of health interventions and the quality of any healthcare system 
(Anderson and Burckhardt, 1999; Clark 2002; Chwalisz, 2008); and (e) it helps in 
forming clinical decisions (Greenhalgh et al., 2005). Therefore, measuring overall 
QoL and HRQoL requires a formal and scientific rigour of assessment in its 
approach. 
3.8. Conceptual model 
The use of a conceptual framework of HRQoL in this study could act as a heuristic 
device to provide a better understanding and clarity of HRQoL. The literature 
review revealed three conceptual frameworks of HRQoL which are most 
frequently used, namely, World Health Organisation International Classification 
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of Functioning Disability and Health (WHO ICF), Wilson and Cleary HRQoL 
Model, and Revised Wilson and Cleary Model of HRQoL by Ferrans et al (2005). 
Critically reviewing these models, the WHO ICF was more of a mapping and 
classification framework than a guide for hypothesis generation in the area of 
HRQoL (Bakas et al., 2012), and for that reason, was not considered in the 
current study; whereas the Wilson and Cleary model of HRQoL and the revised 
Wilson and Cleary model of HRQoL by Ferrans et al were more relevant to guide 
this study. 
The original model of Wilson and Cleary, which combines two paradigms of 
biomedical and social science, was published in 1995. Conceptually, it links four 
well-defined health concepts on a continuum (biological functioning, symptoms, 
functional status, and general health perception) with HRQoL as an outcome. The 
model also considers individuals’ interaction with the environment to perceive a 
level of HRQoL which address the difference between the clinical reported 
outcomes and the patient reported outcomes (Diagram 2.1). 
The definition of the four determinants of health-related outcomes of this model 
that interlink the different aspects of life with the perception of HRQoL are:   
1. Biological functioning: includes the physiological processes that support 
life, such as cells function and disease severity. It includes body mass 
index, skin colour, and family history related to genetic disease. It is 
considered the most fundamental factor of one’s health status and focuses 
on the performance of body cells and organ systems.  Biological 
functioning can be measured through laboratory tests and physical 
assessment (Wilson and Cleary, 1995). Alterations in biological function 
can affect all subsequent determinants of QoL, including symptoms, 
functional status and general health perceptions.  
2. Symptoms: refers to the physical and psychological symptoms that the 
patient may express. The physical symptoms relate to feelings about 
physical status (body), while psychological symptoms relate to feelings of 
fear, worry and frustration (mind).  According to Wilson and Cleary, a 
symptom is defined as “a patient’s perception of an abnormal physical, 
emotional or cognitive status” (Wilson and Cleary, 1995: p. 61).  Common 
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to these definitions is that a symptom is a subjective feeling which reflects 
a change in normal functioning that may be physical, psychological and/or 
social (Lenz et al, 1997). It is therefore important to measure the influence 
of symptoms on a patient’s overall QoL using symptom-specific measures. 
3. Functional health status: this is defined as the patient’s ability to perform 
particular defined tasks or maintain day-to-day activities. The main 
domains include physical functioning, social functioning, role functioning 
and cognitive functioning. Many factors may be related directly or indirectly 
to functional health status, such as physiological factors, symptom status, 
individual characteristics and environmental factors (Wilson and Cleary, 
1995). According to Wilson and Cleary (1995), four areas of functioning 
are often measured: physical, social, role and psychological can all be 
assessed by generic types of measures. 
4. Perception of general health: this is subjective in nature and allows 
patients to evaluate and weigh up their past and current overall health 
status. According to the framework, symptoms can be key predictors of 
general health perception. It represents all health concepts together and 
all other concepts that may not be depicted by the model (Wilson and 
Cleary, 1995). Therefore, assessing the association between symptom 
status and general health perception is important. A patient’s perception 
of general health is usually measured by one single global question 
reflecting an overall health rating on a Likert-type scale from poor to 
excellent.   
 
Diagram 2. 1 Wilson and Cleary Model of HRQoL 
Characteristics of the individual 
Characteristics of the environment 
Biological 
functioning 
Symptoms 
Functional 
status 
General health 
perception 
HRQoL 
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Although Wilson and Cleary provided explicit definitions for the four main domains 
in the model, the domains of individual and environmental characteristics were 
not explicit (Bakas et al., 2012). Ferrans and colleague (2005) published a 
revision of the Wilson and Cleary’s HRQoL Model (Diagram 2.2). The revised 
model of HRQoL retained the four main domains of the original model and, 
additionally, made, firstly, explicit definitions for the individual and environmental 
characteristics. They categorised the characteristics of the individual as 
demographic, developmental, psychological and biological (Ferrans et al., 2005) 
and for that they added an arrow from characteristics of the individual to biological 
function, whereas for the characteristics of the environment they categorised it 
as either social environment, including influence of family, friends, and health 
providers; or physical environment, including neighbourhood and workplace that 
influence health outcomes. Secondly, they simplified the description of the model 
by removing non-medical factors and labels on the arrows depicting the 
relationships in the figure. They point out that the arrows’ directions can be 
reversed to show shared relationships and that the absence of arrows between 
framework levels does not suggest that relationships do not exist (Ferrans et al., 
2005). This complexity allows for characteristics of the environment to influence 
characteristics of the individual, which can impact on HRQoL. This pathway is 
important because it signifies that a completely non-health-related factor, such as 
a lack of local entertainment, can influence the psychological component of 
characteristics of the individual, which can in turn affect the perception of overall 
quality of life.  
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Diagram 2. 2 Revised Wilson and Cleary Model of HRQoL by Ferans et al (2005)  
 
The inclusion of the main antecedents of life domains in a clear depiction of 
relationship to the HRQoL, as an outcome, empowered the model to become a 
holistic diagram for understanding patients’ HRQoL. It may also provide a 
guidance in selecting the variables of this study which may influence patients’ 
HRQoL. It is believed that using the model to guide this study would provide a 
rigorous approach to assessing HRQoL in the Omani context. 
4. Discussion 
This narrative review attempts to gain a general understanding of the QoL 
concept and to track its theoretical development. It is clear that QoL and HRQoL 
are multidimensional concepts and the ambiguity of the terms is possibly due to 
the different ways in which they are defined and the nature of the factors that 
influence these definitions. The concept of QoL is popularly used in general public 
life and is very much based on the positive meaning of the general term “quality”. 
Even among the researchers and clinical experts, a wide range of definitions and 
interpretations of the term “QoL” exists. This has resulted in a trend for some 
researchers to mix the term with other concepts and employ interchangeable use 
of these concepts. Life satisfaction, health status and happiness are all examples 
of this.  
Characteristics of the individual 
e.g., demographic, developmental, psychological 
Characteristics of the environment 
e.g., clinical, socio-economic factors, neighbourhood and workplace 
Biological 
functioning 
Symptoms 
Functional 
status 
General health 
perception 
e.g. How individuals 
perceived their 
general health) 
HRQoL 
(outcome) 
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Increased application of HRQoL measures to different diseases and populations 
has encouraged different responses equally from advocates and opponents of 
patient-based health-outcomes assessment. While the advocates view HRQoL 
measurement as necessary to make judgements about clinical intervention, 
opponents have argued that HRQoL lacks conceptual clarity and measurement 
feasibility (Hunt, 1997). As a result of such debate, developing relevant and 
accurate HRQoL measurements for use in research has resulted in the 
development of different measures. However, the utilisation of HRQoL measures 
has resulted in setting a clear need for a pragmatic priority known as the 
“construction of measures” (Hacker et al., 2013).  
Although this debate has resulted in broad acceptance of HRQoL and has 
increased the number of studies published, the conceptual and theoretical 
foundation has put limits on its progress for a number of reasons. First, the normal 
epistemology order of theory, formulation and testing, with the goal of falsification 
and its continuing examination against alternative theories, has not been followed 
(Freestone et al., 2013). Most of the current assessments focus on measuring 
one perspective on HRQoL, which is group-oriented rather than individualised 
(Feeny, 2013). These reasons might limit the development of a coherent body of 
evidence to guide further HRQoL studies and practice. 
Likewise, operationalising the concept of HRQoL can be challenging. The 
questions used to assess HRQoL should be stated within three main levels. 
These levels are: the instrument of measurement used, the study design and the 
statistical analysis (Sheetal et al., 2009). Most of the measures available in the 
literature focus on group-oriented or individual HRQoL assessment. The result of 
the assessment depends on the instrument of measurement used, the study 
design and how the results are analysed. It is recommended that the statistical 
methods used to compare respondents across groups should also be used to 
analyse individual-specific clusters of QoL statements. These, in addition, can 
again be compared with an individual’s cluster (Feeny, 2013).  
However, there are relatively important aspects of patients’ lives that can vary 
over time and with changing circumstances, which may directly affect their level 
of HRQoL. What a person considers to be important depends on the particular 
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stage of their life cycle and on other related personal factors. For instance, 
personal incidents and serious illness, such as chronic disease, often force 
individuals to reassess their lives and therefore the values to which one 
subscribes can lead to extracting as much meaning and enjoyment from life as 
possible (Taylor, 1989). Such significant changes in life circumstances may 
cause or induce temporary changes in life and, as people adapt to these 
circumstances, these becomes stabilised, reflecting the dynamic nature of QoL 
(Hagerty, Cummins et al., 2001). The shift from normal health status to chronic 
health status, as with ESRD, is accompanied by changes in their perceptions 
about themselves and others (Heiwe et al., 2003). 
It is, therefore, crucial to understand the influencing factors that might enhance 
or hinder patients’ HRQoL. Changes in life satisfaction throughout the course of 
life and across different groups of people need to be understood (Bailey et  al., 
2007). Unfortunately, there is no clear way to determine the extent to which the 
level of life satisfaction should be viewed as a stable dimension (Bailey et al., 
2007). Individualised instruments, that report patients’ satisfaction with their QoL, 
are supported by many researchers as the most appropriate approach to 
assessing overall QoL (O'Boyle, 1997; Beckie and Hayduk, 2004; Inglehart et al., 
2013; Eckersley, 2013). They argue that satisfaction with QoL is essentially a 
cognitive assessment of an individual’s progress towards desired goals. Hence, 
this PhD project should perhaps, initially, consider exploring the concept of QoL 
among Omani patients prior to measuring possible factors that might influence 
their QoL through using individualised QoL measures. This approach would 
provide a close insight first into the meaning of QoL among this group of patients. 
The individualised QoL instrument could be helpful in examining QoL among 
rapidly changing societies (Becker et al., 2014). However, the disadvantage of 
individualised measures might possibly be that they rely on much time and effort. 
Because the respondents’ concerns will be stated within specific aspects and 
addressed in depth, the researcher should then personally conduct an interview. 
This necessitates greater resources of time for researchers and participants 
when compared with self-completed instruments. Although O’Boyle et al (1992) 
were able to produce some comparative health data with individuals using the 
SEiQoL instrument, low practical feasibility remains the main potential 
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disadvantage of this method of measurement as it is less easy to produce 
population-based competitive or normative data (O'Boyle 1994). 
Likewise, it has been argued that self-reporting, or using individualised 
instruments to measure QoL per se, are influenced by participants’ mood, 
orientation and the timing of the measurement (Diener et al, 1999). Such 
influences indicate a social-desirability bias that arises from cultural norms. This 
can be seen in cultures that have traits of humility or self-aggrandisement towards 
one another. However, these influences were observed to have had a greater 
effect on overall QoL measurement than did the specific-aspects scores 
(Cicerchia, 1996;  Lee et al., 2005), thereby providing a more detailed view of 
satisfaction within key life areas. It is not yet understood by cognitive 
psychologists exactly how the human brain integrates personal factors into an 
overall judgement of QoL (Kurpas et al., 2013). This is an area which may require 
more investigation. 
Assessing individualised QoL, however, among a group of patients can be 
challenging due to the variance in thinking processes and the skills required to 
manage their life situations. Thus, the use of HRQoL measures alongside QoL 
measures could provide a wide assessment of a patient’s wellbeing. Perhaps a 
combination of three approaches to measurement (generic, disease-specific and 
individualised measures) could have the following effects: (a) it could provide an 
understanding of the causes and consequences of the difference in QoL among 
individuals and groups (Chang et al., 2005); (b) it could help to assess the impact 
of social and environmental factors related to QoL and HRQoL (Brutt et al, 2008; 
Krahn et al., 2011); (c) it could estimate the needs of a target population; and (d) 
it could help in forming clinical decisions (Greenhalgh et al., 2005). However, an 
important question that can be raised with regard to measuring QoL is whether 
the concept can be effectively measured with the same measures across different 
populations. Despite the availability of several measures designed to assess 
HRQoL, it has been argued that differences in health conditions and cultures are 
two important components (Barger et al., 1998; Moreira-Almeida and Koenig, 
2006). Using a cognitive-debriefing method, for example, can be a helpful method 
in testing the readability of HRQoL measures among the target population. 
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The use of a combination of different measures to assess QoL and HRQoL, 
however, can be affected by the ability of participants to understand or interpret 
the questions of the measure. Although this is less of an issue with measures 
assessing concrete concepts such as alcohol consumption, it can be a significant 
problem when assessing more abstract concepts such as QoL and HRQoL 
(O’Connor, 1993). One of the methods presented by the literature that can be 
used to test the readability of or respondents’ understanding of a measure is to 
use a cognitive debriefing method. Cognitive debriefing is a method used to test 
the readability of a measure among patients to determine whether participants 
are able to understand the items of the measure in the same way as the original 
would be understood (Tavernier et al., 2011). The method can be also used to 
determine if a translated questionnaire or a measure from original language can 
be deemed to be appropriate for the target population. Using the cognitive 
debriefing method in this project to test the readability of HRQoL measures by 
Omani ESRD patients would help in assessing their acceptance and 
understanding of the used measures.  
To sum up, for the purpose of this PhD project, the definition of QoL by the WHO 
(1995) and the revised version of the HRQoL conceptual model of Wilson and 
Cleary by Ferrans et al (1995) can be recommended to guide this PhD project 
and also to provide a rigorous approach to assessing QoL in the Omani context.  
5. Conclusion and recommendations  
The majority of authors who conceptualise QoL and HRQoL have introduced the 
individual factor as a common criterion of QoL and HRQoL. Personal indicators 
describe individuals’ feelings about whether they are satisfied with their well-
being and whether they feel good about things in general. It is believed that these 
indicators exist in the consciousness of an individual and identifying the 
importance of them to an individual can only be known by asking the person to 
state them (Abellan-Perpifian and Pinto-Prades, 2005). Measuring personal 
factors, however, is difficult and is a subject that is always under debate due to 
its dynamic and individualised nature.  
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Most QoL researchers suggest that the number of aspects of life is less important 
when compared with the ability to recognise and represent individual needs. This 
element should be reflected by QoL frameworks to recognise the need for a multi-
element framework and to realise that individuals know what is important to them. 
The essential characteristics of any set of life aspects is that they represent, in 
aggregate, the complete QoL construct (Schalock, 2004). Therefore, QoL 
aspects should be considered as the set of elements to which a variable is limited 
(Wiesmann et al., 2008), or, in other words, the range over which the concept of 
QoL extends.   
The concepts that researchers depend on when measuring QoL and HRQoL are 
not theory-based, or at the very minimum are not based on a tested conceptual 
model. QoL and HRQoL are composed of personal, health, as well as socio-
environmental, dimensions and these should be considered equally in any 
intended measurement of both concepts. Therefore, measurement should 
consider both personal perceptions and socio-environmental conditions. The 
Revised HRQoL conceptual model of Wilson and Cleary, by Ferrans et al (1995), 
can be used to clarify the aspects of HRQoL and the causal relationship between 
them.  
The use of specific measures, including self-evaluation measures, is a helpful 
way of providing a comprehensive picture of individuals’ perception of their lives. 
Generic QoL instruments assess global QoL, whereas specific measures of 
HRQoL assess the influence of a particular illness. They appear to be more 
sensitive to change over time and can be a better discriminator of differences 
between subgroups. However, this requires a more structured review to assess 
the related validity and reliability in any tested population. Additionally, the 
selected measures should be subjected to an acceptable method of psychometric 
testing.  
Future researchers who examine HRQoL should consider that the terms “QoL”, 
“life satisfaction”, “functional status” and “wellbeing” cannot be used 
interchangeably because this causes confusion for both the researcher and the 
participants whose perceptions they intend to measure.  
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Cultural and language adaptations should also be considered and more cross-
cultural research is needed to examine the relationship between QoL and cultural 
effects. This might include using individualised QoL instruments to explore the 
meaning of QoL across cultures. Likewise, using cognitive-debriefing methods to 
test the readability of HRQoL measures to targeted population would help in 
exploring whether the measures are acceptable and understood by them. 
Given the breadth of meaning of QoL and health-related QoL and their 
underpinning factors, it was therefore recommended that an integrative review be 
conducted, focusing on QoL and HRQoL among ESRD patients and examining 
the levels, and predictors, of QoL and HRQoL in this group of patients. This 
review is presented in chapter three of this study. 
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Chapter-3: QoL and HRQoL in patients with ESRD Undergoing 
Haemodialysis (Literature review-two) 
Background: The aims of this structured integrative review are to present and 
critically analyse the nature and significance of the predictors of QoL and HRQoL 
in patients with ESRD and to evaluate how these concepts are operationalised.  
Method: the SCOPUS, Cochran Library, ProQuest (ASSIA) and EBSCO 
(CINAHL and Medline) were the main databases searched as well as secondary 
internet resources (ScienceDirect and PubMed. Selected articles were assessed 
for sample size, design, and methodological limitation. The revised Wilson and 
Cleary conceptual framework of HRQoL and WHO definition of QoL were used 
to guide this review. 
Results: For this review, 124 articles were screened, out of which 45 articles 
were selected. Of the 45 studies, 36 were observational, cross-sectional studies 
and nine were prospective studies. Papers reported a wide range of factors 
related to QoL and HRQoL of patients with ESRD which were characterised as 
physical health, mental health, socio-economic, biological, and symptoms. Few 
studies looked at spiritual beliefs and cultural beliefs. There is a lack of 
consistency in the use of measures of QoL and HRQoL in ESRD. The most 
validated measures of HRQoL identified were the Short-Form 36v2 (SF36v2), 
Quality of life Index-Dialysis (QLI-D), Hospital Anxiety Depression Scale (HADS), 
Fatigue Severity Scale (FSS), Itch Scale (5-D Itch), Spiritual Wellbeing Scale 
(SWB), and QoL (The Schedule for the Evaluation of Quality of Life-Direct 
weighting (SEIQoL-DW)).  
The majority of these studies were conducted within Western culture, with only 
two found that examined QoL and HRQoL aspects in ESRD patients in the Arab 
world. No studies had been conducted in Oman to assess QoL in this group of 
patients, or to assess how these patients perceived their QoL.  
Conclusions: The possible measures of QoL and HRQoL for this project are 
health status, disease-specific, symptom-specific, spiritual life and individualised 
QoL measure. This set of measures is anticipated to capture patients’ own 
perceptions concerning their QoL and HRQoL.
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1. Introduction  
This review builds upon results from review-one (Chapter two) that was 
conducted to analyse the conceptual and theoretical issues associated with QoL 
in general as well as the related concept of HRQoL. Results indicated that QoL 
and HRQoL are composed of personal perceptions, health, as well as socio-
environmental, dimensions and these should be considered equally in any 
intended measurement of both concepts. For the purpose of clarity, the term 
“QoL” refers to individuals’ perceptions of their position of life in relation to culture, 
goals, and expectations, whereas “HRQoL” is determined by the way in which 
changes in health- and treatment-related symptoms affect the dimensions of a 
patient’s well-being. Five aspects of life were identified to correlate the concepts 
of QoL and HRQoL, though mainly related to HRQoL. These aspects are: 
physical wellbeing, psychological wellbeing, spiritual wellbeing, cognitive 
wellbeing and social-environmental wellbeing.  
End Stage Renal Disease (ESRD) is a serious, irreversible condition that has a 
profound impact on patients’ lives. It causes serious implications on different 
aspects of patients’ lives including physiological, psychological and 
socioeconomic status (Talas and Bayraktar, 2004; Trivedi, 2011). Although 
considerable progress has been made in treating ESRD patients and HD 
procedures, HRQoL remains a significant problem for haemodialysis patients 
(Cukor et al., 2013). The multiple physiological and psychological complications 
due to the disease and related treatment that dialysis patients may experience 
impair their life style which might change and subsequently lower their HRQoL 
level.  
Literature reported several factors that contribute to and influence the level of 
QoL and HRQoL in patients affected by ESRD. Functional status, for instance, is 
usually limited in patients with ESRD including physical functioning, role 
functioning, social functioning, and mental functioning as a result of disease 
symptoms and treatment regimens (Coons et al., 2000).  Studies that have used 
physical performance, health, and self-reported measures reported low physical 
functioning in patients with ESRD (Guney et al, 2010; and Morsch et al, 2005). 
Demographical and clinical factors, such as older age, lower socioeconomic 
49 
 
status, malnutrition, are negatively associated with HRQoL in ESRD patients 
(Fidan et al, 2013).  
Assessing health-related QoL and overall QoL, therefore, becomes a vital and 
often required part of health outcomes appraisal (Anderson and Burckhardt, 
2003). Assessment of QoL and HRQoL for patients with ESRD, in particular, 
could provide a meaningful way to determine the impact of health care when cure 
is not possible. However, QoL and HRQoL are multi-dimensional and scattered 
concepts that have a significant impact on research exploring patient experience 
and practice (Berlim et al., 2006). Both concepts are composed of personal as 
well as socio-environmental dimensions and these two dimensions should be 
considered equally in any intended measurement.  
The aim of this review, therefore, is to present and analyse the levels of and 
predictors of QoL and HRQoL in patients with ESRD and to examine how these 
concepts are operationalised. The approach used to answer the enquiry came 
through formulating focused search questions. These questions are:  
1. What predicts QoL and HRQoL in patients with ESRD? 
2. How are QoL and HRQoL operationalised in patients with ESRD? 
3. What are the most common validated instruments used to measure QoL 
and HRQoL in ESRD patients? 
4. How effective are the identified QoL and HRQoL instruments? 
a. How accurate are they at measuring the concept of QoL and 
HRQoL in ESRD patients?  
b. Do they measure what they are supposed to measure?  
 
2. Method  
2.1. Search strategy 
A comprehensive search was made using several electronic literature databases 
accessed via the Library and Learning Centre website of the University of 
Dundee. The search was conducted in three phases: first, by accessing the topic-
relevant internet database electronic literature databases [SCOPUS, Cochran 
Library, ProQuest (ASSIA) and EBSCO (CINAHL and Medline)]; second, 
50 
 
secondary internet resources were consulted, such as ScienceDirect and 
PubMed; and finally, a retrograde search was made through citations from the 
articles already identified. EBSCO, which consists of CINAHL and Medline, was 
the initial database accessed as it is known to contain regularly updated 
evidence-based healthcare literature. All searches were done in the first half of 
April 2014 and updated by May 2017. 
The literature search was not limited to any specific year of publication in order 
to screen most of the existing relevant evidence. English and translated articles 
from different languages were used in the search to include different populations 
in the review, thereby validating the generalisation of the results. The keywords 
used in the search were: (ESRD AND QoL OR ESRD AND HRQoL); (“QoL AND 
HRQoL AND predictors”); (“chronic kidney failure OR chronic renal failure AND 
QoL”); (“HRQoL AND QoL AND measurement”); (QoL AND HRQoL AND 
conceptualisation OR domains); (“QoL AND HRQoL AND ESRD AND 
operationalisation”) AND haemodialysis.   
Inclusion and exclusion criteria were used to produce the final literature to be 
appraised and discussed (Table 3.1). 
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Table 3. 1  Inclusion and exclusion criteria 
Inclusion Exclusion 
Population 
Adult patients aged >18 years 
Patients affected by ESRD on HD 
Patients affected by ESRD on HD 
with post-renal transplant failure 
Study selection 
Articles assessing QoL and HRQoL 
among HD population 
Prospective studies measuring 
patient-reported outcomes 
Articles published in English 
Patients affected by acute renal failure 
Patients who have had a kidney transplant 
or who are waiting for kidney 
transplantation 
Patients aged < 18 years 
Patients on peritoneal dialysis 
Critically ill patients on HD 
Articles published as general information, 
abstracts, dissertation, editorials, reports 
and clinical opinions 
 
3. Results 
The database search yielded a total of 4,319 publications with an additional 34 
retrieved from secondary resources. The identified articles were screened 
against titles in order to match inclusion and exclusion criteria, which then 
resulted in the exclusion of 4,189 articles. Likewise, 164 articles were excluded 
due to duplication. A further four screening stages took place as follows. (1) the 
titles of the 4,189 articles were screened; 4,067 articles were excluded because 
they were irrelevant (22 were non-English language, 283 were discussion 
articles, 804 related to paediatrics and 2,958 were not related to HD). (2) A 
retrograde search was made through citations from the articles that were already 
identified and two articles were identified to provide a total of 124 articles to be 
reviewed.  (3) Abstracts of the remaining articles were screened by three 
independent reviewers (the PhD student and the study supervisors), of which 79 
appeared to be irrelevant (Excluded articles with reasons are shown in Appendix 
3.1). The aim was to maintain a rigorous selection process and minimise selection 
bias. Agreement between reviewers was reached in 45 articles. (4) The full text 
of the remaining 45 articles was then reviewed, resulting in the inclusion of all 
these in this review. Figure 3.1 shows the flowchart of articles selection.  
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Figure 3. 1 Selection of articles flowchart 
 
3.1. Characteristics of reviewed articles that study HRQoL 
Twenty-seven papers studied HRQoL and QoL as the main outcome, 11 papers 
studied symptoms as the main outcome and seven papers studied validation and 
comparison of different HRQoL measures in ESRD. The quality of the reviewed 
studies was assessed using the quality appraisal form (Appendix 3.2) that was 
developed based on the Critical Appraisal Skills Programme (CASP) criteria. All 
Articles identified through database search (Medline, Cochrane, SCOPUS, ASSIA and TRIP) 
4,319 search results from all 
databases 
4,189 articles retrieved 
Articles 
excluded 
Duplicates: 164 
Articles excluded 
22 Non-English 
language 
283 review studies 
804 related to 
paediatrics 
2,958 not related to 
HD 
Additional 
articles retrieved 
from secondary 
resources: 34 
Full articles obtained: 122 
Full-text articles reviewed: 124 
Additional articles 
retrieved from 
citation lists of 
reviewed articles: 2 
Full-text articles included: 45 
Articles 
excluded after 
review: 79 
Application of selection criteria 
against titles 
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the studies that met the inclusion criteria were used and no study was excluded 
because of its quality. The results of all studies are reported in tabular form based 
on the Joanna Briggs Institute (JBI) Data Extraction Form for 
Experimental/Observational Studies (Appendix 3.3).  
 
 
Figure 3. 2 Characteristics of identified studies  
All papers were written in English and were published over a 15-year period 
between 1999 and 2017 (see Appendix 3.2 for the methodological characteristics 
of the 45 studies). Fourteen of them were conducted in North and South America 
between 1999 and 2014 (USA 5; Canada 2; and Brazil 7). In Europe, 10 studies 
were conducted from 2001-2013. In Asia, nine studies were conducted from 
2000-2014. The lowest number of published studies was in the Middle East and 
Africa: Iran, four studies; Turkey, two studies; and Egypt, one study (in 2013). No 
studies were published that assess QoL or HRQoL in patients with ESRD in 
Oman. Although the Middle East and Africa recorded a lesser number (two 
articles) of published studies related to HRQoL compared with North and South 
4
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9 clinical issues
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11 symptom
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America and Europe, this suggests that there is a growing interest worldwide in 
assessing HRQoL and QoL in patients affected by ESRD.  
3.2. Studied population 
A total of 16,234 participants were involved in the observational and prospective 
studies and were defined as being ESRD patients undergoing maintenance 
haemodialysis. The study sample sizes varied between 40 and 800 patients in 
the 45 studies. Twenty-four studies had ≤202 patients (between 22-202 patients) 
and 21 studies had more than 202 patients (202-1,186 patients). The inclusion 
and exclusion criteria were clear and provided limitations for a specific group that 
received mainly haemodialysis (HD).  However, in Rao (2000) and Abd El 
Hafeez’s (2012) studies, the main outcome was to develop subscales from 
previously validated HRQoL instruments to assess their internal consistency 
reliability.  
3.3. Design of studies 
Of the 45 studies, 36 were observational, cross-sectional studies and nine were 
prospective studies. There were no randomised control trial studies identified. Of 
the nine prospective studies, the longest duration of data collection was three 
years by Unruh et al (2008) in their study of the influence of age on changes in 
HRQoL in patients undergoing HD. The shortest duration was one year, from 
January 2007 to 31 December 2007, by Tsai et al (2009) in their study of the 
relationship between QoL and the risks of ESRD and mortality in ESRD patients. 
The survey, particularly the cross-sectional design, is the most commonly used 
method in studies that assess HRQoL in ESRD. This limits the ability of studies 
to identify causal relationships between the studied variables and HRQoL (Naik, 
N., et al, 2012). 
Despite the appropriateness of the methodologies used by literature, there are a 
number of methodological limitations of studies identified that should be 
highlighted in this review. First, there is a limitation on methodological basis in 
ESRD research that can build a bridge between theory and practice, with only 
three articles using a theoretical framework for the research. Second, there is a 
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lack of consistency in the definitions of QoL and HRQoL, which results in 
overlapping between the two terms, as well as with other concepts such as 
functioning health. Third, there is a lack of consistency measuring the aspects of 
HRQoL throughout the studies. Finally, there is a lack of consistency in the use 
of measures of QoL and HRQoL in ESRD. Despite these limitations, particularly 
in the Arab world, no study was excluded because of its quality. 
3.4. Predictors of QoL and HRQoL in ESRD patients (answers search 
question-one) 
The 45 studies included in this review reported a wide range of factors related to 
QoL and HRQoL of patients affected by ESRD. Although these factors may not 
reflect an individual’s priorities, the literature indicates that ESRD patients have 
several QoL and HRQoL predictors pertaining to this disease (refer to Appendix 
3.3). These factors and predictors have been congregated under relevant 
domains of the selected conceptual model that guides this study, reported in 
Review One–Chapter two, of The Revised Wilson and Cleary of HRQoL by 
Ferrans et al (2005), and supported by tables that summarise these factors and 
predictors, as follows:  
3.4.1. Individualised characteristics 
Evidence from observational studies found that some socio-demographic 
factors, such as women, older age, lower employment and marital status 
correlated with poorer HRQoL in ESRD patients (summarised in Table 3.2). For 
instance, female patients on HD consistently reported lower HRQoL when 
compared with men. Mujais et al (2009) reported that women, when compared 
with men, had lower physical functioning (p < 0.0001), role physical (p < 0.0001), 
pain (p < 0.0001) and general health (p < 0.0001). Similarly, women that had 
lower scores on role emotional (p < 0.0001), social function (p < 0.0001) and 
fatigue (p < 0.0001) associated with poorer HRQoL. 
 
Age was reported to correlate with poorer results in most HRQoL measures 
(Fidan, 2013; Loos, 2003; Unruh, 2008). As the patients’ ages increase, their 
HRQoL scores, particularly those of physical function, usually decrease (Loos et 
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al, 2003). The association of age with HRQoL in ESRD patients is quite complex 
as age is a main factor linked with deterioration of QoL. Studies conducted cross-
culturally have also demonstrated that age is strongly inversely associated with 
the physical function scores (Rambod, 2010; Weisbord, 2008). Patients on 
dialysis in southern Brazil reported that a younger age accounted for better 
physical component summaries within the SF-36 measure (β -0.16; 95% 
confidence interval, CI: -0.27 to -0.05) (Bohlke et al, 2008). This result was in 
parallel with Mujais et al’s (2009) findings that physical functioning is lower in 
patients >65 years old (p < 0.0001).  
Employment and marital status were associated with better HRQoL in patients 
with ESRD. Patients who are employed (β 8.4; 95% CI: 1.715.1) and are married 
or have a marriage-like relationship (β 4.56; 95% CI: 0.98.2) were shown to be 
predictors of higher mental component summary scores (Bohlke et al, 2008). 
Similarly, there was a statistically significant relationship between higher 
educational status and better functionality status (p < 0.05) (Oren and Enc, 2013). 
Table 3. 2  Summary of results of studies of assessed predictors of HRQoL related 
to the demographic/individualised characteristics 
Factor Predictor 
Quality of life parameters 
PF RP P GH EWB Health 
C
h
a
ra
c
te
ri
s
ti
c
s
 o
f 
th
e
 i
n
d
iv
id
u
a
l 
 
Gender 
(female) 
* 
[1] 
*** 
[1,2] 
*** 
[1,2] 
*** 
[1] 
*** 
[1,2] 
  
Age 
(younger) 
β -
0.16 
     
Age (older) 
    
*** [2] 
 
Marital 
status 
(married/part
nered) 
   
β= 
0.174 
[4] 
 
aβ=0.1
61 [3]a 
Educational 
status 
 * 
[3] 
     
PF – Physical functioning; RP – Role physical; P – Pain; GH – General health; EWB – 
Emotional well-being. 
 = Predictor associated with lower scores on the quality of life parameter 
 = Predictor associated with higher scores on the quality of life parameter 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
[1] Saffari et al, 2013; [2] Mujais et al, 2009; [3] Oren and Enc, 2013; [4] Bohlke et al, 
2008; Notes: aβ=0.174 
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3.4.2. Socio- environment and clinical factors 
A group of socio-environmental and clinical factors were reported that could lower 
HRQoL in patients with ESRD (Table 3.4). Four studies (Rambod and Rafi, 2010; 
Bohlke et al, 2008; Kao et al, 2008; and Oren and Enc, 2013) indicate that the 
lower socio-environmental status of patients affected by ESRD is considered to 
be an actual burden (Table 3.3). Chronic dialysis imposes a substantial burden 
on patients and families and therefore the relationships of the patients with their 
family members could be affected. Kao et al (2008) report that increased social 
activities and high monthly income are associated with better HRQoL (p < 0.05), 
whereas social isolation and decreased social interactions are associated with 
worse HRQoL (p < 0.01). Similarly, Bohlke et al (2008) report that a result of the 
HRQoL was significantly correlated with perceived social support (r= 0.72, p ≤ 
.00). In a study assessing the perception of social support and HRQoL in Iranian 
dialysis patients, results showed a statistically positive relationship between 
perceived social support and health-functioning (r= .65, p ≤ .05), psychological-
spiritual (r= .63, p ≤ .05) and family sub-scales of QoL (r= .51, p ≤ .05) (Rambod 
and Rafi, 2010).  
The clinical factors reported that might predict HRQoL in ESRD patients were the 
length of time over which a patient has had HD sessions and dialysis treatment 
adequacy. The length of time over which a patient has had HD sessions plays an 
important role in levels of HRQoL of ESRD patients. The relationship between 
the duration of dialysis and the SF-36v2 subscales was found to be statistically 
significant and there was a negative relationship found between the duration of 
dialysis and the general perception of health (r = -0.21; p < 0.01). The scores on 
the general perception of health subscale decreased as the duration of dialysis 
increased (Oren and Enc, 2013). In parallel to this study, Hsieh and his 
colleagues (2007) made a similar observation that duration of dialysis treatment 
had a reverse correlation with HRQoL. It was observed that an increase of 
dialysis duration was associated with low QoL. As well, the overall score of QoL 
was observed to be better in HD patients who had experienced dialysis duration 
of less than eight months compared with patients with a dialysis duration of more 
than eight months. 
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Similarly, adequacy of dialysis is another factor linked to the improvement of 
HRQoL in ESRD patients. It is clinically measured by either the method of urea-
reduction ratio (URR) or Kt/v. URR is a laboratory test that refers to the 
percentage of urea reduction in blood as a result of HD and the range should be 
around 70% or higher (KDOQI guideline, 2006). Cohen and Kimmel (2013) 
showed an association between social and emotional well-being domains of SF-
36v2 and adequacy of dialysis. In their study specifically assessing doses of HD 
and QoL, they reported a positive increase in QoL by increasing the HD dose 
from Kt/V 75 % to 95%.   
Table 3. 3  Summary of the results of studies that assessed predictors of HRQoL 
related to socio-environmental characteristics in ESRD  
Factor Predictor 
Quality of life parameters 
HF PS FR OQoL GH 
S
o
c
io
-e
n
v
ir
o
n
m
e
n
ta
l 
c
h
a
ra
c
te
ri
s
ti
c
s
  
Social support  * 
[1] 
 * 
[1] 
 * 
[1] 
    
Socioeconomic        aβ=8.4 
[2] 
  
High monthly income        * [1]   
Duration of 
haemodialysis 
         ** [4] 
Social activities         * [3]   
  
HF – health functioning; PS – psychological-spiritual; FR – family relationship; OQoL – overall 
quality of life; GH – General health 
 = Predictor associated with lower scores on the quality of life parameter 
 = Predictor associated with higher scores on the quality of life parameter 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
[1] Rambod and Rafi, 2010; [2] Bohlke et al, 2008; [3] Kao et al, 2008; [4] Oren and Enc, 2013  
Notes: aβ=0.174 
 
3.4.3. Biological function 
Biological function can be an important determinant of HRQoL and includes the 
physiological processes that support life. It focuses on the performance of body 
cells and organ systems which can be measured by laboratory tests, physical 
assessment and medical diagnosis (Ferrans et al, 2005). Two biological factors 
retrieved from literature may impact on QoL in ESRD patients (Table 3.4): 
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a) Malnutrition is common in ESRD and severe malnutrition has been associated 
with decreased HRQoL (Laws et al, 2000). Laws reported that hypoalbuminemia 
(albumin <35g/L) influenced physical health negatively by affecting physical 
functioning (p< 0.02) and lowering overall general health (p<0.0001). Similarly, it 
influenced mental health negatively by impacting on emotional well-being (p< 
0.05) and the emotional role (p<0.005). Low albumin has also been identified as 
a significant predictor of mortality (DeOreo, 1997; Lowrie and Lew, 1990). These 
findings emphasise the importance of using albumin serum as a measure in 
HRQoL studies.  
b) Anaemia is measured by Hb and haematocrit, which has also been shown to 
impact on HRQoL in persons with ESRD. It is a condition that is significantly 
related to low HRQoL and is highly predominant in patients undergoing HD. It is 
associated with adverse clinical outcomes and diminished HRQoL (Bonner et al, 
2013). The most common symptoms associated with anaemia are fatigue, 
dyspnoea and reduced sense of well-being (Joe et al, 2004; Jablonski et al, 
2007). Hansen et al (2009) assessed HRQoL in clinic patients receiving 
comprehensive anaemia care and reported that anaemia severity (haematocrit 
<33%) was associated with poor physical role (p<0.001). 
Table 3. 4  Summary of results of studies assessing predictors of HRQoL related 
to biological function 
Factor Predictor 
Quality of life parameters 
PF RP P GH EWB SF Fatigue MH  
B
io
lo
g
ic
a
l 
fu
n
c
ti
o
n
 Anaemi
a 
 (ES0.23) 
[2] 
*** 
[1] 
 
(ES0.2
3) [2] 
*** 
[1] 
  * 
[1] 
   
(ES
0.33
) [2] 
 
Hypoalb
u-
minemia 
** [1]     *** 
[1] 
*[1]   ***[1]    
PF – Physical functioning; RP – Role physical; P – Pain; GH – General health; EWB – Emotional well-
being; OQoL – overall quality of life; SF – social function; MH – mental health 
 = Predictor associated with lower scores on the quality of life parameter 
 = Predictor associated with higher scores on the quality of life parameter 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
[1] Mujais et al, 2009 
[2] Oren and Enc, 2013 
[3] Bohlke et al, 2008 
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3.4.4. Symptoms 
Symptoms including fatigue, pain, pruritus and difficulty with sleep exhibit a 
particularly high prevalence of depression and substantial impairments in QoL 
(Table 3.5).  
Fatigue can be considered an obvious symptom burden and the most commonly 
reported symptom by individuals undergoing dialysis at a variation of prevalence 
of around 84% (Frank et al., 2003), 90% (Curtin, Bultman et al., 2002) 74% 
(Weisbord et al., 2003) and 86% (Norhayati Ibrahin et al., 2002). Fatigue has 
been defined as a subjective sense of weakness, lack of energy and tiredness 
(Stone et al., 1998) in patients with ESRD. Loos et al (2003) predicted that high 
fatigue might be associated with higher risk of cardiovascular conditions (hazard 
ratio: 2.17; p <0.01), having controlled for the well-known risk factors, including 
age, diabetes and cardiovascular diseases, inflammation and malnutrition 
indicators (Loos et al, 2003). Also, the comparisons of the risks in the main 
subgroups showed that the risk of high fatigue score for cardiovascular events 
was more significant in well-nourished patients, including those with an absence 
of past cardiovascular diseases, higher serum albumin and high non-HDL 
cholesterol (Koyama et al, 2010).  
A correlational analysis showed that high bodily pain associated negatively with 
lower physical health (r = -0.56, p <0.001; 95% CI = -0.96-0.36) and mental health 
over time (r = -0.84, p <0.0001; 95% CI = -0.1-0.22) (Bonner et al, 2013). Equally, 
in a study that measured the prevalence of symptoms and their distress on 
patients affected by ESRD, fatigue and pain were rated as the most distressing 
to ESRD patients. Davison and Jhangri (2009) measured the impact of pain and 
fatigue on the HRQoL of HD patients using KDQoL-SF at baseline and after six 
months. The results indicated that fatigue was an independent predictor of 
physical HRQoL at baseline (r = - 1.78, p <0.001; 95% CI = -2.08- 1.48) and 
similar results were obtained after six months (r = - 1.84, p <0.001; 95% CI = -
2.22- 1.47).  
Uraemia is known as a predominant condition in ESRD patients and this is 
because urea is unlikely to be dialysable due to its molecular size and, as a 
consequence of raised urea levels, it can cause itching (Merkus et al, 2000). It is 
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also augmented by itching which is again another constant problem in patients 
undergoing HD, resulting in high urea level and fluid imbalance (Mallick and 
Gokal, 2000). A study conducted in Hong Kong to explore the symptom burden 
and QoL of ESRD patients on dialysis, in comparison with a palliative care group, 
indicated that pruritus was associated with the most intense symptoms and 
correlated negatively with HRQoL domains (p< 0.001) (Yong et al, 2009). In this 
study, the scores of the SF-36 scale correlated negatively with the total number 
of symptoms in ESRD patients (physical functioning r= -0.316; p <0.001, mental 
health r= -0.350; p <0.001). 
Patients who experienced pain reported significantly poorer QoL in relation to 
physical health, psychological health and level of independence when compared 
with individuals without pain (Soni et al, 2011; Kimmel and Patel, 2005). Davison 
and Jhangri (2009) measured the impact of the pain and symptom burden on the 
HRQoL of HD over six months and it was shown to be an independent predictor 
of physical HRQoL at baseline (r = - 0.74, p <0.001; 95% CI= -1.02, - 0.46) and 
after six months (r = - 0.59, p <0.001; 95% CI= -0.98, -0.19). The impact of the 
pain and symptom burden on mental HRQoL at baseline was r = - 0.76, p <0.001; 
95% CI= - 1.04, - 0.48 and, after six months, r = - 0.87, p <0.001; 95% CI= -1.31, 
- 0.43.  
Anxiety and depression were among the significant reported conditions that could 
reduce the QoL of patients affected by ESRD. Oren (2013) indicated that two-
thirds of ESRD patients in Turkey had depression and found an association 
between depressed mood and HRQoL. In similar studies, Liu et al (2013) and 
Pakpour et al (2010) showed that ESRD patients suffered from depression in both 
studies. In a univariate analysis, the scores of depressed patients were 
significantly lower (p <.0001) in all the domains assessed by the Beck Depression 
Inventory measure (physical health, psychological health, social relationship, 
environment and overall QoL). However, after performing multiple regression 
analysis on the data, the QoL profile of depressed patients remained significantly 
worse (Berlim et al, 2005).
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Table 3. 5   Summary of results of studies that assessed predictors of HRQoL 
related to ESRD symptoms 
Factor Predictor 
Quality of life parameters 
PF RP GH EWB SF OQoL MH 
S
y
m
p
to
m
 
Fatigue *** 
[1,4] 
*** 
[1,4] 
** 
[2,3,4] 
   
*** 
[1,3,4] 
Pruritus *** 
[4,5] 
*** 
[4,5] 
      *** [5] *** [4,5] 
Pain *** 
[4] 
          *** [4] 
Depression *** 
[6] 
    *** 
[6] 
*** 
[6] 
*** [6] 
 
Sleep 
     
* [7] 
 
PF – Physical functioning; RP – Role physical; GH – General health; EWB – Emotional well-
being; SF – social function; OQoL – overall quality of life; MH – mental health 
 = Predictor associated with lower scores on the quality of life parameter 
 = Predictor associated with higher scores on the quality of life parameter 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
[1] Bonner et al, 2013; [2] Koyama et al, 2010; [3] Jablonski A, 2007; [4] Davison & Jhangri, 
2009; [5] Young et al, 2009; [6] Berlim et al, 2005; [7] Nejad & Qlich-Khani, 2013 
 
3.4.5. Functional status 
Three studies (Fidan et al, 2013; Guney et al, 2010; and Morsch et al, 2005) 
indicate that physical functioning is usually limited in patients affected by ESRD 
(Table 3.6). This limitation is a result of disease symptoms and treatment regimen 
(Cleary et al, 2005; Pai et al, 2009). Fidan et al (2013) reported that physical 
functioning in ESRD patients may also depends patient’s age, as patients aged 
65 years or over had poorer functional status scores (p < 0.05).  
Guney et al (2012) evaluated the mortality status of haemodialysis patients in a 
prospective study over five years and the association between mortality and 
HRQoL. Their results showed that surviving patients scored significantly lower 
than non-surviving patients in domains including functional capacity (p <0.001), 
physical role functioning (p <0.026), mental health (p <0.033) and total SF-36 
score (p <0.001).
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Table 3. 6  Summary of results of studies that assessed predictors of HRQoL related to 
functional status 
Predictor 
Quality of life parameters 
PF RP OQoL MH 
F
u
n
c
ti
o
n
a
l 
s
ta
tu
s
 
 * [1,2,3]  * [1,2]  *** [1,2,3]  ** [1,2,3] 
PF – Physical functioning; RP – Role physical; OQoL – overall quality of life; MH –  mental 
health 
 = Predictor associated with lower scores on the quality of life parameter 
 = Predictor associated with higher scores on the quality of life parameter 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
[1] Fidan et al, 2013; [2] Guney et al, 2010; [3] Morsch et al, 2005 
 
3.4.6. General health perceptions 
Perceptions of general health are considered to be central to an individual’s life 
experience and contain measurable aspects involving an overall assessment of 
any individual’s life (Schmitt and Jüchtern, 2001; Stanley and Cheek, 2003). In 
most studies, the cognitive appraisal of life experience, satisfaction and emotional 
reactions of individuals about their life events are integrated into the overall 
assessment of QoL. Such a combination of personal well-being, life satisfaction 
and emotional reactions to life events can all be seen as forms of subjective well-
being which might present an “umbrella” term for different evaluations that 
individuals make about their lives, the events occurring to them and the conditions 
in which they live (Diener, 2006). 
3.4.7. Spiritual wellbeing 
Spiritual wellbeing was among the less reported factors that might affect QoL in 
patients with ESRD (Table 3.7). Ramirez et al (2011) examined the relationship 
between spiritual/religious factors in Christian patients affected by ESRD. They 
reported that spiritual/religious struggle is associated with depression (r = 0.43; p 
<0.0001) and anxiety (r = 0.32; p <0.0001) symptoms. Despite multivariate 
adjustment to clinical and socio-demographic variables, these associations 
remained significant, whereas, in contrast, positive religious coping was 
associated with a better overall HRQoL (0.17; p <0.02) and better social relations 
(0.23; p < 0.01). Similarly, Saffari et al (2013) examined the relationships between 
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spiritual, demographic and clinical variables and QoL among Iranian Muslims 
undergoing haemodialysis. Regression analysis revealed that demographics, 
clinical variables and particularly spiritual factors, explained about 40% of the 
variance in the results for QoL and approximately 25% of the variance in health 
status (Saffari et al, 2013). 
Table 3. 7 Summary of results of studies that assessed predictors of HRQoL related to 
health perceptions in ESRD patients  
Factor Predictor 
Quality of life parameters 
PC SS DS AN OQoL SR 
G
e
n
e
ra
l 
h
e
a
lt
h
 
p
e
rc
e
p
ti
o
n
 
Psychosocial 
(r = 65) 
[1] 
(r = 38) 
[1,2] 
    
Religious struggle   
 *** [2]  *** [2]   
Positive religious 
coping     
 ** [2] 
 *** 
[2] 
PC – perceived control; SS – social support; DS – depressive symptom; AN – anxiety; OQoL – 
overall quality of life; SR – social relations 
 = Predictor associated with lower scores on the quality of life parameter 
 = Predictor associated with higher scores on the quality of life parameter 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
[1] Tovbin et al, 2002; [2] Ramirez et al, 2011; [3] Jablonski A, 2007 
 
In conclusion, the main limitations of this literature are the lack of an explicit 
theoretical framework as well as the interchangeable use of the terms HRQoL 
and QoL. The summary of the common predictors of QoL and HRQoL have been 
identified in the literature and those that may contribute to explaining HRQoL in 
patients with ESRD are: 
a) Individual characteristics: Age, gender, educational level, marital status, 
monthly income; 
b) Biological factors: anaemia and malnutrition; 
c) Clinical factors: length of time on HD, duration of HD session, time to reach 
HD; 
d) Symptoms: fatigue, pruritus, pain, anxiety and depression; 
e) Functioning status: ability to maintain-day-to-day activities; 
f) Socio-environmental factors: social and family support, income status; 
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g) General health perception: a representation of the satisfaction level of all 
health concepts together; 
h) Spiritual life: perception about existential need for wholeness and 
connection with the universe and ability to perform religious rituals. 
3.5. How are QoL and HRQoL operationalised in patients with ESRD 
(answers search question-2) 
Numerous measures, accordingly, were developed to examine the relationship 
between the aforementioned factors of HRQoL and patients’ perceptions about 
their overall QoL as well. The developed measures can be characterised in terms 
of three continuums: 1) generic measures; 2) disease and symptoms-specific 
measures; 3) individualised QoL instrument.  
Of the 45 studies reviewed, 15 different measures were identified that assess 
QoL and HRQoL. These measures, as with literature review-one, can be 
categorised as: 1) generic and health-outcome measures; b) disease-specific 
measures; and c) individualised QoL measures. Nineteen studies used 
generic/health measures; 16 studies used both generic and symptom- and 
condition-specific measures; nine studies used only disease- or condition-specific 
measures; and one study was found to measure QoL by using an individualised 
instrument. Figure five illustrates the number of studies using QoL and HRQoL 
measures and the most common validated instruments. 
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(SF-36v2): Short Form36 version 2; (WHOQoL-Bref): World Health Organisation Quality of Life-Bref; (EQ)-
5D: EuroQol; (QoLS): Quality of Life Scale; (SWBQ): Spiritual Wellbeing Questionnaire; (KDQoL-SF): 
Kidney Disease Quality of Life-Short Form; (HADS): Anxiety and Depression Scale; (ESRD-SI): End Stage 
Renal Disease Severity Index; (IPQ): Illness Perceptions Questionnaire; (MSAS-SF): Memorial Symptom 
Assessment Scale Short Form; (QoL-ID): Ferrans and Powers Quality of Life Index-Dialysis; (ICQ): Illness 
Cognition Questionnaire; (PSQI): Pittsburgh Sleep Quality Index; (IDS): Fatigue Severity Scale (FSS) Index 
of Disease Severity; (IPQ-R): Revised Illness Perception Questionnaire. 
Figure 3. 3  Number of studies using HRQoL measures 
3.6. The most common validated instruments used to measure QoL and 
HRQoL in ESRD patients and their effectiveness (answer search 
question-3 and 4) 
The accuracy and relevance of the identified measures were explored and 
evaluated against specific quality criteria of measurement properties. The criteria 
used for the evaluation of these measures were adopted from the Scientific 
Advisory Committee (SAC) of the Medical Outcomes Trust. It covers issues of 
validity, reliability, responsiveness, feasibility and cultural and language 
adaptation as well as the number of life domains covered. Appendix 3.4 
summarises the results of psychometric qualities, feasibility and life domains 
covered pertaining to the identified measure. However, given the range of 
measures identified, and for the purpose of this study, the section below will 
classify and discuss the most common validated and appropriate measures to be 
used to assess QoL and HRQoL in ESRD patients in this study.  
45 studies 
19 studies (42.2 %)
used generic HRQoL 
measures
16 studies (35.5%) 
used both generic and 
disease-specific 
HRQoL measures
35 studies used SF-
36, WHOQoL-Bref, 
EQ-5Q, QoLS 
25 studies used SWBQ, 
KDQoL-SF, HADS, BDI, 
MSAS-SF, QoL-ID, ICQ, 
PSQI, IDS, IPQ-R, FSS, 
Itch scale
9 studies (20%) used 
disease-specific HRQoL 
measures
1 study (2.2%) 
used an 
individualised QoL 
instrument
Schedule for the 
Evaluation of 
Individual QoL 
(SEiQoL) 
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3.6.1. Health status measure  
Short Form-36v2 (SF36v2) is a simple and effective health-related quality of life 
measure. The 36v2 is a 36-item measure assessing eight health concepts: 
physical functioning, social functioning, physical role limitation, emotional role 
limitations, bodily pain, mental health, vitality and general heath perceptions. 
These concepts can also be presented as two summary scores representing 
physical and mental health. The scoring range of the SF-36v2 is 0-100 for each 
of the eight domains. Zero indicates poor health status and 100 indicates very 
good health status. Its internal consistency, based on Cronbach’s alpha, was >α 
0.80 for most of the domains except social functioning (0.76) (Ware JR, 1992). 
This finding suggests that all domains are reliable for comparisons between 
groups of patients. The test-retest reliability showed a correlation coefficient over 
a two-week period (>.080) across all domains (Green et al, 2001; Morsch et al, 
2006; Schell et al, 2013). 
The SF-36v2 has been translated into many different international languages 
and is now considered the most frequently used generic health status instrument 
across the world (Bowling, 2005): among these languages are French, German, 
Dutch and Arabic. The method of administration of the SF-36 instrument can be 
self-completed or interviewer-administered (by face-to-face interview or 
telephone). The anticipated time to complete the questionnaire is around 10 
minutes for most participants and 15-20 minutes for some elderly participants 
(Pakpour et al, 2010).  
3.6.2. Disease-specific measures 
The Quality of Life Index-dialysis (QoLI-D) is the version that was primarily 
developed by Ferrans and Power (1984) for use with dialysis patients. It consists 
of 68 items that measures four key aspects: health and functioning, social and 
economic, psychological and spiritual, and family. It consists of two sections 
assessing participant satisfaction and the relative importance of each aspect, 
respectively. Six-point ordinal response scales range from “very dissatisfied” or 
“very unimportant” (1), to “very satisfied” or “very important” (6). Its index scores 
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range from zero to 30, where higher scores indicate a better quality of life 
(Bowling, 1995, p54).  
A high range of internal consistency was reported on the QLI across three 
studies: Ferrans and Powers (1985) reported α 0.90, Ferrans and Powers (1992) 
α 0.93 and Tasy and Healsted (2002) reported α 0.88. The QLI concurrent 
validity was supported for each domain when compared with a life-satisfaction 
questionnaire with a correlation for the spiritual domain (Song et al, 2009). A 
computable response rate of 46% of patients through postal administration was 
reported by Ferrans and Powers (1992) in their later study. This rate was drawn 
from a large population of 394 HD patients. A higher response rate was reported 
by Killingworth and Van Der Akker (1996) in their study of measuring QoL of 
renal-dialysis patients using QLI (86% response rate from PD patients and 48% 
from HD patients). 
The Ferrans and Powers QLI-D instrument has been frequently used to study 
HRQoL in ESRD patients (Joe et al, 2004; Cheung, 2012; Rambod et al, 2010). 
The QLI-D was used together with other HRQoL measures, such as SF-36, Index 
of Well-Being, KDQoL-SF and the Personal Resources Questionnaire (PRQ-85), 
in a renal-failure population with a positive factor analysis which confirmed the 
instrument’s construction. The QLI-D covers many dimensions important to an 
ESRD population, yet there are a few areas that are not covered, such as sleep, 
cognitive function and areas specific to treatment, such as length of dialysis time. 
3.6.3. Symptom-specific measures 
Several measures were developed to assess different symptoms related to 
ESRD. As mentioned earlier, fatigue, pruritus, anxiety and depression are the 
symptoms most reported by ESRD patients.  
The Fatigue Severity Scale (FSS): is a nine-item scale measuring the severity 
of fatigue and its effect on a patient’s daily life activities and overall QoL. FSS 
items are scored on a seven-point scale with 1 = strongly disagree and 7 = 
strongly agree. The minimum score is nine and the maximum possible score is 
63. The higher the score, the greater the fatigue severity. It is a self-reported 
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measure and easy to administer. The FSS is reported to be valid as test-retest 
reliability was found to have an intraclass coefficient (ICC) of 0.91 and an internal 
consistency of α = 0.94 (Grace et al, 2006). Hagell et al (2006) reported an 
excellent reliability score of Cronbach’s α 0.91. When the FSS test was used in a 
study with patients affected by Parkinson’s disease in the treatment arm (p < 
0.04), a reduction of 6.5 points in the FSS score was observed from an original 
score of 43.8 points at baseline (Cohen’s d = 0.79). 
Hospital Anxiety Depression Scale (HADS): HADS was developed by Zigmond 
and Snaith in 1993 as a quick way to assess symptoms of depression and general 
anxiety in non-psychiatric patients. It has 21 items in total and assesses anxiety 
and depression as separate components, each with seven items (Zigmond and 
Snaith in 1993). The advantage of HADS is that the items exclude somatic 
symptoms and therefore avoid symptom overlap between mood disorders and 
somatic illnesses (Harter et al., 2006).  HADS is an easily administered 
questionnaire and takes around 5-10 minutes to complete (Scand and Caring, 
2013). The internal consistency for HADS ranges from a Cronbach’s alpha of 
0.73 to 0.91; likewise, similar reliabilities have been found for the 14 items of the 
instrument (Martin et al, 2004). HADS shows high internal consistency with alpha 
coefficients of 0.86 and 0.91 in populations of psychiatric and non-psychiatric 
patients (Zigmond and Snaith, 1993). However, HADS scores can be easily 
exaggerated or minimised by the participants, as is the case in other self-reported 
questionnaires. Similarly, if patients are affected by physical illness, such as 
fatigue, HADS scores might become inflated and indicate other symptoms rather 
than those related specifically to depression. 
The 5-D Itch:  The literature revealed limited measures of pruritus in ESRD. The 
most frequently used quantifying measure is the visual analogue scale (VAS). 
Although VAS is considered adequate in measuring the severity of pruritus, it is 
a unidimensional measure and does not take into account the relative impact of 
pruritus on QoL. The 5-D Itch was developed as a brief and multidimensional 
measure that can detect different aspects of pruritus as well as changes over 
time. As its name indicates, it consists of five items that measure five dimensions: 
the degree of pruritus and its duration, direction, disability and distribution (Elman 
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et al., 2010). The first four items are measured on a five-point Likert scale, while 
the fifth item has four sub-items that can be scored to provide a sum equal to the 
other four. The scores of each of the five items are achieved separately and then 
added together to obtain a total score. The overall scores can potentially range 
between 5 (no pruritus) and 25 (most severe pruritus). The 5-D Itch scale is 
reported to be valid as test-retest reliability was found to have an interclass 
coefficient (ICC) of 0.89 and an internal consistency of α = 0.73 (Elman et al., 
2010). Khan et al (2013) found that the reliability of the five aspects of the 5-D 
Itch indicates the practical applicability of the measure with inter-correlation of 
0.847 (p < 0.05).  
3.6.4. Individual QoL instrument 
Limited tools were reported that measure individual QoL. SEIQoL-DW can be 
considered as an innovative measure as it attempts to capture the individual 
nature of QoL. Unlike many other instruments of QoL and HRQoL, SEIQoL-DW 
is based on an underlying theory of what makes up QoL from an individual’s own 
perspective and on his/her own perception and understanding of QoL 
(Kolewaski, 2005).  
With regard to the psychometric quality of SEIQoL-DW, the internal consistency 
cannot be assessed as SEIQoL-DW is a profile measure where each of the listed 
areas/domains by a patient is considered distinct and related only to that 
particular patient. For test-retest reliability, Ruta et al (1994) reported a Pearson’s 
correlation of 0.70 over a two-week period. In a more recent evaluation, Loos et 
al (2003) reported that some elderly patients incorrectly interpret scoring 
instructions (intraclass correlation coefficient = 0.55), which might reduce the 
reliability assessment. Content validity is also specified by each individual patient, 
thus confirming validity for each patient. However, for construct validity, SEIQoL-
DW was able to discriminate between patients at different stages of renal failure. 
The possible limitations of this instrument are that illiterate patients cannot 
express themselves clearly unless assisted by someone else, while the list of 
possible affected life domains is limited to five areas.  
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3.6.5. Religious and Spiritual measure 
The review identified a number of measures that that assess some aspects of 
spirituality in ESRD patients. However, the Spiritual Wellbeing Scale (SWBS) is 
deemed as an appropriate measure for this study as it assesses spirituality, 
religiousness, and existential concerns in ESRD patients. It contains 20 items of 
which 10 assess existential wellbeing and 10 religious wellbeing. Daaleman and 
Frey (2004) reported significant correlations with other QoL instruments that 
measure well-being and spirituality: the Zung Depression Scale (r = 0.42, p 
<.001), the General Well-Being Scale (r = 0.64, p <.001) and the Spiritual Index 
of Well-Being (SIWB) (r = 0.62, p <.001). Additionally, they reported a total scale 
of α = 0.91 and a test-retest result of r = 0.79, showing very good reliability.  
In summary, various HRQoL measures, such as generic and disease-specific 
instruments, were used in ESRD studies. Health measures were the most 
commonly used to evaluate different aspects of health: physical, psychological 
and social as well as perceived well-being, with the SF-36v2 being the most 
commonly used. Similarly, disease- or condition-specific measures evaluate the 
particular symptom or condition that might be associated with the level of QoL. 
These measures are available in several languages, such as English, Dutch, 
Chinese and Arabic. However, demographic and clinical factors have also been 
shown to have an impact on QoL in ESRD patients. Yet there were fewer 
research studies found that considered assessing HRQoL and QoL by using a 
combination of generic, disease-specific and individualised measures. It is 
believed that using such a tripartite approach (generic, disease- or condition-
specific and individualised measures) in assessing the quality of life of patients 
affected by ESRD would help in understanding the overall sense of well-being of 
this particular population.  
72 
 
4. Discussion 
The heterogeneity of the participants in most of the studies included in this review 
is problematic regarding the generalisability of its findings to patients affected by 
ESRD in Oman. There is a concern regarding the composition of the samples in 
many of the studies as most of the participants were male. Ultimately, this makes 
the generalisability of these findings to other groups of ESRD patients, and to 
those from different cultural backgrounds, questionable, as in the case of Omani 
ESRD patients.  Furthermore, the majority of the reviewed studies did not clearly 
state the encountered confounding factors. Confounding factors could interact 
and negatively affect measurement of the outcomes.  However, some studies 
indicated that the tackling of confounding factors came through limiting the 
following covariates: type of dialysis (HD or Peritoneal dialysis); age; patient 
condition, such as diabetes, depression and hypertension; gender; and common 
laboratory tests such as albumin and haematocrit (HCT) (Billington et al, 2008; 
Fidan et al, 2013; Brekke et al, 2014). In contrast, Cleary (2005), Morsch et al 
(2006) and Hayashino et al (2009) used a statistical matching technique to 
minimise confounding factors and compromise the factors that estimated the 
study outcomes. Factors that should be considered when replicating HRQoL 
studies or generalising the results were found to be: type of dialysis; increased 
acceptance rate for dialysis of elderly patients; patients affected by serious 
comorbid diseases; and an increased case mix increasing the difficulties of 
measuring the QoL of patients on maintenance dialysis. 
The review showed that socioeconomic, functional, psychological, clinical and 
biological factors describe HRQoL in ESRD. Equally, they demonstrate a growing 
interest in assessing the perceived HRQoL and QoL in this group of patients. All 
the included studies that have been carried out reached the same conclusion, 
that ESRD patients have a poorer generic and disease-specific HRQoL. Yet the 
studies are not clear about which areas of HRQoL are most affected. The lower 
level of QoL among ESRD patients could be related to the complications 
associated with disease (Phillips et al., 2001; Patel et al., 2002; Weisbord et al., 
2003), clinical factors, socioeconomic factors, and demographic factors. 
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The term “HRQoL” was more dominant than the overall term “QoL” in literature. 
Few authors, however, interchanged the use of the QoL and HRQoL terms 
(Bakewell et al., 2001; Drayer et al., 2006; Morsch et al., 2006). Farquhar (1995), 
Oort et al (2005), Debout (2011), LA-Placa et al (2003) defined QoL and HRQoL 
according to self-reported health status and functioning status. These studies, 
however, did not attempt to define the concept of QoL and HRQoL, or at 
minimum, clarify the areas associated with QoL and HRQoL. Without clear 
definitions of QoL and its delineated aspects, conceptual clarity can still be 
achieved through the use of a conceptual framework or theory (Cortina, 1993). 
Out of the 45 studies reviewed, only three studies provided a theoretical 
foundation.  
Despite that, the measures used to assess QoL and HRQoL were proven relevant 
according to the reported psychometric-qualities results. Most of the researchers 
acknowledged that there were difficulties in determining whether the measures 
used measured QoL exactly. This is possibly due to the absence of a consensus 
or gold standard for the meaning of QoL. It is indeed a challenge to determine 
whether any measures of QoL and HRQoL tap into the intended aspect of any 
one individual’s experience (Lee et al, 2009). There is also the possibility of 
variation between the standardised QoL measures and the patient-perceived 
QoL instrument, which adds a further limitation to the measurement of QoL. 
Possible reasons for this potential disconnect might be cultural differences, 
coping mechanisms and patient values. Using a more individualised measure of 
QoL would perhaps allow and advise patients to select areas of their life that they 
view as being most relevant to their own well-being (Ferri and Pruchno, 2009). 
Likewise, selecting a measure of QoL can be difficult because of the 
extensiveness of the concept of QoL. The measure should provide an inclusive 
view of most of the life aspects that might influence QoL in patients affected by 
ESRD. The disease-specific measures are helpful for researchers as they provide 
a better focus on functional areas of a particular concern (Glover et al, 2011). 
Although instruments that measure a specific condition/symptom or disease 
appear attractive for use in clinical practice and research as a screening 
instrument to identify a symptom’s severity, they are limited in their scope for 
measuring broader areas of life aspects (Fryback et al, 2010). Using a generic 
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measure could provide a broader view on the overall aspects associated with 
QoL. But again, this is unlikely to show the real benefits of specific interventions 
which demand a use of disease-specific measures. To overcome this, there 
should be a balance in capturing the aspects, based entirely on the patient’s own 
perceptions, impacted upon by the disease in a patient’s life and in his or her 
overall aspects of life.  
In spite of the fact that the majority of studies that examine QoL and HRQoL have 
been conducted within a Western culture, a limited number of studies are 
available examining QoL and HRQoL aspects in the Arab world. These studies 
showed a low HRQoL among Arab patients affected by ESRD, with a significant 
score variation evident within the different subdomains of HRQoL that were 
assessed (Abd Elhafeez et al, 2012; Al-Jumaih et al, 2011).  A possible reason 
for this variation could be the specificities of each country in terms of social and 
cultural life, economic status and level of healthcare services. Thus, the 
determinants and influencing factors of QoL and HRQoL are likely to differ among 
patients within different countries (Bergland, 2007).  
In Oman, there is hardly any evidence of previous assessment of the QoL and 
HRQoL in ESRD patients. Great consideration is needed when determining the 
most appropriate measures that will capture the different aspects of QoL within 
Omani context. It is believed that using the revised Wilson and Cleary model of 
HRQoL to guide this study would provide a rigorous approach to assessing 
HRQoL in the Omani context including aspects of biological function, symptoms, 
functional status, general health perceptions and various characteristics of the 
individual and the environment. This can be achieved, as one approach, through 
the use of: 1) a generic measure to capture aspects related to overall quality of 
life; 2)a kidney disease-specific measure to help in measuring aspects related 
entirely to ESRD patients which would also gather the clinical-related factors; 
3)an individualised QoL measure to help in exploring how Omani ESRD patients 
perceive the meaning of QoL; and 4)a spiritual and religious measure to assess 
patient’s relationship with God and sense of their life purpose. 
It is believed that assessing the perceptions of this patient group in Oman would 
increase the general understanding of how to improve their QoL and of how to 
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support the shift of healthcare services from episodic treatment to a treatment 
that meets their ongoing needs. 
5. Conclusion and recommendations 
ESRD is a chronic condition that causes a great negative impact on patients’ 
HRQoL mainly due to the accompanied impairment or to the imposed limitations 
in almost all aspects of their life. Numerous studies have examined QoL and 
HRQoL in patients with ESRD. The majority of these studies have mainly focused 
on health-related QoL. Also, no studies have been found that use a 
comprehensive perspective on analysing aspects of biological function, 
symptoms, functional status, general health perceptions and various 
characteristics of the individual and the environment as one approach. This 
narrow conceptualisation may have left a gap in the understanding of QoL and 
its influencing factors in patients with ESRD.  
Most of these studies were conducted within Western culture, with only two found 
that examined QoL and HRQoL aspects in ESRD patients in the Arab world (Abd 
El Hafeez’s et al., 2012; Abdel-Kader et al., 2009). The results of these studies 
showed a low HRQoL among ESRD patients including Arab patients. As with 
Arab countries, no studies were found that had been conducted in Oman to 
assess QoL in this group of patients, or to assess how these patients perceive 
their QoL. As a result, there is a need to explore the concept of QoL within the 
Omani context prior to describing and measuring the levels of factors of QoL and 
HRQoL. The individualised QoL (SEIQoL-DW) is a suggested instrument can be 
employed to explore the perception of Omani ESRD patients. SEIQoL-DW 
instrument can reveal areas of life not typically included in standardised 
measures, generic and disease and symptom-specific, but designated as 
relevant by the patients.  
The most frequent measures that were valid and utilised to measure QoL and 
HRQoL in patients with ESRD were identified and evaluated against specific 
quality criteria of measurement properties. Therefore, the possible measures of 
QoL and HRQoL in ESRD patients for this project are related to health status, 
condition or disease-specific, symptom-specific, and religious/spiritual life. 
Although suggested measures are available in the Arabic language, they have 
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not been tested and validated within the Omani context. Exploring patients’ 
understanding of the suggested measures is crucial. Hence, cognitive 
interviewing method can be used to explore patients’ interpretations of the 
measure’s items, elaborate on their responses and report any difficulties they 
might have in answering these items (Beatty & Willis, 2007). It also helps and 
guides in modification and improvement of the measures.
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Chapter 4- Methodology 
 
This chapter presents the theoretical framework that was used to guide this study, 
study design, sampling, and procedures for data collection including the 
measurement used as well as clinical setting. The data analysis plan of the three 
phases of this study is also described. Finally, data management, and the plan of 
risk assessment that was placed to anticipate potential risks to the project are 
discussed. 
1. Introduction  
End-stage renal disease (ESRD) is a serious and chronic disease that negatively 
impacts patients’ HRQoL mainly due to the accompanied impairment or to the 
imposed limitations in almost all aspects of their lives. Despite the considerable 
progress which has been made in treating ESRD patients and HD procedures, 
HRQoL remains a significant problem for haemodialysis patients (Cukor et al., 
2013). Numerous studies using different measures have examined both the 
concepts of HRQoL and overall QoL in patients with ESRD and have revealed 
that the multiple physiological and psychological factors that patients may 
experience could impair their life style which in turn might change and 
subsequently lower their QoL level.  
Treating ESRD and its related treatment might consume large amounts from the 
health budget. The determination of successful health outcome for patients with 
ESRD has been limited to clinically-focused measures including HD adequacy, 
acceptable laboratory values and intradialytic management (De Geet and Moons, 
2000). Alternative outcome measures of the efficacy of provided treatment and 
HD are therefore required (Brekke et al., 2014). This seems to be through 
assessing HRQoL which could be included when health care professionals 
assess the benefits of different ESRD treatment options. This however might not 
be sufficient because dialysis patients may not experience satisfaction with their 
HRQoL despite physiological measures being met. Thus, more subjective, 
patient-focused, disease-focused measures are needed to enhance the health 
outcome assessment for patients on HD.  
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Most of the studies that assess QoL and HRQoL among ESRD patients were 
conducted within Western culture, with only two studies (Abd Elhafeez et al, 2012; 
Al-Jumaih et al, 2011) found within Arab countries. The results of these studies 
showed low scores of HRQoL among Arab patients with ESRD. Similar to Arab 
countries, no studies were found that had been conducted in Oman to assess 
QoL in this group of patients, or on how these patients perceive their QoL.  Also, 
no studies were found that have used the approach of assessing the biological 
function, symptoms, functional status, general health perceptions, and various 
characteristics of the individual and their environment.  Even with studies that 
used more than one measure of QoL (Saffari et al, 2013; Green et al, 2001; 
Ramirez et al, 2012; Griva et al, 2009; Kao et al, 2009; Cleary et al, 2005) the 
researchers did not articulate a holistic conceptual framework to guide their study, 
providing little justification of the independent variables used to explain QoL. This 
study is needed to fill these gaps in knowledge. 
Accordingly, three different phases were employed to answer the research 
questions. Phase one (Chapter Five) explored the meaning of QoL to an Omani 
population, using a cognitive interviewing and a measure of individual QoL. In the 
second phase (Chapter Six), the practicality of the study measures were piloted 
and tested within the Omani ESRD population. This phase also assessed the 
feasibility of the third phase (main study), informed the sampling size, assessed 
the likely success of the proposed recruitment approaches and identified possible 
logistical problems. This third phase (Chapter Eight) involved conducting a large 
cross-sectional study to determine the factors that affect QoL and HRQoL in 
patients with ESRD, and investigating the associations between symptom 
burdens and physical, psychological, clinical and socio-demographical factors.  
2. Philosophical paradigm, research approach, and theoretical framework 
For the purpose of conducting this study objectively and systematically, the 
Research Onion Diagram by Saunders et al. (2009) was adapted and followed 
(Diagram 4-1). This diagram illustrates the steps of the research process which 
was followed to produce valid and replicable data. It consists of philosophical 
paradigm; selected study method; selected study design; determined time 
79 
 
horizon according to the study; and planned data collection procedure and 
analysis. 
 
 
2.1. Philosophical paradigm and research approach 
The term paradigm refers to the roadmap that directs a research journey (Black, 
1999). Different philosophical paradigms are available that represent different 
ideas about reality and how knowledge can be gained (Black, 1999), such as 
positivism, realism and pragmatism. These paradigms include specific 
methodological strategies which allow researchers to use the research approach 
and method, and to recognise any limitations that might disrupt the research 
(Broom and Willis, 2007).  For this study, the positivist paradigm was adopted 
based on the assumption that nature is basically ordered and has antecedent 
causes (Sapsford, 2007) as is the case with perceived low HRQoL which can be 
caused by more than one factor.   
 
Quantitative research assumes that phenomena are stable and can be predicted, 
thus, they can be measured (Matthews and Ross, 2010). The outcomes of this 
PhD study such as physical health, mental health, symptoms, and even spiritual 
life, can be measured, therefore, the quantitative approach was considered 
Positivism 
Quantitative 
Survey 
Cross-sectional 
Data collection,  
Data analyses 
Multi Method 
quantitative 
Philosophies 
Approaches 
Design 
choices 
Time horizon 
Procedure of 
data 
collection 
and analyses 
Diagram 4. 1  Research Onion Diagram (adapted from Saunders et al. 2009) 
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appropriate for this study to find the frequency and association between factors. 
In healthcare research, quantitative approach is an essential part and most the 
common method (Sapsford, 2007). It is a good approach to minimise bias and 
also to maintain an objective view while studying a phenomenon to develop valid 
results (Matthews and Ross, 2010). 
2.2. Conceptual framework  
A conceptual framework could act as a heuristic device to provide a better 
understanding and clarity of QoL and HRQoL. It also can help in specifying 
research concepts, and selecting the appropriate measurements for testing these 
concepts. The revised version of Wilson and Cleary’s (1995) model for health-
related quality of life (Ferrans et al., 2005) was used to guide this study. This 
conceptual framework incorporates important health-related factors, as well as 
individual and environmental characteristics which address the difference 
between the clinical reported outcomes and the patient reported outcomes. 
These health-related factors are biological functioning, symptoms, functional 
status, and general health perception. A summary of all the study variables are 
combined and shown in Diagram 4.2. 
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Biological function includes the physiological processes that support life (Ferrans 
et al, 2005). This describes the patient's biophysical status as a result of the 
ESRD condition in terms of the status of anaemia and malnutrition. The 
symptoms experience is the patient's perception of the presence of physical and 
emotional problems that reflect the severity of their symptoms (Wilson and 
Cleary, 1995).  Although functional status is usually influenced by biological 
function and symptoms, it is important that it is measured as a separate variable 
because it may not be completely correlated with biological function or with 
symptoms. Two aspects of functioning were measured in this study: (1) physical 
functioning and (2) psychological functioning using the SF36v2 measure. Socio-
environmental characteristics were defined as the perceived family, socio-
economic and spiritual life, from a patient's perspective, and their influence on 
the patient’s health. For this study, the characteristics of the family and socio-
environmental variables were measured by the subscales of QoLI-dialysis.  
As the religious and spiritual domain appeared to be important within an Omani 
context, it was essential that it be tested as a separate variable in this study. It 
refers to the affirmation of an individual’s life in relation to God, self and 
community (Johnson, Piderman et al, 2007). It falls very much in line with 
patients’ personal values and the spiritual beliefs that shape their lives. Thus, the 
spiritual wellbeing variable will refer to a patient’s sense of wellbeing in relation 
to God and to a patient’s perception of life’s purpose and satisfaction.  
General health perception is considered to be central to patients’ health, a 
representation of all health concepts together, and contains measurable aspects 
involving an overall assessment of any individual’s life (Schmitt and Jüchtern, 
(2001); Stanley and Cheek (2003). The cognitive appraisal about health, and 
emotional reactions of patients about their life events are integrated into the 
overall assessment of HRQoL. Such a combination of personal well-being, life 
satisfaction and emotional reactions to life events can all be seen as a subjective 
well-being which might present an ‘umbrella’ term of different valuations that 
patients make regarding their lives, the events happening to them, their bodies 
and minds, and their circumstances in which they live (Diener, 2006). General 
health perception is most commonly measured with a single global question, 
indicating an overall health rating on a Likert-type scale from poor to excellent. 
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The components of this conceptual model acknowledge that health exists on a 
continuum from simple to complex outcomes with four determinants, each having 
multiple variables (Peterson and Bredow 2009). These determinants, as well as 
overall quality of life, are ultimately affected by the characteristics of the individual 
and the environment (Ferrans et al., 2005; Kring, 2008). Further details on the 
level of the revised version of Wilson and Cleary’s (1995) model for HRQoL 
(Ferrans et al., 2005) are in Chapter Two.
Characteristics of the individual 
Age, gender, educational level, marital status, monthly 
income, religious and spiritual life 
Characteristics of the environment 
Social support, duration of HD, social activities 
Biological 
functioning: 
Anaemia 
and 
malnutrition 
Symptoms: 
Fatigue, 
pruritus, 
pain, 
depression 
Function
al status: 
Ability to 
maintain 
day-to-
day 
activities 
General 
health 
perception 
 
HRQoL 
(outcome) 
  
Individualised 
QoL 
Diagram 4. 2 Summary of factors that may contribute to explain HRQoL in patients affected by 
ESRD 
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3. Research Methods 
3.1. Study Design 
This non-experimental study used a cross-sectional, correlational design to 
explore and assess QoL and HRQoL and to identify its related predictors 
regarding Omani patients with ESRD. Given that no studies were found that had 
been conducted in Oman to assess HRQoL in this group of patients or on how 
these patients perceive their QoL, it was essential to use a design that allowed 
for, firstly, the  identification of the factors and patients’ perception that made up 
their HRQoL/QoL at a specific point in time. The use of cross-sectional design in 
this study provided data that may reflect the entire Omani population as data were 
collected across the country. However, the concept of HRQoL is considered 
dynamic (Pastrana et al., 2008) and cross-sectional design might be limited in 
capturing dynamic factors. That is, the concepts of and factors influencing HRQoL 
are dynamic and could change over time depending on one’s perception. In the 
context of this study, and because the study is not examining the changes in QoL 
and HRQoL over time, a cross-sectional design was deemed appropriate and 
data were collected at one point in time from patients to examine their level of 
QoL and HRQoL as well as related factors. It is also believed that the benefit of 
employing a cross-sectional design is to describe the status of phenomena or the 
relationship among phenomena (Polit & Beck, 2008). 
The correlation design was used to examine the association among study 
variables.  
 
3.2. Population 
3.2.1. Inclusion criteria 
The characteristics of patients included in all three phases were: adult patients 
with ESRD receiving HD; those aged ≥ 18 years; and those who have been on 
HD for at least three months so that they are adjusted to life on dialysis.  
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3.2.2. Exclusion criteria  
Patients who did not survive on HD longer than three months; patients with acute 
renal failure; patients aged under 18; patients diagnosed with dementia or any 
other condition that could impair their ability to answer questions; patients who 
have recently been diagnosed with cancer; and patients who have recovered their 
renal function. 
3.2.3. Sample size 
Phase one sample size was informed by literature that used the cognitive 
interviewing and individual QoL instruments method in data collection as well as 
studies using individual QoL measures (Tavernier et al., 2011; McGee et al., 
1991; Becker et al., 2014). An average of eight to 15 participants is considered 
applicable. Accordingly, it was planned for 16 patients to be approached and 
interviewed during their waiting time before starting their routine HD sessions.  
The target sample in Phase two was 50 participants in total, during their 
presence for HD, at a rate of 15 patients from Site 1, 15 patients from Site 2 and 
20 from Site 3. Based on the response rate obtained from phase one, 60 patients 
were approached to avoid any inaccuracy in the list as patients sometimes stop 
HD for transplants or from personal preference. Participants from phase one were 
excluded from this phase by excluding their names from the randomisation list.  
The statistical analyses in Phase three required the calculation of a sample 
meeting the assumptions of factor statistical analysis and sequential multiple 
regression analysis. Thus, in order to perform the planned statistical analyses a 
sample size of 448 is needed. 
4. Ethical approval and data management 
The study was conducted in accordance with the ethical approval granted by the 
University Research Ethical Committee (UREC) at the University of Dundee 
(UoD)-UREC 15060 (Appendix 4.1.a), the Directorate of Research and Ethical 
Review and Approve Committee, Ministry of Health, Oman, 
MH/DGP/R&S/PROPOSAL_APPROVAL/16/2015 (Appendix 4.1.b). 
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It was expected that no potential risks would occur and that any risk of physical 
or psychological harm was at a minimum level because this study did not involve 
any clinical interventions. Also, there was no risk of social or economic harm 
because the participants who took part in this study did not travel to take part, as 
they were recruited during their regular attendance at HD.  
The researcher ensured that patients had complete autonomy to decide whether 
or not to participate without any pressure being applied. They were informed that 
their participation was entirely voluntary and they could withdraw from the study 
at any time without negatively affecting the treatment or care they received. The 
confidentiality of the participants was preserved throughout the study and 
participants were reassured that interview content was kept confidential and 
would be used for study purposes only without identities being mentioned in any 
documents related to this study.  
Participants were informed verbally and in writing, using the information sheet 
approved by both ethical committees. For patients who could not read, the 
information sheet and consent form were explained verbally. Participants were 
required to sign the consent form and for those who could not write, an available 
witness was required to sign instead. The witness had to be a family member 
(husband, wife, sister, brother, or close relative such as a cousin). 
Confidentiality was maintained on all data-collection forms by using codes to 
identify patients instead of names or any other personal identifiers. The main list 
of patients’ names was kept separate from the data-collection forms. This list was 
used during the data-collection period to ensure that patients were not recruited 
twice.  
Collected data, including digital recordings and transcripts of interviews, are 
stored in a locked filing cabinet for a period of 10 years as per the University of 
Dundee data-protection policy, after which they will be destroyed. All the data will 
be accessed only by the researcher.  
The data-management process was ensured in compliance with The Research 
Council Royal Decree (No. 54/2005) and the Directorate of Research and 
Studies, Ministry of Health, Oman, and with the Data Protection Act 1998, as 
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required by the University of Dundee, UK. Participants were notified of this in the 
information sheets. 
To empower the ethical part of this study, the researcher has undertaken a 
master-level research course for one academic year prior to commencing the 
study. Also, continuous professional development sessions, seminars and 
conferences were attended, including Good Clinical Practice (GCP) training to 
gain the necessary skill to carry out this study (GCP is the ethical and practical 
standard to which all clinical research is conducted in the UK). The study-
monitoring supervisors were well qualified researchers who have published 
extensively. 
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5. Data Collection Process 
5.1. Measurements  
Seven measures and an individualised QoL instrument were used to collect the 
data (appendix 4.2.a – 4.2.h):  
1) Background data sheet  
2) Short-Form 36v2 (SF36v2) 
3) Quality of life Index-Dialysis (QLI-D) 
4) Hospital Anxiety Depression Scale (HADS) 
5) Fatigue Severity Scale (FSS) 
6) Itch Scale (5-D Itch) 
7) Spiritual Wellbeing Scale (SWB) 
8) The Schedule for the Evaluation of Quality of Life-Direct weighting 
(SEIQoL-DW). 
Further details of these instruments and its psychometric qualities are discussed 
in Chapter Three of this thesis.  
- Background data sheet   
For this study, the variables that determine the characteristics of the individual 
are: age, gender, educational level, monthly income, region and marital status 
that might influence health outcomes. A background data sheet was used to 
collect the patients’ characteristics. This sheet was developed based on the 
structured reviews (chapters 2 and 3) conducted among ESRD patients. Data 
relating to marital status, educational level, current employment status and 
income status were collected from the patients themselves, as this data is not 
usually recorded on patient file. All socio-demographic data were classified 
according to the Oman norm, using the National Centre for Statistics and 
Information, Oman (2016). These data are detailed as follows: the category for 
marital status (single, married, widowed, divorced); level of education (illiterate, 
low-intermediate, intermediate, high-intermediate, high); employment status 
(employed or unemployed); and income, measured in Omani Rials (OMR), One 
Rial = £2.00 (< OMR 250/month; OMR 250-600/month; OMR 601-1000/month; 
OMR 1001-1500/month; OMR >1500/month). 
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The treatment characteristics factors related to HD prescription which might affect 
patients’ HRQoL were collected by the background data sheet. The determinants 
of treatment characteristics are: time since starting HD in months; time to reach 
HD in minutes; duration of HD session in hours; and adequacy of HD. The 
adequacy of HD is measured by the urea-reduction ratio which measures the 
reduction in blood urea in percentage as a result of HD and the effectiveness of 
HD treatment in removing waste products from the body. 
Biological function (haemoglobin, albumin, haematocrit levels). Biological 
function can often be measured by the lab tests of Hb, HCT and Albumin. The 
normal range values of these investigations are adopted from The National 
Kidney Foundation Kidney Disease Outcomes Quality Initiative (2007). 
- Short-Form 36v2 (SF36v2) 
It consists of 36 items that make up eight health domains: physical functioning, 
social functioning, physical role limitations, emotional role limitations, bodily pain, 
mental health, vitality and general heath perceptions. The scoring range of the 
SF-36 is 0-100 for each of the eight domains, zero indicating poor health status 
and 100 indicating very good health status. As there is no Omani study that has 
used the SF-36v2 to establish a norm-based standard of comparison between 
patients with ESRD and normal individuals, a cut-off score of a mean of 50 and 
a standard deviation of 10, suggested by Ware et al (2008), was used. That is, 
any score above or below 50 (standardised score) can be considered above or 
below the population’s average health status for that domain.  
Two subscales of the SF36v2 were also used independently to measure: 
a) Bodily pain (BP) which refers to the unpleasant sensory and emotional 
experience associated with ESRD and its related treatment. The BP 
subscale consists of two items, one of which assesses the rating of the 
severity of bodily pain during the past four weeks. Its response choices 
range from “none” to “very severe”.  The second item assesses the level 
of bodily pain’s effect on/interference in daily life activities including in-
house and out-house activities. The total scores of both items are reverse 
scored, that is, the higher value indicates less bodily pain. 
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b) General health perception which describes patients’ perceptions of their 
overall health status (Wilson and Cleary 1995).  It is a one item subscale 
asking patients to rate their general health on a five-point scale ranging 
from 1 = "excellent" to 5 = "poor". 
 
- Quality of life Index-Dialysis (QLI-D) 
Quality of Life Index – Dialysis version (QLI-D) was used as a disease-specific 
measure of ESRD and consists of 68 items (14 items are disease-specific and 
four items are related to dialysis treatment).  For each pair of items, the first item 
asks the degree to which patients are satisfied with an aspect of their life and the 
answer is measured on a six-point Likert-type scale (1 = very dissatisfied, 6 = 
very satisfied). The second item asks the level of importance of that aspect of 
their life and this is likewise measured on a six-point Likert-type scale (1 = very 
unimportant, 6 = very important). The pair of items are finally added together to 
produce an overall score.  
- Hospital Anxiety Depression Scale (HADS) 
HADS was used to test mood symptoms, anxiety and depression. It consists of 
14 items; seven items related to anxiety and seven related to depression, forming 
two subscales (HADS-A and HADS-D). Responses are measured on a four-point 
Likert scale, from 0-3, with 0 representing no symptoms and 3 representing the 
presence of symptoms related to anxiety or depression. Each subscale is 
summed up separately providing a sum of 21, and the overall score can be 
obtained by adding up subscales, providing a sum of 42. The possible scores 
range are 0-6 normal, 7-10 mild, 11-14 moderate, and 15-21 severe (Zigmond 
and Snaith, 1983). 
- The Fatigue Severity Scale (FSS)  
Fatigue is defined as extreme and persistent tiredness and weakness that 
patients experience due to ESRD (Pawlikowska et al., 1994). It is measured by 
the Fatigue Severity Scale (FSS) that measures the severity of fatigue and its 
effect on patients’ daily life activities and overall QoL. These items are scored on 
a seven-point scale with 1 = strongly disagree and 7= strongly agree. The 
90 
 
minimum score is nine and the maximum possible score is 63. The higher the 
score, the greater the fatigue severity.   
- Itch Scale (5-D Itch) 
The 5-D Itch Scale was used to assess itching in a brief, easy-to-complete, easy-
to-score format that is sensitive to the multidimensional nature of pruritus and its 
effect on HRQoL. The scores of each of these five items are calculated separately 
and then added together to obtain a total 5-D score. Scores can possibly range 
between 5 (no pruritus) and 25 (most severe pruritus).  
- The religious and spiritual wellbeing measure (SWB) 
SWB has 20 items, with 10 items to reflect religious wellbeing (RWB) and 10 
items for existential wellbeing (EWB).  The RWB subscale contains the word 
“God” – “Allah” in the Arabic version – to assess the patients’ relationship with 
“God or higher spiritual power” in whatever sense is meaningful to them. The 
EWB contains no specific religious terms and is instead worded in terms of 
connection and general satisfaction to assess the patients’ sense of life purpose 
and life satisfaction. Items are scored on a Likert-scale from 1-6 with a higher 
number reflecting higher wellbeing. The SWB scale produces three scores: 1) a 
global SWB score; 2) a score for the religious-wellbeing subscale; and 3) a score 
for the existential-wellbeing subscale.  
The SWB overall scores range from 20 to 120, with 20-40 considered low spiritual 
wellbeing, 41-99 moderate, and 100-120 high spiritual wellbeing. The scores of 
religious and existential wellbeing subscales range from 10 to 60, with 10-20 
considered as low, 21-49 moderate, and 50-60 high religious and existential 
wellbeing (Bufford et al., 1991). 
- Individualised QoL instrument 
The Schedule for the Evaluation of Quality of Life-Direct weighting (SEIQoL-DW) 
was used to assess patients’ own perspective on, and perception and 
understanding of, QoL (Kolewaski, 2005). It assesses three elements of QoL by 
asking patients to: a) first nominate five aspects of life they value most; b) rate 
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their functioning/satisfaction level with each aspect of life; and c) rate the 
importance of each aspect of life in judging overall QoL. 
5.2. Overview of clinical settings 
In phase one, data collection took place in the Nizwa Dialysis Unit. This unit is 
located in central Oman and is one of the largest dialysis units. There are around 
73 patients regularly attending out-patient HD. 
In phase two, three HD units were involved. These units were located in: a) 
northern Oman (Sumail Dialysis Unit, Site 1), central Oman (Nizwa Dialysis Unit, 
Site 2) and western Oman (Ibri Dialysis Unit, Site 3) to provide a representative 
sample across Omani culture and to test the feasibility of the main study. 
In phase three, 13 HD units across the Sultanate were involved. These units 
provide routine HD for out-patients affected by ESRD from a variety of regions 
and are managed by the Omani Ministry of Health (MOH). The MOH provides HD 
therapy for a total of 1,381 registered patients with ESRD (Annual Health Report, 
2016, Oman). These patients have varied socio-economic, cultural and 
educational backgrounds and are likely to provide a representative cross-section 
of the population, thus allowing generalisation of the study results.  
5.3. Recruitment process 
5.3.1. Data collection assistant  
To assist with conducting phases two and three of the study, nurses from all study 
sites were recruited and trained to administer the study measures and to apply 
research ethics principles. Initially, the researcher approached dialysis-unit 
managers to explain the study with the ethical-approval letter and the participants’ 
information sheets, and also to recruit nephrology nurses to assist in the study. 
The intention here was that the unit managers would circulate the recruitment 
request to nurses. The nurses who expressed interest in assisting the study were 
asked to indicate this to their managers who in turn informed the researcher to 
approach these nurses. To avoid the possible risk of a low recruitment rate for 
nurses assisting in the study, an advertisement strategy for the study was 
considered through posters and presentations including an inclusive description 
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and explanation of the study aims, inclusion criteria and methods of data 
collection. 
Training on measures administration was provided to the recruited nurses by the 
researcher to ensure efficiency in conducting this procedure (Appendix 4.3).  It 
was stressed to nurses that participation in the study was voluntary and that 
patient care should not be affected in any way. In addition, the participation 
information sheet contained the number of the “complaints call centre” so that 
patients could use it in case any coercion occurred during their participation in 
the study. 
They were also trained in correct data-management procedures to maintain 
confidentiality. The training session took the form of a practical introduction and 
consisted of a series of short lectures interspersed with practical activities. Topics 
covered included: the aims and objectives of study, patient recruitment, obtaining 
a consent form, and method of questionnaire administration. Subsequently, each 
research assistant was observed in a simulated data-collection session by the 
researcher and then both researcher and assistant simultaneously collected data 
from two patients before the research assistant was able to administer the 
measures independently. The recruited nurses were not directly responsible for 
the outcome of the study.  
5.3.2. Identification of participants and data collection procedure 
Patients were identified from the National Renal Registry of patients treated with 
ESRD in Oman. This registry records registered patients affected by ESRD based 
on a numerical identifier, contact information, medical history and updated lab 
results and is organised in a logical and systematic fashion. The authorisation to 
access the registry was based on the letter from the Directorate of Research and 
Ethical Review and Approve Committee, Oman. 
Phase-one comprised a semi-structured interview process to test the validity of 
the concept and to explore the understanding of QoL within Omani patients with 
ESRD. For this phase, patients were approached by the researcher in the 
allocated waiting area for their regular HD sessions. An explanation about study 
objectives and an information sheet was provided (Appendix 4.4.a). Patients had 
93 
 
48 hours in which to indicate their interest in participating in the study to the 
researcher, who was physically available in the dialysis unit when they arrived for 
their next session, and sign consent form (Appendix 4.4.b). For patients who 
agreed to participate, an interview venue and time were decided based on the 
participant’s preference. All the interviews were audio-recorded with the patients’ 
permission and the recordings included the administration process of the 
individualised QoL instrument and the interactions between the patients and the 
researchers during this process.  
Data in this phase were obtained in two ways:  
1) A cognitive interviewing method was used to explore the cognitive and 
sociocultural processes associated with answering the HRQoL measures. Data 
were collected in a semi-structured interview and transcribed based on the “think-
aloud” technique – patients are asked to think out loud while completing the 
measure – and the “verbal probing” technique in which the researcher searches 
for potential problems and explores the basis of the participant’s answers within 
the course of the interview (Willis, 1999). The question appraisal system (QAS), 
a coding form of probed interviews (Willis, 2005) was used to record the process 
(Appendix 4.5). Patients were asked to complete each measure exactly as 
normal, but also to “read aloud” each item and to “think aloud” their thoughts as 
they responded to these items. After each interview, field notes and audio 
recordings were reviewed to identify any potential problems with the measures 
so that any issues could be addressed.  
2) An individualised QoL instrument (SEiQoL-DW) was administered to identify 
the aspects of life that Omanis value in relation to their QoL and to measure the 
current satisfaction with these aspects. SEiQoL-DW was administered in a form 
of a semi-structured interview, in which the researcher first introduced QoL as an 
individually defined construct, then asked the patients to nominate their own five 
most important aspects of QoL. Patients were asked to think about which aspects 
of life determined their own happiness, or QoL, and then nominated aspects were 
rated numerically.  
Phase-two comprised a pilot study to: a) test the acceptability and practicality of 
use of the SF36v2 and QoLID within Oman; b) test recruitment, participation and 
94 
 
feasibility to ensure that any variations in the research design were effectively 
managed; and c) identify issues of concern for the main study; for instance, 
whether the allocated time for field work was enough to recruit a large enough 
sample for the main study.  
 
Applying inclusion and exclusion criteria, 60 (10% of the sample size for the main 
study) patients were selected randomly using the “RANDOM” function in the 
Excel programme (Field and van Belle, 2002; Julious, 2005). A patient-
information sheet (Appendix 4.6.a) that explained the purpose of the pilot study, 
the advantages and disadvantages of participation, the expected duration of 
participation and the researcher’s contact details was provided to eligible patients 
who were then approached by nephrology nurses during their attendance for 
regular HD to obtain consent forms (Appendix 4.6.b) and to respond to study 
measures. 
Patients were asked to complete the study measures before starting their HD 
session. However, if data were to be collected during the HD session, 60 minutes 
were allowed before data collection began. This gap in time was designed to 
prevent any possible errors that might occur, as patients might experience 
cognitive changes due to fluid and electrolyte shifts.  
Using the National Renal Registry, patients in Phase three were identified based 
on an opt-in strategy from 13 dialysis units across Oman. Those who agreed to 
participate were identified by nurses who were recruited and trained by the 
researcher to assist in obtaining consent forms, administering the questionnaire 
package, following up and collecting the completed study questionnaires. These 
were then stored in a secure box provided by the researcher. As with phases one 
and two, patients were given 48 hours to decide on their participation so that, 
when they attended their next HD session, they could indicate their decision to 
nephrology nurses and sign the consent form (see Appendix 4.6.b). 
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6. Data Analysis 
6.1. Phase One 
Data obtained from the cognitive interviewing process were analysed using a 
matrix-based method of data analysis proposed by Knafl et al., (2007).  The 
matrix illustrated items in a tabular form in which items appeared in a row and 
patients appeared in a column. The issues identified with were entered into the 
appropriate intersecting cells, promoting systematic analysis and decision-
making regarding item revisions. The matrix-display approach was then used to 
construct item summaries, linked to all the participating patients, including a 
coding scheme to reflect problem types specific to each item tested. The findings 
were then aggregated across all patients, producing a summarised item-by-item 
analysis of the results associated with the SF-36v2 and QoLI-D.  
Data obtained from SEiQoL-DW were presented in a tabular form for each patient 
including the nominated aspects of life, their levels and weights. The levels of 
each elicited aspect of life were measured by asking the respondents to draw five 
bars on the “Levels Record Form”. Levels were then scored by measuring the 
vertical height of each bar in millimetres, using a roller.  This produced five scores, 
which were independent continuous measurements, ranging from 0 to 100, 
whereas the measuring of the weights of elicited aspects of life was achieved by 
asking patients to quantify the importance of each aspect, represented by five 
differently coloured areas of a disc weighing system which was produced by the 
SEiQoL-DW developers specifically for this purpose. The disc consisted of five 
interlocking laminated circular discs of different colours on a percentage base 
which could be rotated independently. Each disc was labelled with one of the 
cues elicited by the respondent.  The weight of each aspect was divided by 100 
since the weights, when calculating the SEiQoL-DW Index, range from 0.00-1.00. 
This was so that the overall SEiQoL-DW Index could be calculated by multiplying 
the level by weight of each aspect and then adding these products across the five 
aspects [SEiQoL Index = ∑ (levels x weights)].
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6.2. Phase Two and Three 
6.2.1. Screening and cleaning data 
Collected data were entered into the SPSS software and doubled-checked to 
avoid any possible errors. Initial analysis outputs were checked for missing, 
invalid and extreme values that might have fallen out of the range of normal 
possible values. The nominal and categorical data were inspected by running 
frequency tables, while continuous data were inspected by running descriptive 
statistics. The frequency and descriptive tests outputs were checked to correct 
any errors before starting data analysis. Missing data and extreme values of 
categorical variables were checked visually by observing frequencies in output 
tables.  
Missing data is one of the pervasive problems in data analysis. Tabachnick and 
Fidell (2014) pointed out that the pattern of missing data is more important than 
the actual amount missing. The common pattern of missing data can be 
characterised as either missing completely at random or missing at random 
(Tabachnick and Fidell, 2014). The missing at random can be considered less 
serious and almost any procedure for handling missing data produces similar 
results (Tabachnick and Fidell, 2014). Since the missing data in current study were 
in random pattern, it was managed by using the individual mean substitution 
method when missing values were not significant or ≤ 10%. If they were more 
than 10%, then the affected scale/subscale was excluded in related analyses 
(Tabachnick and Fidell, 2014). Means were calculated from available data of that 
particular participant and were used to replace missing values as it is considered 
the best guess about the value of that variable. The main advantage of this 
method is that it is conservative in the way that the mean for the distribution as a 
whole does not change and therefore is not required to guess at missing values. 
6.2.2. Computing scales scores 
Following data cleaning and missing-data replacement, five measures – Short 
form 36v2 (SF36v2), Hospital Anxiety Depression Scale (HADS), Fatigue 
Severity Scale (FSS), Itch-5D and Spiritual Wellbeing Scale (SWB) – were 
computed and a syntax was created using the SPSSv22 programme. For the 
Quality of Life Index-Dialysis (QoLI-D), the syntax developed by Ferrans et al 
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(2005) was used to score the QoLI-D and its four subscales. This was developed 
specifically to fit the SPSS programme. It should be noted that the scores of the 
bodily-pain scale are reverse scored: the higher the value, the less the bodily 
pain. 
6.2.3. Checking data normality and outliers  
Data normality were checked by running a frequency distribution for each variable 
and if data-normality assumptions were violated, data were transformed by using 
square root, logarithm and inverse function, respectively. Outliers were checked 
by Q-Q Plot. Multivariate outliers were inspected by running standardised 
residual values, and if greater or less than 3.0, values were categorised as an 
outlier (Tabachnick and Fidell, 2007). Where presented, outliers were handled by 
being rescored or deleted or by creating separate regression models. Data 
linearity was checked using scatter-plots to illustrate differences between each of 
the independent variables compared with the dependent variable.  
6.2.4. Statistical analysis procedures 
Descriptive analysis 
The SPSS (Statistical Package for the Social Sciences) software (Version 22) 
was used to compute the frequency for nominal and categorical variables, and 
mean and standard division for continuous variables. The Pearson product 
correlation coefficient (r) was conducted to assess the relationship between two 
parametric variables and the Spearman's rank order correlation (rho) was used 
to assess the relationship between non-parametric variables.  
Reliability 
To test the reliability of measures within the Omani context, a Cronbach's alpha 
was computed to examine the internal consistency of the SF36v2 and HADS 
measures. Cronbach’s alphas, as indicators of internal consistency, were 
computed for each item and the whole scale. DeVellis (1991, p.85) and Nunnally 
and Bernstein (1994) suggest 0.60 and above as an acceptable reliability 
coefficient since smaller reliability coefficients are seen as inadequate. This value 
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was used since the aim of reliability test is to measure a trait with enough 
accuracy to establish the existence of a relationship with other traits. 
 
Factor analysis  
Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) tests 
were performed to explore the factor structure underpinning the mood measure 
(HADS) and health outcome measure (SF-36v2). The “Mplus” statistical software 
version 7 (Muthen and Muthen, 1998) was used for these analyses. To perform 
this test, the ratio of 4-10 cases per item was the rule of thumb employed 
(Tabachnick and Fidell, 2014). Among the study measures, QoLI-D has the 
highest number of items (64). Thus, for QoLI-D, around 7 cases x 64 items = 448 
participants and this total was deemed sufficient to provide a reliable factor 
structure.  
EFA was done on the 14 items of HADS to explore the best fit among the Omani 
ESRD patients. Likewise, an EFA series was carried out to explore a range of 
possible factor structures (from 1-8) on the 35 items of SF36v2. The best 
structures to come out of EFA were verified by conducting CFA. The approach 
used to determine and retain the number of extracted factors was eigenvalue (>1) 
and visual investigation of scree plot (against which the eigenvalues were 
plotted). The weighted least squares (WLSMV) method, chosen for factor 
extraction, was selected on the basis that this approach is particularly useful in 
extracting at least one factor indicator of categorical variables (Muthén et al., 
1997). The oblique and orthogonal factor rotation procedures were used to 
determine the best fit between variables and latent factors. The determination of 
a significant item-factor loading was set at a coefficient level of ≥.30 (Tabachnick 
and Fidell, 2007). 
The best factor structure identified from HADS and SF36v2 was then verified by 
CFA. The parameters used to assess the fit of the CFA models were as follows: 
the chi-square (2); the comparative fit index (CFI); the Tucker-Lewis Index (TLI); 
and the root mean square error of approximation (RMSEA), plus the Chi-Square 
Test of Model Fit for the Baseline Model and the Weighted Root Mean Square 
Residual for the Bi-Factor Model (WRMR). The adequacy of the model fit is 
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considered when: the chi-square is less than 2 or 3 (Kline, 1998; Ullman, 2001); 
the RMSEA is below 0.08 (MacCallum et al, 1996); the CFI is greater than 0.95 
(Hu and Bentler, 1999); the TLI is over .90 (Hu and Bentler, 1999). 
Regression analysis 
 
The nature of this study, predictive correlational design, along with the nature of 
the study questions guided the selection and use of sequential multiple 
regression. It is a statistical method, sometimes called hierarchical regression, in 
which independent variables are entered cumulatively according to a prior 
specified hierarchy which is based on the purpose and logic of the research (Polit 
and Beck, 2008). The strength of sequential multiple regression is that it adds to 
the researcher's understanding of the concept being studied since it requires 
thoughtful input by the researcher in determining the order of entry of independent 
variables and yields successive tests of the validity of the concept which 
determine that order (Tabachnick and Fidell (2014).  
 
However, there is no one way recommended for the order of entry of study 
variables into a sequential regression equation. It can be based on logical or 
theoretical consideration. For instance, the independent variables that are 
perceived/presumed by the researcher to be causally prior are given higher 
priority of entry. For example, in the current study, demographical variables were 
considered prior to the biological variables in predicting HRQoL and accorded a 
higher priority of entry (Cohen and Cohen, 1983). On the other hand, important 
variables can also be entered on later steps, with lesser importance given higher 
priority for entry in that they were entered first. Finally, after all the variables are 
entered, summary statistics are provided along with the information available at 
the last step. Thus, the order of entry of study variables into the sequential 
regression models was based on the sequence of the study questions, and the 
literature reviews underpinning this study. 
 
Using the BM SPSSv22, three main sequential multiple regression analyses were 
conducted to test the predictive value of the demographic, treatment, clinical, 
socio-environmental, symptoms, functional status and general health perception 
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on HRQoL in patients with ESRD: SF36v2 physical component summary–PCS 
(Two-factor standard model); 2) SF36v2 mental component summary–MCS 
(Two-factor standard model); 3) QoLI-dialysis; and 4.a) SF36v2–PCS (Three-
factor model), SF36v2–MCS (Three-factor model), and SF36v2–Role-functioning 
component summary–RCS (Three-factor model).  
Six of the nominal variables in this analysis (gender, marital status, education 
status, job, monthly income, and region) required dummy coding prior to being 
entered into the model. These variables were coded as dichotomous variables 
(Munro, 2005) according to the most frequent response obtained from 
respondents. The order of entry of study variables into the sequential regression 
models was informed by the order of the study questions, the literature reviews 
underpinning this study and the result of the pilot study conducted in phase-two. 
A ratio of cases-to-independent variables is suggested by Tabachnick and Fidell 
(2007) to test the overall fit of the model (R2): N ≥ 50 + 8m (m is the number of 
IVs) and to test the contribution of each IVs variable to explain dependent factors: 
N = 104 + m. There were 22 IVs in this study and the minimum required sample 
sizes were 226 to test the overall fit of the model and 126 to test the individual 
independent variable. These sample-size suggestions were based on detecting 
a medium effect size β =0.20 with α = or <.05 with a power of 80% (Tabachnick 
and Fidell 2007). Therefore, a sample size of 451 was considered sufficient for 
developing four main regression models. 
Next, all independent variables were correlated with each other and checked for 
multi-co-linearity. In the case of two variables correlating at 0.85 or higher, one 
variable was eliminated from the regression analysis. When all variables were 
examined together, the tolerance level and variance inflation factor of all IVs were 
calculated to determine multi-co-linearity. A tolerance value <0.10 and a variance 
inflation factor >10 was used to identify multi-co-linearity for possible elimination 
of variables (Mertler & Vannatta, 2002). 
A Mahalanobis Distance was computed for each case to detect any extreme 
multivariate outliers and, once that was done, the Mahalanobis scores were 
screened in the same manner as the univariate outliers. Hence, frequency 
distributions were run for each variable and examined for outliers. In addition, 
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multivariate outliers were detected through “standardised residual” values >3.0 
or <-3.0. Outliers would either be rescored or deleted, or separate regression 
models were created (Tabachnick and Fidell, 2007). 
All variables were checked for data distribution (multivariate normality, linearity 
and homo-scedasticity) by visually examining standardised residual scatterplots. 
Violations of any of the assumptions for multiple regression usually reveal a 
different scatterplot shape. In case any assumptions were violated, data were 
transformed in an attempt to stabilise the variance and to achieve linearity and 
normality (Polit, 1996). 
The statistical significance for a variable inclusion into a statistical model was set 
at α= .15 (Tabachnick and Fidell, 2014). This determined liberal probability level 
was to avoid excluding important variables from the model. Independent variables 
were entered simultaneously into a sequential multiple regression model to 
determine how well biological factors, symptoms, functional status, general 
health perception and socio-demographic and treatment factors predicted a 
patient’s overall HRQoL.  
Variables were entered in sequence in six steps: 1) Patient age, Gender, 
Education, Job, Income; 2) Time since starting HD, Time to reach HD; 3) Social 
and Economic, Family; 4) Itch, Fatigue; 5) Anxiety, Depression; 6) Perceived 
general heath.  
The improvement in the regression model at each step was evaluated by the R 
square (R2) and Adjusted R2 values. The process of adding more variables would 
stop when all the potential variables had been included or when it was not 
possible to make a statistically significant improvement in R and R2 (Pallant, 
2013). To evaluate which variables included in the model contributed to the 
prediction of the dependent variables, the unstandardised regression coefficients 
(B), the standard errors (SE B), the standardised regression coefficients ( ), the 
t-statistic, the significance of the t-statistic, the R, the F statistic (F), R2 and the 
change in R2 (R2) were reported. 
Finally, the accuracy of each regression model was evaluated by conducting a 
Bootstrapping test. Bootstrapping is considered a sound test which can be 
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performed to obtain robust estimates of the intercept and beta weights 
(Tabachnick and Fidell, 2014, p 179). It is a process by which regression weights 
are generated over a very large number of replications (up to 1,000 bootstraps) 
with samples drawn and replacement from the available data set. Each case may 
be selected more than once, or not at all, because of replacement (Tabachnick 
and Fidell, 2014). Conclusions were drawn based on the bootstrapped 
coefficients’ parameter estimates of the overall final model: the unstandardised 
regression coefficients (B), bias, bootstrapped standard errors (SE B), 
significance of the regression coefficients, the normal approximated 95% 
confidence intervals (OLS 95% CI) and the bootstrapped confidence interval 
(BCa 95% CI). 
7. Risk Assessment 
As part of the project planning process, a risk analysis took place to anticipate 
potential risks to the project, with the aim being to formalise actions to prevent or 
manage these risks. A table outlining each identified risk, and actions to prevent 
or manage the risk, is presented in Appendix 4.6. 
8. Conclusion   
A three-phase, cross-sectional, correlational study was conducted to explore the 
meaning of QoL and to determine factors affecting QoL and HRQoL in Omani 
patients with ESRD. A targeted sample of around 450 patients undergoing HD at 
outpatient dialysis units located across Oman was used. The study was approved 
by the UREC at the University of Dundee, as well as the central research 
committee at the Ministry of Health, Oman. Eight measures, in total, were 
administered to patients undergoing regular HD sessions. Data analyses 
included descriptive statistics and exploratory and confirmatory factor analysis, 
as well as various sequential multiple-regression models, to determine the 
influence of study-predictor variables on physical-component summary, mental-
component summary, role-functioning component summary and QoL index-
dialysis, according to the revised Wilson and Cleary model of HRQoL (Ferrans et 
al., 2005). 
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Chapter 5- Testing the concept of Quality of life and measures 
assessing Health-Related Quality of Life in Omani ESRD patients. 
   
Background: Little is known about how Omani patients with end-stage renal 
disease (ESRD) view their life quality, yet this is an outcome of increasing 
importance. Most research in this area has been conducted within a Western 
context using measures that have not been validated within the Omani context.    
Method: Participants were 12 patients randomly selected from a dialysis unit 
centre in Oman. The understanding of Quality of Life concept was explored using 
an individualised QoL instrument (SEIQoL-DW). A cognitive interviewing method 
was used to explore patients’ interpretations of the Arabic versions of two 
standardised measures of HRQoL, SF36v2 and QoLI-Dialysis, measures’ items, 
and report any difficulties they might have in answering these items.  
Findings: Mean patient age was 53 years; 8 (78%) were male. All patients 
completed the SEIQoL-DW, (mean time 16.08 minutes).  Omani patients appear 
to understand the notion of QoL. Fifty-nine cues were identified and categorised. 
The most important/common aspects of life that determined individual QoL in 
Omani patients were spiritual life, family, personal health, social life, and leisure 
activities.  
A good completion response rate was obtained (100%) on SF36v2 and QoLI-
Dialysis. Patients were able to comprehend most of the items.  Two items in QoLI-
D measure were identified as sensitive and two items in the SF36v2 also were 
reported to contain complicated syntax.   
Conclusion: SEIQoL-DW was an applicable instrument to explore the meaning 
of the concept of QoL among this population. Spiritual life aspect should be 
incorporated in any assessment of QoL and HRQoL in this group of patients. 
Cognitive interviewing was able to helpfully identify the range and depth of 
difficulties with items of SF36v2 and QoLI-Dialysis within this context, yet these 
measures should be tested on a larger group.  
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1. Introduction 
Health-related QoL is an essential part of evaluating dialysis treatment 
effectiveness and assessing health outcomes of patients with end-stage renal 
disease. Several measures have been developed to assess HRQoL and can be 
categorised as generic and condition- or disease-specific measures. Generic 
instruments attempt to measure a broad range of domains that are related to 
overall quality of life and HRQoL. These instruments cover a range of areas and 
can be used across different populations. Disease-specific are designed to 
address areas of life that are particularly pertinent for patients with a specific 
condition or disease in a predefined list of items which must be rated in a 
particular manner (Bergland and Narum 2007). Despite these tools being 
criticised for having a narrow focus, they have been credited with being more 
sensitive to changes in health status compared to generic instruments (Hall, 
Krahn et al. 2011).  
However, the current methods of measuring HRQoL impose an external value 
system on individuals, rather than allowing them to describe their lives in terms 
of those factors which they consider important. Measuring such personal and 
complex concepts is, therefore, difficult and may miss aspects of life that are 
important to the individual.  These aspects may be captured by an individualised 
QoL tool. Individualised measurement tools were developed as an attempt to 
explore the aspects of life that the individual perceives to be most important and 
to assess the level of functioning or satisfaction within each aspect (Tavernier, 
Totten et al. 2011). The Schedule for the Evaluation of Individual Quality of Life- 
Direct Weighting (SEIQoL-DW) is one of the individualised QoL instruments 
developed by O’Boyle et al. (1993). The main advantage of such methods of QoL 
measurement is the ability to address an individual’s own concerns about their 
life rather than impose standard questions which might be less relevant (Gall, 
Malette et al. 2011). 
There are very few studies that have used a combination of generic HRQoL 
measures, disease-specific measures and QoL individualised measures. The 
majority of studies assessing the QoL of patients with ESRD mainly focus on 
HRQoL. This is perhaps due to the broad agreement that the concept of positive 
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health is more than the absence of disease or even disability, but rather is about 
full functioning, efficiency of mind and body and social adjustment (Kaasa and 
Loge 2003, Krethong, Jirapaet et al. 2008, Fang, Fleck et al. 2011). HRQoL is, 
therefore, a concept that includes aspects related to physical, mental, social and 
role functioning and can be measured using distinct components that can be 
interpreted separately (Crosby, Kolotkin et al. 2003).  
Even with available studies that assess HRQoL, the majority have been 
conducted mainly in Western cultures. Limited studies have examined HRQoL 
aspects in ESRD patients in an Arab population (Abdel-Kader et al., 2009). The 
results of these studies showed low HRQoL among Arab patients with ESRD, but 
none were conducted in Oman. This phase of the study therefore considers this 
gap in assessing QoL through exploring the understanding of the concept QoL 
among Omani patients using SEIQoL-DW instrument. Besides, a cognitive 
interviewing method was used to test the readability and relevance of items of 
HRQoL measures among this group of patients. 
Cognitive interviewing is qualitative in nature, with participants asked to explain 
their interpretations of a measure’s items, elaborate on their responses and report 
any difficulties they might have in answering these items (Beatty & Willis, 2007). 
It also helps and guides in modification and improvement of the measures, but 
the major advantage is that the process can be iterative, with further rounds of 
testing leading to further improvements (Willis, 2005). Tourangeau (1984) 
presented a structured model of cognitive interviewing which consists of a 
sequential process of: a) comprehension of the item, b) retrieval from memory of 
relevant information, c) decision process and d) response processes. The model 
tests the participants’ comprehension of terminology used in the measured items, 
their sensitivity to answering items (e.g. items related to sexual activities, religious 
items).  
The process of cognitive interviewing includes two techniques, think aloud and 
verbal probing. Think aloud technique is used to ask participants to vocalise their 
thought processes while responding to questionnaire items (Willis, 2005). The 
advantage of this technique is that it does not require highly trained interviewers, 
and there is less bias imposed by the interviewer. However, it might also have 
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the disadvantage of causing a burden on respondents especially among those 
whose first language is not English. Verbal probing is a way used to ask 
respondents to provide additional information related to their answers to 
questionnaire items either at the time of responding to the question (concurrent 
probing) or after the completion of the entire questionnaire (retrospective 
probing). The advantage of this technique is that it maintains a focus and control 
over the interview, whereas the disadvantage is the potential for interviewer-
imposed bias (Willis, 2005). 
The overall aim of this phase is to answer RQ1– What does QoL/HRQoL mean 
to an Omani population using individualised QoL instrument, SEIQoL-DW; and 
cognitive interviewing to explore their interpretations of the Arabic versions of two 
standardised measures of HRQoL, SF36v2 and QoLI-D measures’ items, and 
report any difficulties they might have in answering these items.  
 
2. Methods 
2.1. Population and sample size 
The study population was a subset of the target population from whom a 
randomised sample was taken over the three-week period of data collection, first 
three weeks of May 2015, based on study-inclusion criteria. The inclusion criteria 
were: adult patients with ESRD receiving HD; those aged ≥ 18 years; and those 
who had been on HD for at least three months so that they were adjusted to life 
on dialysis.  Exclusion criteria were: patients who did not survive on HD longer 
than three months; patients with acute renal failure; patients aged under 18; 
patients diagnosed with dementia or any other condition that could impair their 
ability to answer questions; patients who had recently been diagnosed with 
cancer; and patients who had recovered their renal function. 
This sample size of this phase was informed by literature that used the cognitive 
interviewing method in data collection as well as studies using individual QoL 
measures (McGee et al. 1991; Becker et al. 2014; Tavernier et al, 2011). 
Although the sample size determined at this phase was 12 participants, 16 
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patients were approached to avoid any inaccuracy of the list as patients sometime 
quit dialysis for transplant or personal preferences. 
Patients were identified from the Dialysis-Unit Registry which records registered 
patients with ESRD. Using the Dialysis-Unite Registry, eligible patients were 
approached by the researcher in the allocated waiting area for their regular HD 
sessions. An explanation about the objectives of this phase and a related 
information sheet were provided. Patients had 48 hours in which to indicate their 
interest in participating in the study to the researcher who was physically available 
in the dialysis unit when they came for their next HD session. For patients who 
agreed to participate, interview venue and time were decided based on the 
participant’s preference. 
2.2. Ethical consideration 
Ethics permission was granted by the University Research Ethical Committee 
(UREC) at the University of Dundee and the Directorate of Research and Ethical 
Review and Approve Committee, at the Ministry of Health, Oman.  
2.3. Setting 
Participants were recruited from the Nizwa Dialysis Unit. This unit is located in 
central Oman and is one of the country’s largest dialysis units. There are around 
83 patients regularly attending out-patients’ HD. 
2.4. Data collection process 
2.4.1. Measures 
Three measures were used in this phase: an individualised QoL instrument 
(SEIQoL-DW), generic health status measure (Short Form-36v2), and disease-
specific measure (QoLI-Dialysis). More details of these measures are presented 
in Chapter Three including psychometric qualities.  
SEIQoL-DW instrument is an individualised QoL instrument. It was administered 
to test the understanding of the concept of QoL by asking the patients to nominate 
five areas of life that they value most. SEIQoL-DW is based on an underlying 
theory of what makes up QoL from an individual’s own perspective and on his/her 
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own perception and understanding of QoL (Kolewaski, 2005). The main 
advantage of such methods of QoL measurement is the ability to address an 
individual’s own concerns about their life rather than impose standard questions 
which might be less relevant (Gall, Malette et al. 2011).   
The SF36v2 measures eight health concepts: physical functioning, social 
functioning, physical role limitation, emotional role limitations, bodily pain, mental 
health, vitality and general heath perceptions. These concepts can also be 
presented as two summary scores representing physical and mental health. The 
scoring range of the SF-36v2 is 0-100 for each of the eight domains. Zero 
indicates poor health status and 100 indicates very good health status. The 
response options for the SF36v2 are rated on a Likert scale.  
QoLI-Dialysis was the second HRQoL measure used to explore patients’ 
understanding of items related to QoLI-Dialysis. The QoLI-Dialysis is the version 
that was primarily developed by Ferrans and Power (1984) for use with dialysis 
patients. It consists of 68 items and measures four key aspects: health and 
functioning, social and economic, psychological and spiritual, and family. It 
consists of two sections assessing participant satisfaction and the relative 
importance of each aspect, respectively. Six-point ordinal response scales range 
from “very dissatisfied” or “very unimportant” (1), to “very satisfied” or “very 
important” (6). Its index scores range from zero to 30, where higher scores 
indicate a better quality of life (Bowling, 1995, p54).  
2.5. Procedure and Data analysis 
Participants were informed verbally and in writing, using the information sheet 
developed specifically for this phase of the study (see Appendix 4.3.a). For 
patients unable to read, an information sheet and consent form were explained 
verbally to them. The consent form was required to be signed by participants and, 
for those who could not write, an available witness signed instead (see Appendix 
4.3.b). The witness was a family member (husband, wife, sister, brother, or close 
relative such as a cousin). Their preferences for time and venue for the cognitive 
interviewing and for completing the SEIQoL-DW instrument were considered. 
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All the interviews were digitally audiotaped along with the taking of abbreviated 
field notes with the patients’ permission. The recordings included the 
administration process of the SEIQoL-DW and the interactions between patients 
and researchers during this process. 
2.5.1. Individualised Quality of Life instrument (SEIQoL-DW)  
Prior to administration of the SEIQoL-DW, and for the purpose of efficient use of 
SEIQoL-DW, the researcher translated the SEIQoL-DW instruction manual into 
Arabic. This process was merely for the purpose of simplifying the use of the 
manual for the researcher and to avoid any lapses that might occur during the 
reading of instructions to patients. Initially, the instruction manual was translated 
by the researcher into Arabic and then sent to two separate reviewers. Reviewer 
one is a native Arabic speaker who is a doctorate holder and works as a dean for 
a nursing institute in Oman. Similarly, Reviewer two is a native Arabic speaker 
and a doctorate holder working as an English-language teacher in a nursing 
institute in Oman. Both reviewers reviewed and checked the Arabic translation 
and commented on it independently and neither had any criticisms.  
The translated draft was then piloted with three nursing students at their clinical 
placement at Nizwa Hospital. Students were informed about the aim of this pilot 
and a consent form was obtained for them to participate willingly. Each interview 
was audio recorded. The time taken to complete SEIQoL-DW was between 13-
18 minutes. The three participants reported no difficulties in understanding the 
instructions on how to complete the SEIQoL-DW tool, nor did they report fatigue 
or boredom. The acceptability of the SEIQoL-DW was based on time taken to 
complete the tool, on the understanding of the method and on the level of fatigue 
and boredom (O'Boyle et al., 1993). 
SEIQoL-DW was then administered to patients in three stages. Stage one was 
the determination of cues, aspects of life. Patients were asked to think of, and 
nominate, five areas of life (cues) that determine their own happiness, or QoL, 
without prompts from the researcher (the glossary of terms relevant to SEiQoL-
DW in table 5.1). The five cues were elicited by means of a semi-structured 
interview and are referred to henceforth as “elicited cues”. In stage two, the 
patients then ‘levelled’ their functioning status on each cue against a vertical 
110 
 
visual analogue scale (VAS), labelled at the upper and lower extremes by the 
terms “As good as could possibly be” and “As bad as could possibly be” 
respectively (Figure 5.1). These ratings were recorded by the researcher as a bar 
chart, one bar representing each cue nominated by patients. This produced five 
scores, independent continuous measurements, ranging from zero to 100.  In 
stage three, for the purpose of weighing the elicited cues, patients were asked to 
quantify the importance of each aspect, represented by five differently coloured 
areas of a disc weighing system which was produced by the SEIQoL-DW 
developers specifically for this purpose. The disc consists of five interlocking 
laminated circular discs of different colours on a percentage base and can be 
rotated independently (Figure 5.2). 
The weight of each aspect was divided by 100, since the weights, when 
calculating the SEIQoL-DW Index, range from 0.00-1.00, in order that the overall 
SEIQoL-DW Index can be calculated by multiplying the level by weight of each 
aspect and then adding these products across the five aspects [SEIQoL Index = 
∑ (levels x weights)]. 
Table 5. 1  Glossary of terms relevant to SEiQoL-DW 
Cue  
The elicited aspect of life considered most important by each 
patient in assessing their overall QoL. 
Definitions Record 
Form 
The form used to record the meaning of the elicited aspect of 
life and to provide definitions by each patient. 
Level Record Form The rate or level of each aspect of life for the patient at that 
moment. 
Cue Levels Record 
Form 
The form used to record the levels and importance of elicited 
cues. 
Weight of cue The rate of importance of each elicited aspect of life for the 
patient at that moment. 
Disc weighing system The pi diagram used to rate the importance of each elicited 
aspect of life. 
 
For grouped data presentation, three reviewers (researcher, reviewers 1 and 2) 
categorised the elicited aspects of life definitions using a prompt list summarised 
from the literature. The researcher, initially, independently categorised the 
nominated “cues” and these were then emailed separately to reviewers. Any 
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discrepancies that occurred were resolved by discussion. This process was 
entirely anonymous. Where participants’ quotes are used to support the results, 
any personal details will be anonymous. 
   
Figure 5. 1  Cue levels record form of SEIQoL-DW  
The time for each interview, for understanding the method of SEIQoL-DW and for 
possible fatigue/boredom that the patient might experience, and the overall 
validity of the information obtained (in light of the reported understanding of 
method and fatigue/boredom) were reported using the Interview Record Form 
(IRF) suggested by the author of the SEiQoL-DW (Appendix 5.1). 
 
 
Figure 5. 2  Disc weighing system of SEIQoL-DW 
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1) Health-related QoL measures (SF36v2 and QoLI-Dialysis)  
The Arabic version of the SF36v2 and QoLI-Dialysis were administered using the 
cognitive interviewing technique to assess whether they were acceptable and 
understood by Omani ESRD patients. The assumption is that Omani respondents 
interpret the measures’ items in the same way as do the measures’ developers 
(Bowling, 2009) despite cultural differences.  
The Tourangeau’s model was adopted and employed to test patients’ 
understanding of SF36v2 and QoLI-Dialysis by asking them to complete each 
measure exactly as normal, but also to read aloud each question and to “think 
aloud” their thoughts as they respond to these items. After each interview, field 
notes and audio recordings were reviewed to identify any potential problems with 
the measures so that issues were addressed prior to piloting the QoL measure in 
a larger sample. 
The Question Appraisal System (QAS) coding form of probed interviews (Willis, 
2005) was used to record the process (refer to Appendix 4.4). QAS was 
developed to guide researchers through a systematic appraisal of questionnaire 
items and to help to identify potential problems in the wording or structure of the 
items that may lead to difficulties in questionnaire administration or to other 
failings (Willis and Lessler, 1999).  
Data from the cognitive interviewing process were analysed using a matrix-based 
method of data analysis proposed by Knafl et al (2007). Problems were identified 
and systematically analysed to facilitate decisions concerning the measures’ use 
or modification. The matrix illustrates items in a tabular form in which items 
appear in a row and participants appear in a column. Possible problems to be 
identified with items are entered into the appropriate intersecting cells, promoting 
systematic analysis and decision-making regarding item revisions.  The matrix-
display approach was then used to construct item summaries, linked to all the 
patients, including a coding scheme to reflect problem types specific to each item 
that has been tested. The findings were then aggregated across all participants, 
producing a summarised, measure-by-question analysis of the results associated 
with QoL measures (SF36, QoLI-Dialysis). Finally, the item summaries examined 
across the patients informed the reporting and understanding of the measures of 
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QoL within the Omani context and were used to make decisions about retention, 
amendment or deletion of individual items. 
3. Findings 
3.1. Characteristics of participants 
Twelve participants were recruited from the Nizwa Dialysis Unit. The mean age 
was 53 and the SD was 18.90, ranged from 28 to 76 year. Male patients 
constituted 75% (eight patients) of the total and 25% (four) were female, while 
66.7% were married (eight patients), and 33.3% were single (four patients). Their 
education level was: 33.3% illiterate, 8.3% low-intermediate level, 8.3% 
intermediate level, 25% high-intermediate level and 25% were college graduates. 
About one third of the patients were unemployed (33.3%) and housewives 
(16.7%), whereas the remainder were employed. The range of dialysis hours was 
36-48 hrs/month. The dialysis efficiency, based on the test of urea reduction rate 
(URR), was >70 % (n= 11) and only one was <70%. Table 5.2 presents a 
summary of the characteristics of the participants. 
Table 5. 2  Characteristics of the sample  
Characteristics Participants (n= 12) 
Mean SD 
Age [mean (range)] 47.58 18.90 
 Frequency Percentage 
Gender 
Male 
Female 
 
9 
3 
 
75% 
25% 
Marital status 
Married 
Single 
8 
4 
66.7% 
33.3% 
Employment status 
Employed  
Unemployed 
 
8 
4 
 
66.7% 
33.3% 
Educational level % 
High 
High-intermediate 
Intermediate 
Low-intermediate 
Illiterate 
 
3 
3 
1 
1 
4 
 
25% 
25% 
8.3% 
8.3% 
33.3% 
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3.2. Findings of SEIQoL-DW  
3.2.1. Completion of the SEIQoL-DW 
The Interview Record Form (IRF), the form used to record information about each 
participant during the interview, was subjectively analysed for understanding, 
fatigue and overall validity. The IRF data, which was completed by the researcher 
immediately after interviews, indicated an acceptable time to complete the 
instrument (mean= 16.08 minutes), while the determined time to complete 
SEIQoL-DW is 10-20 minutes (O’Boyle et al., 1992). The least time taken to 
complete the tool was 12 minutes and the longest time was 21 minutes. The least 
time taken was scored by a 28-year-old male patient with a high education level 
and the longest by a 54-year-old illiterate female patient, suggesting that 
education level might reflect the level of understanding of SEIQoL-DW. Despite 
the age variation among the participants, low levels of fatigue were observed. 
 Three respondents had difficulty with rating negatively worded aspects in the y 
axis of “worst possible” and “best possible” related to the level of these aspects 
in the IRF. Similar difficulty was observed when participants were asked to mark 
the bar chart with a horizontal line to draw a box from baseline to the mark. This 
problem, however, was dealt with immediately by the researcher at the time of 
chart completion by reminding the respondent that the task was to rate ‘how each 
of these areas are for you at the moment”. The last challenge was encountered 
during the SEIQoL-DW administration with the interpretation of the “importance” 
of levels of areas of life on the five-weighted coloured disk (pie chart). Out of the 
12 participants, six interpreted this step as “level of functioning” on their 
nominated cues rather than as “importance” of cues to them. Here, respondents 
were reminded that the task was to indicate “how important each of the five 
aspects is at present, relative to each other”. 
3.2.2. Description of frequency of elicited and prompted cues and 
categories 
Fifty-nine cues were reported by patients. These cues were assigned categories 
by three independent raters (principal researcher, principal supervisor and 
second supervisor). Sixty per cent of the cues were assigned the same category 
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by the three reviewers, 36% had the agreement of two reviewers and there was 
no agreement between the reviewers on 5% of the cues (Appendix 5.2 
summaries cues definitions and categorisation of cues). 
Of the 12 patients, nine patients (75%) nominated five cues without prompting, 
whereas three required prompting, of which one nominated four cues. 
Once reviewers had assigned cues to categories, the percentage of patients 
nominating each category at least once is shown in Table 5.3. The category of 
Religion/Spiritual Life was mentioned most frequently, 12 times (100%) by 12 
patients, whereas the category of Family was nominated by nine patients (75%), 
six patients nominated Personal Health, Social Life and Leisure Activities (50%), 
five patients nominated Work/Occupation and Role Functioning (41.6%), three 
patients nominated Autonomy/Independence (25%) and 8.3% nominated each of 
these: Family Health, Sexuality, Finances, Relationships, Enjoying Life and 
Quality of Care. The content and variety of categories were as expected from 
reports in the literature. However, it was unique for this study that religious and 
spirituality issues were the most frequent and dominant among this group of 
patients. 
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Table 5. 3 Number of patients nominating category and their percentages 
Category 
Number of patients 
nominating categories (%) 
Religion/Spiritual Life 12 (100) 
Family  9 (75) 
Personal Health  6 (50) 
Social Life 6 (50) 
Leisure Activities 6 (50) 
Work/Occupation 5 (41.6) 
Role Functioning 5 (41.6) 
Autonomy/Independence 3 (25) 
Family Health 1 (8.3) 
Sexuality  1 (8.3) 
Finances  1 (8.3) 
Relationships 1 (8.3) 
Enjoying Life 1 (8.3) 
Quality of Care 1 (8.3) 
 
Having obtained the levels and weights for each of the nominated cues, the 
SEIQoL-DW index was calculated to provide an overall score (Appendix 5.3). 
This is a continuous measure ranging from 0 to 100. The minimum score was 
33.92 and the maximum score was 79.25 (M= 55.60, SD = 13.59). Additionally, 
respondents indicated their current life satisfaction on a visual analogue scale 
that ranged from 0 = worst life imaginable, to 100 = best life imaginable (Table 
5.4). The minimum score was 28 whereas the maximum was 95 (M= 66.67, SD 
= 20.61).  
Table 5. 4  Scores of SEIQoL-DW overall score and SEIQoL-DW linear analogue score 
Instrument 
Participants 
01 02 03 04 05 06 07 08 09 10 11 12 
SEIQoL-DW 
overall score 
44.5 52.5 78.4 79.2 57.9 63.3 42.5 54.5 58.5 56.4 33.9 45.4 
SEIQoL-DW 
linear 
analogue 
score 
28 84 31 85 76 77 53 95 70 74 63 64 
 
In an attempt to examine if there is a possible correlation between the SEIQoL-
DW index overall score and the visual analogue scale, a Pearson’s (r) test was 
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conducted. The result showed that there was no correlation between the 
variables [r= 0.117, n= 12, p= 0.358]. 
3.2.3. Example of cues, levels, direct weightings and overall score of 
SEIQoL-DW 
This section provides an example of SEIQoL-DW result –nominated cues, levels 
and direct weights– of two patients (Figures 5.3.1 and 5.3.2). The description of 
illustrated cues was recorded on the Cue Definitions Record Form by the 
researcher at the time of interview.  The descriptions of these cues reflect 
exclusively the patients’ explanations and not the researcher’s interpretation. 
Patient One: a man of 58 years old and married. He had a low education 
level and worked in the private sector with a low income. He was able to 
nominate all the cues without prompting. The time taken for him to complete the 
SEIQoL-DW was 15 minutes.  
Table 5. 5 Example of description of cue, cue label and related category (Patient One)  
Cue label  Description of cue Categorised in 
Cue 1: family  “… mixing with people and sitting with them. Sitting 
with friends, hanging out with them”. 
 
Social Life 
Cue 2: Body 
image 
“… physical activity, ability to go… shopping and get 
groceries. Ability to climb up the stairs”. 
 
Role Functioning 
Cue 3: Mobility “… transportation. Able to drive to places of interest is 
highly important to me. Also, ability to bank up the 
money required to this”.  
 
Autonomy/ 
Independence 
 
Cue 4: Self-
development  
“I am youth and my future is not clear; the job as well!! 
I don’t know if I will find a job that suits my health 
condition and how my future will be?” 
 
Role Functioning  
Cue 5: Religion “… going to mosque and praying to Allah ‘God’, 
fasting and being able to fast is highly important to 
me”. 
Religion/Spiritual Life 
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Figure 5.3. 1 Level and direct weights of nominated cues (Patient One) 
 
Patient Two: a man of 53 years old and married. His had a high 
education level and worked for the government with a long-term contract and a 
good income level. He was able to nominate the five cues without prompting in 
a time of 15 minutes. 
Table 5. 6 Example of description of cue, cue label and related category (Patient Two)  
Cue label Description of cue Categorised in 
Cue 1:  Family “… my presence at home is very important to 
care for my wife and children. They are taking 
most of my time”. 
 
Family  
Cue 2: Mobility “… going out from home and coming for 
dialysis; also getting groceries to home is 
important. These are all my responsibilities”. 
 
Autonomy/ 
Independence 
Cue 3: Sexual 
relationship 
“… it is important to me to care for my wife. 
Sexual life, for instance, I consider it as an 
important aspect in my life”. 
 
Sexuality  
Cue 4: Health “… diseases; allergies from medications and 
secondary diseases. Basically, my health”. 
 
Personal Health 
Cue 5: 
Worship 
“… being on time for prayers, going to mosque; 
as well as going to Hajj, are important to me”. 
Religion/Spiritual Life 
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Figure 5.3. 2 Level and direct weights of nominated cues (Patient One) 
 
3.3. Findings of cognitive interviewing of the SF36 and QoLI-Dialysis 
3.3.1. SF36v2 
The aim for administering SF36v2 using the cognitive interviewing technique was 
to test the ability of the Omani patients to comprehend and respond to this 
measure. It was anticipated that, if patients were able to comprehend and 
respond to the items of the SF36v2, then this would indicate that it is a readable 
and acceptable HRQoL measure. 
All the patients (n=12) completed SF36v2. However, with regard to their response 
to SF36v2 items, six patients reported some difficulty and a lack of clarity with 
two items (Item-4b and Item-5b). Patients reported that these items were complex 
and contained complicated syntax (Table 5.7). For the remaining items, patients 
were able to supply their answers without any difficulties. A summary of the 
identified problems across all participants related to SF36 items is presented in 
Appendix 5.4. 
Item 4b asked respondents if they had “Accomplished less than they would like” 
in the past four weeks in relation to problems with their work or other regular daily 
activities as a result of their physical health. Only one patient expressed a lack of 
language clarity related to this item. He stated that it was “unclear”. However, 
when the interviewer repeated the question to the respondent, he was then able 
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to comprehend it. Thus, the item appeared to have no problem and was clear to 
all patients. 
Similarly, item 5.b asked respondents if they had “Accomplished less than they 
would like” in the past four weeks in relation to problems with their work or other 
regular daily activities as a result of their emotional problems (e.g. feeling 
depressed or anxious). Half of the respondents (50%) expressed issues related 
to the clarity of the question, such as awkward or complicated syntax.   
Table 5. 7  Items 4b and 5b and identified problems related to SF36v2   
Items Question  
Summary of problem(s) identified 
across participants 
Item 4b 4. During the past four weeks, how 
much of the time have you had 
any of the following problems with 
your work or other regular daily 
activities as a result of your 
physical health: 
 
b. Accomplished less than you 
would  
have liked  
CLARITY: Identify problems related to 
communicating the intent or meaning of 
the question to the respondent. 
Item 5b 
5. During the past 4 weeks, how 
much of the time have you had 
any of the following problems with 
your work or other regular daily 
activities as a result of any 
emotional problems (such as 
feeling depressed or anxious)?  
b. Accomplished less than you 
would  
like  
CLARITY: Identify problems related to 
communicating the intent or meaning of 
the question to the respondent. 
 
3.3.2. QoLI-Dialysis 
QoLI-Dialysis was also administered to patients for the purpose of assessing their 
ability to understand and read this measure. A summary of the identified problems 
across all participants related to QoLI-Dialysis items is presented in Appendix 
5.5. 
Patients, in general, appeared motivated to complete the QoLI-Dialysis. Of the 
64 items of QoLI-Dialysis, three items were left without answer by three patients 
(one male, two female). These items were numbers eight and 27 from the 
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“satisfaction” part and item 12 from both the “satisfaction” and “importance” parts. 
When patients were probed regarding their hesitation in answering these items, 
issues of clarity with item 8 and item 27 and of sensitivity with item 12 were 
reported. The issues related to clarity were on items that asked patients to 
indicate their satisfaction on “chances to live the period of time they wish for’” and 
chances to “have a happy future”. For example, participant M said: “I don’t know 
how I will be tomorrow!! So how can I know how I am going to be after one or two 
years? This disease cannot be predictable in future.” The item that was reported 
to be “sensitive” asked participants to indicate the level of satisfaction and 
importance of their “sexual life” (Table 5.8). 
Table 5. 8  Identified problems related to QoLI-Dialysis questionnaires   
Items QOLI-DIALYSIS Items 
Summary of problem(s) identified 
across participants 
Part 1 (satisfaction) 
Item 8 How satisfied are you with: Your 
chances of living as long as you 
would like?  
CLARITY: Identify problems related to 
communicating the intent or meaning of 
the question to the respondent. 
Item 12 How satisfied are you with: Your sex 
life? 
SENSITIVE CONTENT (general): The 
question asks about a topic that is 
embarrassing, or very private 
Item 27 How satisfied are you with: Your 
chances for a happy future? 
CLARITY: Identify problems related to 
communicating the intent or meaning of 
the question to the respondent. 
Part 2 (importance) 
Item 12  How important to you is: Your sex 
life? 
SENSITIVE CONTENT (general): The 
question asks about a topic that is 
embarrassing, or very private 
 
To examine further the function of items that have issues with clarity and 
sensitivity and its variance with the total QoLI-Dialysis score, Cronbach’s alpha 
test was performed. Results showed that QoLI-Dialysis had good level of 
reliabilities, Cronbach’s α = .870. However, if item 8 is deleted, Cronbach's α will 
lower to .859. Similarly, for item 12, if deleted, α will lower to .867, whereas for 
item 27, Cronbach's α remains at a similar level = 0.870. Hence, it was decided 
to retain these items for use in phase two of this study (Chapter 6). 
These findings suggest that Omani patients with ESRD understand the notion of 
QoL as evidenced by their ability to nominate five main aspects of life that they 
value most and to comprehend the measures of QoL.  
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4. Discussion 
It can be said that Omani patients with ESRD appear to understand the concept 
of QoL. That was clear from the result of SEIQoL-DW in which patients nominated 
“religion/spirituality”, “family”, “personal health”, “social life”, and “leisure 
activities” as the top five aspects of life that determined their QoL. Interestingly, 
this result is in keeping with findings in the literature that were conducted within 
Western context using SEIQoL-DW instrument, except for the 
“religion/spirituality” aspect. In a study conducted in Western Pennsylvania, USA, 
patients with ESRD nominated family, health, work, financial, and leisure as 
aspects of life they valued most (Abed-Kader et al., 2009). Another study 
conducted in the UK among patients with chronic diseases found that family, 
health, leisure, home, money were the aspects of life that made up patients’ QoL 
(Mountain et al., 2004). These comparable findings may suggest that patients 
with ESRD view the aspects of personal health, socioeconomic, and leisure 
activities as important determinant of QoL. 
Religion and spirituality does not seem to be an important aspect of life for some 
western patients, unlike Omani patients. That is maybe because Omanis 
consider religion as the essential reference in dealing with everyday life. It can be 
said that religion can shape the way Omanis view different aspects of life, 
including perceptions of health and illness. In Oman, Muslim patients usually 
understand that illness, suffering and dying are part of their life and a test from 
Allah, “God”. Their perception is that no one can control how long they are going 
to live. Thus, their perceptions about QoL may be associated with their religion 
and spiritual lives. 
This perception may be also associated with the aspect of “personal health” as 
the Islamic religion encourages individuals to live healthily, care for their families 
and support each other and such support might extend even to financial support. 
Such insight is instructed by the Holy book of Muslims (Qur’an): “O mankind we 
have created you male and female, and have made you into nations and tribes 
so that you may know each other. Lo! The noblest of you in the sight of Allah is 
the one with piety or the one who is pious” (Al-Hujurat 49:13). However, the 
degree of religiosity in dialysis patients can be affected by the symptoms of ESRD 
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and related treatment requirements. The need to attend dialysis sessions for an 
average of 12-15 hours per week could interrupt their worship schedules. 
Similarly, their ability to fast during the holy month of Ramadan (the fasting month 
in Islam) could be interrupted due to the dialysis sessions, medication and dietary 
requirements. All these factors may have an impact on their level of functional 
status and satisfaction with their religious practice and consequently on their level 
of overall QoL. 
Omanis live in large families and are considered an introverted type of 
community. Family, therefore, is vital from their cultural perspective. "The family 
is the nucleus of the society; whenever the nucleus is healthy and strong, so will 
be the whole structure" (Shuraida, 2001, p. 10). The main aim of marriage within 
Omani society is to establish a family and to have children. This creates an 
equally important role for both wife and husband in forming the family, although 
the wife will have a different role. Thus, it is not surprising that patients rank 
“family” as one of the most important aspects of life which contributes towards 
their QoL. When sickness occurs, patients first get support from their families and 
it is the family who usually takes the sick person to hospital. They even work 
closely with healthcare providers to ensure that their family member gets the best 
care and the necessary psychological support. With such family support, it can 
be expected that HD patients consider “family” a high priority when assessing 
their QoL level. 
Social life may be one of the most important aspects that determine QoL for 
Omani patients. In Oman, gender is likely to have an influence on a patient’s QoL, 
as men and women have different roles to play. Women, for instance, are not 
encouraged/expected to live alone and men should always be around to assist 
and give a hand in normal life activities, such as shopping. It is also highly 
recommended that women do not meet with a non-relative man due to cultural 
and religious reasons. The social position of women might affect their QoL as this 
could influence their feeling of self-value. In contrast to women’s social position, 
the male gender role might also influence men’s QoL as there are fewer 
restrictions on them socially. However, male patients with ESRD and on HD could 
be burdened by poor financial status if they are unemployed or if their job is 
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affected by their health condition. Such changes in their normal life activities could 
affect their functional role and subsequently lower their level of QoL. 
Patients with ESRD experience a number of disease- and treatment-related 
factors that restrict their lifestyle and undermine QoL. In contrast to transplant 
patients who perceive their condition to be less chronic (Edalat-Nejad and Qlich-
Khani, 2013; Bakewell et al, 2001), HD patients reported an uncertain future and 
limited personal freedom and control (Brekke et al, 2014). Loss of freedom might 
also cause wider implications in altering marital, family and social relationships 
(Christensen and Ehlers, 2003). Such instability in feelings caused by physical 
and psychological alterations in ESRD patients may lead to reluctance in 
predicting the level of their satisfaction with their future. This gets worse when 
patients attempt to have balance in their lives when trying to maintain their roles 
of function, worship practice and care of their family.   
Patients were able to understand the SF36v2 measures and comprehend most 
of its items, but with less clarity on items 4b and 5b. Both questions asked patients 
if they had “Accomplished less than they would like” in the past four weeks in 
relation to problems with their work or other regular daily activities as a result of 
their physical and mental health. Although the question statement of both items 
(Items 4b and 5b) was similar in the English version, the translated question 
statement to Arabic was slightly different. The item 4b can be understood, in 
Arabic, as “Accomplished less than you want”, whereas item 5b translated as 
“Accomplished less than you wish”. This convergence in the meaning of both 
items has perhaps led to issues of clarity. To the researcher’s knowledge, no 
studies have been conducted within Oman that tested the validity of SF36v2. The 
published studies that translated and validated SF36 into Arabic language were 
in Tunisian (Guermazi et al., 2012), and Saudi populations (Al Abdulmohsin et 
al., 1997). Both reported acceptable reliability and equivalence of both versions. 
It should be noted, however, that the Arabic language contains many dialects 
which significantly differ across Arabic countries. In North Africa, for instance, 
spoken Arabic may be incomprehensible to an Arabic speaker from the Levant 
or the Arab Gulf. Hence, existing variations in dialects of the Arabic language may 
be a factor that affects the clarity of items 4b and 5b. Administering the SF36v2 
to a larger group of Omani patients may further explore the clarity issue. 
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The QoLI-Dialysis was also an acceptable measure to Omani patients. Two 
items, however, were possibly sensitive. These questions asked about sex lives 
and partnerships. This conclusion was reached when patients refrained from 
answering three items specifically related to this area of life. Sensitive items might 
lower the percentage of respondents who respond to the item truthfully. That is, 
this aspect affects questionnaires or survey outcomes in relation to: (a) overall 
response rates, (b) participants declining to respond to that particular sensitive 
item, and (c) also the accuracy of the respondent’s answer (Tourangeau, 2007). 
From a religious perspective, in Oman, single men and women are forbidden to 
have any kind of sexual relationship before marriage. Even after marriage, this 
topic is considered a family secret and it is a taboo to share sexual-activity 
information outside the confines of the couple. The majority of Omanis may feel 
offended if they have been asked to share information about their sexual life, 
whether they are married or not. This perception is manifested in cognitive 
interviewing when the female participants are reluctant to answer orally to a male 
interviewer regarding items related to sexual life. A question can be raised here 
as to whether such reluctance might have been erased by self-reporting as 
opposed to an interview.  
Different modes of administering QoL measures might affect data quality. Chang 
& Krosnick (2010), in their comparison study between oral interviewing and self-
administered measures, reported that self-administration can increase a 
respondent’s willingness to disclose sensitive information, compared with face-
to-face or telephone interviews. Greater anonymity offered in surveys has been 
reported to lead to high item response and more accurate reporting on sensitive 
topics such as behaviour and relationships. These results, however, contradicted 
an earlier result, reported by Roberts et al (2004), which showed that item 
response in face-to-face interviews was higher. The explanation for this was that 
interviewers motivate people to respond and interviewers have greater control 
over the situation, for instance, by ensuring that questions are answered and not 
missed. Such variance in this set of evidence suggests that certain features, and 
the choice, of the questionnaire-administration format depends on characteristics 
of the participants and on the study site. 
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From a cultural perspective, within a Western context, self-administration seems 
to improve the quality of reports about sexual behaviour in surveys. Bowling 
(2005) found that self-administration eliminated the gap between the results of 
men and women, decreasing the average number of sexual partners reported by 
men and increasing the average number reported by women. Likewise, self-
administration increases the reporting of socially undesirable behaviour, such as 
illegal attitudes or sexual information, usually under-reported in surveys 
(Newman et al., 2002). This, however, might not be the case in Arabic culture 
where sensitive items can be seen as socially unacceptable or socially 
undesirable. It is believed that, if confidentiality can be ensured when 
administering the questionnaires in the pilot study, the response rate to sensitive 
items might be improved. Also, it would be useful to explore the effects of different 
administration formats of QoL and HRQoL questionnaires on a large sample of 
patients with ESRD in Oman. 
A number of limitations can be highlighted in this phase. First, the sample size 
was relatively small, n= 12, which might affect the reliability of the results. Second, 
for patients waiting to commence their dialysis session, particularly those who are 
older, participating in such a study could be overwhelming. It was also observed 
that using “think aloud” technique could create a false milieu when the researcher 
was present in the room with participants; and also, that the patients have to talk 
aloud, which they may not normally do. However, overall, the approach used to 
answer the RQ1 was shown to be applicable and useful. The cognitive interview 
method revealed how patients understand the questions of the HRQoL 
measures. Likewise, SEIQoL-DW appeared to be relevant in exploring the 
meaning of QoL among this group of patients. In fact, the nominated aspects of 
life by patients were alike in the domains of the SF36v2 and QoLI-D measures, 
e.g. psychological and social aspects which may be indicating that the SEIQoL-
DW is measuring QoL on a subjective level. This result may represent a small 
step towards validating the SEIQoL-DW in patients with ESRD. 
5. Conclusion  
Two methods, the individual QoL instrument and cognitive interviewing, were 
used to explore the understanding of the concept of QoL in the context of the 
127 
 
Omani population and to address the potential drawbacks of HRQoL instruments 
that might limit the factors that comprise participants’ QoL. The nominated 
aspects of life – Religion and Spiritual Life, Family, Personal Health, Social Life, 
and Leisure Activities – contribute significantly to the level of QoL in Omani ESRD 
patients. Within this group of patients, QoL is a cultural construct that is impacted 
by social and life events. Findings also show that QoL is an individualised 
perception and the individual experience is shaped and influenced by Omani 
society’s values and culture. Hence, it is recommended that the level of the effect 
of these aspects on QoL and HRQoL in this group of patients should be 
measured. Thus, incorporating and considering these aspects in assessing QoL 
and HRQoL in phases two and three of this project is recommended in order to 
enrich its outcomes including a separate measure that assesses spirituality 
domain.  
Results suggest that Omani patients understand the notion of QoL and this is 
clearly manifested by their ability to nominate the aspects of life that they consider 
most important. The SEIQoL-DW revealed a reasonable lay definition of QoL in 
patients with ESRD within Oman. Nominated aspects of life by ESRD patients 
could be a reliable guide to most important priorities for medical interventions by 
nephrologist, nephrology nurses, as well as policy makers within healthcare 
system in Oman.  
The association between spirituality domain and health-related QoL should be 
considered in the main study. The degree of religiosity in dialysis patients can be 
affected by the symptoms of ESRD and related treatment requirements. This can 
be manifested by the frequent attendance at HD treatment (12 to 15 hours per 
week) which can interrupt their religious rituals such worship and fasting during 
the holy month of Ramadan.  These are some possible factors that may have an 
impact on their satisfaction and level of physical and role functioning status.  
The influence of religion and spirituality manifested clearly through the cognitive 
interviewing method. Although it revealed that Omani patients comprehended the 
QoL and HRQoL questionnaires (Arabic versions), with a very good response 
rate to both measures (SF36 and QoLI-Dialysis), they were sensitive to items 
related to sexual life and partnerships. The low level of response to sensitive 
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items may be attributed to the method of face-to-face interviewing. Cultural and 
religious factors in Oman could influence patients’ responses to such questions 
as it is considered taboo to discuss sensitive subjects, such as sexual life, with 
anyone other than partners. One possible way to overcome this issue is to 
administer the measures in a larger sample size and to use a different method of 
administration, such as self-completion. 
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Chapter 6- Health-Related Quality of Life of Omani Patients with 
End-Stage Renal Disease: A Pilot Study 
 
Background 
Measurement of HRQoL has the potential to provide important additional 
information about the wellbeing of individuals affected by ESRD. A limited number 
of studies, however, have been found which address the impairment of HRQoL 
among Omani patients. It was essential to pilot the selected HRQoL measures, 
and test the applicability of the selected design among this group of patients.  
Method 
Six Arabic-version measures that assess health status, mood, physical 
symptoms and spiritual wellbeing, bound together, were piloted among adult 
Omani patients who were randomly identified from the National Renal Registry in 
Oman. Six nurses were recruited and trained to assist in recruitment and data 
collection. Parametric and non-parametric correlation tested the association 
between HRQoL variables and study outcomes. Predictors of HRQoL were 
tested using multiple sequential regression analysis.  
Findings 
The piloted measure, including socio-demographic questions, has been shown 
to be reliable in the Omani context. Two measures, however, SF36v2 and 
HADS, may require further exploration of factor construct using the factor-
analysis test.  
Forty-four patients participated in the study with a good response rate of 73% 
over a period of 21 days. The rate of measures completion ranged from 96.7%-
100%, indicating a preliminary acceptance and applicability of the measures. 
The study was guided by the revised Wilson and Cleary model of HRQoL 
(2005) which seemed to be an applicable conceptual model to guide the main 
study.  
Conclusion  
Results indicated the usefulness of the proposed study measures, and design. 
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1. Introduction and background 
The pilot study builds upon a structured review of the conceptual structure of QoL 
and HRQoL (review one); a review of the measures used to capture HRQoL and 
its predictors including the symptom burden, physical, psychological and socio-
demographical factors and clinical factors (review 2); a small study tested the 
concept of QoL and HRQoL and the appropriateness of standardised 
questionnaires in Omani ESRD patients (phase-one).  
 
Measurement of HRQoL has the potential to provide important additional 
information about the wellbeing of individuals affected by ESRD, which is not 
readily available from the clinical and laboratory assessments currently used to 
monitor patients (Soni et al, 2011). Various measures are used targetting different 
languages, including Arabic, to assess HRQoL and its predictors, such as 
generic-health outcome and disease-specific measures. Generic-health outcome 
measures are the ones most commonly used to evaluate different aspects of 
HRQoL including physical, psychological and social factors, as well as perceived 
well-being, whereas disease- or condition-specific measures evaluate symptoms 
or conditions that might be associated with the level of HRQoL. However, in 
reviews one and two, no studies were found that measured HRQoL among 
Omani patients with ESRD.  
 
The majority of studies that assess HRQoL in ESRD are limited in the approach 
used to measure HRQoL. That is, no studies were found which comprehensively 
assessed biological function, symptoms, functional status, general health 
perceptions, or various characteristics of the individual and their environment.  
Even with studies that used more than one measure of HRQoL (Saffari et al., 
2013; Kao et al., 2009; Cleary et al., 2005), the researchers did not articulate a 
comprehensive conceptual framework to guide their study, providing little 
justification of the independent variables used to explain HRQoL. Even the limited 
number of studies that have assessed HRQoL among Arab patients with ESRD 
(Abd Elhafeez et al, 2012; Al-Jumaih et al, 2011) reported low HRQoL scores.  
Prior to conducting this pilot study, chapter 5, a cognitive interviewing test and 
administration of an individualised QoL instrument were used to explore the 
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understanding of the concept of QoL and HRQoL among the Omani patients, 
which revealed “Religion and spirituality” as the most valued aspect of life, 
followed by “personal health”, “social life”, “family health” and “leisure activities” 
respectively. The result also revealed the necessity to determine and test the 
level of HRQoL in Omani patients affected by ESRD.  
This pilot study, therefore, was planned, to: 1) test the practicality – and 
acceptability to respondents – of the selected HRQoL measures within an Omani 
context; 2) inform the study sampling size; 3) assess the likely success of the 
proposed recruitment approaches if sufficient participants could be generated; 4) 
test the feasibility of recruiting research assistants (nephrology nurses) to help in 
recruiting patients and administering study measures; 5) develop and test the 
response rate; and 6) practice the analysis plan. Likewise, this pilot study 
highlighted the feasibility to answer RQ2 and RQ3 (presented below in result 
section).  
Conducting a pilot study can be useful in identifying possible problem areas and 
deficiencies in study measures and protocol prior to the implementation of a 
larger scale study (Lancaster et al., 2004). However, there are limited benefits for 
the researchers themselves from a professional perspective including research 
informed practice, and identification of learning needs pertaining to a specific area 
of research (Kraemer et al., 2006; Teijlingen and Hundley, 2001). For the 
researcher of this study, and for the purpose of maintaining a rigorous method of 
analysis, performing a sequential multiple regression analysis was recognised as 
an area of a learning need. The analytical protocol of the pilot phase in this study, 
therefore, consisted of testing the planned sequential multiple regression analysis 
so that its applicability can be trialled and evaluated prior to conducting the main 
study. In case of any pitfalls identified, these can be then tackled either by further 
reading, practice, or statistician consultation.  
 
2. Methods 
This section describes the inclusion and exclusion criteria, the methods of 
recruitment of the research assistants and patients, the data collection and the 
proposed statistical analyses pertaining to the pilot study.   
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2.1. Inclusion and exclusion criteria 
The inclusion criteria were: adult patients affected by ESRD receiving HD, aged 
≥ 18 years and who had been on HD for at least three months so that they were 
adjusted to life on dialysis.  
Exclusion criteria were: patients with acute renal failure; patients aged under 18; 
patients diagnosed with dementia or any other condition that could impair their 
ability to answer questions; patients recently been diagnosed with cancer; and 
patients who had recovered their renal function. 
2.2. Ethical aspects  
Ethical approval to conduct this pilot study was obtained from the University 
Research Ethical Committee (UREC) at the University of Dundee (UoD), 
reference UREC 15060, and the Directorate of Research and Ethical Review and 
Approve Committee, Oman.   
2.3. Setting  
Three HD units were involved that function under the Ministry of Health, Oman. 
These units were located in: a) northern Oman (Sumail Dialysis Unit, Site 1), 
central Oman (Nizwa Dialysis Unit, Site 2) and western Oman (Ibri Dialysis Unit, 
Site 3) to provide a representative sample across Omani culture and to test the 
feasibility of the main study. 
2.4. Data collection assistant  
Six nurses were recruited and trained to assist in recruiting and administering the 
study measures. The training session took the form of a practical introduction and 
consisted of a series of short lectures interspersed with practical activities: the 
aims and objectives of the study, patient recruitment, obtaining a consent form 
and the method of measures administration. Subsequently, each research 
assistant was observed in a simulated data-collection session by the researcher, 
and then both the researcher and the assistant simultaneously collected data with 
two participants before the research assistant was able to administer the 
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measures independently. The recruited nurses were not directly responsible for 
the outcome of the study.  
2.5. Recruitment strategy and data collection 
Patients were identified from the National Renal Registry of patients treated with 
ESRD in Oman, which records registered patients affected by ESRD based on a 
numerical identifier, contact information, medical history and updated laboratory 
results. Applying inclusion and exclusion criteria, 60 (10% of the sample size for 
the main study) patients were selected randomly, using the “RANDOM” function 
in the Excel programme (Field and van Belle, 2002; Julious, 2005).  
Nurses approached all eligible patients regarding the study to obtain an initial 
determination of interest using the study information sheet. The patient 
information sheet (refer to Appendix 4.5.a), was in Arabic, explaining the purpose 
of the pilot study, the advantages and disadvantages of participation and the 
expected duration of participation. Patients who agreed to participate in the study 
were then approached by a nurse during their attendance for regular HD to obtain 
a consent form (refer Appendix 4.5.b) and to respond to study questionnaires.  
Patients were asked to complete the study measures before starting their dialysis 
session, or during their dialysis session. If data were collected during the HD 
session, 60 minutes were allowed before data collection began. This gap in time 
was designed to prevent any possible errors that might occur, as patients might 
experience cognitive changes due to fluid and electrolyte shifts.  
Six Arabic-version measures, bound together, were piloted and used to collect 
the data: Short-Form 36v2 (SF36v2); Quality of life Index-Dialysis (QLI-D); 
Hospital Anxiety Depression Scale (HADS); Fatigue Severity Scale (FSS); Itch 
Scale (5-D Itch); and Spiritual Wellbeing Scale (SWB). Further details of these 
instruments and its psychometric qualities were discussed in Chapter Three of 
this thesis.  
Besides these measures, a background data sheet was included within the 
measures package which consisted of the patients’ age, gender, marital status 
(single, married, widowed, divorced); level of education (illiterate, low-
intermediate, intermediate, high-intermediate, high); and employment status 
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(employed – working currently, unemployed – not working currently) and were 
collected from the patients prior to administering the study measures. All socio-
demographic data were classified according to the Omani norm, using data from 
the National Centre for Statistics and Information, Oman. Clinical data were 
obtained from each patient’s file, in the form of closed questions that asked for 
up-to-date lab results showing levels of haemoglobin, haematocrit and albumin. 
The normality level of these tests was considered according to the National 
Kidney Foundation (2007).  
2.6. Statistical analysis  
Data entry was double-checked to avoid any possible entry errors. Initial analysis 
outputs were checked for missing, invalid and extreme values that might have 
fallen out of the range of normal possible values. The nominal and categorical 
data were inspected by running frequency tables, while continuous data were 
inspected by running descriptive statistics. The initial analysis outputs of 
frequency and descriptive tests were checked to correct any errors before starting 
data analysis. Likewise, missing data were examined and managed using one of 
the schemes suggested by Tabachnick & Fidell (2014). Missing data and extreme 
values of categorical variables were checked visually by observing frequencies 
in output tables. This was managed by using ipsative individual mean substitution 
if they were found not to be significant or ≤ 10%, and if > 10%, then the affected 
measure/subscale was excluded in future analyses (Tabachnick & Fidell, 2014). 
The data normality and outliers test was performed by running a frequency 
distribution for each variable and outliers were checked by Q-Q Plot. Multivariate 
outliers were detected by running standardised residual values, and if greater or 
less than 3.0, values were categorised as an outlier (Tabachnick & Fidell, 2014). 
Outliers were handled either by being rescored, being deleted, or by creating 
separate regression models. Data linearity was checked using scatter-plots to 
illustrate the differences between each of the independent variables compared 
with the dependent variable. In case data normality assumptions were violated, 
data were transformed by using square root, logarithm and inverse function 
respectively.  
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The response rate was calculated by counting the number of participants who 
answered the questionnaires, divided by the number of individuals in the sample 
at this phase. Similarly, the percentage of all potentially eligible items that did not 
have responses was calculated by the frequencies rate of the actual responses 
compared with the total sample.  
To predict the recruitment and participation rate for the main study, the involved 
study sites in the pilot study were used as a representative of the range of sites 
in the main study in order to best estimate typical recruitment rates. That is, the 
patients meeting the study criteria (50 patients) were tracked and recorded per 
site over a period of one month. Accordingly, the recruitment rate was calculated 
based on the number of patients who provided written consent divided by the 
number of eligible patients per site. The recruitment rate over the month was then 
calculated based on the obtained response rate, divided by the number of piloted 
sites. 
Six measures – SF36v2, QoLI-Dialysis, HADS, FSS, Itch-5D and SWB – were 
scored and calculated using a syntax developed specifically to fit the SPSS 
programme. The procedure of scoring and calculating these measures was in 
accordance with the measure’s scoring guidelines. It should be noted that the 
scores of the bodily-pain scale are reverse scored: the higher the value, the less 
the bodily pain. 
To explore the association between HRQoL variables and outcomes (SF36: PCS, 
MCS and QoLI-D), a correlation test was conducted. The Pearson product 
correlation coefficient (r) was conducted to assess the relationship between two 
parametric variables and the Spearman's rank order correlation (rho) was used 
to assess the relationship between non-parametric variables. The statistical 
significance for a variable inclusion into a statistical model was set at α= .15 
(Tabachnick and Fidell, 2014). This determined liberal probability level was to 
avoid excluding important variables from the model. Independent variables were 
entered simultaneously into a sequential multiple regression model to determine 
how well biological factors, symptoms, functional status, general health 
perception and socio-demographic and treatment factors predicted a patient’s 
overall HRQoL. The guide from Tabachnick and Fidell (2007) on sample-size 
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estimation for conducting regression analyses was used to determine the main 
study sample.  
3. Results 
This section describes the results of the pilot-study statistical analysis. It first 
describes results from recruitment of research assistants, followed by recruitment 
of participants and subsequently the statistical analysis pertaining to RQ2 and 
RQ3. 
3.1. Recruitment of research assistants 
Six nurses were recruited at a rate of two nurses from each study site. They were 
all qualified nephrology nurses. Out of the six, five were female nurses and one 
was male.  
The training sessions were delivered in an average of two hours. The majority of 
participating nurses showed confidence and were able to administer the study 
measures effectively. The effectiveness of the training session was tested by 
conducting a simulated data collection and simultaneous administration of the 
measures to patients.  
 
3.2. Recruitment of Participants 
A total of 44 patients participated in the pilot study, with a participation rate of 
73% over the period from 13 October 2015 to 24 October 2015. Figure 6.1 shows 
the flow of participation in the pilot study. At site 1 – Sumail HD Unit – the 
participation rate was 79.16% (24 patients were approached, 19 gave consent 
and returned the surveys, four refused to participate and gave no reasons, while 
one gave verbal consent but did not complete the survey). At site 2 – Nizwa HD 
Unit – 55.55% was the participation rate (18 patients were approached and, out 
of those, 10 provided written consent and eight refused to participate, providing 
no reasons). At site 3 – Ibri HD Unit – 83.33% was the participation rate (18 were 
approached, 15 gave written consent and three refused). 
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Figure 6. 1 Flow of participants in the pilot study 
3.3. Preliminary Examination of Data 
The overall completion rate of study measures ranged between 96.76% and 
100% (Table 6.1). The highest completion rate was for the HADS and FSS 
measures (100%) and the lowest was for the QoLI-D (96.76%). These high 
results for the level of completion might reflect acceptability to patients.  
Table 6. 1  Overall completion rate of piloted measures 
Measur
e  
# of 
measure 
items 
Expected total # of 
items  
x 44 participants 
Number of 
missing 
items 
Missing 
items in % 
Measure 
completion 
rate (%) 
SF36 36 1,584 2 0.13 % 99.87 
QoLI-D 68 2,992 97 3.24 % 96.76 
HADS 14 616 - - 100 
Itch-5D 5 220 3 1.36 % 98.64 
SWB 20 880 12 1.36 % 98.64 
FSS 9 396 - - 100 
 
Obtained data were then entered into SPSS version 22.0. Data entry was double-
checked and proofread against the original questionnaire.  No errors were 
identified. 
60 eligible patients were invited to take part in the pilot study 
Site 1: Sumail HD unit 
24 patients approached 
19 gave written consent 
Response rate 79.16% 
 
Site 2: Nizwa HD unit 
18 patients approached 
10 gave written consent 
Response rate 55.55% 
44 (73.33%) gave written consent 
Site 3: Ibri HD unit 
18 patients approached 
15 gave written consent 
Response rate 83.33% 
Site 1: 
1 gave verbal consent  
4 refused to participate 
 
Site 2: 
8 refused to participate with no 
reason given 
Site 3: 
3 refused to participate 
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No missing data or extreme values were noted in the categorical variables. For 
continuous variables, descriptive statistics were run to check for missing data and 
extreme values. Four measures were identified as having missing values (SF36, 
QoLI-D, Itch-5D and SWB). Missing data were managed by replacing individual 
means substitution as if they were 10% missing data, except for case numbers 3 
(20%) and 19 (40%) in the Itch-5D measures and case numbers 4 (20%) and 23 
(25%) in the SWB measure, which were excluded in the inferential analysis 
pertaining to regression analysis. Subsequently, frequencies and descriptive 
analyses were repeated to check whether missing data were entirely replaced. 
No further missing data were shown and this provided the confidence to move to 
detect outliers and check data distribution. 
Following data cleaning, the six measures were computed and a syntax was 
created using the SPSS programme.  
Data were explored to examine distribution, outliers and linearity by observing 
histogram, Q-Q Plot, scatter-plots and the skewness and kurtosis values. 
Appendix 6.1 summarises the study variables that have been explored along with 
outliers, skewness and kurtosis values and tests of normality. 
Each continuous variable was examined for normality by calculating skewness 
and kurtosis statistics. All continuous variables demonstrated acceptable 
skewness and kurtosis values. 
Cronbach’s alpha was computed for each measure to check for internal reliability. 
(Table 6.2). The result indicated that most of the piloted measures were reliable 
(α= > .70) (DeVellis, 1991; DeVon et al., 2007). The subscales of SF36v2 [Mental 
Component Summary (α= .500) and Physical Functioning Subscale (α= .508)] 
and 5D-Itch measure (α= .655), however, were found to be less reliable. By 
checking the item-total statistics for the 5-D Itch measure, item number -3 
seemed to be problematic because, if deleted, alpha would increase to α= .732; 
whereas for SF36v2, alpha value remained relatively low. Hence, a further 
investigation may be required to explore the factor structure of SF36v2 using 
oblique and orthogonal rotation methods. 
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A further testing might be required to establish construct validity, such as factor 
analysis and structural equation modelling, to test and confirm the original models 
of SF36, QoLI-D and HADS against the Omani culture. 
Table 6. 2 Internal reliability of total scores and subscales of the piloted measures 
Measure  
Cronbach’s 
alpha 
SF36v2  .875 
SF36v2 Physical Component Summary .799 
SF36v2 Mental Component Summary .500 
SF36v2 Physical Functioning Subscale .508 
QoLID .825 
SWB .829 
Itch-5D Scale .655 
FSS .886 
HADS-Anxiety subscale .845 
HADS-Depression subscale .773 
SF36V2: Short Form 36v2; QoLID: Quality of Life Index-Dialysis; SWB: Spiritual Wellbeing Scale; FSS: 
Fatigue Severity Scale; HADS: Hospital Anxiety Depression Scale. 
3.4. Characteristics of participants 
Most participants were men (63.3%), married (65.9%), unemployed (63.6%) and 
illiterate (29.5%). For illiterate participants, the measure was read to them by the 
nurses without any prompts. Likewise, the majority (70.5%) reported having low 
incomes of < OMR 250/month (equal to approximately £370).  Participants’ ages 
ranged from 22 to 76 years old, with a mean age of 45 (SD = 14.23). 
Demographical data are shown in Table 6.3. 
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Table 6. 3  Demographical statistics (N = 44) 
 
Variable  Frequency (%) 
Gender 
Men  28 (63.6 %) 
Women 16 (36.4 %) 
Marital status 
Married  29 (65.9 %) 
Separated 2 (4.5 %) 
Widow 3 (6.8 %) 
Single  10 (22.7 %) 
Educational status 
Illiterate 13 (29.5 %) 
Low-intermediate 6 (13.6 %) 
Intermediate 10 (22.7 %) 
High-intermediate 11 (25 %) 
High 4 (9.1 %) 
Job 
Employed 16 (36.4 %) 
Unemployed  28 (63.6 %) 
Income per month 
OMR <205 31 (70.3 %) 
OMR 251-600 3 (6.8 %) 
OMR 601-1,000 4 (9.1 %) 
OMR 1,001-1,500 3 (6.8 %) 
OMR >1,500 3 (6.8 %) 
OMR: Omani Rial 
Laboratory variables were within therapeutic values (based on KDOQI clinical 
practice guideline for haemodialysis, 2015) except for Haemoglobin (M= 11.16, 
SD= 1.42). For clinical variables, time on HD in hours per month ranged from 28 
to 63 hours (M = 42.87 SD = 6.78), the adequacy of dialysis, measured by urea 
reduction rate, was within the normal range (M= 70.20, SD = 7.73).  Results are 
shown in Table 6.4. 
Table 6. 4  Clinical data (n 44) 
Variable  Mean (SD) Range  Therapeutic values*  
Hb g/L 11.16 (1.42) 8.20-15.5 
Male: 13 - 18 g/L  
Female: 12 - 16 g/L  
Haematocrit level 35.68 (5.07) 27.10-49.10 33-36 % 
Albumin level 38.51 (3.98) 25.60-44.66 35-48g/L  
Dialysis adequacy (urea reduction 
rate) 
70.20 (7.73) 70–90 ≥ 65 % 
Dialysis hours per month 42.87 (6.78) 28-63 - 
* source: KDOQI clinical practice guideline for haemodialysis (2015) 
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3.5. Research Question 2: What is the level of QoL/HRQoL for 
patients with ESRD on HD in Oman?  
This question was answered by descriptive analysis of the generic health 
measure (SF36v2), the condition-specific measure (QoLI-Dialysis), the 
emotional-status measure (HADS), the physical symptom-specific measures 
(Itch-5D, Fatigue Scale) and the spiritual measure (SWB). Means and standard 
deviation of the scale and subscales were calculated for the entire sample.  
3.5.1. SF36v2 
Patients reported low health-status scores on PCS (M = 40.77, SD = 8.61) and 
MCS (M = 43.40, SD = 10.82) (Table 6.5). Role limitation due to physical health 
(RP) and physical functioning (PF) were the lowest rated among the physical-
health domain (M = 46.73, SD =29.57 and 47.39, SD = 27.92 respectively). 
Scores for mental-health domains were better, compared with physical health. 
The mental-health score was the highest (M = 65.68, SD = 20.64), followed by 
social functioning (M = 54.26, SD = 26.81).  
Table 6. 5  Mean scores of SF36 (n = 44) 
SF36 domains Mean (SD) Possible range  
Physical health PF 47.39 (27.92) 0 - 100 
RP 46.73 (29.57) 0 - 100 
BP 54.86 (24.86) 0 - 100 
General health 53.47 (21.20) 0 - 100 
Mental health Vitality  52.98 (23.13) 0 - 100 
SF 54.26 (26.81) 0 - 100 
RE 50.56 (31.91) 0 - 100 
MH 65.68 (20.64) 0 - 100 
Component Summary Scores 
PCS                                  40.77 (8.61) 0 - 100 
MCS                                   43.40 (10.82) 0 - 100 
PF: Phsycial functioning; RP: Role physical; BP: bodily pain; DF; Social functioning; RE: Role 
emotion; MH: Mental health; PCS: physical component summary; MCS: mental component 
summary. 
3.5.2. General health perception (item one in SF36v2) 
A single item (number one in SF36) was used to ask patients to rate their health 
in general. This item is rated on a five-point Likert scale ranging from one as 
“excellent” to five as “poor” health status. Patients perceived their health status 
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as fairly good (M = 2.93, SD = 1.16). The majority, consisting of 16 (36.4%) 
patients, perceived their health as “fair”, followed by 12 patients (27.3%) who 
perceived their health as “good”.  Very few patients rated their health as 
“excellent” or “poor”. Table 6.6 shows the rating of perceived general health in 
numbers and percentages. 
 
Table 6. 6  Perceived general health as rated by ESRD patients (n = 44) 
 
Rating of perceived general health  n (%) 
Poor  3 (6.8 %) 
Fair 16 (36.4 %) 
Good 12 (27.3 %) 
Very good 7 (15.9 %) 
Excellent  6 (13.6 %) 
 
3.5.3. QoLI-Dialysis 
The overall QoLI-D was 22.62 (SD = 2.97) out of a possible score of 30 (Table 
6.7). The higher score on the QoLI-D indicates a better HRQoL. Each subscale 
was also measured on a 0-30 scale. The health and functioning subscale was 
the lowest scored subscale (M = 20.34, SD = 4.45), followed by the socio-
economic subscale (M = 21.88, SD = 3.91). 
 
Table 6. 7  Mean scores of QoLI-D (n = 44) 
 
QoLI-D domains  Mean (SD) Possible range 
Health and functioning 
20.34 (4.45) 0-30 
Socio-economic 
21.88 (3.91) 0-30 
Psychological/spiritual 
24.94 (4.63) 0-30 
Family 26.91 (2.21) 0-30 
QoLI-Dialysis 
22.62 (2.97) 0-30 
QoLI-D: Quality of life index-dialysis 
3.5.4. HADS 
The mean anxiety score was 6.61 (SD = 4.08), with scores ranging from 0-15. 
Forty-three percent of patients (19) obtained a score of ≥8 on the anxiety 
subscale, which possibly indicates the presence of clinical anxiety. The mean 
depression score was 6.34 (SD = 3.81), with scores ranging from 0 to 13. Thirty-
143 
 
nine percent of patients obtained a score of ≥8 on the depression subscale, 
indicating possible clinical depression (Table 6.8). 
Table 6. 8  HADS scores and possible caseness of anxiety and depression  
 N (%) Mean (SD) 
(out of scores 0-21) 
Minimum Maximum Caseness 
(HADS ≥ 8) 
 HADS-A 
Anxiety 
44 6.61 (4.08) 0 15 N = 19 (43%) 
 HADS-D 
Depression 
44 6.34 (3.81) 0 13 N= 17 (39%) 
HADS: Hospital anxiety depression scale 
3.5.5. Itch-5D 
The Itch 5-D scale was used to quantify pruritus in this group of patients. Scores 
can potentially range between 5 (no pruritus) and 25 (most severe pruritus). The 
average Itch-5D score was 10.01 (SD = 3.41), with scores ranging between 5 and 
23. The average was below the mid-range value, which may suggest that Omani 
ESRD patients had a low level of pruritus symptoms (Table 6.9). 
Table 6. 9  Itch 5-D scale scores  
 N (%) Mean (SD) Minimum Maximum Possible range 
Itch scale 44 10.01 (3.41) 5 19 5-25 
 
3.5.6. Fatigue Scale 
FSS is an unidimensional scale used to measure fatigue severity in ESRD 
patients. It consists of nine items scored on a seven-point Likert scale with scores 
<36 suggesting no fatigue and scores ≥36 suggesting possible fatigue that may 
need future evaluation (Hagell and Hoglund, 2006). The mean FFS score was 
44.40 (SD = 14.58), with scores ranging from 16-63. Sixty percent (29) of 44 
patients obtained a score of ≥36, indicating that a further evaluation of fatigue is 
required for those patients (Table 6.10). 
Table 6. 10 FFS scores possible caseness 
 N (%) Mean (SD) Minimum Maximum Cassenas (FSS ≥ 36) 
 FSS 44 44.40 (14.58) 16 63 N= 29 (59.90%) 
FSS: Fatigue severity scale 
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3.5.7. Spiritual Wellbeing Scale 
The overall SWB score was 97.88 (SD =16.77). The mean scores for the EWB 
and RWB subscales were 46.31 (SD = 9.71) and 51.57 (SD = 8.55) respectively. 
This result might suggest that both the existential and religious domains of 
spirituality were clinically relevant to patients in this study and might have an 
impact on their HRQoL (Table 6.11). It also emphasises the need to estimate the 
impact of this domain on patients’ physical health, mental health and HRQoL 
related to the disease. 
 
Table 6. 11 SWB score and subscale scores 
 N (%) Mean (SD) Minimum Maximum Possible range 
Existential subscale 44 46.31 (9.71) 20 60 10 - 60 
Religious subscale 44 51.57 (8.55) 21 60 10 - 60 
SWB 44 97.88 (16.77) 41 120 20 - 120 
SWB: Spiritual wellbeing 
3.6. Research Question 3: To what extent do the following factors predict 
QoL/HRQoL in Omani patients with ESRD? 
a) Individual characteristics (age, gender, educational status, income, region and 
marital status), measured by demographics 
b) Treatment characteristics (duration of dialysis, dialysis adequacy and length of 
time to get to dialysis), measured by clinical data 
c) Socio-environmental factors (family support, socio-economic, religious and 
spiritual), measured by disease-specific and generic instruments 
d) Biological function (anaemia and malnutrition), measured by clinical data such 
as serum albumin, haematocrit and serum Hb 
e) Symptoms (fatigue, pain, mood, pruritus), measured by symptom-specific 
instruments 
f) Functional status and general health perceptions, measured by health-status 
instruments 
A sequential regression method was used to predict the relationship between 
study independent variables on the SF36 (PCS and MCS) and QoLI-D scores. 
Thus, three separate regression models were developed for each of these 
dependent variables. The sequences for entering predictors into the regression 
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models were determined according to the literature review and the sequence of 
the research questions.  
It should be acknowledged that the assumption of sample size was not met for 
this pilot study, however, and the test was mainly performed for the purpose of 
developing and testing the syntax of sequential regression and, if it functioned, it 
was to be replicated in the main study. 
Five of the nominal variables in this analysis (gender, marital status, education 
status, job and monthly income) required dummy coding prior to being entered 
into the model. These variables were coded as dichotomous variables (Munro, 
2005) according to the most frequent response obtained from respondents (Table 
6.12). 
Table 6. 12 Dummy coding for nominal variables 
Nominal variable Reference value = 0 Non-reference values = 1 
Gender Male  Female 
Marital status Married Divorced 
Widow 
Single  
Education status Illiterate Low-intermediate 
Intermediate 
High-intermediate 
High 
Job Unemployed Employed  
Monthly 
Income (OMR) 
<250 251-600 
601-1,000 
1,001-1,500 
>1,501 
OMR 1= £2. 
 
3.6.1. Physical component summary (PCS) 
Prior to conducing the multiple regression to test the predictors of PCS, the 
relevant assumptions of this statistical analysis were tested. The assumption of 
singularity was met as the independent variables (age, marital status, job, 
income, fatigue, 5-D itch, anxiety, depression and general health perception) 
were not a combination of other independent variables. An examination of 
correlations between study IVs (Table 6.13-6.14) revealed that no independent 
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variables were above .85 (Tabachnick & Fidell, 2014). The co-linearity statistics 
(i.e., tolerance and variance inflation factors) were all above 0.10 and the VIF 
were all < than 10.0, indicating no concerns with multicollinearity (Tabachnick & 
Fidell, 2014). The assumption of multicollinearity was deemed to have been met 
(Coakes, 2005; Hair et al., 1998). No extreme univariate outliers were identified. 
Also, an examination of the Mahalanobis distance scores indicated no 
multivariate outliers. Residual and scatter plots indicated that the assumptions of 
normality, linearity and homoscedasticity were all satisfied in this regression (Hair 
et al., 1998; Pallant, 2001). 
Table 6. 13 Spearman's rho correlations of PCS with independent variables (N = 44) 
 Gender Marital 
status 
Educational 
status 
Job Income PCS 
Gender - -.07 -.46** .57** -.18 -.31* 
Marital status  - .31* .35* -.20 -.29* 
Educational 
status 
  - -.30* .45** .09 
Job    - -.41** -.27$ 
Income     - .27$ 
PCS       - 
p ≤ .15$; p ≤ .05*; p < .001** 
PCS: Phsyical component summary  
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Table 6. 14 Pearson’s correlations of PCS with independent variables (N = 44) 
 PCS 
Pt 
age 
Hb 
HCT 
level 
Albumin 
level 
HD 
hours 
per 
month 
HD 
adequacy 
QoLID 
socio-
eco 
QoLID 
Family 
General 
Health 
Perception 
Anxiety Depression 
5D 
Itching 
SWB FFS 
PCS - .20 .17 .21 .01 -.01 -.14 .16 -.06 .52** -.47** -.56** -.30* .20 -.47** 
Pt age  - -.44** -.41** -.01 -.26 -.12 -.08 -.03 .06 -.17 -.12 -.40** -.01 -.37* 
Hb   - .89** .10 -.01 -.04 .23$ .14 -.01 -.13 -.19 .19 -.01 -.03 
HCT level    - .17 -.09 .01 .24$ .23 -.10 -.18 -.20 .16 .13 .02 
Albumin 
level 
    - -.09 -.01 .06 .41** -.13 .06 -.02 -.03 -.07 .01 
HD hours 
per month 
     - .18 .07 -.11 -.05 -.01 .18 .02 .01 .09 
HD        - -.01 .10 .08 -.36* -.30* -.08 .26 -.08 
QoLID 
socio-eco  
       - .59** .12 .07 -.11 -.01 .10 -.08 
QoLID 
Family  
        - .01 .04 -.06 .02 .14 -.07 
QoLID          .58** -.60** -.73** -.09 .55** -.58** 
General 
Health 
Perception 
         - -.43** -.54** -.17 .34* -.43** 
Anxiety            - .75** .19 -.50** .60** 
Depression             - .18 -.43** .57** 
5D Itching              - .16 .17 
SWB               - -.34* 
FFS                - 
p ≤ .15$; p ≤ .05*; p < .001** 
PCS: physical component summary; Hb: Haemoglobalin; HD: Heamodialysis; QoLID: Quality of life index-dialysis; SWB: Spiritual wellbeing; FFS: Fatigue severity scale
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A four-stage sequential multiple regression was conducted with physical health 
as the dependent variable. Socio-demographic variables were entered at step 
one of the regression to control for socio-demographic effects. The physical-
symptom variables (fatigue and itch) were entered at step two, mood symptoms 
(anxiety and depression) at step three and general health perception at stage 
four. Apart from the sample size, no other violation in assumptions was noted. 
At step one, with demographic variables in the equation, Finc (4,37) =.450, p = .78 
these accounted for 21% of variance in the PCS score. None of the demographic 
variables were found to be significant predictors of SF36v2 PCS scores. 
Introducing the physical-symptom variables in step two explained an additional 
22% of variance in the PCS scores and this change in R2 was significant, Finc (2, 
35) =5.472, p < .01. Among the two variables added in step two, only high fatigue 
scores associated with low SF36v2 physical health components cores (p = .008). 
Adding the mood symptoms to the equation, the regression model explained an 
additional 13.7% of variance in PCS scores and this change in R2   was significant, 
Finc (2,33) =3.832, p = .032. Neither symptom appeared to be significant 
predictors of SF36v2 PCS.  Finally, after the addition of perceived general health 
at step four, the R2 was =.476 (adjusted R2 =.329), Finc (1, 32) =4.054, p= .053. In 
the final model, no significant predictors were found. Regression statistics are in 
Table 6.15. 
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Table 6. 15  Sequential Multiple Regression Analysis predicting SF36v2 PCS (two-factor 
standardised model) from Treatment Characteristics, Family Support, Symptom Specific 
Measures, Emotional Measures and Health Status Measures 
Variable  B SE B  t-
statisti
c 
Significa
nce 
R F R2 R2 
Step 1 
       Patient age  
       Marital status 
       Job 
       Income 
 
.10 
-.06 
-1.93 
-2.13 
 
.10 
3.21 
3.32 
3.40 
 
.18 
-.04 
-.10 
-.11 
 
1.06 
.02 
.58 
.62 
 
.29 
.98 
.56 
.53 
.21 
 
.43 .04 .05 
Step 2 
       Itch 
       Fatigue 
 
-.60 
-.25 
 
.39 
.09 
 
-.23 
-.43 
 
1.53 
2.79 
 
.13 
.01* 
.52 5.47 .27 .14 
Step 3 
       Anxiety 
       Depression 
 
-.17 
-.92 
 
.46 
.48 
 
-.08 
-.41 
 
.36 
1.89 
 
.71 
.06 
.64 3.83 .41 .26 
Step 4 
       Perceived 
General Health 
        
Overall Final 
Model  
        Intercept 
        Pt age 
        Marital statu  
       Job 
       Income 
       Itch 
       Fatigue 
       Anxiety  
       Depression 
       Perceived 
General Health 
      
F-test for the 
whole model 
Significance of F-
test 
R 
R2 
Adjusted R2 
 
2.36 
 
 
 
 
45.5 
.01 
.58 
-.79 
-.73 
-.46 
-.05 
-.14 
-.58 
2.36 
 
 
4.054 
 
.053 
 
.690 
.476 
.329 
 
1.17 
 
 
 
 
 
.09 
2.62 
2.72 
2.75 
.35 
.10 
.44 
.49 
1.17 
 
.32 
 
 
 
 
 
.02 
.03 
.04 
.03 
.18 
.09 
.06 
.26 
.32 
 
 
2.01 
 
 
 
 
 
.13 
.22 
.29 
.26 
1.31 
.53 
.31 
1.18 
2.01 
 
 
.05 
 
 
 
 
 
.89 
.82 
.77 
.79 
.19 
.59 
.75 
.24 
.05 
.69 4.05 .47 .32 
Note:  N = 44. CI, confidence interval; NS, not significant; HD, Haemodialysis. 
The   weights are the standardised regression coefficients at each step.  
*p < .05. **p< .01, *** p< .001 
 
In summary, none of the tested variables predicted the physical-health scores in 
this sample of ESRD patients. However, given that the aim of performing this 
model was to practice the syntax of sequential regression and its functioning, to 
be replicated in the main study, results evident feasibility of this syntax to the 
main study.  
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3.6.2. Mental Component Summary (MCS) 
The assumptions relating to this regression model were tested. The assumption 
of singularity was met as the independent variables (gender, HD adequacy, 
fatigue, itch, anxiety, depression, physical health and general health perception) 
were not a combination of other independent variables. An examination of 
correlations (tables 6.16 and 6.17) revealed no independent variables above .85 
(Tabachnick & Fidell, 2014). The co-linearity statistics (i.e., tolerance and 
variance inflation factors) were all above 0.10 and the VIFs were all < than 10.0, 
indicating no concerns with multicollinearity (Tabachnick & Fidell, 2014). The 
assumption of multicollinearity was deemed to have been met (Coakes, 2005; 
Hair et al., 1998), except for sample size. No extreme univariate outliers were 
identified. Also, an examination of the Mahalanobis distance scores indicated no 
multivariate outliers. Residual and scatter plots indicated that the assumptions of 
normality, linearity and homoscedasticity were all satisfied (Hair et al., 1998; 
Pallant, 2001). 
 
Table 6. 16 Spearman's rho correlations of MCS with independent variables (N = 44) 
 Gender 
Marital 
status 
Educational 
status Job Income MCS 
Gender - -.04 -.44** .57** -.17 -.32* 
Marital status  - .15 .34* -.25 -.13 
Educational 
status 
  - -.28 .20 .21 
Job    - -.44** -.04 
Income     - .04 
MCS      - 
p ≤ .15$; p ≤ .05*; p < .001** 
 
MCS: Mental component summary
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Table 6. 17 Pearson’s correlations of MCS with independent variables (N = 44) 
 
M
C
S 
Pt 
age 
Hb HCT 
Albumi
n level 
HD 
hours 
per 
month 
HD 
adequa-
cy 
QoLID 
socio-
eco 
QoLID 
Family 
General 
Health 
Percept
ion 
Anxiet
y 
Depressi
on 
5D 
Itching 
SWB FFS 
Bodily 
pain 
PCS 
MCS - .08 .01 -.01 -.01 -.16 .24$ -.14 -.17 .45** -.64** -.71** -.28$ .35* -.56** .76** .49** 
Pt age  - -.41** -.41** .02 -.20 -.09 -.02 .03 .08 -.14 -.10 -.30* -.02 -.32* .12 .17 
Hb   - .84** .06 -.14 -.02 .22$ .10 -.02 -.10 -.16 .08 -.06 -.05 .21 .14 
HCT    - .20 -.18 -.05 .16 .20 -.13 -.17 -.16 .17 .08 .02 .20 .14 
Albumin 
level 
    - -.13 -.01 .07 .44** -.11 .07 -.06 -.04 -.16 -.02 .11 .05 
HD hours 
per month 
     - .10 .09 -.16 -.09 -.02 .16 .02 -.01 .06 -.12 .01 
HD 
adequacy 
      - -.05 .07 .09 -.36* -.28 -.10 .28 -.11 -.04 -.14 
QoLID 
socio-eco 
       - .64** .06 .09 -.07 -.05 -.02 -.02 -.02 .13 
QoLID 
Family 
        - -.08 .10 .03 .02 .03 -.03 -.17 -.05 
General 
Health 
Perception 
         - -.45** -.55** -.15 .34* -.40** .38* .57** 
Anxiety           - .76** .13 -.38* .61** -.53** -.50** 
Depression            - .14 -.33* .58** -.60** -.57** 
5D Itching             - .20 .17 -.31* -.30* 
SWB              - -.27 .17 .15 
FFS               - -.46** -.453* 
Bodily pain                - .74** 
PCS                 - 
GH 
perception 
                 
p ≤ .15$; p ≤ .05*; p < .001** 
MCS: Mental component summary; Hb: Haemoglobalin; HD: Heamodialysis; QoLID: Quality of life index-dialysis; SWB: Spiritual wellbeing; FFS: Fatigue severity scale
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A five-stage sequential multiple regression was conducted with mental health as 
the dependent variable. The socio-demographic variable (gender) was entered 
at step one of the regression to control for socio-demographic effects. The clinical 
variable (HD adequacy) was entered at step two, physical symptoms at step 
three, emotional symptoms at step four and perceived general health and 
physical functioning at step five. The regression-statistics result is in Table 6.18.  
 
Table 6. 18 Sequential Multiple Regression Analysis predicting MCS From Demographic, 
Treatment Characteristics, Symptom-Specific Measures, Emotional Measures and Health 
Status Measures 
Variable  B SE B  t-
statistic 
Significan
ce 
R F R2 R2 
Step1 
       Gender  
 
-7.90 
 
3.28 
 
-.35 
 
2.40 
 
.02* 
.35 5.77 .12 .10 
Step2 
       HD Adequacy  
 
.35 
 
.20 
 
.25 
 
1.74 
 
.08 
.43 3.05 .19 .14 
Step 3 
      Itch 
      Fatigue 
      Bodily pain 
 
-.06 
-.11 
.28 
 
.28 
.07 
.04 
 
-.01 
-.15 
.66 
 
.21 
1.56 
6.56 
 
.83 
.12 
.00*** 
.86 25.45 .74 .70 
Step 4 
       Anxiety 
       Depression 
 
.04 
-.53 
 
.39 
.42 
 
.01 
-.19 
 
.91 
.21 
 
.91 
.21 
.86 .95 .75 .70 
Step 5 
       Perceived 
General Health 
       Physical health 
        
Overall Final Model  
       Intercept 
       Gender 
       HD adequacy 
       Itch 
       Fatigue 
       Bodily pain 
       Anxiety  
       Depression 
       Perceived 
General Health 
   Physical 
functioning 
 
F-test for the whole 
model 
Significance of F-
test 
R 
R2 
Adjusted R2 
 
1.23 
 
-.31 
 
 
32.96 
-2.97 
.20 
-.18 
-.08 
.29 
-.04 
-.57 
1.23 
 
-.31 
 
 
 
1.37 
 
.26 
.88 
.77 
.71 
 
1.04 
 
.20 
 
 
 
2.22 
.15 
.29 
.08 
.06 
.39 
.44 
1.04 
 
.206 
 
.13 
 
-.25 
 
 
 
-.13 
.14 
-.05 
-.11 
.68 
-.01 
-.20 
.13 
 
-.25 
 
1.18 
 
-.154 
 
 
 
-1.33 
1.32 
-.63 
-1.01 
4.89 
-.12 
-1.27 
1.18 
 
-1.54 
 
.24 
 
.13 
 
 
 
.19 
.19 
.53 
.31 
.00*** 
.90 
.21 
.24 
 
.13 
.88 1.37 .77 .71 
Note:  N = 44. CI, confidence interval; NS, not significant; HD, Haemodialysis. 
The  weights are the standardised regression coefficients at each step.  
*p < .05. **p< .01, *** p< .001 
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At step one, with gender variables in the equation Finc (1,40) =5.774, p = .021, 
these accounted for 35% of the variance in the PCS score. Gender was found to 
be a significant predictor of MCS scores (p = .021). Introducing the clinical 
variable (HD adequacy) in step two explained an additional 6% of variance in the 
MCS scores and this change in R2 = .774, Finc (1, 39) =3.054, p < .088. The HD 
adequacy variable was found not to be a significant predictor of MCS. At step 
three, with physical symptoms in the equation Finc (3,36) =25.451, p < .001, of the 
three variables added at this step, lower bodily pain associated with better mental 
health component scores (p< .001).  Adding the mood symptoms to the equation 
in step four, the regression model explained an additional 55% of variance in 
MCS scores and this change in R2   was not significant, Finc (2,34) = .955, p = 
.395. Both symptoms appeared not to be significant predictors of MCS.  Finally, 
the addition of the perceived general health and physical functioning at step five, 
explained an additional 20% to model, R2 =.774 (adjusted R2 =.710), Finc (2, 32) 
=1.371, p= .268. None of the perceived general health and physical functioning 
factors were significant. In the final model the only significant predictor of MCS 
scores was bodily pain. Together, all the IVS accounted for 77.4% of the variance 
in the SF36v2 MCS scores. 
In summary, lower bodily pain predicted better mental-health scores in patients 
with ESRD. 
3.6.3. Quality of Life Index-Dialysis (QoLID) 
The relevant assumptions of this statistical analysis were tested. The assumption 
of singularity was met as the independent variables (HD adequacy, haematocrit, 
itch, fatigue, bodily pain, anxiety, depression, perceived general health and 
physical functioning) were not a combination of other independent variables. An 
examination of correlations (tables 6.19 and 6.20) revealed that no independent 
variables were highly correlated (Tabachnick & Fidell, 2014). The co-linearity 
statistics (i.e., tolerance and variance inflation factors) were all above 0.10 and 
the VIF were all < than 10.0, indicating no concerns with multicollinearity 
(Tabachnick & Fidell, 2014). The assumption of multicollinearity was deemed to 
have been met (Coakes, 2005; Hair et al., 1998). No extreme univariate outliers 
were identified. Also, an examination of the Mahalanobis distance scores 
indicated no multivariate outliers. Residual and scatter plots indicated that the 
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assumptions of normality, linearity and homoscedasticity were all satisfied (Hair 
et al., 1998; Pallant, 2001). 
 
Table 6. 19 Spearman's rho correlations of QoLID with independent variables (N = 44) 
 Gender 
Marital 
status 
Educational 
status Job Income QoLID 
Gender - -.04 -.44** .57** -.17 -.09 
Marital 
status 
 - .15 .34* -.25 .11 
Educational 
status 
  - -.28 .20 .16 
Job    - -.44** .08 
Income     - -.06 
QoLID      - 
p ≤ .15$; p ≤ .05*; p < .001** 
QOLID: Quality of life index dialysis
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Table 6. 20 Pearson’s correlations of QoLID with independent variables (N = 44) 
 
QoL
ID 
Pt 
age 
Hb HCT Albumi
n level 
HD 
hours 
per 
mont
h 
HD 
adequac
y 
General 
Health 
Perceptio
n 
Anxiet
y  
Depressi
on 
5D 
Itchin
g  
SWB FFS Bodily 
pain 
PCS 
QoLID - .02 .25 .31* .04 -.03 .27$ .53** -.66** -.70** -.08 .44** -.58** .47** .57** 
Pt age 
 
- -.41** -.41** .02 -.20 -.09 .08 -.14 -.10 -.30* -.02 -.32* .12 .17 
Hb 
  
- .84** .06 -.14 -.02 -.02 -.10 -.16 .08 -.06 -.05 .21 .14 
HCT 
   
- .20 -.18 -.05 -.13 -.17 -.16 .17 .08 .01 .20 .14 
Albumin 
level 
    
- -.13 -.01 -.11 .07 -.06 -.04 -.16 -.02 .11 .05 
HD hours 
per month 
     
- .10 -.01 -.02 .16 .01 -.01 .06 -.12 .01 
HD 
adequacy 
      
- .09 -.36* -.28 -.10 .28 -.11 -.04 -.14 
General 
Health 
Perception 
       
- -.45** -.55** -.15 .34* -.40** .38* .57** 
Anxiety  
        
- .76** .13 -.38* .61** -.53** -.50** 
Depression 
         
- .14 -.33* .58** -.60** -.57** 
5D Itching  
          
- .20 .17 -.31* -.30* 
SWB 
           
- -.27 .17 .15 
FFS 
            
- -.46** -.45** 
Bodily pain 
             
- .74** 
PCS 
              
- 
GH 
perception 
               
p ≤ .15$; p ≤ .05*; p < .001** 
PCS: physical component summary; Hb: Haemoglobulin; HD: Heamodialysis; QoLID: Quality of life index-dialysis; SWB: Spiritual wellbeing; FFS: Fatigue severity scale 
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A five-stage sequential multiple regression was conducted with quality of life-
index dialysis related as the dependent variable. The treatment characteristic 
variable was entered at step one of the regression and haematocrit was entered 
at step two.  Physical symptoms were entered at step three, mood symptoms at 
step four and perceived general health and physical functioning at step five. The 
regression statistics are in Table 6.21. Apart from the sample size, no violations 
in assumptions were noted. Thus, these were considered as having been 
sufficiently met. 
Table 6. 21 Sequential Multiple Regression Analysis predicting QoLID Treatment 
Characteristics, Symptom-Specific Measures, Mood Measures and Health Status Measures 
Variable  B SE B  t Significance R F R2 R2 
Step 1 
       HD adequacy  
 
.10 
 
.05 
 
.27 
 
1.79 
 
.08 
.273 3.22 .07 .05 
Step 2 
      Haematocrit 
 
.19 
 
.08 
 
.33 
 
2.31 
 
.02* 
.431 5.33 .18 .14 
Step 3 
       Itch 
       Fatigue 
       Bodily pain 
 
.04 
-.09 
.02 
 
.10 
.02 
.01 
 
.04 
-.45 
.23 
 
.39 
-3.48 
1.65 
 
.69 
.01** 
.10 
.730 8.90 .53 .46 
Step 4 
       Anxiety 
       Depression 
 
-.08 
-.30 
 
.13 
.14 
 
-.11 
-.38 
 
-.59 
-2.124 
 
.55 
.04* 
.788 3.91 .62 .54 
Step 5 
       Perceived 
General Health 
   Physical 
functioning 
 
Overall Final 
Model  
       Intercept 
       HD adequacy 
       Haematocrit 
       Itch 
       Fatigue 
       Bodily pain 
       Anxiety  
       Depression 
       Perceived 
General Health 
       Physical 
functioning 
      
F-test for the 
whole model 
Significance of F-
test 
R 
R2 
Adjusted R2 
 
.48 
 
.09 
 
 
 
 
10.01. 
.07 
.16 
.04 
-.05 
-.01 
-.03 
-.17 
.48 
.09 
 
 
 
.3.91 
 
.03* 
 
.83 
.69 
.60 
 
.34 
 
.06 
 
 
 
 
 
.04 
.06 
.09 
.02 
.01 
.12 
.13 
.34 
 
.06 
 
 
.19 
 
.28 
 
 
 
 
 
.19 
.28 
.05 
-.26 
-.12 
-.05 
-.22 
.19 
 
.28 
 
1.40 
 
1.61 
 
 
 
 
 
1.63 
2.57 
.47 
-2.02 
-.78 
-.29 
-1.26 
1.40 
 
1.61 
 
.16 
 
.11 
 
 
 
 
 
.11 
.01* 
.64 
.05 
.43 
.77 
.21 
.16 
 
.11 
.834 3.91 .69 .60 
Note:  N = 44. CI, confidence interval; NS, not significant; HD, Haemodialysis. 
The  weights are the standardised regression coefficients at each step.  
*p < .05. **p< .01, *** p< .001 
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At step one, with the HD adequacy variable in the equation Finc (1,40) =3.228, p 
= .080, this accounted for 7.5% of the variance in the QoLID score. The HD 
adequacy variable was found not to be a significant predictor of QoLID scores. 
Adding the haematocrit variable in step two, Finc (1,39) =5.335, p = .026, 
explained an additional 11% of variance in QoLID scores and this change in R2, 
was significant (p = .026). That is, higher percentage of haematocrit associated 
with better QoLI-Dialysis. Introducing the physical-symptom variables in step 
three explained an additional 34% of variance in the QoLID scores and this 
change in R2 was significant, Finc (3, 36) =8.906, p < .01. Among the three 
variables added in step three, only higher fatigue was found to be a significant 
predictor of low QoLID scores (p = .001).  Adding the mood symptoms to the 
equation, the regression model explained an additional 8% of variance in QoLID 
scores and this change in R2 was significant, Finc (2,34) =3.832, p = .029. Higher 
depression scores associated with lower QoLI-Dialysis.  Finally, after the addition 
of perceived general health and physical functioning at step five, R2 =.695 
(adjusted R2 =.609), Finc (2, 32) =3.914, p= .030. In the final model, the only 
significant predictor of QoLID scores was haematocrit. Together, all the IVS 
accounted for 67% of variance in the QoLID scores. 
In conclusion, haematocrit was found to be a significant factor that positively 
predicted QoLI related to dialysis. That is, the higher scores of haematocrits 
predicted high QoLID scores in patients with ESRD. For each unit increase in the 
haematocrit, the QoLID score is predicted to increase on average by .166 units, 
with 95% confidence limits from .035 to .298 and this association is statistically 
significant (p = .015). 
4. Discussion 
The aims of this pilot study were to test the practicality of the selected HRQoL 
and spiritual-wellbeing measures within an Omani context and their acceptability 
to patients. Findings reflected the practicality of using the cross-sectional design 
to test the factors that predict HRQoL among patients with ESRD within Oman. 
Forty-four patients completed six measures with a completion rate of more than 
80%. Likewise, the method employed to recruit research assistants was suitable 
and can be replicated in the main study.   
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In preparing the pilot study, the researcher’s concern was based on conducting 
and ensuring a rigorous sequential regression analysis. As a novice researcher, 
the pilot study provided the opportunity to gain the necessary experience in 
conducting the test and identifying practical issues or difficulties in data-analysis 
and interpretation. Thus, a pilot study can be considered highly useful for novice 
researchers to safely practice planned statistical analysis and familiarise 
themselves with any statistical plan prior to conducting the main study. Another 
advantage for the researcher is that piloting the quantitative approach can be 
carried out if the researcher lacks confidence particularly when using advance 
statistical tests such as sequential regression statistics. 
Despite the assumption that sample size was not met in this pilot study, results 
indicate the usefulness of the statistical syntax. To determine the sample size for 
regression analysis, a rule of thumb suggested by Tabachnick and Fidell (2001) 
can be used: (N > 50 + 8m, where N = number of participants and m = number 
of independent variables). A sample size of 194 responses would be required to 
make an overall fit of the model. To test the contribution of each individual 
independent variable to explain the dependent variable, this rule of thumb was 
used: N = 104 + k. Thus, 122 samples are required to test the individual 
independent variable. These methods would assume a medium-effect size 
relationship between independent and dependent variables of α = 0.05 and β= 
0.20 when data are normally distributed. Likewise, for factor analysis, the ratio of 
4-10 cases per item was the rule of thumb employed (Tabachnick & Fidell, 2014). 
For instance, SF36v2 has 36 items. Thus, for SF36v2, around 7 cases x 36 items 
= 252 participants and this total was deemed sufficient to provide a reliable factor 
structure. 
 
The piloted measure, including socio-demographic questions, has been shown 
to be reliable in the Omani context. Two measures, however, SF36v2 and HADS, 
may require further exploration of factor construct using the factor-analysis test. 
This is to test whether these measures literally reflect the true theoretical meaning 
of their concepts within the Omani context. The low Cronbach’s alpha of the two 
subscales of the mental-component summary (α .500) and physical functioning 
(α .508) of SF36v2 may suggest the existence of a latent variable within the 
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Omani context that needs to be explored. The HADS result showed a slight 
variation between the concepts of anxiety and depression among this group of 
patients. To explore the nature of this variation further and to validate the HADS 
among Omanis, it would be useful to conduct a factor analysis that explores the 
factor structure. 
In current study, it was observed that the mental-health domain was higher 
among ESRD patients compared with the physical-health domain. This may 
indicate that ESRD has a greater impact on physical health and that patients may 
have developed a mechanism to maintain their mood status throughout their time 
spent on dialysis. Similarly, Hopman et al (2009) conducted a systematic review 
and concluded that all chronic health conditions might negatively impact on a 
patient’s physical-health status, with relatively better mental-health status. The 
review included 10 studies using SF36 administered to 2,418 patients with 
different chronic health conditions. This could support the argument that patients 
with chronic diseases, including ESRD, may develop controllability and coping 
mechanisms to rebalance their perception of life. 
Two measures were used to examine overall health status and HRQoL in Omani 
patients. The means and standard deviation of the scale and subscales were 
calculated for both measures for the entire sample. On SF36, patients reported 
low scores on physical health. Their role limitation, due to physical health and 
physical functioning, were the lowest rated among the physical-health domain. 
The scores for mental-health domains were slightly better compared with physical 
health and the mental-health score was the highest, followed by social 
functioning, within this aspect. Likewise, for QoLI-D, the overall scores indicated 
a low level of HRQoL. The health and functioning subscale was the lowest scored 
subscale, followed by the socio-economic subscale. In addition to SF36 and 
QoLI-D, a single item (number one in SF36) was used to ask participants to rate 
their health in general. Overall, the majority of patients perceived their health as 
“fair” or “good”, with very few rating it as “excellent” or “poor”.  
The health and functioning scores were the lowest compared with scores of family 
support and spiritual-life subscales of QoLI-Dialysis. This result was similar to 
findings by Ferrans and Powers (1993) in which health and functioning scores 
were lower than family-support subscale scores. Although it is not clear why 
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patients value family higher in relation to their HRQoL than health and functioning 
status, it may be that patients place greater importance on non-health factor 
values as a supportive mechanism for coping with their poor health and 
functioning. The contribution of non-health factors, such as family and socio-
environmental support, was emphasised by the revised Wilson and Cleary model 
of HRQoL. Family and psychological/spiritual aspects were both rated as high by 
Omani patients, which may suggest that they use it as a coping mechanism with 
which to rebalance their life. Additionally, this finding may also explain the focus 
on the burden of the disease in the majority of studies assessing HRQoL in 
patients with ESRD. 
Albumin variable was a predictor of QoLI-Dialysis and explained 28% of the total 
variance (p = .015). Studies that examined the haematocrit effect on patients with 
ESRD have used the SF36 health-status measure (Patel et al., 2002; Lopes et 
al., 2007). Interestingly, these studies did not report any significant correlation 
between haematocrit and overall health status. It may be that haematocrit is a 
dialysis-related health factor rather than an overall health-status factor, yet it 
correlates with overall health status. Clinically, the haematocrit level is usually 
affected by clinical factors such as malnutrition, blood loss during the dialysis 
procedure and other medical conditions. Ebben et al. (1998) found, in a 
comparison study between ESRD patients with ≥30% haematocrit and ≤29% 
level, that patients with less than 30% haematocrit had a higher risk of mortality. 
This might indicate that albumin may not directly impact on health stauts unless 
it is at a severely low level. For this study sample, the mean haematocrit level 
was 38.42 (SD = 5.13), with therapeutic values around 35-48g/L according to the 
KDOQI clinical-practice guideline for haemodialysis (2015), which shows the 
clinically acceptable level of haematocrit. Prior to determining the exact 
relationship between haematocrit and QoLI-Dialysis, future studies should 
perhaps be considered which test the haematocrit factor as an outcome.  
Higher general health perception was associated with better physical-health 
status (r = .527, p < .001), mental-health status (r = .459, p < .001), and QoLI-
Dialysis (r = .537, p < .001) in patients with ESRD. The contribution of general 
health perception to better physical health was found by Wu A et al. (2004) in an 
examination of overall health status in two groups of ESRD patients, on peritoneal 
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and haemodialysis dialysis, in which general health perception was associated 
with better physical functioning (r = .341, p < .001). Cleary et al. (2005) also found 
a positive correlation between general health perception and mental-health 
status. These findings might contribute to formulating a conclusion that general 
health perception might be associated with a better level of HRQoL in patients 
with ESRD. It also supports the notion of the importance of using individualised 
measures when assessing QoL and HRQoL. 
Fatigue was a prevalent variable in this study and associated with low HRQoL. 
Twenty-nine patients (56% of 319) were possible cases which may need further 
clinical evaluation (≥ 36 may require clinical evaluation; Hagell et al., 2006). 
Although the fatigue variable was an insignificant factor in study outcomes, it was 
associated with low physical health, mental health, and QoLI-Dialysis. The finding 
was similar to that in a study by Williams et al (2007) in which fatigue was high in 
American patients on haemodialysis (M = 44.6, SD = 33.1). These results 
furnished evidence that fatigue is associated with poor HRQoL and may be a 
main symptom that impacts on a patient’s overall health, requiring clinical 
intervention. 
Bodily pain was assessed by the bodily-pain (BP) subscale of SF36v2, with 
reverse scoring meaning that the lower BP scores indicated better health status, 
and the mean score was 54.86 (SD = 24.86). Although there is no published norm 
for the bodily-pain scale in Oman, this score was comparable with the pain mean 
of 55.6 (SD = 28.8) among Russian ESRD patients (Vasilieva and Irina, 2006). 
Dudgeon et al (2005) observed that low perceptions of control over pain may lead 
to decreased motivation to cope with pain and to poorer psychological health. 
Therefore, the presence of pain, if it is not effectively treated and relieved, might 
have a detrimental effect on all aspects of HRQoL in patients with ESRD. Thus, 
future research is required to examine the hidden implication of pain on a patient’s 
HRQoL.  
Despite physical symptoms associated with lower HRQoL, the mean itch 
symptom was 10.01 (SD = 3.41), with a maximum range of 25. The literature did 
not report a norm or a cut-off value for the 5-D Itch scale. However, scores remain 
lower compared with scores for fatigue and bodily pain. This score also remains 
slightly lower compared with international published studies that examine itch 
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among ESRD patients (Lai et al., 2017; Khan et al., 2014). Uraemia (high urea in 
blood) is often the main cause of itching in ESRD patients and is usually treated 
by an adequate dialysis regimen. The urea clearance (URR) was within the 
recommended therapeutic value (≥ 65% based on the KDOQI Guideline, 2007). 
This reflects the fact that receiving an efficient dialysis regimen helps to reduce 
uraemia and other toxic consequences. It may also suggest that patients have a 
good compliance with the recommended dietary intake related to ESRD. 
Anxiety was associated with poorer study outcomes. The mean anxiety score 
was 6.61 with 43% (19 patients) beyond a cut-off score of 8. This indicates that 
anxiety is a substantial symptom among Omani patients with ESRD. Ramirez et 
al. (2012) reported similar findings among haemodialysis patients in a study in 
which 170 patients (25.9%) were anxious.  
Six instruments were administered in this pilot to test the practicality of the 
selected HRQoL measures within an Omani context and their acceptability to 
patients. The obtained response and completion rate on all administered 
measures was optimistic (above 80%). It is therefore deemed to be reliable within 
an Omani context to administer the main study to explore the factors and levels 
that determine HRQoL in patients with ESRD. However, two measures, SF36v2 
and HDAS, may require further construct validation within the Omani context. The 
low Cronbach’s alpha of the two subscales of Mental Component Summary (α 
.500) and Physical Functioning (α .508) of SF36v2 may suggest the existence of 
a latent variable within the Omani context that needs to be explored. For this, an 
exploratory factor analysis may be required, using oblique and orthogonal 
rotation methods to explore the factor construct of SF36v2 within the given 
context. The HADS result showed a slight variation between the concepts of 
anxiety and depression among this group of patients. To explore the nature of 
this variation further and to validate the HADS among Omanis, it would be useful 
to conduct a factor analysis to explore the factor structure. 
Given that no studies have been conducted assessing HRQoL among ESRD 
patients within Oman, the nephrology services and literature were lacking in this 
area of practice. Hence, information on HRQoL is needed to fill this gap and how 
ESRD patients can be helped. This pilot study may guarantee new knowledge 
and expanded understanding of HRQoL among dialysis patients. It makes a 
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valuable contribution to the validation of HRQoL among ESRD patients and to 
the international literature with new knowledge from the piloted measures. The 
information generated by this study about the cultural relevancy of the HRQoL 
measures could help researchers aiming to standarised the SF36v2, QoLI-
Dialysis, HADS, Itch-D Scale, and FFS measures across cultures.  
 
A number of limitations in this pilot study should be acknowledged. First, the 
sample was taken from three dialysis units in Oman. This sample therefore may 
not be representative of the Oman ESRD population. Patients from different 
regions may perceive their HRQoL differently. Patients from different regions and 
rural areas may have different backgrounds and value systems. A larger group 
of patients from different regions in Oman would strengthen the study. Second, 
although this pilot study used a random group from the ESRD patients in Oman, 
results might only provide regional norms of the piloted measures which can be 
used for comparison purposes until establishing normative values for the Omani 
population. Third, around 30% of the patients in this study were illiterate. Although 
the measures were read to illiterate patients by the trained nurses without any 
prompts, the answers provided may not reflect their true perception of helath. 
Finally, because patients spend around 12-15 hours on dialysis per week, 
recruitment may be enhanced by asking patients to participate during their regular 
dialysis schedule. Haemodialysis can cause hypotension and electrolytes 
imbalance. Patients may not have felt at their best while answering the piloted 
measures related to their HRQoL. 
 
5. Conclusion  
This pilot study tested the acceptability and practicality of the use of study 
measures within Oman, as well as recruitment procedures, rate of participation 
and feasibility to ensure that any variations in the research design were effectively 
managed. Forty-four patients participated in the study with a good response rate 
of 73% over a period of 21 days. The rate of measures compeletion ranged from 
96.7%-100%, indicating a preliminary acceptance and applicability of the 
measures. The study was guided by the revised Wilson and Cleary model of 
HRQoL (2005) which seemed to be an applicable conceptual model to guide the 
main study. It has various domains, including biological function, symptoms, 
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functional status, general health perceptions and various characteristics of the 
individual and their environment, which provide sufficient justification of the 
independent variables used to explain HRQoL.  
The piloted measure, including socio-demographic questions, has been shown 
to be reliable in the Omani context. Two measures, however, SF36v2 and HADS, 
may require further exploration of factor construct using the factor-analysis test. 
This is to test whether these measures literally reflect the true theoretical meaning 
of their concepts within the Omani context. The low Cronbach’s alpha of the two 
subscales of the mental-component summary (α .500) and physical functioning 
(α .508) of SF36v2 may suggest the existence of a latent variable within the 
Omani context that needs to be explored. The HADS result showed a slight 
variation between the concepts of anxiety and depression among this group of 
patients. To explore the nature of this variation further and to validate the HADS 
among Omanis, it would be useful to conduct a factor analysis that explores the 
factor structure. 
Religion and spirituality is an important factor that may determines a patient’s 
HRQoL and is associated with better mental health and QoLI-Dialysis. Patients, 
however, may experience religious struggle or be unsettled about their religious 
activities due to the burden of the disease. Their physical functioning and/or role-
functioning status might not help them to perform their obligated religious rituals. 
This possible negative association between physical functioning and role-
functioning needs to be further explored in the main study. 
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Chapter 7- Exploratory and Confirmatory Factor Analysis of the 
Arabic Version of SF36v2 and HADS within an Omani Context 
 
Background  
Studies that examined factor structure of the Short-Form 36v2 (SF36v2) and 
Hospital Anxiety Depression Scale (HADS) have yielded inconsistent findings. 
SF36v2 and HADS have not been validated within the Omani context, and   
currently their factor structure is not known. This study, therefore, aims to explore 
the underlying structure of the both measures, using factor analysis and internal-
reliability test. 
Method  
Data from a cross-sectional study conducted across 13 dialysis units in Oman 
were used in this analysis. Internal consistency, exploratory factor analysis (EFA) 
and confirmatory factor analysis (CFA) were conducted to test both measures. 
Factors number were determined by using Eigenvalues and were then explored 
using oblimin and orthogonal rotation methods. The simplest and clearest 
identified structures out of EFA were then confirmed using CFA. 
Findings  
SF36v2 had an acceptable internal consistency. EFA revealed a three-factor 
structure underpinning the SF36v2 in this population. This was confirmed by CFA 
which manifested good-fit indices parameters: RMSEA (.06), CFI (.90) and TLI 
(.90).  
HADS did not have an exclusive factor-structure. EFA revealed one-factor 
structure, and a potential two-factor structure correlated at α .53 Items-6,7,8,10 
were problematic and showed inconsistency loading on its hypothesised factor. 
CFA revealed acceptable fit indices to data for the one-factor (RMSEA: .08, CFI: 
.92, TLI: .90), original two-factor (RMSEA: .07, CFI: .94, TLI: .92), and emergent 
two-factor structures (RMSEA: .05, CFI: .96, TLI: .95). Internal-consistency 
values were better with the original two-factor structure of HADS.  
Conclusion 
SF36v2 is best described as a three-factor structure and can be used in this 
study. HADS may require further investigation in relation to improving screening 
methods to make problematic items more sensitive and specific.  
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1. Introduction and rationale   
 
Patients affected by end-stage renal disease (ESRD) are confronted with limited 
choices of treatment, namely dialysis or kidney transplantation. Irrespective of the 
mode of treatment, patients also encounter numerus difficulties due to the 
disease and treatment sometimes such as symptom severity, psychosocial 
distress, biological functioning deterioration, sexual difficulties, and 
neurocognitive impairment (Agneta et al., 2012; Bonner et al., 2013; Drayer et 
al., 2006). Consequently, their health-related quality of life (HRQoL) is negatively 
affected including enormous burden of psychological stress. For that, HRQoL and 
mood measures were developed and psychometrically tested to evaluate the 
health outcomes of this group of patients. 
The Short-Form 36 version 2 (SF36v2) is well established and a common 
measure of health-related quality of life in ESRD patients. It is a multi-item type 
of measure in which the 35 items form eight scales (first-order structure) and the 
eight scales are aggregated in two-component summary (second-order structure) 
(Appendix 7.1.).  The SF36v2 has proven useful in surveys of general and specific 
populations, comparing the relative burden of disease, and in differentiating the 
health benefits produced by a wide range of different treatments. It has been 
translated in more than 40 countries and normed in 12 countries including Arabic 
countries (Al Abdulmohsin et al., 1997). It consists of eight scales that can be 
summarised in two independent aggregate scores: physical component scores 
(PCS) for physical functioning (PF), physical role (PR), bodily pain (BP) and 
general health (GH), and the mental component score (MCS) for mental health 
(MH), vitality (VT), emotional role (ER) and social functioning (SF). Ware et al. 
(2000) suggest a norm-based score using a cut-off point of mean 50 (SD= 10). 
SF36v2 can then be interpreted using the norm-based score without the need to 
use previous studies as a norm. That is, higher mean scores (above 50) indicate 
better functional health and wellbeing, whereas lower scores (below 50) indicate 
poorer health functioning and wellbeing (Maruish and DeRosa 2009).  
Studies that address the psychological issues in ESRD patients suggest that 
anxiety and depression should be explored in depth, using valid and reliable 
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measures (Drayer et al., 2006; Fidan et al., 2013; Hofmann et al., 2010). Several 
instruments were developed to examine and measure emotional disorders, 
including the Hospital Anxiety Depression Scale. HADS was developed by 
Zigmond and Snaith (1983) as a two-construct measure to assess anxiety and 
depression in the non-psychiatric population. It is a 14-item, self-report rating 
measure with a 0-3 response rating scale. It is an easily administered measure 
and takes approximately 6-10 minutes to complete. HADS is commonly used 
among ESRD patients to assess their psychological distress. The internal 
consistency of HADS ranges from a Cronbach’s alpha of adequate to excellent 
(0.68 to 0.93) (Bjelland et al., 2002; literature review of 747 articles). 
However, there is inconsistency among the literature that uses factor analytical 
techniques, including EFA and CFA, to test the construct validity of the SF36v2 
and HADS. De Vet HC et al (2005) reviewed 28 published studies across different 
populations to examine the structure of SF36v2 that used factor analytical 
techniques. He found that only six studies explored and confirmed the first-order 
factor (35 items level), whereas 25 studies explored and confirmed second-order 
factor (aggregated component summary). This finding is in parallel with Ware et 
al (1998) in which the factor analysis performed was limited to the second-order 
structure and was not among the first-order structure (35 items) of the SF36.   
Several studies have conducted factor analysis to examine the construct validity 
of HADS (Dunbar et al., 2000; Friedman et al., 2001; Cosco., 2012). Despite 
HADS being a valid and widely used measure, several psychometric issues were 
reported that require further clarification. Razavi et al. (1990) conducted an EFA 
in a cohort of cancer in-patients and concluded that HADS was a two-structure 
measure. On the other hand, Friedman et al. (2001) reported three structures to 
HADS – depression, psychic anxiety and psychomotor agitation – in a group of 
clinically depressed patients. Identification of an underlying structure of three 
factors has also occurred in the non-clinical population, as explored by Caci et al. 
(2003). Cosco et al. (2012) conducted a systematic review on studies examining 
the latent structure of the HADS and reported different structures of HADS 
including one-factor structure, two-factor structure, three-factor structure, and 
even four-factor structure. The heterogeneous results of the review may indicate 
168 
 
that the latent structure of HADS is unclear and dependent on the statistical 
methods invoked and the population studied.  
However, to the researcher’s knowledge, the SF36v2 and HADS have not been 
validated or used to assess the health status or HRQoL within the Omani 
population with ESRD. This raises a question as to whether these measures are 
able to measure what they are intended to measure within this population. The 
aforementioned ambiguity in the factor structure of SF36v2 and HADS measures 
drives the need for further examination of their underlying dimensional structure, 
and the need to identify the most consistent factor structure of SF36v2 and HADS 
across clinical populations. Unfortunately, no attempts were made to evaluate the 
underlying structure of both measures within the Omani population and 
specifically in ESRD patients. It was crucial, therefore, to conduct factor analyses, 
EFA and CFA, on SF36v2 and HADS within the given context to describe the 
possible variability among patients suffering from ESRD. 
Social, cultural and education-system may influence patients’ HRQoL. Results 
from international studies raised an argument regarding possible cultural 
influences on the structure factor of SF36v2, in particular, components of mental 
health among Asian countries (Fukuhara et al., 1998; Suxukamo et al., 2011; Wu 
CH et al., 2007). In Japan, for instance, Fukuhara found that the scores on the 
vitality subscale loaded significantly on the physical-health component summary 
among the general population. Similarly, in Taiwan, the vitality scale was 
observed as a stronger measure of physical health than of mental health (Wu CH 
et al., 2007). These findings were in contrast to the work of Ware et al. (1993), 
the developer of SF36, when reporting the scores on the vitality subscale. It is 
worth noting that Ware (2004) proposed, at a later date, a three-factor structure 
model including a “social role” factor in addition to MCS and PCS, suggesting that 
cultural difference might play a role in how people perceive different health areas. 
Factor analysis is a statistical method commonly used to evaluate a measure 
structure. It is an essential step in validating a multi-item or multi-dimensional 
measure (Field, 2000). “The goal of factor analysis is to reduce the dimensionality 
of the original space and to give an interpretation to the new space, spanned by 
a reduced number of new dimensions which are supposed to underline the old 
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ones” (Rietveld and Van Hout, 1993, p 254). Subjecting SF36v2 and HADS to a 
factor analysis would help to explore and confirm the possible underlying latent 
concepts of these measures within the related collected data. This can be done 
by using the EFA to explore the underlying structure of SF36v2 and HADS and 
then using CFA to test whether the study data fit the identified factor structure out 
of EFA and comparing it against its hypothesised model (Ware et al., 1995).  
Given that SF36v2 and HADS were not validated within the Omani context, and 
that their factor structure is not known, this study, therefore, aims to explore the 
underlying structure of the both measures, SF36v2 and HADS, within the ESRD 
population using EFA to establish the factor structure among their items and 
consequently to validate its use within this context.  
2. Method   
Data from a cross-sectional study (see chapter eight) conducted across 13 
dialysis units in Oman were used in this analysis. Both, SF36v2 and HADS were 
an Arabic version and self-completed measures. Factor analyses were 
conducted using the statistical software Mplus version 7. Mplus is a powerful 
statistical programme that can be used to estimate a wide range of models 
containing latent variables. The fact that it handles models with both continuous 
and categorical latent variables, and its capabilities for estimating multi-level 
models, are considered the strengths of this statistical software (Muthén, L. K., & 
Muthén, B. O. 1998-2011).  
Analyses were conducted using the following steps:  
i. The sufficiency of the sample size was determined using the ratio of 7-10 
cases per item (Tabachnick and Fidell 2014). For SF36v2, since it has 35 
items (one item about self-reported health transition is not included in the 
scores), around 7 cases x 35 items = 245 participants were required. 
Whereas for HADS, has 14 items, around 7 cases x 14 items = 98 
participants were required. Around 440 patients completed the SF36v2 
and HADS and this total was deemed sufficient to provide a reliable factor 
structure.  
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ii. Internal-consistency reliability for SF36v2 and HADS subscales was 
measured in a variety of ways: Cronbach’s α for each subscale, 
Cronbach’s α for a subscale if a single item is removed, the range of inter-
item correlations and the individual inter-item correlations of the subscale. 
All correlations are Pearson’s r correlations. The criteria used to interpret 
alphas are shown in Table 7-1. 
 
Table 7. 1  Internal Consistency Criteria for SF36v2 and HADS 
Reliability Statistics Criteria for a Good 
Scale 
Reference 
Cronbach’s alpha Greater than or .60 Nunnally & Bernstein 
(1994); DeVellis (2003) 
Range of inter-item 
correlations 
between .15 and .85 Clark and Watson (1995) 
Range of corrected item-
scale correlations 
Greater than or equal to 
.50 
Clark and Watson (1995) 
Range of Cronbach’s 
alpha if item deleted 
Deleting any item would 
decrease the alpha 
Tabachnick and Fidell 
(2014) 
iii. Initial data output of the Mplus version-7 was checked for the number of 
missing data patterns and covariance coverage of data. That is, if a 
variable has missing values, Mplus would provide information on the 
number and distribution of those missing values. The proportion of values 
presented for each variable is illustrated by a covariance coverage matrix 
(Bruin, 2006). 
iv. To obtain factor solutions, polychoric correlations were used. Polychoric 
correlation is used when variables in the analysis are normally distributed 
(Muthén and Muthén, 1998), as the case in this data. Polychoric 
correlations provide a more accurate reproduction of the measurement 
model to generate the data (Holgado-Tello et al., 2010). 
v. EFA was performed on the 35 items of SF36v2 and 14 items of HADS. 
Since the data were ordinal and the sample size was above 200, the 
weighted least squares (WLSMV) estimator was used to check the data 
fitting and suitability for analysis (Muthén et al., 1997; Rhemtulla et al., 
2012). The WLSMV is considered a robust estimator which does not 
assume normally distributed variables and provides the best option for 
modelling categorical data (Brown, 2006). The criterion used to determine 
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the number of extracted factors accounting for a reasonably large 
proportion of the total variance was based on eigenvalue above one. Also, 
the Scree plot of the eigenvalues, plotted against the factor numbers, was 
observed to inform on the number of factors to be retained (Tabachnick & 
Fidell, 2007). For factor rotation, the oblique rotation method was used 
since it is identical to that used by the measure developer, Ware et al. 
(1998). The determination of a significant-item factor loading was set at a 
coefficient level of ≥ .30 (Tabachnick and Fidell, 2014). This level was 
selected to allow a maximum number of items loading on to emerging 
factors.  
vi. The best identified factor structure out of EFA was then verified using CFA. 
Four fit indices were looked at: the chi-square (2); the comparative fit 
index (CFI); the Tucker-Lewis Index (TLI); and the root mean square error 
of approximation (RMSEA). The model has good fit when: the chi-square 
is less than 2 or 3 (Kline 1998 & Ullman 2001) – the chi-square test was 
likely to be significant because of the large sample size, N>350); RMSEA 
is below 0.06 (MacCallum et al 1996); CFI is greater than 0.90 (Hu and 
Bentler 1999); TLI is over .90 (Hu & Bentler 1999). 
For HADS, CFA was performed to confirm the best simple structure in EFA 
along with the other five most published models: 1) Zigmond and Snaith’s 
(1983) original two-factor model; 2) Moorey et al.’s (1991) two-factor 
model; 3) Razavi et al.’s (1990) single-factor model; 4) Friedman et al.’s 
(2001) three-factor model; and 5) Caci et al.’s (2003) three-factor model. 
The characteristics of these tested models are shown in Table 7-B.2. 
Independence of error terms was determined for all the models. To assess 
the fit of the models, four fit indices were looked at. 
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Table 7. 2  Characteristics of the published models of HADS  
Model 
Number of 
factors 
extracted 
Sample  
Items underlying factor structure 
Anxiety  Depression  
Third 
factor 
Zigmond and 
Snaith’s (1983) 
2 Medical  1,3,5,7,9,11,13 2,4,6,8,10,12,14 - 
Moorey et al.’s 
(1991) 
2 Cancer patients 1,3,5,9,11,13 
2,4,6,7,8,10,12,
14 
- 
Razavi et al.’s 
(1990) 
1 Cancer patients Single-factor: 1,2,3,4,5,6,7,8,9,10,11,12,13,14 
Friedman et 
al.’s (2001) 
3 
Depressed 
patients 
3,5,9,13 2,4,6,8,10,12,14 1,7,11 
Caci et al.’s 
(2003) 
3 Non-clinical 1,3,5,9,13 2,4,6,8,10,12 7,11,14 
 
3. Findings  
Four-hundred and forty-nine patients participated in the study. The detailed 
description of the participants characteristics including clinical data are in Chapter 
Eight. 
3.1. SF36v2 
3.1.1. Reliability analysis of the established SF36v2 
Prior to conducting EFA and CFA to SF36v2, a reliability analysis of the SF36v2 
total all-items and the eight subscales, using Cronbach coefficient alpha, was 
conducted to ensure that the measures fulfilled the criteria for research purposes 
(Tables 7.3 to 7.10). The Cronbach's α value for the total SF36v2 was .92, 
whereas for the eight subscales they were: .82 for PF, .83 for RP, .76 for BP, .65 
for GH, .74 for VT, .53 for SF, .84 for RE and .74 for MH. Most of the alphas were 
above α .65 except for the GH and SF subscales which were .65 and .53, 
respectively. Thus, the result suggests that majority of the subscales can be 
considered as reliable (Nunnally & Bernstein, 1994; DeVellis, 2003). However, 
items that showed a lower correlation might require further examination.
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Table 7. 3 Cronbach’s alphas of physical functioning (PF) subscale, inter-item, corrected 
item-scale and alpha if item deleted, n = 443 
PF Subscale 
Cronbach’s α: .82 
Range of inter-item correlation: .09 to .58 
Corrected item-scale 
correlation 
Cronbach’s α if item 
deleted 
Vigorous activities (PF01) .20 .84 
Moderate activities (PF02) .54 .81 
Lifting, carrying groceries 
(PF03) 
.56 .80 
Climbing several flights 
(PF04) 
.56 .80 
Climbing one flight (PF05)  .59 .80 
Bending, kneeling (PF06) .55 .80 
Walking one mile (PF07) .64 .80 
Walking several blocks 
(PF08) 
.61 .80 
Walking one block (PF09) .50 .81 
Bathing, dressing (PF10) .39 .82 
 
Table 7. 4 Cronbach’s alphas of role physical (RP) subscale, inter-item, corrected item-
scale and alpha if item deleted, n = 443 
RP Subscale items 
Cronbach’s α: .83 
Range of inter-item correlation: .47 to .62 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Cut down time (RP01) .65 .78 
Accomplished less (RP02) .68 .77 
Limited in kind (RP03) .62 .80 
Had difficulty (RP04) .67 .78 
 
 
Table 7. 5 Cronbach’s alphas of bodily pain (BP) subscale, inter-item, corrected item-scale 
and alpha if item deleted, n = 439 
 
BP Subscale items 
Cronbach’s α: .76 
Range of inter-item correlation: .63 to .63 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Pain-magnitude (BP01) .63 .39 
Pain-interfere (BP02) .63 .39 
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Table 7. 6 Cronbach’s alphas of general health (GH) subscale, inter-item, corrected item-
scale and alpha if item deleted, n = 436 
GH Subscale items 
Cronbach’s α: .65 
Range of inter-item correlation: .12 to .43 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
EVGFP rating (GH1) .39 .60 
Sick easier (GH02) .32 .64 
As healthy (GH03) .34 .63 
Health to get worse (GH04) .39 .60 
Health excellent (GH05) .58 .50 
 
Table 7. 7  Cronbach’s alphas of vitality (VT) subscale, inter-item, corrected item-
scale and alpha if item deleted, n = 438 
VT Subscale items 
Cronbach’s α: .74 
Range of inter-item correlation: .31 to .63 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Pep/Life (VT01) .58 .66 
Energy (VT02) .53 .69 
Worn out (VT03) .52 .70 
Tired (VT04) .53 .69 
 
Table 7. 8  Cronbach’s alphas of social functioning (SF) subscale, inter-item, 
corrected item-scale and alpha if item deleted, n = 440 
SF Subscale items 
Cronbach’s α: .53 
Range of inter-item correlation: .36 to .36 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Social-extent (SF01) .36 .13 
Social-time (SF02) .36 .13 
 
Table 7. 9  Cronbach’s alphas of role emotion (RE) subscale, inter-item, corrected 
item-scale and alpha if item deleted, n = 442 
RE Subscale items 
Cronbach’s α: .84 
Range of inter-item correlation: .57 to .72 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Cut down time (RE01) .70 .79 
Accomplished less (RE02) .77 .73 
Not careful (RE03) .66 .83 
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Table 7. 10 Cronbach’s alphas of mental health (MH) subscale, inter-item, corrected item-
scale and alpha if item deleted, n = 437 
MH Subscale items 
Cronbach’s α: .74 
Range of inter-item correlation: .20 to .49 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Nervous (MH01) .49 .71 
Down in dumps (MH02) .56 .68 
Peaceful (MH03) .48 .71 
Blue/sad (MH04) .57 .68 
Happy (MH05) .44 .72 
 
3.1.2. Exploratory factor analysis of SF36v2 
Exploratory factor analysis was performed on the all 35-items of SF36v2. The 
WLSMV estimator was confirmed that the data distribution satisfied the criteria 
for factor extraction. Chi-Square Test of Model Fit for the Baseline Model (2 (df) 
= 6375.178 (561) (Muthén et al., 1997). 
Following extraction and oblique rotation, seven factors with eigenvalues greater 
than one (>1) emerged from analysis of the SF36v2, Figure 7.1, and 
accumulatively accounted for 62.2% (28%, 11%, 6.2%, 5.8%, 4.3%, 3.6% and 
3.3%, respectively). An additional factor, however, Factor-eight, accounting for 
2.8% of variance, was included in the test to explore if any factoring might load 
related to the eight subscales of the SF36v2. 
 
Figure 7. 1 Eigenvalues in SF36 v2 (35-item) 
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The results of factor loadings of individual SF36v2 items in relation to the three-
factor solution are shown in Tables 7.11. This three-factor solution was the only 
solution which provided simple and clear items structure. It is worth noting that 
the remaining two and four- to eight-factor structure solutions did not provide a 
clear item structure among the 35, thus, for the purpose of brevity, full details of 
the remaining factor solutions are not included and attached with appendices (can 
be found in Appendix 7.2).  
In the three-factor solution, the correlation between Factor 1 and Factor 2 was 
.25; that of Factor 1 and 3 was .40; and that of Factor 2 and 3 was .42. This 
solution revealed a clear, simple structure compared with the rest of the identified 
factor structures, which may suggest three concepts underlying the SF36v2 
within the Omani context. These concepts can be labelled as the physical-health 
component, the role-functioning component and the psychological-functioning 
component. The PF items loaded on Factor-1 were items related to bodily pain, 
general health, vitality and social functioning, whereas items related to mental 
health clustered on Factor 2 and items pertaining to role functioning (physical and 
emotional) loaded together on Factor 3. 
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Table 7. 11  Factor structure underlying Factors 1-3 with oblique rotation for the SF36v2 (N 
= 443) 
Item Factor 1 Factor 2 Factor 3 
Vigorous activities (PF01) 0.36 0.05 -0.07 
Moderate activities (PF02) 0.66 0.09 -0.01 
Lifting, carrying groceries (PF03) 0.67 0.09 -0.02 
Climbing several flights (PF04) 0.71 0.01 -0.02 
Climbing one flight (PF05)  0.71 -0.02 0.05 
Bending, kneeling (PF06) 0.67 0.09 0.06 
Walking a mile (PF07) 0.76 0.01 0.01 
Walking several blocks (PF08) 0.77 -0.09 0.02 
Walking one block (PF09) 0.67 0.05 0.06 
Bathing, dressing (PF10) 0.57 -0.06 0.08 
Cut down time (RF01) 0.06 -0.01 0.73 
Accomplished less (RF02) -0.08 0.07 0.72 
Limited in kind (RF03) 0.12 -0.06 0.66 
Had difficulty (RF04) 0.15 0.15 0.64 
Pain-magnitude (BP01) 0.13 0.70 -0.03 
Pain-interfere (BP02) 0.13 0.69 0.01 
EVGFP rating (GH1) 0.09 0.50 -0.06 
Sick easier (GH02) 0.09 0.33 0.10 
As healthy (GH03) -0.08 0.45 -0.01 
Health to get worse (GH04) 0.09 0.39 0.02 
Health excellent (GH05) 0.07 0.64 -0.01 
Pep/Life (VT01) -0.03 0.74 -0.14 
Energy (VT02) 0.10 0.66 -0.22 
Worn out (VT03) -0.02 0.68 0.06 
Tired (VT04) -0.08 0.68 0.07 
Social-extent (SF01) 0.06 0.63 0.04 
Social-time (SF02) 0.15 0.37 0.08 
Cut down time (RE01) -0.01 0.22 0.72 
Accomplished less (RE02) -0.07 0.13 0.79 
Not careful (RE03) 0.04 0.14 0.62 
Nervous (MH01) -0.01 0.47 0.05 
Down in dumps (MH02) -0.09 0.65 0.09 
Peaceful (MH03) -0.08 0.59 0.01 
Blue/Sad (MH04) -0.09 0.56 0.09 
Happy (MH05) -0.03 0.63 -0.04 
 
Bold values indicate that item loading on a factor is ≥ .30 
PF: Physical functioning; RF: Role functioning; BP: bodily pain; GH: general health; VT: vitality; SF: social 
functioning; RE: Role emotion; MH: Mental health. 
It can be concluded that the EFA results indicated that the hypothesised eight-
factor structure was not supported in the ESRD population in Oman. The simple 
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structure was identified for the 35 items of SF36v2 and can be named as the 
physical-health component, the role-functioning component and the emotional-
effect component. 
3.1.3. Confirmatory factor analysis 
The results of CFA for factor models and accompanying fit indices are shown in 
Table 7.12. The chi-square estimate of fit was statistically significant (P < .001), 
demonstrating that a proportion of the total variance was unexplained. The result 
of the fit indices revealed that the two-correlated factor model had a weak fit, 
indicated by the RMSEA (0.9), CFI (.78) and TLI (.77). Conversely, the three-
correlated factor model offered the best fit for the data (see Figure 3) manifested 
by the result of the fit-indices parameters: RMSEA (.06), CFI (.90) and TLI (.90).  
For the item-level models of both structures, the completely standardised 
solutions are shown in Figures 7.2 and 7.3. 
Table 7. 12  Factor structure of the two- and three-correlated factor SF36v2 determined by 
CFA 
Model 2 RMSEA CFI TLI 
Model 1: based on two-correlated factors 
(physical functioning, emotional effect)  
2882.461 (55) .09 .78 .77 
Model 2: based on three-correlated factors 
(physical functioning, role functioning, emotional 
effect) 
1582.927 (55) .06 .90 .90 
Bold values indicate good fit indices 
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Figure 7. 2 Two-correlated factor model, first-order solution, based on confirmatory factor 
analysis 
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Figure 7. 3 Three-correlated factor model, first-order solution, based on confirmatory factor 
analysis 
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3.1.4. Reliability analysis of the emerged three-factor structure of SF36v2 
To ensure that the emerged three-factor solution of SF36v2 satisfy the criteria for 
regression analysis and clinical use, a reliability analysis was conducted. The 
calculated Cronbach’s alpha values for emergent factors (Emergent-Physical 
functioning subscale, Emergent-Role functioning subscale, and Emergent-
pyschological functioning subscale) were .82, .88, .88, respectively, exceeding 
.06 criterion for acceptable measure internal reliability (Tables 7.13 to 7.15). 
These result support the application and use of the three-factor structure of 
SF36v2 as an outcome in regression analysis to predict the level of HRQoL within 
a given context. 
Table 7. 13 Cronbach’s alphas of Emergent-Physical functioning (PF) subscale, inter-item, 
corrected item-scale and alpha if item deleted, n = 443 
PF Subscale 
Cronbach’s α: .82 
Range of inter-item correlation: .09 to .58 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Vigorous activities (PF01) .20 .84 
Moderate activities (PF02) .54 .81 
Lifting, carrying groceries 
(PF03) 
.56 .80 
Climbing several flights 
(PF04) 
.56 .80 
Climbing one flight (PF05)  .59 .80 
Bending, kneeling (PF06) .55 .80 
Walking one mile (PF07) .64 .80 
Walking several blocks 
(PF08) 
.61 .80 
Walking one block (PF09) .50 .81 
Bathing, dressing (PF10) .39 .82 
Table 7. 14 Cronbach’s alphas of Emergent-Role (RP) functioning subscale, inter-item, 
corrected item-scale and alpha if item deleted, n = 441 
RP Subscale items 
Cronbach’s α: .88 
Range of inter-item correlation: .39 to .72 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Cut down time (RP01) .64 .86 
Accomplished less (RP02) .66 .86 
Limited in kind (RP03) .58 .87 
Had difficulty (RP04) .71 .85 
Cut down time (RE01) .72 .85 
Accomplished less (RE02) .72 .85 
Not careful (RE03) .60 .87 
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Table 7. 15 Cronbach’s alphas of Emergent-Emotional effect subscale, inter-item, corrected 
item-scale and alpha if item deleted, n = 432 
BP Subscale items 
Cronbach’s α: .88 
Range of inter-item correlation: .12 to .63 
Corrected item-
scale correlation 
Cronbach’s α if item 
deleted 
Pain-magnitude (BP01) .64 .87 
Pain-interfere (BP02) .64 .87 
EVGFP rating (GH1) .43 .88 
Sick easier (GH02) .37 .88 
As healthy (GH03) .36 .88 
Health to get worse (GH04) .38 .88 
Health excellent (GH05) .59 .87 
Pep/Life (VT01) .58 .87 
Energy (VT02) .48 .87 
Worn out (VT03) .60 .87 
Tired (VT04) .61 .88 
Social-extent (SF01) .58 .83 
Social-time (SF02) .39 .88 
Nervous (MH01) .42 .87 
Down in dumps (MH02) .56 .87 
Peaceful (MH03) .51 .87 
Blue/sad (MH04) .48 .87 
Happy (MH05) .51 .87 
PF: Physical functioning; RF: Role functioning; BP: bodily pain; GH: general health; VT: vitality; SF: social 
functioning; RE: Role emotion; MH: Mental health. 
3.2. Hospital Anxiety Depression Scale 
3.2.1. Reliability analysis of the established two-factor structure HADS  
Primarily, a reliability analysis for the original anxiety subscale was examined 
prior to conducting factor analysis (Table 7.16). The Cronbach's α value for the 
total items of the anxiety subscale was .79 (7 items), with inter-item correlation 
ranging from .18 to .51.  Checking the corrected item-scale correlation, three 
items had lower corrected item-scale correlation below .50 (item-7 “I can sit at 
ease and feel relaxed”; item-9 “I get a sort of frightened feeling like ‘butterflies’ in 
the stomach”; and item-11 “I feel restless as if I have to be on the move”). 
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Table 7. 16 Cronbach’s alphas of anxiety subscale, inter-item, corrected item-scale and 
alpha if item deleted, N = 434 
Anxiety Subscale  
Cronbach’s α: .79 
Range of inter-item correlation: .18 to .51 
Corrected item-scale 
correlation 
Cronbach’s α if 
item deleted 
(1) I feel tense or wound up .53 .76 
(3) I get a sort of frightened feeling as if 
something awful is about to happen .65 .74 
(5) Worrying thoughts go through my 
mind .60 .75 
(7) I can sit at ease and feel relaxed .42 .78 
(9) I get a sort of frightened feeling like 
‘butterflies’ in the stomach .43 .78 
(11) I feel restless as if I have to be on 
the move .43 .78 
(13) I get sudden feelings of panic .58 .75 
Likewise, internal reliability test of the original depression subscale of HADS was 
examined (Table 7.17). The Cronbach's α value for the total items of the 
depression subscale was .67, lower than the determined value, with inter-item 
correlation ranging from .10 to .37. Three items had less than .40 corrected item-
scale correlation and, in each case, the overall Cronbach’s α for the subscale 
would be higher with the item removed. The lowest Cronbach’s α was for item-
14 (“I can enjoy a good book or TV programme”), possibly indicating that this item 
is not sensitive enough to test depressive symptoms.  
Table 7. 17 Cronbach’s alphas of depression subscale, inter-item, corrected item-scale and 
alpha if item deleted, N = 433. 
HADS items 
Cronbach’s α: .67 
Range of inter-item correlation: .10 
to .37 
Corrected item-
scale correlation 
Cronbach’s α if 
item deleted 
(2) I still enjoy the things I used to enjoy .39 .62 
(4) I can laugh and see the funny side of things .43 .61 
(6) I feel cheerful .37 .63 
(8) I feel as if I am slowed down .40 .62 
(10) I have lost interest in my appearance .40 .62 
(12) I look forward with enjoyment to things .40 .62 
(14) I can enjoy a good book or TV programme .22 .67 
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Overall, it is unclear whether the anxiety subscale items (item-7, item-9, item-11) 
and depression subscale items (item-14) are sensitive enough to assess related 
symptoms. Further attention is perhaps required to observe the function of these 
items in EFA and CFA. Overall, given that the Cronbach's α values for the both 
subscales exceeded .60 criterion for acceptable measure internal reliability 
(Nunnally & Bernstein, 1994; DeVellis, 2003), the result suggests that these 
subscales, anxiety and depression, can be considered reliable, despite the low 
correlation of some items. 
3.2.2. EFA of HADS 
Exploratory factor analysis was performed on all 14-items of HADS. The data 
distribution satisfied the criteria for factor extraction, Chi-Square Test of Model Fit 
for the Baseline Model (2 (df)= 3049.898 (91) (Muthén et al., 1997). 
Following extraction and oblique rotation, three factors with eigenvalues greater 
than 1 emerged from analysis of the completed 14-items of HADS, explaining 
5.21%, 1.4% and 1.1% of the variance (Figure 7.4).  
 
 
Figure 7. 4 Eigenvalues of the complete HADS 
 
Factor loadings of individual HADS items in relation to the one-factor solution are 
shown in Table 7.18. Using a coefficient level of 0.3, the HADS items clustered 
under one factor except for item-14, r= .29, suggesting that, overall, HADS is a 
good measure for identifying psychological distress within this group of patients.  
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Table 7. 18 One-factor solution of HADS items following with oblique rotation  
Items of HADS Factor 1 
Anxiety sub-scale   
(1) I feel tense or wound up 0.64 
(3) I get a sort of frightened feeling as if something awful is about to 
happen 
0.74 
(5) Worrying thoughts go through my mind 0.72 
(7) I can sit at ease and feel relaxed 0.59 
(9) I get a sort of frightened feeling like ‘butterflies’ in the stomach 0.51 
(11) I feel restless as if I have to be on the move 0.53 
(13) I get sudden feelings of panic 0.74 
Depression sub-scale  
(2) I still enjoy the things I used to enjoy 0.43 
(4) I can laugh and see the funny side of things 0.50 
(6) I feel cheerful 0.55 
(8) I feel as if I am slowed down 0.54 
(10) I have lost interest in my appearance 0.60 
(12) I look forward with enjoyment to things 0.52 
(14) I can enjoy a good book or TV programme 0.29 
Bold values indicate that item loading on a factor is ≥ .30 
 
Although the one-factor solution showed a clear factor structure, the two-factor 
solution clearly shows that HADS is possibly a two-dimensional instrument 
(anxiety and depression) with significant positive correlation r = .53, p< 0.001, 
explaining 47% of the common variance between factors. The loadings of 
individual HADS items in relation to the two-factor solution are shown in Table 
7.19. It is observed, however, that item-7 “I can sit at ease and feel relaxed”, item-
6 “I feel cheerful”, item-8 “I feel as if I am slowed down” and item-10 “I have lost 
interest in my appearance” were loading inversely in favour of the opposite factor. 
In this solution, notably, item-14 was shown to load under Factor-2 with a 
coefficient level of .38, was insignificant in one-factor solution. It can also be 
observed that item-7 of the anxiety subscale loaded under factor-2, depression 
subscale. Using CFA, it would be useful to confirm and compare the fit of this 
model to the data relating to one-factor structure, Table 7.18, and other published 
models.
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Table 7. 19 Two-factor solution of HADS items following with oblique rotation 
 
Items of HADS Factor 1 Factor 2 
Anxiety sub-scale    
(1) I feel tense or wound up 0.69 -0.01 
(3) I get a sort of frightened feeling as if something awful is 
about to happen 
0.86 -0.08 
(5) Worrying thoughts go through my mind 0.68 0.1 
(7) I can sit at ease and feel relaxed 0.22 0.49 
(9) I get a sort of frightened feeling like ‘butterflies’ in the 
stomach 
0.42 0.14 
(11) I feel restless as if I have to be on the move 0.57 0.00 
(13) I get sudden feelings of panic 0.65 0.15 
Depression sub-scale   
(2) I still enjoy the things I used to enjoy 0.04 0.49 
(4) I can laugh and see the funny side of things -0.11 0.77 
(6) I feel cheerful 0.35 0.29 
(8) I feel as if I am slowed down 0.34 0.28 
(10) I have lost interest in my appearance 0.45 0.23 
(12) I look forward with enjoyment to things 0.01 0.63 
(14) I can enjoy a good book or TV programme 0.00 0.38 
Bold values indicate that item loading on a factor is ≥ .30 
 
 
From the preceding factor solutions, it can be suggested that HADS can be 
regarded as one- dimensional structure and two-dimensional instrument. Yet, to 
further ensure that the results of the EFA were not confounded by the factor 
extraction and rotation methods used, an orthogonal rotational (uncorrelated 
factors) method was performed on this set of data. Table 7.20 shows the two-
factor loadings of HADS following orthogonal rotation. This solution seems to 
support the notion that HADS is a more of a two-dimensional instrument when all 
the items are loaded on to Factor 1, despite the cross-loading of items 3, 4 and 
12. As with the aforementioned one-factor solution, Table 7.18, item-14 again 
failed to load significantly on both factors, which may suggest that this item has 
poor performance among this group of patients. 
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Table 7. 20 Two-factor solution of HADS items following orthogonal rotation (uncorrelated 
factors) 
Items of HADS Factor 1 Factor 2 
Anxiety sub-scale    
(1) I feel tense or wound up 0.63 -0.26 
(3) I get a sort of frightened feeling as if something awful is 
about to happen 
0.73 -0.36 
(5) Worrying thoughts go through my mind 0.71 -0.18 
(7) I can sit at ease and feel relaxed 0.60 0.21 
(9) I get a sort of frightened feeling like ‘butterflies’ in the 
stomach 
0.51 -0.06 
(11) I feel restless as if I have to be on the move 0.53 -0.20 
(13) I get sudden feelings of panic 0.73 -0.14 
 Depression sub-scale  
(2) I still enjoy the things I used to enjoy 0.43 0.28 
(4) I can laugh and see the funny side of things 0.50 0.51 
(6) I feel cheerful 0.55 0.04 
(8) I feel as if I am slowed down 0.54 0.05 
(10) I have lost interest in my appearance 0.60 -0.02 
(12) I look forward with enjoyment to things 0.52 0.38 
(14) I can enjoy a good book or TV programme 0.29 0.23 
Bold values indicate that item loading on a factor is ≥ .30 
 
Overall, EFA findings showed that HADS is good measure of psychological 
distress among ESRD patients as indicated by one-factor solution, but also can 
measure distinct constructs of anxiety and depression (r = .34, p< 0.001) as 
indicated by the two-factor solution. 
3.2.3. CFA of HADS 
CFA was used to evaluate the fit statistics for the models found in the literature, 
along with the current one-factor and two-factor models out of EFA. Table 7.21 
shows the tested factor models and accompanying fit indices along with the 
current models. The chi-square estimate of fit for all the models was statistically 
significant (P < 0.001) demonstrating that a proportion of the total variance was 
unexplained by each of these models. Surprisingly, CFA revealed that all the 
tested models had good fit indices indicating good fit to data. The emerged 
models – the one-factor model and the two-correlated factor model – offered the 
best fit for the data. Despite the one-factor model’s good fit with the study data, 
the emerged two-factor model showed the best fit across all fit indices followed 
by the Moorey et al. (1991) two-factor structure, identical to original two-factor 
structure of HADS by Zigmond and Snaith (1983). Overall, this result possibly 
confirms that HADS is a measure able to distinguish between the concepts of 
anxiety and depression. 
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Table 7. 21 Factor structure of the published HADS models and the current model 
determined by CFA 
Model Sample Number 
of factor 
Items underlying factor 
structure 
CFA indices 
Anxiety  Depressio
n  
Third 
factor 
2 RMS
EA (< 
.90) 
CFI 
(> 
.90) 
TLI 
(> .90) 
Zigmond 
& Snaith 
(1983) 
Medical 2¥ 1,3,5,7,9,1
1,13 
2,4,6,8,10,
12,14 
- 252.41
3 (76) 
.07 .94 .92 
Moorey et 
al. (1991) 
Cancer 2 1,3,5,9,11,
13 
2,4,6,7,8,1
0,12,14 
- 225.92
7 (76) 
.06 .94 .93 
Razavi et 
al. (1990) 
Cancer 
patients 
1 1,2,3,4,5,6,7,8,9,10,11,12,13,14 311.36
7 (77) 
.08 .92 .90 
Friedman 
et al. 
(2001) 
Depress
ed 
patients 
3 3,5,9,13 2,4,6,8,10,
12,14 
1,7,11 274.05
2 (74) 
.07 .94 .92 
Caci et al. 
(2003) 
Non-
clinical 
3 1,3,5,9,13 2,4,6,8,10,
12 
7,11,1
4 
243.60
1 (74) 
.07 .94 .93 
Emerged 
2-factor 
model 
(correlated 
ESRD 2 1, 3, 5, 6, 
8, 9, 10, 
11, 13 
2, 4, 7, 12, 
14 
- 186.36
0 (76) 
.05 .96 .95 
Emerged 
1-factor 
model 
ESRD 1 1,2,3,4,5,6,7,8,9,10,11,12,13,14 304.89
8 (91) 
.08 .92 .90 
Bold values indicate best-fit indices. All chi-squared statistics were significant at P < 0.001. 2 degrees of 
freedom in parentheses. ¥ original two-factors.  Current models: result from current study. 
 
3.2.4. Reliability analysis of emergent two-factor structure of HADS 
Since the EFA and CFA revealed some interesting and conflicting findings 
regarding the structure of HADS, a reliability test was conducted to determine the 
internal consistency of the emerged two-factor structure, and to compare it with 
the internal consistency of original two-factor structure (Zigmond and Snaith, 
1983; Moorey et al., 1991). Tables 7.22 to 7.23 show the result of internal 
reliability of emergent two-factor structure of HADS. 
The Cronbach's α value for the total items of the emerged anxiety subscale was 
very good .81 (9 items), with inter-item correlation ranging from .13 to .52. 
Checking the corrected item-scale correlation, four items had lower corrected 
item-scale correlation below .50 (item-6, item-8, item-9, item-11). For emerged 
depression, the Cronbach's α value for the total items was .63, lower than the 
determined value, with inter-item correlation ranging from .13 to .52.  
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Notably, the Cronbach's α value of emerged two-factor structure of depression 
subscale was lower than the original two-factor structure .67. All the items of the 
emerged two-factor structure had less than .50 corrected item-scale correlation 
and, in item14, the overall Cronbach’s α for the subscale would be higher with 
the item removed. Also, this item had the lowest Cronbach’s α (“I can enjoy a 
good book or TV programme”).  
Table 7. 22 Cronbach’s alphas of Emergent-Anxiety subscale, inter-item, corrected item-
scale and alpha if item deleted, n = 432 
Anxiety Subscale  
Cronbach’s α: .81 
Range of inter-item correlation: .13 to .52 
Corrected item-scale 
correlation 
Cronbach’s α if 
item deleted 
(1) I feel tense or wound up .53 .79 
(3) I get a sort of frightened feeling as if 
something awful is about to happen .64 .78 
(5) Worrying thoughts go through my mind .63 .78 
(6) I feel cheerful .43 .80 
(8) I feel as if I am slowed down .42 .81 
(9) I get a sort of frightened feeling like 
‘butterflies’ in the stomach .37 .81 
(10) I have lost interest in my appearance .51 .80 
(11) I feel restless as if I have to be on the 
move .44 .80 
(13) I get sudden feelings of panic .63 .78 
 
Table 7. 23 Cronbach’s alphas of Emergent-Depression subscale, inter-item, corrected 
item-scale and alpha if item deleted, n = 432 
HADS items 
Cronbach’s α: .63 
Range of inter-item correlation: .13 to .37 
Corrected item-scale 
correlation 
Cronbach’s α if 
item deleted 
(2) I still enjoy the things I used to enjoy .34 .59 
(4) I can laugh and see the funny side of 
things 
.44 .53 
(7) I can sit at ease and feel relaxed  .43 .54 
(12) I look forward with enjoyment to things .43 .54 
(14) I can enjoy a good book or TV 
programme 
.26 .64 
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4. Discussion  
This section discusses the results of EFA and CFA in relation to the RQ1 and 
published literature. 
4.1. SF36v2 
The EFA and CFA revealed a three-factor structure of SF36v2 in patients with 
ESRD with Oman. However, out of the eight EFAs, only the three-factor structure 
solution had a simple and clear structure of the SF36v2 within this population. It 
characterised the first-order structure (35 items) into three main areas: 1) physical 
functioning; 2) limitation on role functioning due to physical and mental problems; 
and 3) bodily pain, general health, vitality, social functioning and mental health. 
This result suggests that the original eight-factor structure of the SF36v2 was not 
supported within this population.  
Notably, the emergent three-factor structure underpinning SF36v2, including the 
current study, were reported among Asian and Arab populations, an inversion of 
the result from studies examining the structure of SF36v2 within Western 
countries (Wagner et al., 1998; Ware et al., 1998; Bullinger et al., 1995). The 
results of the studies conducted in a Western context revealed a two-factor 
structure (physical-health and mental-health concepts) underpinning SF36v2. 
However, the EFA that was carried out in these studies was on the second-order 
factor structure of SF36v2, contrary to the current study which is on the first-order 
factor structure. Again, this may support the suggestion that the SF36v2 measure 
might not be precise across different cultures and populations. Yet this needs to 
be confirmed in a larger sample and in different populations.  
Numerous studies reported possible cultural influences on self-administered 
HRQoL measures, which can be considered a challenge in generalising the 
findings of these studies. Researchers attempt to overcome such issues in 
generalising findings by applying rigorous translation methods and statistical-
validation methods to the intended health-status measures.  The SF36 measure 
was translated and validated across 40 countries (Ware, 2000). Translating a 
measure from one language to another may produce differences in the delivery 
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of the measure, which could appear as differing scale dimensionality (Guermazi 
et al., 2012). Although SF36 can be considered a well-established HRQoL 
measure across many different cultures, it does not account for the fact that 
patients may have different perceptions and expectations for their health that are 
unrelated to linguistic differences in the phrasing of the measure questions. 
Despite this seeming to be undeniable, the result of the current study suggests 
that the SF36v2 measure is generally acceptable to the Omani population. This 
was evidenced by the good completion rate of the items of SF36v2, 0.9% missing 
data. 
It is anticipated that ESRD could have an influence on the factor structure of a 
measure. The emerged three-factor structure may suggest that the ESRD 
condition has an influence on how patients perceive these areas of HRQoL. The 
items of SF36v2 clustered under three factors: physical functioning; limitation on 
role functioning due to physical and mental problems; and bodily pain, general 
health, vitality, social functioning and mental health. Physical functioning is 
usually limited in patients affected by ESRD (Fidan et al, 2013; Guney et al, 2010; 
and Morsch et al, 2005). This limitation is a result of disease symptoms and 
treatment regimen (Cleary et al, 2005; Pai et al, 2009). The same can be said 
about limitations on role functioning as patients may perceive these as a restraint 
on different life situations such as family life, partner relationships, social life 
(including interactions with friends), leisure activities, community involvement and 
everyday living activities (Anatchkova and Bjorner, 2007). This is clearly 
manifested in results from the QoL individual instrument (SEiQoL-DW) with 
around 18% of patients (8/45) reporting “role functioning” as an important aspect 
of life.  
Similarly, the loading of items of bodily pain (BP0) with vitality may reflect the fact 
that patients who experienced pain reported significantly poorer HRQoL in 
relation to physical health, psychological health and levels of independence when 
compared with those without pain (Soni et al, 2011; Kimmel and Patel, 2005). 
Davison and Jhangri (2009) measured the impact of pain and the symptom 
burden on the HRQoL of haemodialysis patients over six months and it was 
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shown to be an independent predictor of physical HRQoL at baseline (r = - 0.74, 
p <0.001; 95 % CI= -1.02, - 0.46) and after six months (r = - 0.59, p <0.001; 95 
% CI= -0.98, -0.19). The impact of pain and the symptom burden on mental 
HRQoL at baseline was (r = - 0.76, p <0.001; 95 % CI= - 1.04, - 0.48) and after 
six months it was (r = - 0.87, p <0.001; 95 % CI= -1.31, - 0.43). 
The response category to items related to role physical (RP01-RP04) and role 
emotional (RE01-RE03) of SF36v2 may possibly influence a participant’s answer, 
which may affect the scale structure. Although the relationship between the 
response category and the scale structure here is not clear, it could indirectly 
result in in common method variance (CMV). That is, it represents a 
measurement-method issue rather than a construct of the measure. For instance, 
the response categories to these items are “All of the time”, “Most of the time”, 
“Some of the time”, “A little of the time” and “None of the time”. From a context 
perspective, this may suggest that it is difficult for ESRD patients to distinguish 
and understand how much “Some of the time” differs from “A little of the time”. 
Although this misunderstanding did not emerge significantly in the result of the 
cognitive interviewing phase, Chapter Five, some of the participants suggested 
that one response category could be overshadowed by neighbouring categories. 
This, however, did not affect the completion of SF36v2 by participants. Perhaps, 
in future studies, researchers might need to conduct a study using a large sample 
at a specific point in time so as to ensure that common method variance is not an 
issue with SF36v2.  
In summary, out of the eight EFAs explored, the three-factor structure can be 
considered the simplest and clearest structure underpinning the concepts of 
health measured by SF36v2 among Omani patients. It is recommended that an 
EFA be conducted to test the second-order factor structure using the SF36v2 
subscale scores. Later a CFA might be conducted, based on this result, to 
investigate the second-order factor structure among the eight-subscale scores. 
Alternatively, a CFA might be conducted to verify the first- and second-order 
factor structure of SF36v2.  
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4.2. HADS 
Overall, HADS performed quite well within the given context, yet, in the EFA, all 
items loaded significantly except for item-14 which had poor correlation (r = .29). 
The item-loading on the emergent two-factor solution was different from the 
original two-factor structure to this population with items-1, 3, 5, 6, 8, 9, 10, 11 
and 13 tapping on the anxiety scale and items-2, 4, 7, 12 and 14 tapping on the 
depression scale. The correlation between the factors of anxiety and depression 
was r = .53. CFA was then performed on both solutions along with other five 
published models, including original structure. Fit indices indicated that the 
emergent two-factor solution structure had better fit with the data followed by the 
two-factor structure model of Moorey et al. (1991), identical to original two-factor 
structure conducted among cancer patients. The internal consistency for both the 
original two-factor and emergent two-factor structures of HADS was examined 
using Cronbach’s alpha. The internal consistency test of the original two-factor 
structure revealed a good α value overall and total HADS (r = .82) for anxiety (r 
= .79) and for depression (r = .66). No significant increases in alpha for any of the 
scales could have been achieved by deleting any items; whereas the Cronbach’s 
alpha values of emerged two-factor structure subscales were .81 for anxiety 
subscale, and slightly lower than original structure for depression subscale, .63. 
Nevertheless, these diverse results force the researcher to question which 
analysis has best uncovered the structure of the HADS scale. And for the 
emergent two-factor structure, can they still be referred to as anxiety and 
depression scales or are they components of a broader distress scale? 
Indeed, it is difficult to determine whether one-factor solution or emergent two-
factor solution or original two-factor solution best reflected the structure of HADS 
within this population. That is because one-factor solution had clear and simple 
structure, emerged two-factor structure had good fit to data like original two-factor 
structure of HADS. The only slight difference noted was on the result of internal 
consistency test between the emergent and original two-factor structure in which 
original two-factor structure had better internal consistency on depression 
subscale. For the purpose of this study, it is perhaps advisable to retain and 
consider using the original two-factor structure of HADS, Zigmond and Snaith 
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(1983), in this group of patients. Future research then can be carried out to test 
and explore different factor analysis methodologies than can provide more 
confidence on determining the structure of HADS within ESRD patients.  
Selecting the appropriate technique to be used in exploring the factor structure of 
a screening tool can be challenging and difficult to an “average second-language” 
researcher on statistical methodology. Although EFA showed a clear one-factor 
structure of HADS that measured psychological distress, results also showed that 
levels of anxiety and depression were not entirely independent in this group of 
patients, correlated at the level of .53. This may suggest that the use of oblique 
rotation was efficient in providing the most psychologically meaningful way of 
analysing the data in this study sample. Similarly, this method of rotation was 
used by most of the studies that tested the item structure of HADS across clinical 
and non-clinical subjects. It should be noted, however, that the estimates of 
model fit for the original two-factor model did not deviate much from those for the 
emergent two-factor model, that is it offered an acceptable fit for the data and 
was consistent with some research on HADS across a variety of clinical groups 
(Dunbar et al., 2000; Friedman et al., 2001; Caci et al., 2003). This can perhaps 
be confirmed by using CFA method in different groups of patients with different 
medical conditions and management.  
The ability of HADS to distinguish between anxiety and depression is vital as 
otherwise it might be more appropriately used as an instrument of general 
distress. Clinically, distinguishing between anxiety and depression in patients 
with ESRD is important as it may help in determining the right intervention. A 
prospective study, of four years’ duration, by Preljevic et al. (2013) reported that 
around 50% of patients experienced depression, 28% anxiety and 33% MADD 
disorder. Despite many EFAs supporting the two dimensions of HADS, Johnston 
et al. (2000) suggested that, for an HADS to achieve validity in separating anxiety 
and depression, a CFA should be performed to demonstrate this separation. 
Interestingly, in the current study, the findings from the CFA revealed acceptable 
fit indices for the all tested factor structures of HADS (refer to Table 7.21).  
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This inconsistency of items loading on supposed factors may be related to 
sensitivity issues with those items in detecting emotional disorders, as for item-7. 
It has been reported by previous studies that the original two-factor structure of 
HADS showed high loading on depression, rather than anxiety as shown in this 
study (Crawford et al., 2001; Harter et al., 2006). This inconsistency may be 
caused by the ambiguous wording as it refers to psychomotor agitation and inner 
tension (Beck et al., 1996). Also, cultural differences may be a factor that 
influences the understanding of an instrument item. Most of the studies exploring 
the factor structure were conducted in a Western context and no studies found 
were found conducting similar tests in Omani. Such an argument, similarly, 
applies to item-6 “I feel cheerful”, item-8 “I feel as if I am slowed down” and item-
10 “I have lost interest in my appearance”. This finding may be specific to the 
Omani population. Despite the language equivalence of the Arabic version of 
HADS being well established (Malasi et al., 1991), the response bias might 
change the basic nature of the depression item to that of an anxiety item 
(Matsudaira et al., 2009).  As a strategy to deal with such conversely loading 
items, Hulley et al (1996) suggest that such items should be divided into two 
sentences in future studies and then tested using EFA.  
Another query might be raised with regard to the sensitivity of items that detect 
emotional disorders as to whether they are all valid across different populations 
with different medical conditions and different forms of management. In the real 
world, there might be a chance that some items are inappropriate for particular 
patients. For instance, item-8 “I feel as if I am slowed down” might reflect the 
effect of a stroke condition, or item-9 “I get a sort of frightened feeling like 
‘butterflies’ in the stomach” might interfere with some symptoms of cardiac 
diseases. Likewise, item-14 “I can enjoy a good book or TV programme” could 
be a direct result of ESRD symptoms rather than a reflection of a patient’s low 
mood. That is, the level of bodily pain and low physical functioning that patients 
with ESRD might have could confound their ability to sit and enjoy reading a book 
or watching a TV programme. Also, the response to item-14 could be affected by 
cognitive impairment or the level of reading ability. Twenty-seven percent (27%) 
of the study sample were illiterate and 22% had a low intermediate level of 
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education. It is anticipated that illiterate patients and patients with cognitive 
impairment would not be able to enjoy reading a book. Thus, item-14 would not 
be appropriate for assessing psychological distress among patients with cognitive 
impairment and a low education level. One way to overcome the issue of possible 
inappropriateness of some items in some specific patients may be to revise 
(rewrite) these items (Dunbar et al., 2000).  
Although the emerged two-factor structure model shown in Table 7.19 (correlated 
factors) was comparable to the original anxiety and depression subscales, four 
items, however, demonstrated a split-loading on to the opposing factor. Anxiety 
item-7 “I can sit at ease and feel relaxed” was jointly loading on both factors, with 
split-loading slightly in favour of Factor-2 (depression), and depression item-6 “I 
feel cheerful”, item-8 “I feel as if I am slowed down” and item-10 “I have lost 
interest in my appearance” were inversely loading in favour of Factor-1 (anxiety). 
The inverse loading of these items on to opposite factors may reflect the fact that 
these items may be problematic, or they may measure something different from 
other items within this population, or they may measure a similar concept. Going 
through these items, the first available response option shifts from “not at all”, to 
“definitely”, to “nearly all the time”, to “definitely”. The “not at all” is for item-6 and 
item-7. It might it not be clear whether some of these responses refer to actual 
level of negative affect or to a comparison with ‘usual’. Perhaps adequate 
revalidation of the Arabic version of HADS among different groups of Arab 
patients with different medical conditions would elaborate further on the accuracy 
of HADS response options.  
A number of limitations should be acknowledged in this section. First, the primary 
aim of this chapter was to test and validate HADS among Omani ESRD patients 
and the full psychometric validation of HADS was beyond this aim. Second, 
HADS is a self-administered measure and this type of instrument usually tends 
to inflate the result. Patients with ESRD are also affected by adjustment disorders 
due to personal and clinical factors and this may influence their response 
accuracy. 
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5. Conclusion 
This chapter has explored and discussed the process undertaken to validate the 
SF36v2 and HADS measures among ESRD patients using factor analyses and 
internal reliability test. 
For SF36v2, three-factor structure was identified as underpinning SF36v2 which 
can be named as physical functioning, emotional effect and role functioning. The 
result seems to suggest that the role-functioning concept emerged due to cultural 
differences in item interpretation or possibly because of differences in perception 
of health. That is, the concept of role functioning may be more dominant and more 
valued by Omani patients. This result recommends that researchers should take 
more cautious steps when translating HRQoL standard measures into Arabic. In 
addition, intensive psychometric testing should be carried out on translated 
measures.  
The three-factor solution was subjected to CFA which proved to fit the data of this 
study. It can be concluded, then, that the HRQoL status of Omani patients with 
ESRD is influenced by physical functioning, limitations on role functioning due to 
physical and mental problems and emotional impact. Hence, SF36v2 needs to 
be scored according to the emerged three-factor structure. To ensure a rigorous 
scoring process, a comparison of scoring between the original factor structure of 
SF36v2 and the emerged three-factor structure can be carried out. These two 
structures underpinning SF36v2, the standardised two-factor structure and the 
emerged three-factor structure, can then be regressed with independent 
variables in the main study.  
For HADS, results did not show an exclusive factor-structure of HADS. EFA 
revealed one-factor structure and a possible two-factor structure correlated at α 
.53. CFA revealed acceptable fit indices to study data for the one-factor, original 
two-factor, and emergent two-factor structures, though it was in favour of 
emergent two-factor structure. Internal reliability test was conducted on original 
and emergent two-factor structures and results showed better internal 
consistency of original two-factor structure. 
 198 
The response rate of HADS in this population reflected the fact that it is an easily 
administered scale which is not unduly burdensome to ESRD patients who are 
on continuous dialysis treatment. Despite this, the generalisability of HADS 
should be well noted since different characteristics of patients, cultures and 
statistical methods could be sources of spurious results. Clinically, there is a need 
to develop precise diagnostic criteria for adjustment disorders that can be used 
in ESRD patients. Despite results indicating that HADS is a valid measure within 
this population, clearly differentiating between the concepts of anxiety and 
depression, the sensitivity of items remains an issue. Out of seven items of the 
depression scale, five items were sensitive in measuring depressive symptoms 
and the remaining five were loaded on the anxiety scale. Future studies should 
focus on improving screening methods to make these items more sensitive and 
more specific. Hence, for the purpose of this study, and on the basis of acceptable 
internal-consistency values and fit indices of original two-factor structure to data, 
it is may be advisable to use the original HADS in this study. 
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Chapter 8- Main Study Results 
 
1. Introduction  
This chapter presents the results of the statistical analysis pertaining to phase 
three of this study. This study is a cross-sectional correlational design.  
Since the study is not examining the changes in QoL and HRQoL over time, a 
cross-sectional design was deemed appropriate and data were collected at one 
point in time from patients to examine their level of QoL and HRQoL as well as 
related factors. Patients included in this phase were: adult patients with ESRD 
receiving HD; those aged ≥ 18 years; and those who had been on HD for more 
than three months. Patients with acute renal failure; patients aged under 18; 
patients diagnosed with dementia or any other condition that could impair their 
ability to answer questions; patients who had recently been diagnosed with 
cancer; and patients who had recovered their renal function were excluded from 
study. 
Eight instruments were used to collect the data: 1) Background data sheet; 2) 
Short-Form 36v2 (SF36v2); 3) Quality of life Index-Dialysis (QLI-D); 4) Hospital 
Anxiety Depression Scale (HADS); 5) Fatigue Severity Scale (FSS); 6) Itch Scale 
(5-D Itch); 7) Spiritual Wellbeing Scale (SWB); and 8) The Schedule for the 
Evaluation of Quality of Life-Direct weighting (SEIQoL-DW). 
Thirteen dialysis centres across the Sultanate were involved in this phase. These 
units provide routine HD for out-patients affected by ESRD from a variety of 
regions and are managed by the Omani Ministry of Health (MOH). Patients were 
identified from the National Renal Registry of patients treated with ESRD in 
Oman. Using an opt-in strategy, those who agreed to participate were identified 
by nurses who were recruited and trained by the researcher to assist in obtaining 
consent forms, administering the questionnaire package, following up and 
collecting the completed study questionnaires.  
Collected data were analysed using the SPSS software version 22. Initial analysis 
outputs were checked for missing, invalid and extreme values that might have 
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fallen out of the range of normal possible values. The nominal and categorical 
data were inspected by running frequency tables, while continuous data were 
inspected by running descriptive statistics. The frequency and descriptive tests 
outputs were checked to correct any errors before starting data analysis. Missing 
data and extreme values of categorical variables were checked visually by 
observing frequencies in output tables. Missing data were examined and were 
managed by individual mean substitution if they were found not to be significant 
or ≤ 10% and if > 10%, then the affected scale/subscale was excluded in related 
analyses (Tabachnick and Fidell, 2007).  
HRQoL, disease-specific, and symptoms-specific measures were computed and 
a syntax was created. It should be noted that the scores of the bodily-pain scale 
are reverse scored: the higher the value, the less the bodily pain.  
Data normality were tested by running a frequency distribution for each variable 
and if data-normality assumptions were violated, data were transformed by using 
square root, logarithm and inverse function, respectively. Outliers were checked 
by Q-Q Plot. Multivariate outliers were inspected by running standardised 
residual values, and if greater or less than 3.0, values were categorised as an 
outlier (Tabachnick and Fidell, 2007). Where presented, outliers were handled by 
being rescored or deleted or by creating separate regression models. Data 
linearity was checked using scatter-plots to illustrate differences between each of 
the independent variables compared with the dependent variable.  
Frequency for nominal and categorical variables, and mean and standard division 
for continuous variables were computed. The Pearson product correlation 
coefficient (r) was conducted to assess the relationship between two parametric 
variables and the Spearman's rank order correlation (rho) was used to assess 
the relationship between non-parametric variables.  
Reliability of measures and its subscales was tested using the Cronbach's alpha. 
DeVellis (1991, p.85) and suggest 0.60 and above as an acceptable reliability 
coefficient since smaller reliability coefficients are seen as inadequate. This value 
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was used since the aim of reliability test is to measure a trait with enough 
accuracy to establish the existence of a relationship with other traits. 
 
For regression analysis, three main sequential multiple regression analyses were 
conducted to test the predictive value of the demographic, treatment, clinical, 
socio-environmental, symptoms, functional status and general health perception 
on HRQoL in patients with ESRD: SF36v2 physical component summary–PCS 
(2-factor standard model); 2) SF36v2 mental component summary–MCS (2-
factor standard model); 3) QoLI-dialysis; and 4.a) SF36v2–PCS (emerged 3-
factor model), SF36v2–MCS (emerged 3-factor model), and SF36v2–Role-
functioning component summary–RCS (emerged 3-factor model).  
Independent variables were correlated with each other and checked for multi-co-
linearity. In the case of two variables correlating at 0.85 or higher, one variable 
was eliminated from the regression analysis. When all variables were examined 
together, the tolerance level and variance inflation factor of all IVs were calculated 
to determine multi-co-linearity. A tolerance value <0.10 and a variance inflation 
factor >10 was used to identify multi-co-linearity for possible elimination of 
variables (Mertler & Vannatta, 2002). 
A Mahalanobis Distance was computed for each case to detect any extreme 
multivariate outliers and, once that was done, the Mahalanobis scores were 
screened in the same manner as the univariate outliers. Hence, frequency 
distributions were run for each variable and examined for outliers. In addition, 
multivariate outliers were detected through “standardised residual” values >3.0 
or <-3.0. Outliers would either be rescored or deleted, or separate regression 
models were created (Tabachnick and Fidell, 2007). 
All variables were checked for data distribution (multivariate normality, linearity 
and homo-scedasticity) by visually examining standardised residual scatterplots. 
In case any assumptions were violated, data were transformed in an attempt to 
stabilise the variance and to achieve linearity and normality (Polit, 1996). 
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The statistical significance for a variable inclusion into a statistical model was set 
at α= .15 (Tabachnick and Fidell, 2014). This determined liberal probability level 
was to avoid excluding important variables from the model. Independent 
variables were entered simultaneously into a sequential multiple regression 
model to determine how well biological factors, symptoms, functional status, 
general health perception and socio-demographic and treatment factors 
predicted a patient’s overall HRQoL.  
The improvement in the regression model at each step was evaluated by the R 
square (R2) and adjusted R2 values. The process of adding more variables would 
stop when all the potential variables had been included or when it was not 
possible to make a statistically significant improvement in R and R2 (Pallant, 
2013). To evaluate which variables included in the model contributed to the 
prediction of the dependent variables, the unstandardised regression coefficients 
(B), the standard errors (SE B), the standardised regression coefficients ( ), the 
t-statistic, the significance of the t-statistic, the R, the F statistic (F), R2 and the 
change in R2 (R2) were reported. 
Finally, the accuracy of each regression model was evaluated by conducting a 
Bootstrapping test. Bootstrapping is considered a sound test which can be 
performed to obtain robust estimates of the intercept and beta weights 
(Tabachnick and Fidell, 2014, p 179). It is a process by which regression weights 
are generated over a very large number of replications (up to 1,000 bootstraps) 
with samples drawn and replacement from the available data set. Conclusions 
were drawn based on the bootstrapped coefficients’ parameter estimates of the 
overall final model: the unstandardised regression coefficients (B), bias, 
bootstrapped standard errors (SE B), significance of the regression coefficients, 
the normal approximated 95% confidence intervals (OLS 95% CI) and the 
bootstrapped confidence interval (BCa 95% CI). 
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2. Findings 
2.1. Return rates 
Eight hundred and two survey packages were distributed to 13 dialysis units 
across the Sultanate during the months of May and June 2016. Of the 802 
respondents who received the survey packages, 451 surveys were returned 
providing a return rate of 56.23 % (table 8.1), of which one has only socio-
demographic and clinical data. One hundred and two (27.01%) illiterate patients 
required assistance in filling out the surveys by the assigned nephrology nurses.  
Table 8. 1  eligible patients and number of returned surveys per unit 
Dialysis unit Eligible patients  
Returned questionnaires 
(%) 
Al-Buraimi  36  25 (69.44) 
Bausher and Seeb 210  117 (55.71) 
Musandam 10  07 (70) 
Ibra   44  21 (47.72) 
Ibri Hospital  50  15 (30) 
Jaalan BBA  44  24 (54.54) 
Musanah  114  71 (62.28) 
Nizwa 62  10 (16.12) 
Rustaq 41  18 (43.90) 
Sinaw   25  11 (44) 
Sohar EHC   58  54 (93.10) 
Sohar Hospital  83  58 (69.87) 
Sumail  25  20 (80) 
Total  802  451 (56.23) 
 
2.2. Preliminary examination of data 
Collected data were analysed using the SPSS version 22.0. Data entry was 
double-checked and proofread against the original questionnaire.  No errors were 
identified. 
The sociodemographic data were checked visually for missing data and extreme 
values by running frequencies on all related variables. Questions that were 
related to the demographical variables were all completed except two cases (0.4 
%) for gender, six (1.3 %) cases for marital status, three (0.9 %) cases for 
education level, and seven cases (1.6 %) for income variable (table 8.2). No 
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method was used to replace the missing data on those variables and cases were 
excluded using pairwise method where necessary. No extreme values were 
noted. 
Table 8. 2  Missing data on sociodemographic data (n= 451) 
Variable Frequency (%) 
Gender 2 (0.4 %) 
Marital status  6 (1.3 %) 
Educational level 3 (0.9 %) 
Income  7 (1.6 %) 
 
For study continuous data, identified missing data with ≤ 10 % were replaced by 
the individual mean substitution method; whereas missing data with ≥ 10 % were 
excluded in the inferential analysis pertaining to regression analysis. Table 8.3 
shows the final total number of excluded cases from analysis in relation to each 
scale and subscales.  Subsequently, frequencies and descriptive analyses were 
repeated to check whether missing data were entirely replaced, which showed 
no further missing data and thus provided the confidence to move to detect 
outliers and check data distribution.
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Table 8. 3  Total cases were excluded from analysis (n= 451) 
Scale and subscales 
Missing 
cases 
Valid cases 
N (%) N (%) 
Pt age 12 (2.7) 439 (97.3) 
Hb 7 (1.6) 444 (98.4) 
Haematocrit level 8 (1.8) 443 (98.2) 
Albumin level 8 (1.8) 443 (98.2) 
Dialysis adequacy 12 (2.7) 439 (97.3) 
dialysis hours per month 8 (1.8) 443 (98.2) 
Time since started HD 0 (0) 451 (100) 
Time to reach to Dialysis in minutes 9 (2) 442 (98) 
HADS Anxiety Subscale 11 (2.4) 440 (97.6) 
HADS Depression subscale 10 (2.2) 441 (97.8) 
HADS overall Score 10 (2.2) 441 (97.8) 
Religious wellbeing 12 (2.7) 439 (97.3) 
Existential Wellbeing 14 (3.1) 437 (96.9) 
Spiritual Wellbeing 12 (2.7) 439 (97.3) 
QoLI-Dialysis Scale 8 (1.8) 443 (98.2) 
QoLI-D Health Functioning Subscale 8 (1.8) 443 (98.2) 
QoLI-D Socio Economic Subscale 8 (1.8) 443 (98.2) 
QoLI-D Psycho Spiritual Subscale 9 (2) 442 (98) 
QoLI-D Family Subscale 10 (2.2) 441 (97.8) 
Itch Scale 12 (2.7) 439 (97.3) 
Fatigue Scale 12 (2.7) 439 (97.3) 
SF36v2 Perceived General Health 5 (1.1) 446 (98.9) 
SF36v2 Physical Functioning Subscale 6 (1.3) 445 (98.7) 
SF36v2 Social Functioning Subscale 11 (2.4) 440 (97.6) 
SF36v2 Limitation in role physical 
Subscale 
6 (1.3) 445 (98.7) 
SF36v2 Limitation in role emotional 
Subscale 
9 (2) 442 (98) 
SF36v2 Mental Health Subscale 13 (2.9) 438 (97.1) 
SF36v2 Vitality Subscale 11 (2.4) 440 (97.6) 
SF36v2 Bodily Pain Subscale 12 (2.7) 439 (97.3) 
SF36v2 General Health Subscale 14 (3.1) 437 (96.9) 
HB: Haemoglobulin; QOLI-D: Quality of life index-dialysis; SF36v2: Short form 36 version 2. 
Following data cleaning and missing data replacement, five measures–Short 
form 36v2 (SF36v2), Hospital Anxiety Depression Scale (HADS), Fatigue 
Severity Scale (FSS), Itc-5D, and Spiritual Wellbeing Scale (SWB)–were 
computed and a syntax was created using the SPSSv22 programme. For the 
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Quality of Life Index-Dialysis (QoLI-D), the syntax developed by Ferrans et al 
(2005) was used to score the QoLI-D and its four subscales. This was developed 
specifically to fit the SPSS programme. It should be noted that the scores of the 
bodily-pain scale are reverse scored: the higher the value, the less the bodily 
pain. 
Continuous data were then explored to examine outliers and linearity by visually 
observing scatter-plots. No outliers were observed. 
Each continuous variable was examined for normality by calculating skewness 
and kurtosis statistics. Single sample z-tests were considered normally 
distributed if skewness and kurtosis values were between -3.3 and + 3.3 
(Tabachnick and Fidell, 2014). Nine variables were found to be skewed: Spiritual 
wellbeing, Time to reach HD, Time since started HD, Itch, QOLI-D, Fatigue, 
Psycho-Spiritual subscale of QOLI-D, Family subscale, and HD hours per month. 
In an attempt to stabilise the variance and achieve normality, these variables 
were, gradually, transformed using the methods of square root, logarithm, and 
inverse transformation. These transformations, however, did not significantly 
mend the skewed variables, except slight improvement on two variables, the 
Time since started HD and Itch. It was therefore decided to use the variables 
untransformed and to examine the distribution of the residuals of relevant 
inferential statistics (Table 8.4). 
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Table 8. 4  The effect of data transformation on skewness 
variable 
Pre-transformation 
Square root 
transformation 
Logarithm 
transformation 
Inverse 
transformation 
skewness se z Skewness z skewness z skewness z 
Spiritual 
Wellbeing 
1.5 0.11 12.82 0.34 2.93 -3.45 -29.53 19.74 168.76 
Time to 
reach HD 
1.09 0.11 9.44 0.45 3.96 -0.26 -2.31 2.03 17.50 
Time since 
started HD 
0.96 0.11 8.16 0.23 1.97 -0.58 -4.96 3.39 28.72 
Itch 0.79 0.11 6.76 0.16 1.37 0.16 1.36 6.22 53.17 
QOLID -0.41 0.11 -3.59 -0.63 -5.46 -0.89 -7.67 1.68 14.53 
Fatigue -0.59 0.11 -5.04 -1.03 -8.86 -2.27 -19.40 17.75 151.77 
Psych-
Spiritual 
Subscale 
-0.96 0.11 -8.31 -1.74 -15.0 -1.91 -16.52 4.36 37.62 
Dialysis 
hours per 
month 
-1.05 0.11 -9.06 -1.10 -9.53 -1.16 -10.02 1.29 11.12 
Family 
Subscale 
-1.28 0.11 -11.11 -1.69 -14.5 -2.59 -22.36 10.18 87.82 
*the values of standard error were same across transformation 
Cronbach’s alpha was computed for each measure to check for internal reliability. 
Scores correlated at range of α= .533 to 0.975 (see Table 8.5) with lowest on 
Social Functioning subscale of the SF-36v2 and highest on QOLI-D.  Exceeding 
Cronbach’s Alpha value .60, Nunnally and Bernstein (1994) and DeVellis (2003), 
these findings suggest that study measures are acceptable and reliable within the 
Omani context. 
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Table 8. 5  Internal reliability of total scores and subscales of study measures 
Measure  Cronbach’s alpha 
SF-36v2  .668 
SF36v2 Physical Functioning Subscale .829 
SF36v2 Role Physical Subscale  .830 
SF36v2 Bodily Pain Subscale .766 
SF36v2 General Health Subscale .656 
SF36v2 Vitality Subscale .748 
SF36v2 Social Functioning Subscale .533 
SF36v2 Role Emotion Subscale .848 
SF36v2 Mental Health .747 
QOLID .975 
QOLID-Health and Functioning Subscale .903 
QOLID-Social and Economic Subscale .807 
QOLID-Psychological Spiritual Subscale .905 
QOLID-Family Subscale .805 
SWB .867 
Itch-5D Scale .678 
FSS .922 
HADS .829 
HADS-Anxiety subscale .795 
HADS-Depression subscale .666 
SF36v2: Short form 36v2; QOLID: Quality of life index dialysis; SWB: Spiritual wellbeing; HADS: Hospital 
anxiety depression scale. 
2.3. Participants’ characteristics  
Four hundred and forty-nine (449) patients completed the study measures. Table 
8.6 illustrates the characteristics of the patients. The average age of the patients 
was 46.59 (SD = 13.6 years) and ranged from 18 to 87 years; of which, 56.3% 
were men, and 43.2% women. Most of the participants were married (62.5%), 
employed (37.5%) and illiterate (27.1 %). The majority of the participants were 
from Al Batina region (44.6%), followed by Muscat governate (25.9%). These two 
regions consist of seven HD units and accommodate 55% of the Oman 
population compared to the remaining regions.
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Table 8. 6  Patient’s characteristics (n 451) 
Variable Mean (SD) Range  
Age 46.59 (13.64) 18-87 
Variables  Frequency (%) 
Gender 
male 254 (56.3 %) 
female 195 (43.2 %) 
Marital status 
Married 282 (62.5 %) 
Separated 44 (9.8 %) 
Widow 40 (8.9 %) 
Single 79 (17.5 %) 
Educational status 
illiterate 122 (27.1 %) 
Low-intermediate 98 (21.7 %) 
Intermediate 83 (18.4 %) 
High-intermediate 85 (18.8 %) 
high 60 (13.3 %) 
Job 
Employed 169 (37.5 %) 
Un-employed 278 (61.6 %) 
Income (OMR)  
<250 234 (51.9 %) 
251-600 126 (27.9 %) 
601-1000 25 (5.5 %) 
1001-1500 40 (8.9 %) 
>1500 19 (4.2 %) 
Region   
Muscat 117 (25.9 %) 
Dakhliya 30 (6.7 %) 
Dahira 15 (3.3 %) 
Musandam 7 (1.6 %) 
Buraymi 25 (5.5 %) 
Batina 201 (44.6 %) 
 
2.4. Clinical characteristics  
Table 8.7 summarises results of clinical variables which are Haemoglobin (Hb), 
Haematocrit (HCT), Albumin level, Dialysis adequacy, Dialysis hours per month, 
Time since started HD in years, and Time to get to HD in minutes. Time on HD in 
hours per month ranged from 32 to 48 hours (M = 44.1, SD = 5.5). The length of 
time that patients had been on dialysis ranged from three months to 24 years (M 
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= 6.57, SD = 4.6). The average time taken for the patients to travel to dialysis 
ranged from five minutes to one-and-a-half hours (M = 28.8, SD = 18.0). The 
adequacy of dialysis, measured by urea reduction rate, was within the normal 
range (M = 70.50, SD = 11.58).  
Table 8. 7  Clinical data (n 451) 
Variable  Mean (SD) Range  Therapeutic values*  
Hb g/L 10.98 (1.53) 6-15.5 
Male: 113 - 118 g/L 
Female: 112 - 116 g/L  
Haematocrit level 35.71 (5.15) 21.8-49.4 33-36 % 
Albumin level 38.42 (5.13) 21.8-52.6 35-48g/L  
Dialysis adequacy (urea reduction 
rate) 
70.50 
(11.58) 
31.1-96.7 ≥ 65 % 
Dialysis hours per month 44.14 (5.55) 32-48 - 
Time since started HD in years 6.57 (4.65) 0.3-24 - 
Time to get to HD in minutes 28.87 (18) 5-90 - 
* source: KDOQI clinical practice guideline for haemodialysis (2015) 
 
2.5. RQ2: What is the level of QoL/HRQoL for patients with ESRD 
on HD in Oman? 
This question was answered by descriptive analysis of the generic health status 
measure (SF36v2), condition-specific measure (QOLI-Dialysis), general health 
perception (item one in the SF-36v2), individualised QoL instrument (SEIQoL-
DW), emotional status measure (HADS), and the physical symptom-specific 
measures (Itch-5D, Fatigue Scale).  
2.5.1. Health status (SF-36v2) 
The SF36v2 scores ranged from 0 to 100, with 0 indicating lowest health status 
and 100 being the highest health status. The means and standard deviation (M ± 
SD) of the eight subscales of SF-36v2 and the two component summary scores 
(PCS and MCS) are presented in Table 8.8 The mean scores of the eight 
domains of the SF-36v2 ranged from 52.24 to 63.75, suggesting that these 
patients had moderate health status. Physical functioning due to physical health 
problems (PF) and vitality (VT) due to mental health problems were the lowest 
rated domains (M = 42.24 and 52.90, respectively), while mental health (MH) and 
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social functioning (SF) were the highest rated domains (M = 63.75 and 60.51, 
respectively). Additionally, the PCS score was lower than the MCS score (M = 
54.09 and 58.35, respectively). 
Table 8. 8  Means (SD) and ranges of SF-36v2 domains of patients with ESRD in 
Oman 
SF-36v2 subscales N 
Mean (SD)  
(out of scores 0-100) 
Minimum  maximum 
Physical health  PF 446 52.24 (26.31) 0 100 
RP 445 54.24 (24.87) 0 100 
BP 439 56.72 (26.11) 0 100 
GH 447 53.18 (20.06) 0 100 
Mental health VT 440 52.90 (21.23) 0 100 
SF 440 60.51 (25.44) 0 100 
RE 443 56.25 (27.52) 0 100 
MH 440 63.75 (20.31) 5 100 
Physical Component Summary 
(PCS) 
54.09 (24.33) 2.5 97.5 
Mental Component Summary (PCS) 58.35 (23.62) 10.3 100 
 
2.5.2. Quality of Life Index-Dialysis 
The QOLI-D scores ranged from 0 to 30, with 0 indicating poor QoL and 30 good 
QoL. Findings on the QOLI-D for the patients were all above the midrange value 
of 15 of the scale and subscales scores (table 8.9). The overall QOLI-D was 21.90 
(SD = 4.86) out of a score of 30. Health and Functioning was the lowest rated 
subscale (M = 20.36, SD = 5.33), followed by the Social and Economic subscale 
(M = 21.24, SD = 5.29), the psychological/ spiritual subscale (M = 23.43, SD = 
6.05), and the family subscale (M = 25.15, SD = 5.50).
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Table 8. 9  Mean scores of the quality of life index-dialysis (QOLI-D) 
 
QOLID total and 
subscales 
N 
Mean (SD)  
(out of scores 0-30) 
Possible 
range 
Minimum  Maximum 
QOLID total 443 21.90 (4.86) 
0-30 
7.24 29.80 
Health and 
functioning 
443 20.36 (5.33) 
0-30 
5.11 30 
Social and economic 443 21.24 (5.29) 
0-30 
7.88 30 
Psychological/ 
spiritual 
442 23.43 (6.05) 0-30 .00 30 
Family 441 25.15 (5.50) 0-30 
2.40 30 
 
 
2.5.3. General health perception 
Patients’ perception of their general health was assessed using a single item 
(item one in the SF-36v2) that asked patients to rate their health in general. This 
question is rated on the 5-point ordinal scale ranging from poor = 1 to excellent = 
5. Table 8.10 shows that 132 (29.3%) of the patients rated their general health 
as good followed by 127 (28.2%) patients who perceived their general health as 
fair. Only 69 (15.3%) of the patients thought their general health was excellent, 
whereas the remaining 39 (8.6%) patients rated their general health status as 
poor. 
Table 8. 10 Summarises the description of patients' general health perception (n= 446).  
Rating scale of perceived general health N (%) Mean (SD) 
Poor 39 (8.6 %) M= 3.02 (1.19) 
Fair 127 (28.2%) 
Good 132 (29.3 %) 
Very good 79 (17.5 %) 
Excellent 69 (15.3 %) 
2.5.4. Individualised QoL instrument (SEIQoL-DW) 
As described in Methodology Chapter (Chapter six), SEIQoL-DW was used to 
assess patient’s own perspective and on his/her own perception and 
understanding of QoL. In total, 45 patients completed the SEIQoL-DW. The 
average length of time required for the patients to complete the SEIQoL-DW was 
16.43 (11-25) minutes. The least time taken was scored by a 27 years old male 
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patient with high education level, the longest by a 59 years old illiterate female 
patient suggesting that education level might reflect level of understanding the 
SEIQoL-DW instrument. The majority of patients 39 (86.6%) reported that 
completing the SEIQoL-DW was easy. 
Two hundred and twenty cues were reported by the interviewed patients: forty-
three patients (95.5%) nominated five cues without prompting whereas two 
(4.44%) required prompting and nominated four cues. These cues were 
categorised by three independent raters revealing 19 categories (Table 8.11). 
Fifty seven percent (127) of the cues were assigned the same category by the 
three raters, 33.64% (74) had agreement of two raters, and there was no 
agreement on 19 cues (8.64%). The raters later met to agree and assign a 
category for the cues that they did not agree.   
Table 8. 11 Frequency and percentage of patients nominating each category 
Common category 
Frequency 
(%) 
Religion/spiritual life 36 (80%) 
Family 35 (77.7%) 
Personal health 31 (68.8%) 
Social life 17 (37.7%) 
Work/occupation 15 (33.3%) 
Leisure activities/hobbies 14 (31.1%) 
Autonomy/independence 12 (26.6%) 
Role functioning 9 (20%) 
Living conditions 9 (20%) 
Peace and contentment 7 (15.5%) 
Finance 7 (15.5%) 
Family health 6 (13.3%) 
Quality of care 5 (11.1%) 
Sexual life 4 (8.8%) 
Enjoying life 4 (8.8%) 
Relationships 4 (8.8%) 
Coping  3 (6.6%) 
Emotional well-being 2 (4.4%) 
Exercise/mobility 1 (2.2%) 
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SEIQoL-DW index was calculated for all patients to provide a global QoL score 
(Table 8.12). The minimum score was 27.53 and the maximum score was 83.80 
(M= 60.33, SD = 13.99) with the higher rate indicating better QoL.  At the same 
time, and for the purpose of cross validation with SEIQoL-DW scores, patients 
were asked to indicate their current overall life satisfaction on a visual analogue 
scale (VAS). The mean score was 66.67 (SD = 20.61) with the lowest score of 
28 and highest score of 95. The SEIQoL-DW index and the VAS of life satisfaction 
scores reflect that patients might have moderate levels of QoL and overall life 
satisfaction.  
Table 8. 12 SEIQoL-DW index and AVS life satisfaction scores (n = 45) 
Measure mean (SD) 
SEIQoL-DW index score 60.33 (13.99) 
Life satisfaction AVS score 66.67 20.61) 
SEIQoL-DW: The Schedule for the Evaluation of the Individual Quality of Life-Direct Weighting 
 
2.5.5. Hospital Anxiety and Depression Scale (HADS) 
 
The HADS was used to determine the levels of anxiety and depression that 
Omani ESRD patients might be experiencing. It consists of 14 items of which 
seven relate to anxiety and seven relate to depression. The possible scores range 
are 0-6 normal, 7-10 mild, 11-14 moderate, and 15-21 severe (Zigmond and 
Snaith, 1983; Crawford et al., 2001). Scores of ≥8 are deemed as a possible 
existence of symptoms of anxiety and depression in this group of patients. The 
mean anxiety score was 6.91 (SD= 4.32), with scores ranging from 0-18. Forty 
one percent (183) of patients obtained a score of ≥8 on the anxiety subscale 
which possibly indicates the presence of clinical anxiety. The mean depression 
score was 6.90 (SD= 3.73), with scores ranging from 0 to 17. Forty three percent 
of patients obtained a score of ≥8 on the depression subscale, indicating possible 
clinical depression (Table 8.13). 
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Table 8. 13 HADS scores and possible cassenas of anxiety and depression  
 
 N (%) Mean (SD) 
(out of scores 0-21) 
Minimum Maximum Caseness 
(HADS ≥ 8) 
 HADS-A 
Anxiety 
440 6.91 (4.32) 0 18 N= 183 (41.49%) 
 HADS-D 
Depression 
441 6.90 (3.73) 0 17 N= 189 (42.95%) 
HADS: Hospital anxiety depression scale 
 
2.5.6. Fatigue severity scale (FSS) 
 
FSS is a unidimensional scale that is used to measure fatigue severity in ESRD 
patients. It consists of nine items scored on a seven-point Likert scale with scores 
<36 suggesting no suffering from fatigue, and scores ≥36 suggesting possible 
fatigue that may need future evaluation. The mean FFS score was 44.70 (SD= 
14.91), with scores ranging from 1-63. Seventy three percent (319) of 439 
patients obtained a score of ≥36, indicating a further evaluation of fatigue required 
for those patients (Table 8.14). 
Table 8. 14 FFS scores possible cassenas  
 N (%) Mean (SD) Minimum Maximum Cassenas (FSS ≥ 36) 
 FSS 439 44.70 (14.91) 1 63 N= 319 (72.66%) 
FFS: Fatigue severity scale 
 
5.5.7. Itch-5D scale 
 
The itch5-D scale was used to quantify pruritus in this group of patients. Scores 
can potentially range between 5 (no pruritus) and 25 (most severe pruritus).  The 
average Itch-5D score was 9.33 (SD = 3.84), with scores ranging from 1 to 23. 
The average of the Itch-5D is below the midrange value which may suggest that 
Omani ESRD patients had low levels of pruritus symptom (Table 8.15). 
Table 8. 15 Itch5-D scale scores  
 N (%) Mean (SD) Minimum Maximum Possible range 
Itch scale 439 9.33 (3.84) 1 23 5-25 
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5.5.8. Spiritual Wellbeing Scale (SWB) 
SWB scale was used to assess the spiritual life wellbeing of the Omani ESRD 
patients by two subscales, the existential subscale (as an existential need for 
wholeness and connection with the universe) and religiosity subscale (religious 
rituals performance).  
The overall SWB score was 55.54 (SD =17.86). The mean scores for EWB and 
RWB subscales were 28.63 (SD =8.44) and 27.04 (SD =10.10), respectively. 
Findings on the existential and religious subscale for the Omani patients were 
just below the midrange value of 30. Likewise, findings on the overall SWB score 
were under the midrange value of 60. Based on scores range of SWB, this might 
suggest that both the existential and religious domains of spirituality were 
clinically relevant to patients in this study and might have an impact on their QoL 
and HRQoL (Bufford et al., 1991). Table 8.16 shows the overall and subscale 
scores of SWB. 
 
Table 8. 16 SWB score and subscales scores 
 N (%) Mean (SD) Minimum Maximum Possible range 
Existential subscale 437 28.63 (8.44) 3 60 10 - 60 
Religious subscale 439 27.04 (10.10) 1 60 10 - 60 
SWB 439 55.54 (17.86) 1 120 21 - 120 
 
5.6. Research question Three: To what extent do the following factors predict 
QoL/HRQoL in Omani patients with ESRD? 
a) Individual characteristics (age, gender, educational status, income, 
region, and marital status) measured by demographic. 
b) Treatment characteristics (duration of dialysis, dialysis adequacy, and 
length of time to get to dialysis) measured by clinical data 
c) Socio-environmental factors (family support, socio-economic, religious 
and spiritual), measured by disease-specific and generic-instruments. 
d) Biological function (anaemia and malnutrition) measured by clinical data 
such as serum albumin, haematocrit and serum Hb 
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e) Symptoms (fatigue, pain, mood, pruritus), measured by symptom-specific 
instruments 
f) Functional status and general health perceptions, measured by health-
status instruments 
Several sequential multiple regression analyses were performed to test the 
predictive value of the demographic, treatment characteristics, social-
environmental, clinical, physical and emotional symptoms, physical functional 
status, and general health perception on four main outcomes: 1) SF36v2 physical 
component summary–PCS (Two-factor standard model); 2) SF36v2 mental 
component summary–MCS (Two-factor standard model); 3) QoLI-dialysis; and 
4.a) SF36v2–PCS (Three-factor model), 4.b) SF36v2–MCS (Three-factor model), 
and 4.c) SF36v2–Role-functioning component summary–RCS (Three-factor 
model).  
Five of the nominal variables in this analysis (gender, marital status, education 
status, job, monthly income, and region) required dummy coding prior to entering 
into the model. These variables were coded as dichotomous variables (Munro, 
2005) according to the most frequent response obtained from respondents (Table 
8.17). 
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Table 8. 17 Dummy coding for nominal variables 
Nominal variable Reference value = 0 Non-reference values = 1 
Gender Male  Female 
Marital status Married Divorced 
Widow 
Single  
Education status Illiterate Low-intermediate 
Intermediate 
High-intermediate 
higher 
Job Unemployed Employed  
Monthly income <250 251-600 
601-1,000 
1,001-1,500 
>1,501 
Region  Interior regions Muscat 
 
5.6.1. SF36v2 PCS (Two-factor standard model) 
Sequential multiple regression was employed to determine if addition of 
information regarding treatment, then family support, then symptoms, then 
emotional status and then health status improved prediction of the SF36v2 
physical component summary (2-factor standard model), after controlling for the 
influence of demographics.  
Before examining the sequential regression analysis, inspections for 
assumptions and other potential problems that might affect interpreting the 
analysis were conducted. Initially, the output was examined for any issues with 
multicollinearity. Table 18-19 displays the correlation among variables. An 
examination of the correlations revealed that none of the independent variables 
were highly correlated except Family and Social and Economic variables 
(r=.653). However, since the person’s correlation was less than .85 (Tabachnick 
& Fidell, 2014), the assumption of multicollinearity was deemed to have been 
met. In addition, the tolerance values were all greater than 0.10 and the variance 
inflation factors were all less than 10.0, revealing no concerns with 
multicollinearity (Mertler & Vannatta, 2002). Next, the data were checked for 
multivariate outliers. All standardised residual values fell between -3.0 and 3.0, 
indicating no issues with outliers (Tabachnick & Fidell, 2001). Using the criterion 
 219 
p < .001 for Mahalanobis distance, no multivariate outliers among the cases were 
identified.  
 
Table 8. 18 Spearman's rho correlations of SF-36v2 PCS (2-factor standard model) 
Variables  
SF36v2 PCS 
(2-factor 
standard) 
Region Gender 
marital 
status 
Educational 
status 
Job Income 
SF36v2 
PCS (2-
factor 
standard) 
- .01 -.11* -.09 .17** -.07$ .09* 
Region  - .14** .06 -.21** .18** -.13** 
Gender   - .18** -.14** .39** -.12** 
marital 
status 
   - .19** .13** -.08 
Educationa
l status 
    - -.21** .41** 
Job      - -.38** 
Income       - 
$ p ≤ .15; * p ≤ .05; ** p < .001 
PCS: Phsyical component summary 
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Table 8. 19 Pearson’s correlations SF-36v2 PCS (2-factor standard model) 
  
PCS 
(2-
factor 
standa
rd) 
Pt 
age 
Hb HCT 
Albumi
n 
Dialysis 
adequacy 
dialysi
s 
hours 
per 
month 
Time 
since 
starte
d HD 
Time to 
reach 
HD in 
minute
s 
Anxiety Depression 
Spiritual 
Wellbeing 
Socio 
and 
Econo
-mic 
Family  Itch Fatigue 
Perceived 
general 
health 
PCS (2-
factor 
standard) 
 - 
-
.14** 
.01 .03 -.01 .06 .06 -.12* -.15** -.41** -.48** -.04 .32** .20** 
-
.24** 
-.42** .46** 
Pt age    - 
-
.01 
.01 -.03 -.10* -.09* .04 -.07 .03 .11* -.06 -.07 -.02 .02 .04 -.12** 
Hb      - .63** .19** .11* .05 .04 -.08 -.06 -.10* .02 .07 .05 .03 -.02 .07 
HCT        - .14** .03 .04 .01 -.10* .02 -.01 -.03 -.09 -.06 .02 .03 .07 
Albumin          - .14** -.05 .01 .08 -.10* -.08 -.13** .08 .23** .05 -.05 .01 
Dialysis 
adequacy 
           - .10* -.01 .03 -.14** -.16** .01 .19** .32** -.08 -.06 .12* 
dialysis 
hours per 
month 
             - -.08 -.14** .01 -.04 -.05 .02 -.03 -.06 -.08 .08 
Time 
since 
started HD 
              -  -.02 .10* .11* .13** -.12** -.10* .05 .06 -.03 
Time to 
reach to 
HD in 
minutes 
                 - .08 .01 .04 .02 .06 .03 .05 -.02 
Anxiety                    - .58** -.01 -.45** -.40** .20** .46** -.35** 
Depression                      - -.06 -.37** -.34** .18** .41** -.43** 
Spiritual 
Wellbeing 
                       - -.01 .01 .06 -.03 .02 
Social and 
Economic 
                         - .64** 
-
.16** 
-.29** .32** 
Family                            - -.07 -.24** .22** 
Itch                               - .12** -.11* 
Fatigue                                - -.39** 
Perceived 
general 
health 
                                 - 
$ p ≤ .15; * p ≤ .05; ** p < .001 
PCS: physical component summary; Hb: Hemoglobulin; HD: Haemodialysis; FFS: Fatigue severity scale; HCT: Haematocrit  
 221 
For normality test, the distribution of residuals were found to be nearly normal 
and centred at 0. Residual and scatter plots indicated the conditions of normality, 
linearity and homoscedasticity were all satisfied. Thus, all assumptions were 
sufficiently met. 
Variables were entered in sequence in six steps: 1) Patient age, Gender, 
Education, Job, Income; 2) Time since started HD, Time to reach HD; 3) Social 
and Economic, Family; 4) Itch, Fatigue; 5) Anxiety, Depression; 6) Perceived 
general heath.  
Table 20 displays the unstandardised regression coefficients (B), the standard 
errors (SE B), the standardised regression coefficients ( ), the t-statistic, the 
significance of t-statistic, the R, the F statistic (F), R2 and the change in R2 (R2). 
R was significantly different from 0 at the end of each step. After Step 6 with all 
the IVs in the equation, R2 = .398, F (14,368) = 17.414, p <. 001. The adjusted R2 
value of .376 indicates that more than a third of the variability in the SF36v2 PCS 
(2-factor standard model) scores is predicted by Treatment Characteristics, 
Family Support QOLI-D subscales, Symptom Specific Measures, Emotional 
Measures and Health Status measures. 
At Step1, with demographic variables in the equation, Finc (5,377) =2.480, p < .05 
and these accounted for 3.2% of variance in SF36v2 PCS scores (2-factor 
standard model) scores. None of the demographic variables were found to be 
significant predictors of SF36v2 PCS scores (2-factor standard model). 
Introducing the treatment characteristics variables in Step 2 explained an 
additional 3.3% of variance in the SF36v2 physical component summary (2-factor 
standard model) scores and this change in R2 was significant, Finc (2, 375) =6.581, 
p < .01. Among the two variables added in Step 2, only Time to reach HD was 
found to be a significant predictor of SF36v2 PCS (2-factor standard model) 
scores (p= .002).  Adding the Family and Socioeconomic subscales in Step 3 
explained an additional 9.2% of variance in SF36v2 PCS (2-factor standard 
model) scores and the change in R2   was significant, Finc (2,373) =20.248, p < 
.001. Among the two subscales added in step 3, only Family was found to be a 
significant predictor of SF36v2 PCS (2-factor standard model) scores (p < .001). 
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At the end of Step 4, with symptom specific measures in the equation, the 
regression model explained an additional 13.1 % of variance in SF36v2 PCS (2-
factor standard model) scores and this change in R2   was significant, Finc (2,371) 
=34.067, p < .001. Both the symptom specific measures were significant 
predictors of SF36v2 PCS (2-factor standard model); Fatigue (p< .001) and Itch 
(p< .001).  Again, at Step 5 when emotional measures were added, the new 
model now explained an additional 8.2% of variance in SF36v2 PCS (2-factor 
standard model) scores and this change in R2   was also significant, Finc (2, 369) 
=23.826, p < .001. Among the two emotional subscales, Depression was found 
to be a significant predictor of SF36v2 PCS (2-factor standard model) scores (p< 
.001). Finally, after addition of Perceived general health at Step 6, R2 =.398 
(adjusted R2 =.376), Finc (1, 368) =18.224, p< .001. When all the IVs were 
included in Step 6, Family was no longer a significant predictor of SF36v2 PCS 
(2-factor standard model) scores. In the final model the significant predictors of 
SF36v2 PCS (2-factor standard model) scores were Time to reach dialysis, Itch, 
Fatigue, Depression and Perceived general health. The most important 
predictors of SF36v2 PCS (2-factor standard model) scores were Depression and 
Perceived general health. Together all the IVS accounted for 39.8% of the 
variance in the SF36v2 PCS (2-factor standard model) scores 
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Table 8. 20 Sequential Multiple Regression Analysis predicting SF36v2 PCS (2-factor 
standard model) From Treatment Characteristics, Family Support, Symptom Specific Measures, 
Emotional Measures & Health Status Measures 
Variable  B SE B  t-
statist
ic 
Signifi
cance 
R F R2 R2 
 
Step1 
       Patient age  
       Gender 
       Education 
       Job 
       Income 
 
 
-.147 
-2.887 
.566 
-.820 
.025 
 
 
.076 
1.962 
.847 
2.145 
.955 
 
 
-.115 
-.082 
.045 
-.023 
.002 
 
 
-1.92 
-1.47 
.668 
-.382 
.026 
 
 
.056 
.142 
.505 
.702 
.979 
 
.178 
 
2.480* 
 
 
.032 
 
.032 
Step2 
        Time since 
started HD 
        Time to reach HD 
 
-.369 
-.152** 
 
.189 
.049 
 
-.098 
-.157 
 
-1.95 
-3.12 
 
.052 
.002 
.254 3.704** .065 .033 
Step3 
         Social and 
Economic 
         Family 
 
1.078*** 
-.089 
 
.210 
.207 
 
.326 
-.027 
 
5.134 
-.429 
 
.000 
.668 
.395 7.676*** .156 .092 
Step4 
       Itch 
       Fatigue 
        
 
-.765*** 
-.383*** 
 
.201 
.055 
 
-.172 
-.327 
 
-3.81 
-7.00 
 
.000 
.000 
.536 13.588*** .287 .131 
Step5 
       Anxiety 
       Depression 
 
-.319 
-1.397*** 
 
.230 
.248 
 
-.079 
-.297 
 
-1.39 
-5.63 
 
.166 
.000 
.607 16.578*** .369 .082 
Step6 
       Perceived Gen. 
Health 
        
Overall Final Model  
        Intercept 
        Pt age 
        Gender 
        Education status 
       Job 
       Income 
       Time since started 
HD 
       Time to reach HD 
       Social and        
Economic 
       Family 
       Itch 
       Fatigue 
       Anxiety  
       Depression 
       Perceived Gen. 
Health 
      
F-test for the whole 
model 
Significance of F-test 
R 
R2 
Adjusted R2 
 
3.037*** 
 
 
 
79.381*** 
-.119 
-1.998 
.077 
1.248 
-.582 
-.162 
 
-.122** 
.348 
 
-.270 
-.573** 
-.199*** 
-.272 
-1.125*** 
3.037*** 
 
 
   17.414 
 
< .001 
.631 
.398 
.376 
 
.711 
 
 
 
7.392 
.062 
1.594 
.682 
1.749 
.768 
.155 
 
.040 
.190 
 
.179 
.187 
.056 
.225 
.251 
.711 
 
 
 
 
 
.208 
 
 
 
 
-.093 
-.057 
.006 
.035 
-.038 
-.043 
 
-.127 
.105 
 
-.083 
-.129 
-.170 
-.067 
-.240 
.208 
 
4.269 
 
 
 
10.74 
-1.92 
-1.25 
.112 
.714 
-.757 
-1.05 
 
-3.05 
1.834 
 
-1.50 
-3.06 
-3.55 
-1.21 
-4.49 
4.269 
 
 
.000 
 
 
 
.000 
.055 
.211 
.911 
.476 
.449 
.296 
 
.002 
.067 
 
.133 
.002 
.000 
.228 
.000 
.000 
.631 17.414*** .398 .030 
Note:  N=383. CI, confidence interval; NS, not significant; HD, Haemodialysis. 
The  weights are the standardised regression coefficients at each step. *p < .05. **p< .01, *** p< .001 
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The higher scores of Perceived general health associated with better SF36v2 
PCS (2-factor standard model) whereas longer Time to reach dialysis, high 
symptoms of Itch, Fatigue and Depression are associated with lower SF36v2 
PCS (2-factor standard model). Higher Perceived general health is positively 
associated with SF36v2 PCS (2-factor standard model) scores, such that 
adjusting for other variables in the model, for each unit increase in the Perceived 
general health, the SF36v2 PCS (2-factor standard model) score is predicted to 
increase on average by 3.037 units, with 95% confidence limits from 1.638 to 
4.435, and this association is statistically significant (p < .001). High scores of 
depression are associated with lower SF36v2 PCS (2-factor standard model) 
scores, such that adjusting for other variables in the model, for each unit increase 
in Depression the SF36v2 PCS (2-factor standard model) score is predicted to 
decrease on average by 1.125 units, with 95% confidence limits from -1.619 to -
.632, and this association is statistically significant (p < .001). High scores of Itch 
(pruritus) are found to be negatively associated with SF36v2 PCS (2-factor 
standard model) scores, such that adjusting for other variables in the model, for 
each unit increase in the itch scores the SF36v2 PCS (2-factor standard model) 
score is predicted to decrease on average by 0.573 units, with 95% confidence 
limits from -.942 to -.205 and this association is statistically significant (p =.002). 
High score of Fatigue is also found to be associated with lower SF36v2 PCS (2-
factor standard model) scores, such that adjusting for other variables in the 
model, for each unit increase in the fatigue scores the SF36v2 PCS (2-factor 
standard model) score is predicted to decrease on average by 0.199 units, with 
95% confidence limits from -.309 to -.089 and this association is statistically 
significant (p <.001).  The longer Time a patient takes to reach HD centre is 
associated with lower SF36v2 PCS (2-factor standard model) scores, such that 
adjusting for other variables in the model, for each unit increase in the time to 
reach dialysis the SF36v2 PCS (2-factor standard model) score is predicted to 
decrease on average by 0.122 units, with 95% confidence limits from -.201 to -
.043 and this association is statistically significant (p =.002).  
In summary, it can be concluded that Time to reach Dialysis, Itch, Fatigue, 
Depression and Perceived general health are the significant predictors of SF36v2 
PCS (2-factor standard model) scores. Among these, Depression and Perceived 
general health are the strongest predictors of PCS (2-factor standard model), 
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whereas Time to reach dialysis, Itch and Fatigue contribute moderately to that 
prediction. In the final model, Family support subscales have no predictive value. 
The trustworthiness of the regression was evaluated by using the Bootstrap 
technique using the IBM SPSS Bootstrapping method. Table 21 shows the 
bootstrap parameter estimates of the overall final model; the unstandardised 
regression coefficients(B), the bootstrapped standard errors (SE B), the 
significance of the regression coefficients, the normal approximated 95% 
confidence intervals (OLS 95% CI) and the bootstrapped confidence interval 
(BCa 95% CI). From the table, it is observed that the parametric standard errors 
obtained earlier (see Table 20) are quite comparable to the bootstrapped 
standard errors. Also, the significance of the bootstrapped coefficients show that 
Time to reach Dialysis, Itch, Fatigue, Depression and Perceived general health 
are the significant predictors of SF36v2 PCS (2-factor standard model) score, 
which are the same as obtained earlier from non-bootstrapped estimates. 
However, it is noted that Patient age which was not a significant predictor in the 
non-bootstrapped model, is now a significant predictor of SF36v2 PCS (2-factor 
standard model) scores (p= .043), with BCa 95% confidence limits from -.234 to 
-.007.  
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Table 8. 21 Bootstrap Parameter Estimates of the Overall Final Model predicting SF36v2 
PCS (2-factor standard model) From Treatment Characteristics, Family Support, Symptom 
Specific Measures, Emotional Measures & Health Status Measures (N= 383) 
Variable B bias SE B Significanc
e 
OLS 95% CI BCa 95% CI 
 
Intercept 
 
79.381 
 
.510 
 
8.108 
 
.001 
 
[64.845, 93.92] 
 
[63.622, 97.760] 
Pt. age  -.119 -1.76 .058 .043 [-.240, .003] [-.234, -.007] 
Gender -1.998 .045 1.550 .199 [-5.132, 1.136] [-5.291, 1.112] 
Education .077 .026 .677 .900 [-1.265, 1.148] [-1.253, 1.556] 
Job 1.248 -.053 1.747 .489 [-2.191, 4.687] [-2.034, 4.556] 
Income  -.582 -.016 .739 .441 [-2.092, .929] [-1.928, .824] 
Time since 
started HD 
-.162 -.002 .162 .317 [-.467, .143] [-.466, .154] 
Time to reach 
HD 
-.122 6.88 .038 .004 [-.201, -.043] [-.192, -.050] 
 Social and 
Economic 
.348 -.007 .197 .086 [-.025, .721] [-.073, .727] 
Family -.270 -.010 .201 .177 [-.622, .083] [-.661, .096] 
Itch -.573 -.002 .209 .008 [-.942, -.205] [-.986, -.155] 
Fatigue -.199 -.002 .061 .003 [-.309, -.089] [-.317, -.084] 
Anxiety -.272 -.013 .252 .267 [-.714, .170] [-.784, .203] 
Depression -1.125 .014 .274 .001 [-1.619, -.632] [-1.711, -.541] 
Perceived Gen 
health 
3.037 .004 .765 .001 [1.638, 4.435] [1.493, 4.582] 
Note:  N=383. CI, confidence interval; NS, not significant; HD, Haemodialysis; SF36V2, Short-Form 36 
Health Survey; OLS, Ordinary Least Squares; BCa, Bias corrected accelerated. 
 
In conclusion, it can be said that more than a third of the variability in SF36v2 
physical component summary (2-factor standard model) scores is predicted by a 
number of measures. Higher general health perception associated with better 
physical health; whereas the longer time patients take to reach dialysis and higher 
symptoms of itch, fatigue, and depression associated with lower physical health. 
Among these, fatigue, depression and perceived general health are the strongest 
predictors of SF36v2 physical component summary (2-factor standard model) 
scores. Treatment measures and symptom specific measures contribute 
moderately to that prediction; whereas Family support subscales add no further 
prediction. 
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5.6.2. SF36v2 Mental Component Summary–MCS (2-factor standard 
model) 
A sequential multiple regression was conducted to determine if addition of 
information regarding treatment, then socio economic and family support, then 
symptoms, then emotional status and then health status improved prediction of 
the SF36v2 MCS (2-factor standard model), after controlling for the influence of 
demographics.  
Before examining the sequential regression analysis, inspections for 
assumptions and other potential problems that might affect interpreting the 
analysis were conducted. Primarily, the output was examined for any issues with 
multicollinearity. Table 22-23 displays the correlation among variables, their 
means and standard deviations. An examination of the correlations revealed that 
none of the independent variables were highly correlated. All correlations were 
less than .85 (Tabachnick & Fidell, 2014), hence the assumption of 
multicollinearity was deemed to have been met.  
Table 8. 22 Spearman's rho correlations SF-36v2 mental component summary (MCS) (2-
factor standard model) 
 
  SF36 
MCS (2-
factor 
standard) 
Region Gender marital 
status 
Educational 
status 
Job Income 
SF36 MCS 
(2-factor 
standard 
- -.04 -.12** -.05 .08$ -.07$ .11* 
Region  - .14** .06 -.21** .18** -.13** 
Gender   - .18** -.14** .39** -.12** 
marital 
status 
   - .19** .13** -.08 
Educational 
status 
    - -.21** .41** 
Job      - -.38** 
Income       - 
$ p ≤ .15; * p ≤ .05; ** p < .001 
 
 
 228 
In addition, the tolerance values were all greater than 0.10 and the variance 
inflation factors were all less than 10.0, revealing no concerns with 
multicollinearity (Mertler & Vannatta, 2002). Next, the data were checked for 
multivariate outliers. All standardised residual values fell between -3.0 and 3.0, 
indicating no issues with outliers (Tabachnick & Fidell,2001). Using the criterion 
p < .001 for Mahalanobis distance, no multivariate outliers among the cases were 
identified. The distribution of residuals were found to be nearly normal and 
centred at 0. Residual and scatter plots indicated the conditions of normality, 
linearity and homoscedasticity were all satisfied. Thus, all assumptions were 
sufficiently met. 
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Table 8. 23 Pearson’s correlations SF-36v2 MCS (2-factor standard model) standardised   
 
SF36 
MCS (2-
factor 
standard 
Pt 
age 
Hb HCT Albumin Dialysis 
adequacy 
dialysis 
hours 
per 
month 
Time 
since 
started 
HD 
Time to 
reach 
HD in 
minutes 
Anxiety Depression  Spiritual 
Wellbeing 
Social & 
Economic 
Family Itch Fatigue Bodily 
pain 
Perceived 
general 
health 
Phys
ical 
funct
ionin
g 
SF36 
MCS (2-
factor 
standard 
- -.05 .04 .05 -.03 .09$ .02 -.11* -.09* -.52** -.54** -.01 .35** .26** -.26** -.42** .66** .32** 
.343*
* 
Pt age   - -.01 .01 -.03 -.10* -.09* .04 -.07 .03 .11* -.06 -.07 -.02 .02 .04 -.13** -.12** -.12** 
Hb     - .63** .19** .11* .05 .04 -.08 -.06 -.10* .02 .07 .05 .03 -.02 .06 .07 .02 
HCT       - .14** .03 .04 .01 -.10* .02 -.01 -.03 -.09 -.06 .02 .03 .07 .07 .04 
Albumin          - .14** -.05 .01 .08 -.10* -.08 -.13** .08 .23** .05 -.05 -.06 .00 -.04 
Dialysis 
adequacy 
          - .10* -.01 .03 -.14** -.16** .00 .19** .32** -.08 -.06 .08 .12* .00 
dialysis 
hours per 
month 
            - -.08 -.14** .01 -.00 -.05 .02 -.03 -.06 -.08 .04 .08 .05 
Time since 
started HD 
              - -.02 .10* .11* .13** -.12** -.10* .05 .06 -.11* -.03 -.02 
Time to 
reach to 
Dialysis in 
minutes 
                - .08 .01 .04 .02 .06 .03 .05 -.06 -.02 -.16** 
Anxiety                   - .58** -.01 -.45** -.40** .20** .46** -.44** -.35** -.12* 
Depression                     - -.06 -.37** -.34** .18** .41** -.44** -.43** -.16** 
Spiritual 
Wellbeing 
                      - -.01 .01 .06 -.03 .01 .02 -.05 
Social & 
Economic 
                        - .64** -.16** -.29** .30** .32** .10* 
Family                           - -.07 -.24** .16** .22** .04 
Itch                             - .12** -.23** -.11* -.18** 
Fatigue                               - -.40** -.39** -.17** 
Bodily pain                                 -  .41** .28** 
Perceived 
general 
health 
                                 - .15** 
Physical 
functioning 
                                    - 
p ≤ .15$; p ≤ .05*; p < .001** 
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Variables were entered in sequence in six steps: 1) Gender, Education, Job, 
Income; 2) Time since started HD, Time to reach HD, HD adequacy; 3) Social 
and Economic, Family; 4) Itch, Fatigue, Bodily pain; 5) Anxiety, Depression; 6) 
Perceived general heath, Physical functioning.  
Table 24 displays the unstandardised regression coefficients (B), the standard 
errors (SE B), the standardised regression coefficients ( ), the t-statistic, the 
significance of t-statistic, the R, the F statistic (F), R2 and the change in R2 (R2). 
R was significantly different from 0 at the end of each step. After Step 6 with all 
the IVs in the equation, R2 = .602, F (2,364) = 12.260, p <. 001. The adjusted R2 
value of .585 indicates that more than half of the variability in the SF36v2 MCS 
(2-factor standard model) scores is predicted by Treatment Characteristics, 
Family support QOLI-D subscales, Symptom Specific Measures, Emotional 
Measures and health status measures. 
At Step1, with demographic variables in the equation, Finc (4,376) =1.456, p < .05 
and these accounted for 1.5% of variance in SF36v2 MCS scores (2-factor 
standard model) scores. None of the demographic variables were found to be 
significant predictors. Introducing the treatment characteristics variables in Step 
2 explained an additional 3.2% of variance in the SF36v2 MCS (2-factor standard 
model) scores and this change in R2 was significant, Finc (3, 373) =4.459, p < .01. 
Among the three variables added in Step 2, the variables Time since started HD 
(p= .019) and HD adequacy (p= .021) were found to be significant predictors of 
SF36v2 MCS (2-factor standard model) scores.  Adding the social and economic, 
and family subscales in Step 3 explained an additional 12.3% of variance in 
SF36v2 MCS (2-factor standard model) scores and the change in R2   was 
significant, Finc (2,371) =27.624, p < .001. Among the two variables, only social 
and economic scores were found to be a significant predictor (p < .001). At the 
end of Step4, with symptom specific measures in the equation, the regression 
model explained an additional 35.5 % of variance in SF36v2 MCS (2-factor 
standard model) scores and this change in R2   was significant, Finc (3,368) 
=92.259, p < .001. All three symptoms measures were significant predictors of 
SF36v2 MCS (2-factor standard model); Itch (p< .024), Fatigue (p< .001) and 
Bodily Pain (p< .001). When emotional measures were added in step 5, the model 
explained an additional 4.8% of variance in SF36v2 MCS (2-factor standard 
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model) scores and this change in R2   was also significant, Finc (2, 366) =20.659, 
p < .001. The two emotional subscales were found to be a significant predictor of 
SF36v2 MCS (2-factor standard model) scores, Anxiety (p< .041) and Depression 
(p< .001). Finally, after the addition of Perceived general health and Physical 
functioning scores at step 6, R2 =.602 (adjusted R2 =.585), Finc (2, 364) =12.260, 
p< .001. In the final model, the significant predictors of SF36v2 MCS (2-factor 
standard model) scores were Education status, Bodily pain, Anxiety, Depression 
and Physical functioning. The most important predictors in this model were Bodily 
pain, Depression, and Physical functioning. Together all the IVS accounted for 
60.2% of the variance in the SF36v2 MCS (2-factor standard model) scores. 
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Table 8. 24 Sequential Multiple Regression Analysis predicting SF36v2 MCS (two-factor 
standard model) From Treatment Characteristics, Family Support, Symptom Specific Measures, 
Emotional Measures & Health Status Measures (N= 383) 
Variable B SE B  
t-
statisti
c 
Signifi
cance 
R F R2 R2 
Step1 
       Gender 
       Education 
       Job 
       Income 
 
-3.350 
.028 
.713 
1.303 
 
2.072 
.760 
2.268 
.981 
 
-.091 
.002 
.019 
0.82 
 
-1.62 
0.36 
.314 
1.33 
 
.107 
.971 
.753 
.185 
.124 1.456* .015 .015* 
Step2 
        Time since started 
HD 
        Time to reach HD 
        HD Adequacy  
 
-.476** 
 
-.084 
.186* 
 
.201 
 
.051 
.080 
 
-.120 
 
-.084 
.119 
 
-2.365 
 
-1.652 
2.323 
 
.019 
 
.099 
.021 
.222 4.459** .049 .032** 
Step3 
        Social and Economic 
        Family 
 
1.147*** 
.183 
 
.217 
.216 
 
.331 
.055 
 
5.288 
.848 
 
.000 
.397 
.415 27.624*** .173 .123*** 
Step4 
       Itch 
       Fatigue 
       Bodily pain 
 
-.395* 
-.160** 
.379*** 
 
.174 
.049 
.028 
 
-.086 
-.132 
.557 
 
-2.268 
-3.254 
13.406 
 
.024 
.001 
.000 
.726 92.259 .528 .355 
Step5 
       Anxiety 
       Depression 
 
-.414* 
-1.081*** 
 
.202 
.220 
 
-.099 
-.221 
 
-2.053 
-4.913 
 
.041 
.000 
.759 20.659 .576 .048 
Step6 
       Perceived Gen. 
Health 
       Physical functioning 
 
Overall Final Model  
        Intercept 
        Gender 
        Education status 
       Job 
       Income 
       Time since started 
HD 
       Time to reach HD 
       HD adequacy 
       Social and Economic 
       Family 
       Itch 
       Fatigue 
       Bodily pain        
       Anxiety  
       Depression 
       Perceived Gen. 
Health 
       Physical functioning 
 
F-test for the whole model 
Significance of F-test 
R 
R2 
Adjusted R2 
 
-.917 
 
.115 
 
 
46.598*** 
-.216 
-1.660** 
1.402 
1.212 
-.099 
 
-.017 
.014 
.218 
.142 
-.201 
-.080 
.303*** 
-.465** 
-1.094*** 
-.917 
 
.115*** 
 
12.260 
< .001 
.776 
.602 
.582 
 
.623 
 
.024 
 
 
7.061 
1.369 
.504 
1.501 
.646 
.133 
 
.034 
.056 
.162 
.156 
.162 
.049 
.029 
.196 
.219 
.623 
 
.024 
 
 
 
 
-.060 
 
.167 
 
 
 
-.006 
-.126 
.037 
.076 
-.025 
 
-.017 
.009 
.063 
.042 
-.046 
-.066 
.445 
-.111 
-.224 
-.060 
 
.167 
 
-1.471 
 
4.732 
 
 
6.600 
-1.58 
-3.294 
.934 
-1.05 
-.740 
 
-.501 
.259 
1.347 
.913 
-1.296 
-1.648 
10.577 
-2.372 
-4.994 
-1.471 
 
4.732 
 
 
.142 
 
.000 
 
 
.000 
.874 
.001 
.351 
.062 
.460 
 
.617 
.796 
.179 
.362 
.196 
.100 
.000 
.018 
.000 
.142 
 
.000 
.776 12.260 .602 .027 
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Note:  N=383. CI, confidence interval; NS, not significant; Hb, Haemoglobin.  
The  weights are the standardised regression coefficients at each step. *p < .05. **p< .01, *** p< .001 
In the final model, the factors that significantly predict SF36v2 MCS (2-factor 
standard model) scores are Education status, Bodily pain, Anxiety, Depression, 
and Physical functioning. Among these less Bodily pain and better Physical 
functioning are associated with better mental health whereas high Education 
status, Anxiety, and Depression are associated with poorer mental health. Less 
Bodily pain is associated with higher SF36v2 MCS (2-factor standard model) 
scores. Higher Physical functioning is associated with better SF36v2 MCS (2-
factor standard model) scores, such that adjusting for other variables in the 
model, for each unit increase in the Physical functioning scores, the SF36v2 MCS 
(2-factor standard model) score is predicted to increase on average by 0.115 
units, with 95% confidence limits from .067 to .163, and this association is 
statistically significant (p < .001). Higher Education status (low-intermediate and 
above) associated with lower SF36v2 MCS (2-factor standard model) score, such 
that adjusting for other variables in the model, for each unit increase in the 
Education status score is predicted to decrease on average by 1.660 units, with 
95% confidence limits from -2.651 to -.669, and this association is statistically 
significant (p < .001). Higher Anxiety is found to be associated with lower SF36v2 
MCS (2-factor standard model) scores, such that adjusting for other variables in 
the model, for each unit increase in the Anxiety scores the SF36v2 MCS (2-factor 
standard model) score is predicted to decrease on average by 0.465 units, with 
95% confidence limits from -.850 to -.079 and this association is statistically 
significant (p =.022). Similarly, high Depression is found to be associated with 
lesser SF36v2 MCS (2-factor standard model) scores, such that adjusting for 
other variables in the model, for each unit increase in the Depression scores the 
SF36v2 MCS (2-factor standard model) score is predicted to decrease on 
average by 1.094 units, with 95% confidence limits from -1.524 to -.663 and this 
association is statistically significant (p <.001).   
The trustworthiness regression model was evaluated using the Bootstrap 
technique using the IBM SPSS version 22 Bootstrapping method. Table 8.25 
shows the bootstrap parameter estimates of the overall final model; the 
unstandardised regression coefficients(B), the bootstrapped standard errors (SE 
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B), the significance of the regression coefficients, the normal approximated 95% 
confidence intervals (OLS 95% CI) and the bootstrapped confidence interval 
(BCa 95% CI). From the table, it can be observed that the parametric standard 
errors obtained earlier (see Table 18.b) are quite similar to the bootstrapped 
standard errors. Also, the significance of the bootstrapped coefficients shows that 
Education status, Bodily pain, Anxiety, Depression, and Physical functioning are 
the significant predictors of SF36v2 MCS (2-factor standard model) score, which 
are the same as obtained earlier from non-bootstrapped estimates. This similarity 
might indicate having a valid sequential multiple regression model. 
Table 8. 25 Bootstrap Parameter Estimates of the Overall Final Model predicting MCS (2-
factor standard model) From Treatment Characteristics, Family Support, Symptom Specific 
Measures, Emotional Measures & Health Status Measures (N= 383) 
Variable B bias SE B Significanc
e 
OLS 95% CI BCa 95% CI 
Intercept 46.598 .039 7.432 .001 [32.713,60.483] [32.399,61.762] 
Gender -.216 .068 1.324 .859 [-2.909,2.476] [-2.852,2.532] 
Education status -1.660 .013 .486 .001 [-2.651, -669] [-2.632, -.629] 
Job 1.402 -.051 1.526 .352 [-1.550,4.353] [-1.471,4.279] 
Income 1.212 .017 .650 .066 [-.059,2.482] [-.053,2.584] 
Time since 
started HD 
-.099 -.003 .143 .486 [-.361,.164] [-.369,.178] 
Time to reach HD -.017 .000 .032 .598 [-.084,.050] [-.082,.047] 
HD adequacy .014 .000 .049 .758 [-.095,.124] [-.078,.108] 
Social and 
Economic 
.218 .006 .157 .169 [-.101,.537] [-.096,.577] 
Family .142 -.006 .157 .369 [-.164,.449] [-.142,.428] 
Itch -.210 .001 .178 .243 [-.530,.109] [-.558,.126] 
Fatigue -.080 -.001 .052 .124 [-.175,.015] [-.190,.024] 
Bodily pain        .303 -.363 .031 .001 [.246,.359] [.245,.361] 
Anxiety  -.465 .002 .195 .022 [-.850, -.079] [-.813, -.081] 
Depression -1.094 .001 .231 .001 [-1.524, -.663] [-.813, -.081] 
Perceived Gen. 
Health 
-.917 -.016 .678 .193 [-2.143,.309] [-2.181,.275] 
Physical 
functioning 
.115 -.001 .023 .001 [.067,.163] [.070,.158] 
Note:  N=383. CI, confidence interval; NS, not significant; Hb, Haemoglobin; OLS, Ordinary Least Squares; 
BCa, Bias corrected accelerated. 
 
In summary, it can be concluded that less Bodily pain and higher Physical 
functioning are associated with better mental health; whereas high Education 
status, high symptoms of Anxiety, and Depression are associated with lower 
mental health in ESRD patients. Among these, low Bodily pain, Depression and 
Physical functioning are the strongest predictors of SF36v2 mental component 
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summary (2-factor standard model) scores, whereas Education status, and 
Anxiety contribute moderately to that prediction.  
5.6.3. QOLI-Dialysis 
Sequential multiple regression was employed to determine if the addition of 
information regarding treatment, then biological function, then symptoms, then 
emotional status and then health status improved prediction of the QOLI-D, after 
controlling for the influence of demographics.  
The dependent variable ‘QOLI-D scores’ was negatively skewed. In an attempt 
to stabilise the variance and achieve normality, this variable was, gradually, 
transformed using the methods of square root, logarithm, and inverse 
transformation. These transformations, however, did not significantly mend the 
skewness; thus, it was decided to use the variable untransformed (Table 8.4 
shows the effect of data transformation on skewness result of transformation of 
the three methods used).  The distribution of residuals was found to be nearly 
normal and centred at 0. Furthermore, residual and scatter plots indicated the 
conditions of normality, linearity and homoscedasticity were all satisfied. Table 
26-27 displays the correlation among variables, their means and standard 
deviations. An examination of the correlations revealed that none of the 
independent variables was highly correlated, hence the assumption of 
multicollinearity was deemed to have been met. Using the criterion p < .001 for 
Mahalanobis distance, no multivariate outliers among the cases were identified.  
Table 8. 26 Spearman's rho correlations of quality of life index-dialysis (QOLI-D) 
 QOLI-D Region Gender 
marital 
status 
Educational 
status 
Job Income 
QOLI-D - -.12** -.07$ -.02 .11* -.16** .11* 
Region  - .14** .06 -.21** .18** -.13** 
Gender   - .18** -.14** .39** -.12** 
marital 
status 
   - .19** .13** -.08 
Educational 
status 
    - -.20** .41** 
Job      - -.38** 
Income       - 
$ p ≤ .15; * p ≤ .05; ** p < .001 
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Table 8. 27 Pearson’s correlations QOLI-Dialysis 
  QOLI-
D 
Pt 
age 
Hb HCT Albumin  Dialysis 
adequacy 
dialysis 
hours 
per 
month 
Time 
since 
started 
HD 
Time to 
reach 
to 
Dialysis  
Anxiety  Depression  Spiritual 
Wellbeing 
Itch  Fatigue Bodily 
pain 
Perceived 
general 
health 
Physical 
functioning 
QOLI-D - -.06 .06 -.03 .13** .24** .08 -.14** .01 -.58** -.55** -.01 -.21** -.39** .42** .43** .17** 
Pt age   - -.01 .00 -.03 -.10* -.09* .04 -.07 .03 .11* -.06 .02 .04 -.13** -.12** -.13** 
Hb     - .63** .19** .11* .05 .04 -.08 -.06 -.10* .02 .03 -.02 .06 .07 .00 
HCT       - .14** .03 .04 .01 -.10* .00 -.01 -.03 .02 .03 .07 .07 .04 
Albumin         - .14** -.05 .01 .08 -.10* -.08 -.13** .05 -.05 -.06 .00 -.04 
Dialysis 
adequacy 
          - .10* -.01 .03 -.14** -.16** .00 -.08 -.06 .08 .12* .04 
dialysis 
hours per 
month 
            - -.08 -.14** .01 -.00 -.05 -.06 -.00 .04 .08 .05 
Time since 
started HD 
              - -.02 .10* .11* .13** .05 .06 -.11* -.03 -.02 
Time to 
reach to 
Dialysis  
                - .08 .01 .04 .03 .05 -.06 -.02 -.16** 
Anxiety                    - .58** -.01 .20** .46** -.44** -.35** -.12* 
Depression                      - -.06 .18** .41** -.44** -.43** -.16** 
Spiritual 
Wellbeing 
                      - .06 -.03 .01 .02 -.05 
Itch Scale                         - .12** -.23** -.11* -.18** 
Fatigue                           - -.40** -.39** -.17** 
Bodily pain                             -  .41** .28** 
Perceived 
general 
health 
                             - .15** 
Physical 
functioning 
                                - 
$ p ≤ .15; * p ≤ .05; ** p < .001 
Hb: Hemoglobulin; HD: Haemodialysis; QoLID: Quality of life index-dialysis; HCT: Haematocrit  
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The steps used to enter the variables into model were: 1) Gender, Education, 
Job, Income, Region; 2) Time since started HD, Dialysis adequacy; 3) Albumin 
level; 4) Itch, Fatigue, Bodily pain; 5) Anxiety, Depression; 6) Perceived general 
health and Physical functioning.  
Table 28 displays the unstandardised regression coefficients (B), the standard 
errors (SE B), the standardised regression coefficients ( ), the t-statistic, the 
significance of t-statistic, the R, the F statistic(F), R2 and the change in R2 (R2). 
R was significantly different from 0 at the end of each step. After Step 6 with all 
the IVs in the equation, R2 = .505, F (15,367) = 24.980, p <.001. The adjusted R2 
value of .485 indicates that nearly half of the variability in the QOLI-D scores is 
predicted by a number of Treatment Characteristics, Clinical Data, Symptom 
Specific Measures, Emotional Measures and Health Status measures. 
At Step1, with demographic variables in the equation, Finc (5,377) =6.186, p < 
0.001 and these accounted for 7.6% of variance in QOLI-D scores. Among the 
five demographic variables only Region was found to be a significant predictor of 
QOLI-D scores (p<.001). Introducing the treatment characteristics variables in 
Step 2 explained an additional 5% of variance in QOLI-D scores and this change 
in R2 was significant, Finc (2, 375) =10.678, p < .001. Among the two variables 
added in Step 2, only Dialysis Adequacy was found to be a significant predictor 
of QOLI-D scores (p< .001).  Adding the Clinical Data variable in Step 3 explained 
an additional 1.2% of variance in QOLI-D scores and the change in R2 was 
significant, Finc (1,374) =2.169, p < .05. At the end of Step 4, with symptom-
specific measures in the equation, the regression model now explained an 
additional 20.3 % of variance in QOLI-D scores and this change in R2 was 
significant, Finc (3,371) =38.014, p < .001. Among the three symptom specific 
measures, the significant predictors of QOLI-D scores were Fatigue (p< .001) and 
Pain (p< .001).  Again, at Step 5 when emotional measures were added, the new 
model now explained an additional 15.7% of variance in QOLI-D scores and this 
change in R2 was also significant, Finc (2, 369) =57.492, p < .001. Both emotional 
subscales were found to be significant predictors of QOLI-D scores, viz., Anxiety 
(p< .001) and Depression (p< .001). Finally, after addition of health status 
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measures at Step 6, R2 =.505 (adjusted R2 =.485), Finc (2, 367) =2.931. Addition 
of health status measures did not significantly increase R2. Of the two health 
status measures, Perceived General Health was found to be a significant 
predictor of QOLI-D scores (p< 0.01). When all the IVs were included in Step 6, 
neither Fatigue nor Bodily pain were found to be significant predictors of QOLI-D 
scores. The most important predictors of QOLI-D scores were found to be Anxiety 
and Depression. Together all the IVS accounted for 50.5% of the variance in the 
QOLI-D scores. 
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Table 8. 28 Sequential Multiple Regression Analysis predicting quality of Life Index-Dialysis 
(QOLI-D) From Treatment Characteristics, Clinical Data, Symptom Specific Measures, 
Emotional Measures & Health Status Measures (N= 383) 
Variable  B SE B  t-
statistic 
Signific
ance 
R F R2 R2 
 
Step1 
       Gender 
       Education 
       Job 
       Income 
       Region 
 
 
.369 
.129 
-.390 
.316 
-.422*** 
 
 
.540 
.199 
.612 
.253 
.102 
 
 
.037 
.037 
-.039 
.074 
-.224 
 
 
.683 
.647 
-.638 
1.251 
-4.134 
 
 
.495 
.518 
.524 
.212 
.000 
 
.275 
 
6.186*** 
 
.076 
 
.076*** 
 
Step2 
        Time since started HD 
        Dialysis Adequacy 
 
-.100 
.090*** 
 
.053 
.021 
 
-.095 
.214 
 
-1.896 
4.295 
 
.059 
.000 
.354 7.696*** .126 .050*** 
Step3 
        Albumin Level 
 
.112* 
 
.048 
 
.113 
 
2.314 
 
.021 
.371 7.482*** .138 .012* 
Step4 
       Itch 
       Fatigue 
       Bodily Pain 
 
-.107 
-.081*** 
.049*** 
 
.055 
.015 
.009 
 
-.087 
-.249 
.271 
 
-1.953 
-5.333 
5.593 
 
.052 
.000 
.000 
.584 17.424*** .341 .203*** 
Step5 
       Anxiety 
       Depression 
 
-.322*** 
-.367*** 
 
.056 
.063 
 
-.289 
-.281 
 
-5.771 
-5.798 
 
.000 
.000 
.705 28.078*** .497 .157*** 
Step6 
       Perceived Gen. Health 
       Physical Functioning 
 
Overall Final Model  
        Intercept 
        Gender 
        Education status 
       Job 
       Income 
       Region 
       Time since started HD 
       Dialysis Adequacy 
       Albumin Level 
       Itch 
       Fatigue 
       Bodily Pain  
       Anxiety  
       Depression 
       Perceived Gen. Health 
       Physical Functioning 
F-test for the whole model 
Significance of F-test 
R 
R2 
Adjusted R2 
 
.435* 
.003 
 
 
19.816*** 
.758 
-.096 
-.091 
.287 
-.230** 
-.046 
.045** 
.088* 
-.053 
-.022 
.012 
-.317*** 
-.331*** 
.435* 
.003 
24.980 
< .001 
.711 
.505 
.485 
 
.183 
.007 
 
 
2.355 
.408 
.151 
.463 
.191 
.080 
.041 
.016 
.038 
.048 
.014 
.009 
.056 
.065 
.183 
.007 
 
.106 
.017 
 
 
 
.077 
-.027 
-.009 
.067 
-.122 
-.044 
.107 
.089 
-.043 
-.069 
.065 
-.284 
-.254 
.106 
.017 
 
2.377 
.436 
 
 
8.415 
1.858 
-.635 
-.197 
1.500 
-2.870 
-1.139 
2.765 
2.349 
-1.094 
-1.549 
1.379 
-5.700 
-5.129 
2.377 
.436 
 
.018 
.663 
 
 
.000 
.064 
.526 
.844 
.135 
.004 
.255 
.006 
.019 
.274 
.122 
.169 
.000 
.000 
.018 
.663 
 
.711 24.980*** .505 .008 
Note:  N=383. CI, confidence interval; NS, not significant; Hb, Haemoglobin. 
The  weights are the standardised regression coefficients at each step.  
*p < .05. **p< .01, *** p< .001 
 
 
In the final model, the factors that significantly predict QOLI-D scores are Region, 
Dialysis adequacy, Albumin level, Anxiety, Depression and Perceived general 
health. Among these, high Dialysis adequacy, high Albumin Level and better 
240 
 
Perceived general health are associated with high QOLI-D scores whereas 
Region (living outwith the capital), high Anxiety and Depression are associated 
with lower QOLI-D scores. Living outwith the capital (Muscat) is associated with 
lower QOLI-D scores (p= .004). The model predicts that when all else held 
constant, living outside Muscat is associated on average with a decrease of 0.23 
units in QOLI-D scores. Better Dialysis adequacy is associated with higher QOLI-
D scores, such that adjusting for other variables in the model, for each unit 
increase in the Dialysis adequacy scores, the QOLI-D score is predicted to 
increase on average by 0.045 units, with 95% confidence limits from .013 to .077, 
and this association is statistically significant (p = 0.006). Likewise, higher 
Albumin level is associated with better QOLI-D such that adjusting for other 
variables in the model, for each unit increase in the Albumin level, the QOLI-D 
scores is predicted to increase on average by 0.088 units, with 95% confidence 
limits from 0.014 to 0.162, and this association is statistically significant (p =.019). 
Looking at the adjusted regression coefficients (), we see that Anxiety & 
Depression are the strongest predictors of QOLI-D scores. High level of Anxiety 
is associated with lower QOLI-D scores, such that adjusting for other variables in 
the model, for each unit increase in the Anxiety the QOLI-D score is predicted to 
decrease on average by 0.317 units, with 95% confidence limits from -.426 to -
.207, and this association is statistically significant (p < .001). Similarly, higher 
level of Depression is found to be associated with low QOLI-D scores, such that 
adjusting for other variables in the model, for each unit increase in the depression 
scores the QOLI-D score is predicted to decrease on average by 0.331 units, with 
95% confidence limits from -.459 to -.204 and this association is statistically 
significant (p < .001). Finally, better Perception of general health is associated 
with better QOLI-D such that adjusting for other variables in the model, for each 
unit increase in the Perceived General Health scores, the QOLI-D score is 
predicted to increase on average by 0.435 units, with 95% confidence limits from 
0.075 to 0.795, and this association is statistically significant (p =.018). In 
summary we conclude that living outwith the capital, better Dialysis adequacy, 
high Albumin level, high level of Anxiety and Depression, and better perception 
of general health are the significant predictors of QOLI-D scores. Among these, 
the emotional measures, Anxiety & Depression are the strongest predictors of 
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QOLI-D scores, whereas Region, Dialysis adequacy, Albumin level and 
Perceived general health contribute moderately to that prediction. In the final 
model, symptom-specific measures such as Pruritus, Fatigue and Pain have no 
predictive value. 
The trustworthiness of this regression model was evaluated using the Bootstrap 
technique using the IBM SPSS Bootstrapping method. Table 29 shows the 
bootstrap parameter estimates of the overall final model; the unstandardised 
regression coefficients(B), the bootstrapped standard errors (SE B), the 
significance of the regression coefficients, the normal approximated 95% 
confidence intervals (OLS 95% CI) and the bootstrapped confidence interval 
(BCa 95% CI). From the table, it be seen that the parametric standard errors 
obtained earlier (see Table 19.c) are quite comparable to the bootstrapped 
standard errors. Also, the significance of the bootstrapped coefficients show that 
Region, Dialysis adequacy, Albumin level, Anxiety, Depression and Perceived 
general health are all significant predictors of QOLI-D scores, which are the same 
as obtained earlier from non-bootstrapped estimates. However, the BCa 95% 
confidence interval for Albumin level, [-.001, .171] suggests that the clinical 
variable, Albumin level, just misses statistical significance. Perhaps a further 
investigation is required before concluding this variable as a reliable predictor of 
QOLI-D scores. 
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Table 8. 29 Bootstrap Parameter Estimates of the Final Model predicting quality of Life 
Index-Dialysis (QOLI-D) From Treatment Characteristics, Clinical Data, Symptom Specific 
Measures, Emotional Measures & Health Status Measures (N= 383) 
Variable B Bias  SE B Significance OLS 95% CI BCa 95% CI 
 
Intercept 
 
19.816 
 
-.035 
 
2.504 
 
.001 
 
[15.185, 24.446] 
 
[14.804, 24.619] 
Gender .758 .002 .403 .069 [-.044, 1.561] [-.101, 1.555] 
Education -.096 .006 .145 .507 [-.392, .201] [-.391, .223] 
Job -.091 -.017 .488 .850 [-1.002, .819] [-1.027, .808] 
Income  .287 -.001 .193 .144 [-.089, .663] [-.088, .672] 
Region -.230 -.002 .077 .002 [-.388, -.073] [-.382, -.084] 
Time since 
started HD 
-.046 .001 .040 .254 [-.126, .034] [-.123, .033] 
Dialysis 
adequacy 
.045 .001 .017 .013 [.013, .077] [.011, .080] 
Albumin 
level 
.088 -.001 .041 .034 [.014, .162] [-.001,.171] 
Itch -.053 .004 .051 .315 [-.148, .042] [-.154, .061] 
Fatigue -.022 .000 .015 .142 [-.051, .006] [-.049, .008] 
Bodily pain .012 .001 .008 .180 [-.005, .028] [-.006, .031] 
Anxiety -.317 .001 .067 .001 [-.426, -.207] [-.449, -.178] 
Depression -.331 -.003 .065 .001 [-.459, -.204] [-.456, .215] 
Perceived 
general 
health 
.435 -.006 .185 .025 [.075, .795] [.084, .783] 
Physical 
functioning 
 
.003 .000 .007 .658 [-.011, .017] [-.011, .016] 
Note:  N=383. CI, confidence interval; NS, not significant; Hb, Haemoglobin; SF36V2, Short-Form 
36 Health Survey; OLS, Ordinary Least Squares; BCa, Bias corrected accelerated. 
 
In conclusion, nearly half of the variability in QOLI-D scores is predicted by a 
number of measures such as demographics, treatment measures, clinical, 
symptom-specific, and emotional measures. Over a third of variability in QOLI-D 
scores is explained by symptom- specific measures and emotional measures. 
Demographics & Treatment measures contribute moderately to that prediction 
and Clinical measures contribute least; health status measures add no further 
prediction.
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5.6.4. SF36v2 PCS (Emerged Three-factor model) 
A sequential multiple regression was performed to determine if addition of 
information regarding treatment characteristics, then socio-economic and family 
support, then symptoms, then emotional status and then health status improved 
prediction of the SF36v2 PCS (3-factor model), after controlling for the influence 
of demographics.  
Prior to examining the sequential regression analysis, inspections for 
assumptions and other potential issues that might affect interpreting the analysis 
were conducted. Initially, the output was examined for any issues with 
multicollinearity. Tables 30-31 display the correlation among variables, their 
means and standard deviations. An inspection of the correlations revealed that 
all the independent variables correlated less than .85 (Tabachnick & Fidell, 2014), 
hence the assumption of multicollinearity was thought to have been met. All of 
the tolerance values were also greater than 0.10 and the variance inflation factors 
were all less than 10.0, revealing no concerns with multicollinearity (Mertler & 
Vannatta, 2002). The data were also checked for multivariate outliers. All 
standardised residual values fell between -3.0 and 3.0, indicating no issues with 
outliers (Tabachnick & Fidell,2001). Using the criterion p < .001 for Mahalanobis 
distance, no multivariate outliers among the cases were identified.  
Table 8. 30 Spearman's rho correlations SF-36v2 physical component summary (PCS) (3-
factor model) 
  SF36v2 
PCS (3-
factor) 
Region Gender marital 
status 
Educational 
status 
Job Income 
SF36v2 
PCS (3-
factor) 
- .03 -.12** .09$ .20** -.10* .11* 
Region   - .14** .06 -.21** .18** -.13** 
Gender     - .18** -.14** .39** -.12** 
marital 
status 
      - .19** .13** -.08 
Educational 
status 
        - -.21** .41** 
Job           - -.38** 
Income             - 
$ p ≤ .15; * p ≤ .05; ** p < .001 
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Normality was examined and the distribution of residuals was found to be nearly 
normal and centred at 0. Residual and scatter plots indicated the conditions of 
normality, linearity and homoscedasticity were all satisfied. All the assumptions, 
therefore, were sufficiently met. 
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Table 8. 31 Pearson’s correlations SF-36v2 PCS (3-factor three-factor model) 
Variables SF36v2 
PCS 
(3-
factor) 
Pt 
age 
Hb HCT Albumin  Dialysis 
adequacy 
dialysis 
hours 
per 
month 
Time 
since 
started 
HD 
Time to 
reach to 
Dialysis 
in 
minutes 
Anxiety  Depression  Spiritual 
Wellbeing 
Social & 
Economic 
Family Itch  Fatigue Perceived 
general 
health 
SF36v2 
PCS (3-
factor) 
- -.18** .04 .05 -.06 .07$ .05 -.09* -.14
** -.42** -.45** -.01 .29** .17** -.24** -.43** .49** 
Pt age 
 
- -.01 .00 -.03 -.10* -.09* .04 -.07 .03 .11* -.06 -.00 -.02 .02 .04 -.12** 
Hb     - .63** .19** .11* .05 .04 -.08 -.06 -.10* .02 .00 .05 .03 -.02 .07 
HCT       - .14** .03 .04 .01 -.10* .00 -.01 -.03 -.09 -.06 .02 .03 .07 
Albumin          - .14** -.05 .01 .08 -.10* -.08 -.13** .08 .23** .05 -.05 .00 
Dialysis 
adequacy 
          - .10* -.01 .03 -.14** -.16** .00 .19** .32** -.08 -.06 .12* 
dialysis 
hours per 
month 
            - -.08 -.14** .01 -.00 -.05 .00 -.03 -.06 -.00 .08 
Time since 
started HD 
              - -.02 .10* .11* .13** -.12** -.10* .05 .06 -.03 
Time to 
reach to 
Dialysis in 
minutes 
                - .08 .01 .04 .02 .06 .03 .05 -.02 
Anxiety                    - .58** -.01 -.45** -.40** .20** .46** -.35** 
Depression                      - -.06 -.37** -.34** .18** .41** -.43** 
Spiritual 
Wellbeing 
                      - -.01 .01 .06 -.03 .02 
Social & 
Economic 
                        - .64** -.16** -.29** .32** 
QOLID 
Family 
                          - -.07 -.24** .22** 
Itch Scale                             - .12** -.11* 
Fatigue                               - -.39** 
Perceived 
general 
health 
                                - 
$ p ≤ .15; * p ≤ .05; ** p < .001 
PCS: physical component summary; Hb: Hemoglobulin; HD: Haemodialysis; QoLID: Quality of life index-dialysis; FFS: Fatigue severity scale; HCT: Haematocrit  
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The variables in this model were entered in sequence as the following steps: 1) 
Patient age, Gender, Marital status, Education, Job, Income; 2) HD adequacy, 
Time since started HD, Time to reach HD; 3) Social and Economic, Family; 4) 
Itch, Fatigue; 5) Anxiety, Depression; 6) Perceived general heath.  
Table 32 shows the unstandardised regression coefficients (B), the standard 
errors (SE B), the standardised regression coefficients ( ), the t-statistic, the 
significance of t-statistic, the R, the F statistic (F), R2 and the change in R2 (R2). 
R was significantly different from 0 at the end of each step. After Step 6 with all 
the IVs in the equation, R2 = .428, F (1,360) = 32.148, p <. 001. The adjusted R2 
value of .402 indicates that more than a third of the variability of the SF36v2 PCS 
(3-factor model) scores is predicted by Treatment Characteristics, Family support 
QOLI-D subscales, Symptom-Specific Measures, Emotional Measures and 
Health Status measures. 
At Step1, with demographic variables in the equation, Finc (6,370) =3.711, p = 
.001 and these accounted for 5.1% of variance in SF36v2 PCS scores (3-factor 
model) scores. Of the six variables entered in Step 1, Patient Age (p= .011) was 
the only significant variable. Introducing the treatment characteristics variables in 
Step 2 explained an additional 3.2% of variance in the SF36v2 PCS (2-factor 
model) scores and this change in R2 was significant, Finc (3, 367) =4.323, p = 
.005. Among the three variables added in Step 2, the variable Time to reach HD 
(p= .002) was found to be the only significant predictor of SF36v2 PCS (2-factor 
model) scores.  Adding the social and economic, and family subscales in Step 3 
explained an additional 7.0% of variance in SF36v2 PCS (3-factor model) scores 
and the change in R2   was significant, Finc (2,365) =15.084, p < .001. Among the 
two QOLI-D subscales, only the Social and economic scores were found to be a 
significant predictor of SF36v2 PCS (3-factor model) scores (p < .001). At the end 
of Step 4, with symptom-specific measures in the equation, the regression model 
explained an additional 14.4 % of variance in the model scores and this change 
in R2   was significant, Finc (2,363) =37.524, p < .001. The symptoms that were 
significant predictors of SF36v2 PCS (3-factor model)were: Itch (p< .001), and 
Fatigue (p< .001).  At Step 5, when emotional measures were added, the model 
explained an additional 7.4% of variance in SF36v2 PCS (3-factor model) scores 
and this change in R2 was also significant, Finc (2, 361) =21.401, p < .001. The 
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two emotional subscales were found to be significant predictors of SF36v2 PCS 
(3-factor model) scores, Anxiety (p= .019) and Depression (p< .001). Finally, after 
addition of Perceived general health scores at Step 6, R2 =.428 (adjusted R2 
=.402), Finc (1, 360) =32.148, p< .001. In the final model, the significant predictors 
of SF36v2 PCS (3-factor model) scores were Patient age, Time to reach HD, Itch, 
Fatigue, Anxiety, Depression, and Perceived general health. The most significant 
predictor of SF36v2 PCS (3-factor model) scores was Perceived general health. 
Together all the IVs accounted for 42.8% of the variance in the SF36v2 PCS (3-
factor model) scores. 
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Table 8. 32 Sequential Multiple Regression Analysis predicting SF36v2 PCS (3-factor model) From 
Treatment Characteristics, Family Support, Symptom Specific Measures, Emotional Measures & Health 
Status Measures (N= 383) 
Variable  B SE B  
t-
statistic 
Significance R F R2  
Step1           .238 3.711 .057 .057 
 Pt age -.212** .083 -.160 -2.546 .011         
Gender -3.093 2.060 -.084 -1.501 .134         
Marital status -.568 .874 -.037 -.650 .516         
Education status 1.128 .885 .086 1.274 .203         
 Job -.834 2.248 -.022 -.371 .711         
 Income .061 1.002 .004 .061 .951         
Step2      .298 4.323 .089 .032 
HD adequacy .108 .079 .069 1.371 .171 
Time since 
started HD  
-.263 .197 -.067 -1.334 .183 
Time to reach 
HD 
-.157** .050 -.156 -3.114 .002 
Step3      .398 15.084 .159 .070 
Social and 
Economic 
1.060*** .221 .307 4.796 .000 
Family -.198 .228 -.058 -.870 .385 
Step4      .55 37.524 .303 .144 
Itch -.848*** .210 -.183 -4.028 .000 
Fatigue -.415*** .057 -.341 -7.292 .000 
Step5      .614 21.401 .377 .074 
Anxiety -.568** .242 -.134 -2.350 .019 
Depression -1.216*** .261 -.249 -4.654 .000 
Step6      .654 32.148 .428 .051 
Perceived Gen. 
Health 
4.181*** .737 .274 5.670 .000 
      
Overall Final 
Model  
     
Intercept 82.682*** 8.467  9.765 .000 
Pt age -.166** .067 -.125 -2.490 .013 
Gender -2.003 1.656 -.054 -1.210 .227 
marital status -.404 .697 -.026 -.580 .562 
Educational 
status 
.768 .706 .058 1.087 .278 
Job 1.557 1.814 .041 .858 .391 
Income -.679 .802 -.043 -.847 .398 
Dialysis 
adequacy 
-.021 .067 -.013 -.311 .756 
Time since 
started HD per 
month 
-.082 .159 -.021 -.518 .605 
Time to reach to 
HD 
-.116** .041 -.116 -2.836 .005 
Social & 
Economic 
.227 .196 .066 1.161 .246 
Family -.334 .192 -.098 -1.742 .082 
Itch -.676** .193 -.145 -3.496 .001 
Fatigue -.197** .058 -.162 -3.398 .001 
Anxiety -.515* .232 -.121 -2.218 .027 
Depression -.830** .260 -.170 -3.196 .002 
Perceived 
general health 
4.181*** .737 .274 5.670 .000 
F-test for the 
whole model 
32.148         
Significance of F-
test 
< .001         
R 0.654         
R2 0.428         
Adjusted R2 0.402         
Note:  N=383. CI, confidence interval; NS, not significant; Hb, Haemoglobin.  
The  weights are the standardised regression coefficients at each step. *p < .05; **p< .01; *** p< .001  
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Of the factors that were significant in the final model, better perception of general 
health is associated with higher SF36v2 PCS (3-factor model) scores whereas 
older age, longer Time to reach HD, Itch, high level of Fatigue, Anxiety, and 
Depression are associated with lower SF36v2 PCS (3-factor model) scores. 
Patients who perceived better general health seem to have better physical health 
(3-factor model), such that adjusting for other variables in the model, for each unit 
increase in the Perceived general health scores, the SF36v2 PCS (3-factor 
model) score is predicted to increase on average by 4.181 units, with 95% 
confidence limits from 2.731 to 5.631, and this association is statistically 
significant (p = .001). Older age associated with lower SF36v2 PCS (3-factor 
model) scores, such that adjusting for other variables in the model, for each unit 
increase in the Patient age, score is predicted to decrease on average by 0.166 
units, with 95% confidence limits from -.297 to -.035, and this association is 
statistically significant (p = .007). The longer time the patients take to reach HD 
is found to be associated with lower SF36v2 PCS (3-factor model) scores, such 
that adjusting for other variables in the model, for each unit increase in the Time 
to reach HD the SF36v2 PCS (3-factor model) score is predicted to decrease on 
average by 0.116 units, with 95% confidence limits from -.197 to -.036 and this 
association is statistically significant (p =.003). With regards to physical 
symptoms, high level of Itch is found to be associated with lower SF36v2 PCS 
(3-factor model) scores, such that adjusting for other variables in the model, for 
each unit increase in the Itch scores the SF36v2 PCS (3-factor model) score is 
predicted to decrease on average by .676 units, with 95% confidence limits from 
-1.055 to -.296 and this association is statistically significant (p = .002). Similarly, 
higher Fatigue level is found to be associated with lower SF36v2 PCS (3-factor 
model) scores, such that adjusting for other variables in the model, for each unit 
increase in the Fatigue the SF36v2 PCS (3-factor model) score is predicted to 
decrease on average by 0.197 units, with 95% confidence limits from -.311 to -
.083 and this association is statistically significant (p =.003). For mood symptoms, 
high level of Anxiety is found to be associated with lower SF36v2 PCS (3-factor 
model) scores, such that adjusting for other variables in the model, for each unit 
increase in the Anxiety the SF36v2 PCS (3-factor model) score is predicted to 
decrease on average by 0.515 units, with 95% confidence limits from -.971 to -
.058 and this association is statistically significant (p =.040). Also, high level of 
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Depression is found to be associated with lower SF36v2 PCS (3-factor model) 
scores, such that adjusting for other variables in the model, for each unit increase 
in Depression the SF36v2 PCS (3-factor model) score is predicted to decrease 
on average by 0.830 units, with 95% confidence limits from -1.341 to -.319 and 
this association is statistically significant (p =.003).  
The trustworthiness of this regression model was evaluated using the Bootstrap 
technique using the IBM SPSS version 22 Bootstrapping method. Table 33 shows 
the bootstrap parameter estimates of the overall final model; the unstandardised 
regression coefficients(B), the bootstrapped standard errors (SE B), the 
significance of the regression coefficients, the normal approximated 95% 
confidence intervals (OLS 95% CI) and the bootstrapped confidence interval 
(BCa 95% CI). From the table, it can be observed that the parametric standard 
errors obtained earlier (see Table 32) are relatively comparable to the 
bootstrapped standard errors. The significance of the bootstrapped coefficients 
show that Patient age, Time to reach HD, Pruritus, Fatigue, Anxiety, Depression, 
and Perceived general health are the significant predictors of SF36v2 PCS (3-
factor model) score, which are the same as obtained from our non-bootstrapped 
estimates.  
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Table 8. 33 Bootstrap Parameter Estimates of the Overall Final Model predicting SF36V2 
physical component summary (3-factorl model) From Treatment Characteristics, Family 
Support, Symptom Specific Measures, Emotional Measures & Health Status Measures (N= 383) 
Variable B Bias SE B Significance OLS 95% CI BCa 95% CI 
Intercept 82.682 .448 9.522 .001 [66.030,99.333] [65.502,103.469] 
Pt age -.166 .002 .059 .007 [-.297, -.035] [-0.281, -.042] 
Gender -2.003 .025 1.666 .236 [-5.260,1.253] [-5.226,1.675] 
marital status -.404 .009 0.651 .545 [-1.775,.966] [-1.616,.912] 
Educational 
status 
.768 .024 0.691 .280 [-.621,2.157] [-0.527,2.210] 
Job 1.557 -.008 1.785 .386 [-2.010,5.125] [-1.956,4.957] 
Income -.679 -.001 .830 .409 [-2.257,.899] [-2.278,.986] 
Dialysis 
adequacy 
-.021 -.001 .076 .783 [-.154,.112] [-0.172,.126] 
Time since 
started HD 
-.082 -.001 .170 .615 [-.396,.231] [-0.391,.260] 
Time to reach to 
HD 
-.116 .000 .038 .003 [-.197, -.036] [-0.194, -.039] 
Social and 
Economic 
.227 .005 .194 .254 [-.158, .612] [-0.167,.639] 
Family -.334 -.012 .209 .106 [-.712, .043] [-0.771,.044] 
Itch -.676 .002 .211 .002 [-1.055, -.296] [-1.071, -.265] 
Fatigue -.197 -.004 .058 .003 [-.311, -.083] [-0.313, -.091] 
Anxiety -.515 -.006 .252 .040 [-.971, -.058] [-1.014, -.052] 
Depression -.830 -.009 .283 .003 [-1.341, -.319] [-1.373, -.300] 
Perceived 
general health 
4.181 -.023 .813 .001 [2.731,5.631] [2.613,5.779] 
Note:  N=383. CI, confidence interval; NS, not significant; OLS; Ordinary Least Squares; BCa, Bias 
corrected accelerated. 
In conclusion, older age, longer Time to reach HD, high level of Itch, Fatigue, 
Anxiety, Depression, and better Perception of general health are the significant 
predictors of SF36v2 physical component summary (3-factor model) scores. Of 
these variables, Perceived general health is the highest/best predictor of outcome 
scores, whereas Patient age, Time to reach HD, Itch, Fatigue, Anxiety, 
Depression contribute least.  
5.6.5. SF36v2 MCS (Emergent Three-factor model) 
Sequential multiple regression was conducted to examine if addition of 
information regarding treatment, then family support, then symptoms, then 
emotional status and then health status improved prediction of the SF36v2 MCS 
(3-factor model), after controlling for the influence of demographics.  
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Before examining the sequential regression analysis, inspections for 
assumptions and other potential problems that might affect interpreting the 
analysis were conducted. The output was initially examined for any issues with 
multicollinearity. Table 34-35 displays the correlation among variables, their 
means and standard deviations. An examination of the correlations revealed that 
none of the independent variables were correlated above person’s correlation .85 
(Tabachnick & Fidell, 2014), thus the assumption of multicollinearity was deemed 
to have been met. In addition, the tolerance values were all greater than 0.10 and 
the variance inflation factors were all less than 10.0, revealing no concerns with 
multicollinearity (Mertler & Vannatta, 2002). Next, the data were checked for 
multivariate outliers. All standardised residual values fell between -3.0 and 3.0, 
indicating no issues with outliers (Tabachnick & Fidell, 2014). Using the criterion 
p < .001 for Mahalanobis distance, no multivariate outliers among the cases were 
identified. The distribution of residuals was found to be nearly normal and centred 
at 0.  
Table 8. 34 Spearman's rho correlations SF-36v2 mental component summary (MCS) 
 (3-factor model) 
 
 
SF36v2 
MCS (3-
factor) 
Region Gender marital 
status 
Educational 
status 
Job Income 
SF36v2 
MCS (3-
factor) 
- -.05 -.13** -.04 .10* -.09* .12* 
Region 
 
- .14** .06 -.21** .18** -.13** 
Gender 
  
- .18** -.14** .39** -.12** 
marital 
status 
   
- .19** .13** -.08 
Educational 
status 
    
- -.21** .41** 
Job 
     
- -.38** 
Income 
      
- 
$ p ≤ .15; * p ≤ .05; ** p < .001 
 
Residual and scatter plots indicated the conditions of normality, linearity and 
homoscedasticity were all satisfied. Thus, all assumptions were sufficiently met.
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Table 8. 35 Pearson’s correlations SF-36v2 MCS (3-factor model) 
 
MCS 
(3-
factor) 
Pt age Hb HCT Albumin Dialysis 
adequacy 
dialysis 
hours 
per 
month 
Time 
since 
started 
HD 
Time to 
reach 
HD in 
minutes 
Anxiety Depression  Spiritual 
Wellbeing 
Social & 
Economic 
Family Itch Fatigue Bodily 
pain 
Perceived 
general 
health 
Physical 
functioning 
MCS (3-
factor) 
- -.05 .03 .09$ -.00 .10
* .03 -.12* -.07$ -.51
** -.53** .00 .36** .27** -.25** -.41** .66** .34** .26** 
Pt age 
 
- -.01 .00 -.03 -.10* -.09* .04 -.07 .03 .11* -.06 -.00 -.02 .02 .04 -.13** -.12** -.13** 
Hb 
  
- .63** .19** .11* .05 .04 -.08 -.06 -.10* .02 .00 .05 .03 -.02 .06 .07 .00 
HCT 
   
- .14** .03 .04 .01 -.10* .00 -.01 -.00 -.09 -.06 .02 .03 .07 .07 .00 
Albumin 
    
- .14** -.05 .01 .08 -.10* -.08 -.13** .08 .23** .05 -.05 -.06 .00 -.04 
Dialysis 
adequacy 
     
- .10* -.01 .03 -.14** -.16** .00 .19** .32** -.08 -.06 .08 .12* .00 
dialysis 
hours per 
month 
      
- -.08 -.14** .01 -.00 -.05 .02 -.03 -.06 -.00 .04 .08 .05 
Time since 
started HD 
       
- -.02 .10* .11* .13** -.12** -.10* .05 .06 -.11* -.03 -.02 
Time to HD 
in minutes 
        
- .08 .01 .04 .02 .06 .03 .05 -.06 -.02 -.16** 
Anxiety 
         
- .58** -.01 -.45** -.40** .20** .46** -.44** -.35** -.12* 
Depression 
          
- -.06 -.37** -.34** .18** .41** -.44** -.43** -.16** 
Spiritual 
Wellbeing 
           
- -.01 .01 .06 -.03 .01 .02 -.05 
Social & 
Economic 
            
- .64** -.16** -.29** .30** .32** .10* 
Family 
             
- -.07 -.24** .16** .22** .04 
Itch 
              
- 
 
.12** -.23** -.11* -.18** 
Fatigue 
               
- -.40** -.39** -.17** 
Bodily pain 
                
- .41** .28** 
Perceived 
general 
health 
                
 - .15** 
Physical 
functioning  
                
 
 
- 
$ p ≤ .15; * p ≤ .05; ** p < .001; Hb: Hemoglobulin; HD: Haemodialysis; QoLID: Quality of life index-dialysis; HCT: Haematocrit  
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The variables in this regression model were entered in sequence in six steps: 1) 
Gender, Education, Job, Income; 2) HCT; 3) Social and Economic, Family; 4) 
Itch, Fatigue; Bodily pain; 5) Anxiety, Depression; 6) Perceived general health 
and Physical functioning.  
Table 36 displays the unstandardised regression coefficients (B), the standard 
errors (SE B), the standardised regression coefficients ( ), the t-statistic, the 
significance of t-statistic, the R, the F statistic (F), R2 and the change in R2 (R2). 
R was significantly different from 0 at the end of each step. After Step 6 with all 
the IVs in the equation, R2 = .557, F (2,381) = 3.646, p=. 027. The adjusted R2 
value of .541 indicates that more than half of the variability in the SF36v2 MCS 
(3-factor model) scores is predicted by Treatment Characteristics, Social & 
Economic and Family QOLI-D subscales, Symptom-Specific Measures, 
Emotional Measures and Physical and Health Status measures. 
At Step1, with demographic variables in the equation, Finc (4,391) =2.159, p = .07 
and these accounted for 2.2% of variance in SF36v2 MCS scores (3-factor 
model) scores. None of the demographic variables was found to be a significant 
predictor of SF36v2 MCS (3-factor model). Introducing the clinical variable 
Haematocrit in Step 2 explained an additional 1.0% of variance in the SF36v2 
MCS (3-factor model) scores and this change in R2 was significant, Finc (1, 390) 
=3.995, p = .046. Adding the Socio-Economic, and Family subscales in Step 3 
explained an additional 12.4% of variance in SF36v2 MCS (3-factor model) 
scores and the change in R2   was significant, Finc (2,388) =28.389, p < .001. 
Among the two subscales, only the variable Social and Economic scores were 
found to be a significant predictor (p < .001). At the end of Step 4, with symptom-
specific measures in the equation, the regression model explained an additional 
35.5 % of variance in SF36v2 MCS (3-factor model) scores and this change in R2   
was significant, Finc (3,385) =92.811, p < .001. All three symptoms measures were 
significant predictors of SF36v2 MCS (3-factor model); Itch (p= .031), Fatigue (p< 
.001) and Bodily Pain (p< .001).  Again, at Step 5 when emotional measures were 
added, the model explained an additional 3.9% of variance in SF36v2 MCS (3-
factor model) scores and this change in R2   was also significant, Finc (2, 383) 
=16.488, p < .001. The two emotional subscales were found to be a significant 
predictor of SF36v2 MCS (3-factor model) scores, Anxiety (p= .033) and 
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Depression (p< .001). Finally, after addition of Perceived general health and 
Physical functioning scores at Step 6, R2 =.557 (adjusted R2 =.541), Finc (2, 381) 
=3.646, p= .027. In the final model, the significant predictors of SF36v2 MCS (3-
factor model) scores were Education status, Haematocrit, Fatigue, Bodily pain 
(reverse scoring), Anxiety, Depression and Physical functioning. The most 
significant predictors of SF36v2 MCS (3-factor model) scores were Bodily pain 
and Depression. Together all the IVS accounted for 55.7% of the variance in the 
SF36v2 MCS (3-factor model) scores. 
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Table 8. 36 Sequential Multiple Regression Analysis predicting SF36v2 MCS (3-factor model) From 
Treatment Characteristics, Family Support, Symptom Specific Measures, Emotional Measures & Health 
Status Measures (N= 383) 
Variable  B SE B  
t-
statisti
c 
Significanc
e 
R F R2   
Step1          .147  .022 .022 
  Gender -3.349 2.051 -.089 -1.633 .103         
       Education -.026 .756 -.002 -.034 .973         
       Job -.437 2.254 -.011 -.194 .846         
       Income 1.561 .963 .098 1.622 .106         
Step2          .178 3.995 .032 .010 
HCT .361* .181 .10 1.999 .046 
Step3          .394 28.389 .155 .124 
 Social & 
Economic 
1.101*** .219 .312 5.039 .000 
Family .232 .210 .068 1.106 .269 
Step4         .714 92.811*** .510 .355 
       Itch -.383* .178 -.081 -2.159 .031 
       Fatigue -.177*** .050 -.143 -3.540 .000 
Bodily pain .383*** .029 .550 13.236 .000 
Step5         .741 16.488*** .549 .039 
       Anxiety -.434* .203 -.103 -2.138 .033 
     Depression -.928*** .222 -.187 -4.173 .000 
Step6         .746 3.646** .557 .008 
Perceived 
Gen. Health 
-.844 .662 -.054 -1.276 .203 
Physical 
functioning 
.060** .025 .086 2.377  .018 
Overall Final Model           
Intercept 40.891*** 7.811   5.235 .000 
    
Gender -.446 1.426 -.012 -.313 .754 
Educational 
status 
-1.405** .525 -.105 -2.676 .008 
Job .479 1.562 .012 .306 .759 
Income 1.224 .663 .077 1.848 .065 
HCT .253* .127 .070 1.992 .047 
Social & 
Economic 
.142 .171 .040 .834 .405 
Family .188 .158 .055 1.194 .233 
Itch -.245 .171 -.052 -1.431 .153 
Fatigue -.108* .051 -.087 -2.111 .035 
Bodily pain .320*** .030 .459 10.555 .000 
Anxiety -.456* .202 -.108 -2.261 .024 
Depression -.968*** .226 -.195 -4.280 .000 
Perceived 
general 
health 
-.844 .662 -.054 -1.276 .203 
Physical 
functioning 
.060** .025 .086 2.377 .018 
F-test for the 
whole model 
3.646   
      
Significance of 
F-test 
.027   
      
R .746         
R2 .557         
Adjusted R2 .541         
Note:  N=383. CI, confidence interval; NS, not significant; Hb, Haemoglobin. 
The  weights are the standardised regression coefficients at each step.  
*p < .05. **p< .01, *** p< .001 
 
In the final model, lower Bodily pain is associated with higher SF36v2 MCS (3-
factor model) scores, such that adjusting for other variables in the model, for each 
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unit increase in the Bodily pain scores (reverse scoring), the SF36v2 MCS (3-
factor model) score is predicted to increase on average by .320 units, with 95% 
confidence limits from .260 to .380, and this association is statistically significant 
(p = .001). Better Physical functioning is associated with higher SF36v2 MCS (3-
factor model) scores, such that adjusting for other variables in the model, for each 
unit increase in the Physical functioning scores, the SF36v2 MCS (3-factor 
model) score is predicted to increase on average by .060 units, with 95% 
confidence limits from .010 to .110, and this association is statistically significant 
(p = .022). On the other hand, higher Education status associated with lower 
SF36v2 MCS (3-factor model) score, such that adjusting for other variables in the 
model, for each unit increase in the Education status score is predicted to 
decrease on average by 1.405 units, with 95% confidence limits from -2.437 to -
.373, and this association is statistically significant (p = .007). High level of 
Fatigue is found to be associated with low SF36v2 MCS (3-factor model) scores, 
such that adjusting for other variables in the model, for each unit increase in the 
Fatigue scores the SF36v2 MCS (3-factor model) score is predicted to decrease 
on average by 0.108 units, with 95% confidence limits from -.209 to -.007 and 
this association is statistically significant (p =.048). For mood symptoms, high 
level of Anxiety is found to be associated with low SF36v2 MCS (3-factor model) 
scores, such that adjusting for other variables in the model, for each unit increase 
in the Anxiety scores the SF36v2 MCS (3-factor model) score is predicted to 
decrease on average by .456 units, with 95% confidence limits from -.853 to -
.060 and this association is statistically significant (p =.026). Likewise, high level 
of Depression is found to be negatively associated with low SF36v2 MCS (3-
factor model) scores, such that adjusting for other variables in the model, for each 
unit increase in the Depression scores the SF36v2 MCS (3-factor model) score 
is predicted to decrease on average by .968 units, with 95% confidence limits 
from -1.412 to -.523 and this association is statistically significant (p = .001).   
The trustworthiness of the regression model was evaluated using the Bootstrap 
technique using the IBM SPSS version 22 Bootstrapping method. Table 37 shows 
the bootstrap parameter estimates of the overall final model; the unstandardised 
regression coefficients(B), the bootstrapped standard errors (SE B), the 
significance of the regression coefficients, the normal approximated 95% 
confidence intervals (OLS 95% CI) and the bootstrapped confidence interval 
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(BCa 95% CI). From the table, it can be observed that the parametric standard 
errors obtained earlier (see Table 36) are quite similar to the bootstrapped 
standard errors. Also, the significance of the bootstrapped coefficients show that 
Education status, Fatigue, Bodily pain, Anxiety, Depression, and Physical 
functioning are the significant predictors of SF36v2 MCS (3-factor model) score, 
which are the same as obtained from the non-bootstrapped estimates. However, 
it was also noted that Income which was not a significant predictor in the non-
bootstrapped model, is now a significant predictor of SF36 MCS (3-factor model) 
scores (p= .045), with BCa 95% confidence limits from -.078 to -.2.527.  
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Table 8. 37 Sequential Multiple Regression Analysis predicting SF36v2 MCS (3-factor 
model) From Treatment Characteristics, Family Support, Symptom Specific Measures, 
Emotional Measures & Health Status Measures (N= 383) 
Variable B Bias SE B Significance OLS 95% CI BCa 95% CI 
(Constant) 40.891 -.653 9.101 .001 [25.53,56.249] [23.167,56.131] 
Gender -.446 .014 1.433 .756 [-3.250,2.357] [-3.317,2.309] 
Educational 
status 
-1.405 .007 .519 .007* [-2.437, -.373] [-2.468, -.377] 
Job .479 -.014 1.547 .754 [-2.593,3.550] [-2.335,3.654] 
Income 1.224 -.016 .615 .045* [-.078,2.527] [-.037,2.370] 
HCT .253 .004 .139 .068 [.003,.502] [-.024,.559] 
Social & 
Economic 
.142 .013 .156 .383 [-.193,.478] [-.154,.483] 
Family .188 -
1.660 
.161 .245 [-.122,.498] [-.134,.505] 
Itch -.245 .013 .185 .192 [-.582,.092] [-.607,.181] 
Fatigue -.108 -.001 .054 .048* [-.209, -.007] [-.212,.003] 
Bodily pain .320 .000 .033 .001* [.260,.380] [.252,.385] 
Anxiety -.456 .000 .202 .026* [-.853, -.060] [-.851, -.049] 
Depression -.968 .019 .235 .001* [-1.412, -.523] [-1.467, -.439] 
Perceived 
general health 
-.844 .005 .697 .226 [-2.146,.457] [-2.256,.594] 
Physical 
functioning 
.060 .001 .026 .022* [.010,.110] [.007,.115] 
Note:  N=383. CI, co-.009nfidence interval; NS, not significant; Hb, Haemoglobin; OLS, Ordinary Least 
Squares; BCa, Bias corrected accelerated. 
It can be concluded that better Physical functioning is associated with better 
mental health; whereas high Education status, high Fatigue, Bodily pain, Anxiety, 
and Depression are associated with low mental health.  
5.6.6. SF36v2 Role Component Summary-RCS (Emergent three-factor 
model) 
To determine the prediction relationship between the predictors of demographics, 
treatment characteristics, socio-economic and family support, symptoms, 
emotional status, health status on SF36v2 RCS (3-factor model) a sequential 
multiple regression was conducted.  
Prior to examining the sequential regression analysis, inspections for 
assumptions and other potential issues that might affect interpreting the analysis 
were conducted. Firstly, the output was examined for any issues with 
multicollinearity. Table 38-39 displays the correlation among variables, their 
means and standard deviations. An inspection of the correlations revealed that 
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all the independent variables correlated less than .85 (Tabachnick & Fidell, 2014), 
hence the assumption of multicollinearity was thought to have been met. All of 
the tolerance values were also greater than 0.10 and the variance inflation factors 
were all less than 10.0, revealing no concerns with multicollinearity (Mertler & 
Vannatta, 2002). The data were also checked for multivariate outliers. All 
standardised residual values fell between -3.0 and 3.0, indicating no issues with 
outliers (Tabachnick & Fidell,2001). Using the criterion p < .001 for Mahalanobis 
distance, no multivariate outliers among the cases were identified. For normality 
check, the distribution of residuals found to be nearly normal and centred at 0. 
Residual and scatter plots indicated the conditions of normality, linearity and 
homoscedasticity were all satisfied. All the assumptions, therefore, were 
sufficiently met. 
 
Table 8. 38 Spearman's rho correlations SF-36v2 role component summary (RCS) (3-factor 
model) 
Variables SF36v2 
RCS (3-
factor) 
Region Gender marital 
status 
Educational 
status 
Job Income 
SF36v2 
RCS (3-
factor) 
- -.02 -.06 -.06$ .09 .02 .02 
Region 
 
- .14** .06 -.21** .18** -.13** 
Gender 
  
- .18** -.14** .39** -.12** 
marital 
status 
   
- .19** .13** -.08 
Educational 
status 
    
- -.21** .41** 
Job 
     
- -.38** 
Income 
      
- 
$ p ≤ .15; * p ≤ .05; ** p < .001 
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Table 8. 39 Pearson correlations SF-36v2 RCS (3-factor model) 
 
SF36v2 
RCS 
(3-
factor) 
Pt 
age 
Hb HCT Albumi
n  
Dialysis 
adequac
y 
dialysi
s 
hours 
per 
month 
Time 
since 
starte
d HD 
Time 
to 
reach 
HD in 
minute 
Anxiet
y 
Depressio
n 
Spiritual 
Wellbein
g 
Social & 
Economi
c 
Famil
y 
Itch  Fatigu
e 
Bodily 
pain 
Perceiv
ed 
general 
health 
Physical 
functionin
g 
SF36v2 
RCS (3-
factor) 
- -.02 -.04 -.05 .03 .06 .05 -.15* -.11* -.34** -.42** -.09$ .29** .20** -.19** -.29** .43** .27** .42** 
Pt age 
 
- -.01 .00 -.03 -.10* -.09* .04 -.07 .03 .11* -.06 -.07 -.02 .02 .04 -.13** -.12** -.13** 
Hb 
  
- .63** .19** .11* .05 .04 -.08 -.06 -.10* .02 .07 .05 .03 -.02 .06 .07 .00 
HCT 
   
- .14** .03 .04 .01 -.10* .00 -.01 -.00 -.09 -.06 .02 .03 .07 .07 .00 
Albumin  
    
- .14** -.05 .01 .08 -.10* -.08 -.13** .08 .23** .05 -.05 -.06 .00 -.04 
Dialysis 
adequacy 
     
- .10* -.01 .03 -.14** -.16** .00 .19** .32** -.08 -.06 .08 .12* .00 
dialysis 
hours per 
month 
      
- -.08 -.14** .01 -.00 -.05 .00 -.03 -.06 -.08 .04 .08 .05 
Time 
since 
started 
HD 
       
- -.02 .10* .11* .13** -.12** -.10* .05 .06 -.11* -.03 -.02 
Time to 
reach HD 
in minutes 
        
- .08 .01 .04 .02 .06 .03 .05 -.06 -.02 -.16** 
Anxiety  
         
- .58** -.01 -.45** -.40** .20** .46** -.44** -.35** -.12* 
Depressio
n 
          
- -.06 -.37** -.34** .18** .41** -.44** -.43** -.16** 
Spiritual 
Wellbeing 
           
- -.01 .01 .06 -.03 .01 .02 -.05 
Social & 
Economic 
            
- .64** -.16** -.29** .30** .32** .10* 
Family 
             
- -.07 -.24** .16** .22** .04 
Itch 
              
- .12** -.23** -.11* -.18** 
Fatigue 
               
- -.40** -.39** -.17** 
Bodily 
pain 
                
- .41** -.28** 
Perceived 
general 
health 
                 - .15** 
Physical 
functionin
g 
                
  - 
$ p ≤ .15; * p ≤ .05; ** p < .001 
Hb: Hemoglobulin; HD: Haemodialysis; QoLID: Quality of life index-dialysis; HCT: Haematocrit  
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As with other models, variables were entered in sequence in six steps: 1) Marital 
status; 2) Time since started HD, Time to reach HD; 3) Social and Economic, 
Family, Spiritual wellbeing; 4) Itch, Fatigue, Bodily pain; 5) Anxiety, Depression; 
6) Perceived general health and Physical functioning.  
Table 8.40 shows the unstandardised regression coefficients (B), the standard 
errors (SE B), the standardised regression coefficients ( ), the t-statistic, the 
significance of t-statistic, the R, the F statistic (F), R2 and the change in R2 (R2). 
R was significantly different from 0 at the end of each step. After Step 6 with all 
the IVs in the equation, R2 = .389, F (2,374) = 21.256, p <. 001. The adjusted R2 
value of .368 indicates that more than a third of the variability of the SF36v2 RCS 
(3-factor model) scores is predicted by Treatment Characteristics, Social and 
Economic subscales, Symptom-Specific Measures, Emotional Measures and 
Health Status measures. 
At Step1, with demographic variable of Marital status in the equation, Finc (1,386) 
=2.080, p = .150 and these accounted for 0.5% of variance in SF36v2 RCS (3-
factor model) scores. This predictor, however, was not significant of SF36v2 RCS 
(3-factor model) scores. Introducing the treatment characteristics variables in 
Step 2 explained an additional 2.3% of variance in the SF36v2 RCS (2-factor 
model) scores and this change in R2 was significant, Finc (2, 384) =4.449, p = 
.012. Among the two variables added in Step 2, the variable Time since started 
HD (p= .015) was found to be the only significant predictor of SF36v2 RCS (2-
factor model) scores.  Adding the Social and Economic, Family, and Spiritual 
Wellbeing scores in Step 3 explained an additional 10.1% of variance in SF36v2 
RCS (3-factor model) scores and the change in R2   was significant, Finc (3,381) 
=14.671, p < .001. Among the three predictors, Social and Economic scores was 
found to be a significant predictor of SF36v2 RCS (3-factor model) scores (p < 
.001) with the Spiritual Wellbeing scores (p = .037). At Step 4, with symptom-
specific measures in the equation, the regression model explained an additional 
14.5 % of variance in SF36v2 RCS (3-factor model) scores and this change in R2   
was significant, Finc (3,378) =25.186, p < .001.  Of these symptom-specific 
measures, Fatigue (p= .040) and Bodily pain (p< .001) were significant predictors 
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of SF36v2 RCS (3-factor model). Again, at Step 5 when emotional measures 
were added, the model explained an additional 4.6% of variance in SF36v2 RCS 
(3-factor model) scores and this change in R2   was also significant, Finc (2, 376) 
=21.771, p < .001. Among the two emotional subscales, Depression (p< .001) 
was found to be the only significant predictor of SF36v2 RCS (3-factor model) 
scores. At Step 6, with the addition of Perceived general health and Physical 
functioning scores, R2 =.389 (adjusted R2 =.368), Finc (2, 374) =21.256, p< .001. 
In the final model, the significant predictors of SF36v2 RCS (3-factor model) 
scores were Spiritual Wellbeing, Bodily pain, Depression, and Physical 
functioning. The most significant predictors of SF36v2 RCS (3-factor model) 
scores were Bodily pain, Depression, and Physical functioning. Together all the 
IVS accounted for 38.9% of the variance in the SF36v2 RCS (3-factor model) 
scores. 
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Table 8. 40 Sequential Multiple Regression Analysis predicting SF36V2 RCS (3-factor 
model) From Treatment Characteristics, Family Support, Symptom Specific Measures, 
Emotional Measures & Health Status Measures (N= 383) 
Variable  B SE B  
t-
statistic 
Significance R F R2  
Step1            .073 2.080  .005 .005  
Marital status -1.507 1.045 -.073 -1.442 .190     
Step2      .167 4.449** .028 .023 
Time since 
started HD 
-.637* .261 -.123 -2.441 .015 
Time to reach to 
HD 
-.121 .067 -.090 -1.792 .074 
Step3      .359 14.671*** .129 .101 
Social & 
Economic 
1.272*** .287 .281 4.426 .000     
Family .158 .279 .036 .564 .573     
Spiritual 
Wellbeing 
-.136* .065 -.102 -2.098 .037     
Step4      .523 25.186*** .274 .145 
       Itch -.412 .283 -.067 -1.460 .145 
       Fatigue -.164* .079 -.102 -2.061 .040 
       Bodily pain .296*** .045 .332 6.584 .000 
Step5      .566 12.771*** .320 .046 
       Anxiety -.076 .330 -.014 -.232 .817 
       Depression -1.668*** .360 -.258 -4.638 .000 
Step6      .624 21.256*** .389 .069 
Perceived Gen. 
Health 
-1.273 .995 -.062 -1.279 .202 
    Physical 
functioning 
.250*** .039 .275 6.393 .000 
Overall Final 
Model  
     
Intercept  51.417*** 10.428  4.931 .000     
marital status -.837 
.841 -.041 -.996 
.320     
Time since 
started HD 
-.150 
.215 -.029 -.701 
.484     
Time to reach 
to HD 
-.051 .056 -.038 -.911 .363     
Social & 
Economic 
.505 .258 .112 1.954 .051     
Family .036 .243 .008 .149 .881     
Spiritual 
Wellbeing 
-.147** .055 -.110 -2.662 .008     
Itch -.089 .264 -.014 -.338 .735     
Fatigue -.071 .079 -.045 -.904 .367     
Bodily pain .185*** .045 .208 4.084 .000     
Anxiety -.200 .314 -.036 -.636 .525     
Depression -1.590*** .349 -.246 -4.555 .000     
Perceived Gen 
health 
-1.273 .995 -.062 -1.279 .202     
Physical 
functioning 
.250*** .039 .275 6.393 .000     
F-test for the 
whole model 
21.256         
Significance of F-
test 
<.001         
R .624         
R2 .389         
Adjusted R2 .368         
Note:  N=383. CI, confidence interval; NS, not significant; Hb, Haemoglobin; SF36V2, Short-Form 36 Health 
Survey. The weights are the standardised regression coefficients at each step. *p < .05; **p< .01; *** p< .001.   
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In this final model, two of the factors, low Bodily pain and high Physical 
functioning, associated with better Role-functioning.  On other hand, Spiritual 
wellbeing and Depression associated with limited Role-functioning in this group 
of patients. 
Low Bodily pain is associated with high SF36v2 RCS (3-factor model) scores, 
such that adjusting for other variables in the model, for each unit increase in the 
Bodily pain scores, the SF36v2 RCS (3-factor model) score is predicted to 
increase on average by 0.185 units, with 95% confidence limits from .096 to .275, 
and this association is statistically significant (p = .001). Ability to perform Physical 
functioning also associated with high SF36v2 RCS (3-factor model) scores, such 
that adjusting for other variables in the model, for each unit increase in the 
Physical functioning scores, the SF36v2 RCS (3-factor model) score is predicted 
to increase on average by 0.250 units, with 95% confidence limits from .173 to 
.327, and this association is statistically significant (p = .001). In contrast, high 
Spiritual wellbeing score associated with low SF36v2 RCS (3-factor model) score, 
such that adjusting for other variables in the model, for each unit increase in the 
Spiritual wellbeing score is predicted to decrease on average by 0.147 units, with 
95% confidence limits from -.256 to -.038, and this association is statistically 
significant (p = .027). High level of Depression is found to be associated with low 
SF36v2 RCS (3-factor model) scores, such that adjusting for other variables in 
the model, for each unit increase in the Depression the SF36v2 RCS (3-factor 
model) score is predicted to decrease on average by 1.590 units, with 95% 
confidence limits from -2.276 to -.904 and this association is statistically 
significant (p = .001).  
The trustworthiness of regression model was evaluated using the Bootstrap 
technique as with other models using the IBM SPSS version 22 Bootstrapping 
method. Table 8.41 shows the bootstrap parameter estimates of the overall final 
model; the unstandardised regression coefficients(B), the bootstrapped standard 
errors (SE B), the significance of the regression coefficients, the normal 
approximated 95% confidence intervals (OLS 95% CI) and the bootstrapped 
confidence interval (BCa 95% CI). From the table, it can be seen that the 
parametric standard errors obtained earlier (see Table 8.40) are quite 
comparable to the bootstrapped standard errors. The significance of the 
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bootstrapped coefficients show that Spiritual Wellbeing, Bodily pain, Depression, 
and Physical functioning are the significant predictors of SF36v2 RCS (3-factor 
model) score, which are the same as obtained from our non-bootstrapped 
estimates.  
Table 8. 41 Bootstrap Parameter Estimates of the Overall Final Model predicting SF36V2 
RCS (3-factor model) From Treatment Characteristics, Family Support, Symptom Specific 
Measures, Emotional Measures & Health Status Measures (N= 383) 
Variable B 
Bias 
SE B Significance OLS 95% CI BCa 95% CI 
       
Intercept  51.417 -.653 11.400 .001 [30.912,71.922] [29.632,72.814] 
marital status -.837 .007 .853 .331 [-2.490,.816] [-2.565,.810] 
Time since started 
HD 
-.150 
-.014 
.203 .451 [-.572,.271] [-.551,.291] 
Time to reach to 
HD 
-.051 
-.016 
.055 .357 [-.160,.059] [-. 166,048] 
Social & Economic .505 .004 .264 .060 [-.003,1.013] [-.063,1.116] 
Family .036 .013 .254 .892 [-.442,.515] [-.454,.526] 
Spiritual Wellbeing -.147 1.660 .063 .027 [-.256, -.038] [-.272, -.021] 
Itch -.089 .013 .276 .757 [-.608,.429] [-.598,.435] 
Fatigue -.071 -.001 .077 .355 [-. 226,084] [-.235,.093] 
Bodily pain .185 .000 .050 .001 [.096.275] [.093,.281] 
Anxiety -.200 .000 .321 .529 [-.818,.418] [-.808,.453] 
Depression -1.590 .019 .345 .001 [-2.276-.904] [-2.246, -.858] 
Perceived general 
health 
-1.273 .005 1.028 .225 [-3.231,.684] [-3.101,.817] 
Physical 
functioning 
.250 .001 .046 .001 [.173,.327] [.147,.338] 
 
Note:  N=383. CI, confidence interval; NS, not significant; Hb, Haemoglobin; OLS, Ordinary Least Squares; BCa, Bias 
corrected accelerated. 
 
In conclusion, more than a third of the variability in SF36v2 Role Component 
Summary (3-factor model) scores is predicted by a number of measures such as 
Spiritual Wellbeing, Bodily pain (reverse coding), Depression, and Physical 
functioning. Among these, low Bodily pain, high Depression, and better Physical 
functioning are the strongest predictors of SF36v2 Role Component Summary (3-
factor model) scores, whereas Spiritual wellbeing contributed moderately to this 
prediction.  
 
 
267 
 
 
3. Summary  
Four hundred and fifty-one patients with ESRD on HD were surveyed to 
determine the level of HRQoL, and 45 were interviewed to explore their level of 
QoL. The majority of patients were male, married, illiterate, living on low income, 
with a relatively young mean age of 47, and a mean time on haemodialysis of 
over six years. The mean time required for them to get to dialysis centre was 29 
minutes. The clinical parameters such as Hb, HCT, and Albumin were within 
acceptable range.  
 
Patients had moderate physical and mental health status ranged from 52.24 to 
63.75, respectively. The mean scores of the eight domains of the SF-36v2 ranged 
from 52.24 to 63.75. The highest mean scores were in mental health (MH) 
subscale (63.75) and the lowest scores were in physical health subscale (42.24).  
For the QoLI-Dialysis, the highest mean scores were in family subscale (25.15) 
and the lowest scores were in the health and functioning subscale (20.36).  
 
One-hundred and thirty-two (29.3%) patients perceived their general health as 
good followed by 127 (28.2%) patients who perceived their general health as fair. 
 
The individualised QoL instrument (SEIQoL-DW) was completed by 45 patients 
on an interview basis. The average length of time required for them to complete 
the SEIQoL-DW was 16.43 (11-25) minutes. The majority of patients, 39, (86.6%) 
reported that completing the SEIQoL-DW was easy. All patients, except two, were 
able to nominate five areas of life that they valued most. Religion/spiritual life was 
the most frequent domain, 36 (80%), nominated by patients, followed by Family 
35 (77%), Personal health 31 (68.8), Social life 17 (37.7), Work/occupation 15 
(33.3). The mean score of the global index of SEIQoL-DW was 60.33, with a 
minimum score of 27.53 and a maximum score of 83.80. This finding, supported 
by the mean of spiritual wellbeing scores 55.54 (range from 20 to 120), suggests 
that the existential and religious aspects of spirituality are clinically relevant to 
patients in this study and possibly could have an impact on their HRQoL.  
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For the mood measure, HADS, the mean anxiety score was 6.91 (SD= 4.32) and 
the mean depression score was 6.90 (SD= 3.73). Using the cut-off score of ≥8, 
183 (41%) patients obtained a score of ≥8 on the anxiety subscale which possibly 
indicates presence of clinical anxiety. Similarly, around 43% of patients obtained 
a score of ≥8 on the depression subscale, indicating possible clinical depression. 
This cut-off score, however, is debateable since the scores of self-completed 
measures tend to be inflated. It is recommended that this value be compared with 
a higher cut-off score, e.g. ≥11, to provide an accurate conclusion with regard to 
possible cases of anxiety and depression. 
For the symptoms measures, the mean fatigue severity score was 44.70 (SD= 
14.91) indicating a further evaluation of fatigue required for those patients. 73% 
(319) patients obtained a score of ≥36.  The average Itch-5D score was 9.33 (SD 
= 3.84), with scores ranging from 1 to 23 which may suggest that patients had 
low level of pruritus symptom.   
Several sequential multiple regression models were used to examine which 
factors best explained physical health, mental health, quality of life index-dialysis, 
and role functioning.  A summary of results of the performed models is in table 
42 and as follows: 
• SF36v2 physical health component (2-factor standard model): higher 
perception of general health associated with better physical health; 
whereas the longer time patients take to get to dialysis centre and higher 
symptoms of itch, fatigue, and depression associated with lower physical 
health. 
• SF36v2 mental health component (2-factor standard model): less bodily 
pain and higher physical functioning are associated with better mental 
health; whereas high education status, high symptoms of anxiety, and 
depression are associated with lower mental health in ESRD patients.  
• Quality of life Index-Dialysis:  living outwith the capital, higher dialysis 
adequacy, high level of albumin, and better perception of general health 
associated with better QoLI-Dialysis. High level of anxiety and depression 
associated with lower level of QoLI-Dialysis. 
• SF36v2 physical health component (Emergent 3-factor model): older age, 
longer time to get to dialysis centre, high level of itch, fatigue, anxiety, 
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depression are associated with lower physical health. High perception of 
general health is associated with better physical health component.  
• SF36v2 mental health component (Emergent 3-factor model): better 
physical functioning is associated with better mental health; whereas high 
education status, high level of fatigue, bodily pain, anxiety, and depression 
are associated with low mental health.  
• SF36v2 role-functioning component (Emergent 3-factor model): low bodily 
pain and better physical functioning associated with higher role-
functioning; whereas high level of depression and spiritual/religious life 
associated with limited role-functioning.  
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Table 8. 42 A summary of outcome variables, predictors, R2 of significant predictors and overall models 
Regression 
models 
SF36v2 Physical 
Component Summary 
(2-factor traditional 
model) 
SF36v2 Mental 
Component 
Summary (2-factor 
traditional model) 
Quality of life 
Index-Dialysis 
SF36v2 Physical 
Component 
Summary (3-factor 
model) 
SF36v2 Mental 
Component 
Summary (3-factor 
model) 
SF36v2 Role 
Component 
Summary (3-factor 
model) 
Predictors 
(p value) 
Patient age 
(β= -0.9, p < .05) 
 
Time to reach HD  
(β= -.12, p < .01) 
 
Itch 
(β= -.12, p < .01) 
 
Fatigue  
(β= -.17, p < .01) 
 
Depression  
(β= -.24, p < .01) 
 
Perceived Gen health  
(β= .20, p < .01) 
Education status  
(β= -.12, p = .01) 
 
Pain (reverse 
scoring)  
(β= .44, p = <.001) 
 
Anxiety  
(β= -.11, p = <.02) 
 
Depression  
(β= -.22, p = 
<.001) 
 
Phys functioning  
(β= .16, p < .001) 
 
Region  
(β= -.12, p < .01) 
 
Adequacy  
(β= .10, p < .01) 
 
Albumin  
(β= .08, p < .05) 
 
Anxiety 
(β= -.28, p < .01) 
 
Depression  
(β= -.25, p < .01) 
 
Perce Gen health 
 (β= .10, p < .05) 
Patient age  
(β= -.12, p < .01) 
 
Time to HD  
(β= -.11, p < .01) 
 
Itch  
(β= -.14, p < .01) 
 
Fatigue  
(β= -.16, p < .01) 
 
Anxiety  
(β= -.12, p < .05) 
 
Depression  
(β= -.17, p < .01) 
 
Perce Gen health  
(β= .27, p < .001) 
Educational status  
(β= -.10, p < .01) 
 
Income  
(β= .07, p < .05) 
 
Fatigue  
(β= -.08, p < .05) 
 
Pain (reverse 
scoring) 
(β= p < .01) 
 
Anxiety  
(β= -.10, p < .05) 
 
Pain  
(β= .45, p < .001) 
 
Depression  
(β= -.19, p < .001) 
 
Physical functioning  
(β= .08, p < .05) 
 
Physical functioning  
(β= .27, p< .001) 
 
Pain (reverse 
scoring) 
(β= .20, p < .001) 
 
SWB  
(β= -.11, p < .05) 
 
Depression  
(β= -.24, p= <.001) 
 
 
R  63.1 77.6 71.1 65.4 74.60% 62.40% 
R2 of the 
regression 
model 
39.8 60.2 50.5 42.8 55.70% 38.90% 
adjusted R2 37.6 58.2 48.5 40.2 54.1 36.8 
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Chapter 9- Discussion and Recommendations 
 
1. Introduction and summary of results 
This chapter critically evaluates the key findings of the study and the implications 
for improving nephrology healthcare practice in the Arab Islamic world and in 
Oman in particular. Recommendations for future research are explained, followed 
by a critical analysis on the strengths and limitations of the study. Finally, a 
summary is provided.   
This study was carried out in four combined phases. The first phase consisted of 
two integrative reviews that explored the conceptual basis of QoL and how that 
was assessed in this patient group.  It also explored the differences between the 
meaning of QoL for individuals and how health status might impact on an 
individual's life reflecting the notion of HRQoL. A sensitive search was performed 
by accessing five main relevant databases (SCOPUS, Cochran Library, 
ProQuest (ASSIA) and EBSCO (CINAHL and Medline)). Secondary internet 
resources (ScienceDirect and PubMed), and non-electronically published 
relevant articles were also search.  
Main findings showed: 1) a considerable overlap between the terms QoL and 
HRQoL, in which QoL can be defined as the 'individuals’ perceptions of their 
position in life in the context of the culture and value systems in which they live 
and in relation to their goals, expectations, values and concerns' (WHO report, 
1998, p. 551); whereas HRQoL refers to patients’ subjective satisfaction with their 
health status, including domains related to physical, mental, emotional, and social 
functioning (Debout, 2011). Although these two terms share some communality, 
they are not equivalent; therefore any assessment of QoL/HRQoL should 
recognise and differentiate on the use between them. 2) Three main approaches 
are used to assess HRQoL: i.e. those using generic, disease-specific and 
individualised measures. However, none of them combined the use of generic, 
disease-specific and individualised measures as an integrated approach to 
comprehensively assess HRQoL. Finally, and most importantly, most of the 
studies were conducted within Western culture and no studies were found that 
had been conducted in Oman to assess QoL or HRQoL in this group of patients, 
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or to assess how these patients perceived their QoL/HRQoL. As a result, there 
was a necessity to explore the concept of QoL within the Omani context prior to 
describing and measuring the levels of factors of QoL and HRQoL.  
Phase two tested the understanding and acceptability of QoL/HRQoL within a 
small (n=12) subset of Omani ESRD patients.  A cognitive interviewing method 
was used to test a generalised standardised measure of HRQoL (Short Form 
36v2) and a disease-specific measure (Quality of Life Index-Dialysis) (QoLID). In 
addition, an individualised measure (Schedule for the Evaluation of Individual 
Quality of Life-Direct Weighting [SEIQoL-DW]) was used to establish whether the 
concept of QoL could be identified and defined within the Omani culture. The 
cognitive testing of the SF36v2 and QoLI-Dialysis identified few cultural 
sensitivities but was generally well accepted and questionnaire items appeared 
to have meaning to patients. The SEIQoL-DW supported the finding that QoL was 
generally understood and it is a meaningful concept and includes health 
considerations. By establishing the meaning of QoL and suitability of HRQoL 
measures to this group of patients it was necessary to pilot the remaining study 
measures in a larger group.  
Phase three was a small pilot study (n=45) testing the feasibility and acceptability 
of a larger cross-sectional survey.  Six Arabic-version questionnaires that 
assessed HRQoL, mood, physical symptoms and spiritual wellbeing, bound 
together, were piloted among the patients who were randomly identified from the 
National Renal Registry in Oman. The piloted measure, including socio-
demographic questions, has been shown to be reliable in the Omani context. This 
phase informed the data collection strategy and guided the development of 
statistical analysis syntax for the main study phase.   
Phase four (main study) was a large scale cross-sectional design.  Random 
sampling was used to capture a representative national sample from 13 
haemodialysis units across Oman.  A subsample of these participants also 
completed the SEIQoL-DW to further explore the concept of QoL. In this phase, 
planned analytic techniques included testing the psychometric adequacy of key 
measures using exploratory and confirmatory factor analysis.  Despite the 
questionnaires being translated according to WHO guidelines on translation and 
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back translation, further validation is required in this population. This has not been 
done previously within the Arab Peninsula.  
This doctoral research is highly important, given the number of patients in Oman 
with ESRD, the severity of their condition and the cost to the health service in 
providing ongoing support. This study shows that HRQoL was largely not 
predicted by the biomedical markers regularly measured by the ESRD service, 
and that symptoms were key drivers of both disease specific and generic HRQoL.    
2. Discussion  
The following sections discuss the study findings in relation to the research 
questions. 
a. Meaning of QoL/HRQoL among Omani population 
The first RQ1 in this study was: What does QoL mean to an Omani population? 
The meaning of QoL to this group of patients was explored by using the SEIQoL-
DW instrument.  
This is the first study to assess the potential utility of a formal assessment of QoL 
among Omani patients with ESRD. The use of SEIQoL-DW showed the potential 
usefulness of the information in the assessment of individualised QoL instrument 
along with standardised HRQoL. All the participants were able to comprehend 
and complete the SEIQoL-DW in an acceptable time (mean= 16.25 minutes), 
while the determined time to complete SEIQoL-DW is 10-20 minutes (O’Boyle et 
al., 1992). The successful completion of the SEIQoL may reflect patients’ insight 
into the factors that determine their QoL and ability to make judgments. This is 
manifested by their ability to identify the aspects of life that they consider 
important in making up their QoL and then by rating the level and importance of 
these aspects (Appendix 9.1). This is perhaps what distinguishes the individual 
QoL measures from the standardised HRQoL measures in that it is much more 
relevant to patients with incurable diseases such as ESRD. 
With regard to the patients’ views about very important aspects in their QoL, the 
analysis of responses to the SEIQoL-DW indicated that 19 domains 
characterised their self-reports. These were religion/spiritual life, family, personal 
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health, social life, work/occupation, leisure activities/hobbies, 
autonomy/independence, role functioning, living conditions, peace and 
contentment, finance, family health, quality of care, sexual life, enjoying life, 
relationships, coping, emotional well-being, and exercise/mobility. However, the 
most nominated categories were religion and spirituality (80%), family (78%), 
personal health (69%), social life (38%) and work/occupation (33%). These 
categories were in line with the literature that examined QoL in patients with 
ESRD (Tobin et al. 2002), multiple myeloma (Durner et al., 2013), diabetes 
(Walker & Bradely, 2002), and amyotrophic lateral sclerosis (Clark et al., 2001). 
Notably, although not in the same percent, the constant aspects of life nominated 
by these different groups of patients were health, family, work, social life and 
leisure activities.  
Although there is no specific explanation for the emergence of these common 
aspects of life among different groups of patients, it may illustrate a mechanism 
for a disease management (DiMatteo, 2004). Family and social support could 
help patients with chronic conditions to buffer stress, increase self-efficacy, and 
influence change in negative health behaviours (DiMatteo, 2004). The emotional 
support that patients with ESRD might receive from family and friends could 
create a positive influence on global measures of disease management. 
Similarly, this study found that patients with higher scores of family support 
reported better disease-specific HRQoL. Patients were also able to cope better 
with ESRD if they were involved in leisure activities. Increase in confidence and 
self-esteem, and personal achievements are often observed when patients are 
involved in a leisure activity (Misener et al. 2010). A further discussion on 
common nominated aspects of life can be found in Chapter 5. 
It was observed that the inclusion of a religion/spirituality category was different 
and unique for this study group.  Within a Western context, religion may be 
mentioned by certain groups but it would be unlikely to be as consistently 
identified as a domain of QoL. Religion and spirituality does not seem to be an 
important aspect of life for some western patients, unlike Omani patients. That is 
perhaps because Omanis consider religion as the essential reference in dealing 
with everyday life. It can be said that religion can shape the way Omanis view 
different aspects of life, including perceptions of health and illness. In Oman, 
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Muslim patients usually understand that illness, suffering and dying are part of 
their life and a test from Allah, “God”. Their perception is that no one can control 
how long they are going to live. Thus, their perceptions about QoL may be closely 
entwined with their religion and spiritual lives. 
The cognitive interviewing method was used to test the readability and relevance 
of items of SF36v2 HRQoL measure and disease-specific measure (QoLI-
Dialysis) among this group of patients. The preliminary result in phase two 
showed that two items of SF36v2 measure were less clear and two items related 
to QoLI-Dialysis measure were possibly sensitive. This however was not the 
issue when these measures were administered to a larger group of participants 
in the main study. Although these measures were relevant to this group of 
patients, there is a danger that validated and widely used measures of HRQoL 
do not address the entirety of what patients perceive as important in determining 
their HRQoL (Carr and Higginson, 2001). Indeed, measures that are irrelevant 
and do not cover aspects of life that are important to Omanis might not be valid. 
Basically, using standarised measures without checking their relevance to any 
targeted population might assess something distinct from what it is supposed to 
measure, or may fail to measure what is important to the individual. Such 
limitation can be evident in studies that used some standard measures of QoL 
and HRQoL in different groups of patients (Bowling, 1995; Carr, 1996). In this 
study, the tested HRQoL and disease-specific measures were clear and readable 
to this group of patients. 
2.1. Level of QoL/HRQoL for patients with ESRD on HD in Oman 
The second RQ2 was: What is the level of QoL/HRQoL for patients with ESRD 
on HD in Oman? A variety of measures was used to answer this question 
including individualised QoL instrument, HRQoL measures including disease-
specific measure, symptoms-specific measures, and spiritual measures.   
Using the SEIQoL-DW to assess the level of QoL, patients perceived their overall 
level of QoL to be lower than ESRD patients from Iran (Matlabi & Ahmadzadeh, 
2016), USA (Abdel-Kader et al., 2009), and patients with cancer on radiation 
therapy (Becker et al., 2014). The variances in how these patients perceived their 
levels of QoL differently adds further support to the notion that QoL is an 
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individual concept. SEIQoL-DW is an individualised QoL instrument that allows 
individuals to select domains that they view as important to their own wellbeing 
(O'Boyle et al., 1993). Obviously, SEIQoL-DW was able to capture patients’ 
individual values which determined their QoL domains. The findings also 
contribute to the argument that individualised measures are essential to address 
the potential drawbacks of HRQoL instruments that might limit the factors that 
comprise participants’ QoL. 
 Likewise, patients reported low levels of HRQoL particularly on the physical 
health component and mental health components. These findings were 
consistent with results from three observational studies in ESRD patients (Bohlke 
et al., 2008; Poppe et al., 2012; Hopman et al., 2009) and patients with other 
chronic conditions such as osteoporosis (Hopman et al., 2009). However, in 
current study, patients rated their mental health components better when 
compared to physical health components. Familes in Oman are more of an 
introverted type of families .and looking after family memebers is considered as 
an obligation. It was not surprising that patients scored higher in social function 
subscale compared to the other subscales of SF36v2. Social support has been 
reported to be an important factor in ESRD patients’ perceived HRQoL (Giordano 
et al., 2012). Supportive social environment, friends, and family can improve 
patients’ mental health and role functioning (Wilson and Cleary, 1995). Given that 
no previous study has assessed the association between family and social 
support and HRQoL in ESRD patients within Oman, exploring the mechanisms 
at work could be an important area for future research. 
Remarkably, the level of disease-specific HRQoL was better compared to their 
overall HRQoL. Although this result seems curious, as patients on dialysis usually 
experience a burden of symptoms and complications associated with dialysis and 
ESRD, recent studies show that the life expectancy and bearing of the burden of 
disease and treatment among ESRD patients have increased (Bieber et al., 2014; 
Brekke et al., 2014; Griva et al., 2009). This seems encouraging because it 
perhaps reflects that the current standards of, and complex medical care provided 
to, ESRD patients are effective and could be an influencing factor for better 
HRQoL. In fact, it may lend support to nephrology services within and outwith 
Oman to further improve the care of patients with ESRD. Furthermore, results 
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may suggest that QOLI-Dialysis measure is a good tool in HRQoL which is able 
to discriminate between different clinical groups. 
Fatigue and pain were significant in this group and this is consistent with the 
results of previous studies in ESRD patients (Drayer et al, 2006; Jablonski, 2007). 
Fatigue and pain were the most significant burdensome symptoms that patients 
reported in this study. Kimmel et al (2003) found that around 50% of patients with 
ESRD experienced pain, using the McGill QoL Scale.  Although this study did not 
investigate the severity of these symptoms, presence of symptom burden can be 
considered substantial and might impact on patients’ HRQoL. It is not surprising 
that these findings are important for a number of reasons: first, ESRD patients 
have numerous symptoms, many of which can be severe (Davison & Jhangri, 
2010). Second, symptoms that are common in dialysis patients such as muscles 
cramps, drowsiness or restless legs usually are not included in symptoms 
measures, which raises the possibility that symptom burden might be even higher 
than that observed in this study. A prior study conducted in 226 Dutch ESRD 
patients found that physical symptoms accounted for one-third of the impairment 
in HRQoL (Merkus et al., 1999).  
Mood symptoms are commonly experienced by ESRD patients. Forty-one per 
cent of patients reported symptoms of anxiety and 43% reported depressive 
symptoms. These figures are higher than reported results by Ramirez et al. 
(2012) in which 25.9% patients had anxiety and 28% of patients had depressed 
symptoms, using the HADS instrument. However, the diagnosis of mood 
symptom in ESRD patients could be highly variable, from patients showing no 
symptom of the disease to patients who show severe symptoms (CHILCOT et 
al., 2008; FIDAN et al., 2016). This is perhaps due to different concepts of 
depression and anxiety, which may vary from isolated symptoms to major 
depressive and anxiety disorder (FRIEDMAN et al., 2001). Anxiety and 
depression may affect the patient with ESRD in many ways. Overall, patients with 
ESRD have higher morbidity and mortality caused by the chronicity of the disease 
(BERLIM et al., 2006). For this reason, early recognition of mood changes and 
establishment of specific intervention to this group of patients are necessary. 
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Despite religious/spirituality variable being unique in this group of patients, 
surprisingly patients reported low scores (mean 55.54 (possible range 20-120)).  
There is no clear explanation for this; however, Ramirez et al (2012) found that 
religious struggle was independently associated with greater psychological 
distress, impairing HRQoL and increasing anxiety among ESRD patients. Muslim 
patients might encounter difficulties in carrying out some religious rituals, as 
certain rituals require physical endurance. They are obliged to perform acts of 
worship five times a day, consisting of kneeling and prostration. They are also 
obliged not to eat or drink (not even water) over the period of the sun shining 
during the fasting month (Ramadhan). Perhaps failing to honour their religious 
commitment might lower their satisfaction with religious practice. Despite the 
difficulty that patients might face in performing Islamic obligations, they may 
perceive their faith as a coping mechanism with what would otherwise be a poorer 
HRQoL. Family and faith are more controllable factors than health and money 
(Hofmann et al., 2010). Leaning on family and deepening one’s faith may be 
strategies employed by people with ESRD to improve their HRQoL. Accordingly, 
psycho-social interventions can be planned to help them to overcome their 
religious struggles.  
2.2. Predictors of HRQoL 
This section discusses the findings related to RQ3: To what extent do the 
following factors predict QoL/HRQoL in Omani patients with ESRD individual 
characteristics, treatment characteristics, socio-environmental factors, biological 
function, symptoms, and functional status and general health perceptions? The 
sequence of discussion in accordance to the Revised Wilson and Clearly HRQoL 
Modle by Ferrans et al., (2005). 
2.2.1. Practicality of the Revised Wilson and Clearly HRQoL model  
The revised model of Wilson and Cleary by Ferrans et al (2005) was used as a 
conceptual framework to guide this study. It can be concluded that the model 
provides a theoretical basis for the selection of study variables according to the 
series of health concepts which can be then translated to clinical intervention 
based on these findings.  
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This is evident by the result in which an understanding of associations among 
objective clinical outcomes and subjective patients’ experiences in ESRD, 
including biological function, emotional and physical symptoms, functional status, 
and general health perceptions is clear. That is, the domains of characteristics of 
the individual (age), characteristics of the environmental (family support), 
biological function (albumin), emotional symptoms (anxiety and depression), 
physical symptom (fatigue), functional status (physical health), and positive 
health perceptions predicted the HRQoL in this group of patients with ESRD. 
Hhealthcare providers, therefore, should focus on caring for the ESRD patient as 
a holistic being who faces challenges arising from living with ESRD and 
challenges arising from the entire life context which reflect the philosophy of 
integration both of biomedical and social science paradigms in healthcare of the 
revised Wilson and Clearly Model of HRQoL. 
 
2.2.2. Characteristics of the individual  
There were a number of individual characteristics that predicted HRQoL. These 
included age, educational status, and income status.   
Age was a significant predictor for low physical health. This result was in line with 
the findings of studies that examined HRQoL in ESRD patients using SF36v2 in 
which higher age predicted lower physical functioning (Walters et al., 2002; Lopes 
et al., 2007; Frank et al., 2003). As age increases, particularly in the elderly, the 
physical function of their body decreases (Loos et al., 2003). Thus, age might 
become a confounding factor in studies that evaluate and measure HRQoL. For 
that, future studies perhaps should consider measuring HRQoL of elder individuals 
separately from young populations or maybe control age variable in a sequential 
regression. The findings of this study are of value to healthcare workers, in Oman 
particularly, in order that they can devise an advance plan to address the issues 
that might reduce or worsen the level of HRQoL in this group of patients, 
particularly now that Oman has an increasingly older population.  
Educational status variable showed an interesting, as well as a conflicting, 
interpretation. Low education status variable associated with better HRQoL on the 
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mental-health domain by 12% of the total model of MCS (p = .004). This is difficult 
to explain because this finding is contrary to studies that examined educational 
level as a determinant of HRQoL in which higher education level associated with 
better mental HRQoL (Cukor et al., 2013; Finkelstein et al., 2009; Kimmel et al., 
2003). That is, those with higher educational status are differentially, negatively 
affected. These findings force us to question whether there is anything specific 
about Omani culture.  Is ESRD a greater threat to HRQoL for the better 
educated?  Does religion have anything .to do with this? Does educational status 
relate as you would expect to income?  Does higher educational status relate to 
lower HRQoL if you control for income?  Indeed, this is an area that requires further 
exploration. 
Patients with a higher monthly income also reported better mental HRQoL. 
International studies that assessed socio-economic status in patients with ESRD 
reported a positive association between a higher monthly income and better 
emotional and mental HQoL (Kao et al., 2009; Welsch, 2009).  Similarly, a Brazilian 
study showed that lower socio-economic status was related to poorer HRQoL and 
to increasing functional decline over time (Santos et al., 2010).  However, socio-
economic status is a multi-dimensional factor and could vary among different 
national populations depending on types of cultures and healthcare services and 
on countries’ overall economic status. In Oman, citizens with low income (earning 
less that OMR 264 (< GBP 500)) are entitled to financial support (PASI annual 
report, 2015). In addition, the healthcare services under the national health scheme 
are currently provided at no charge for all citizens. This kind of support may not 
reflect patients’ exact socio-economic status and therefore require further 
investigation.  
2.2.3. Charactaristics of the environemnt 
The variable of ‘time spent travelling to dialysis’ was associated with lower physical-
health scores in this group of patients. Unfortunately, none of the reviewed 
literature particularly examined the relationship between time taken to reach the 
dialysis unit and HRQoL. However, given the fact that these patients have lower 
physical health than mental health, it might have been expected that the longer 
time spent travelling to dialysis would be a source for physical health burden. 
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Despite the limited literature that examined the relationship between time spent to 
reach dialysis and HRQoL, this result indeed is important in that it provides valuable 
information regarding the effect of time taken to reach the dialysis unit and HRQoL 
in patients with ESRD. 
Better dialysis adequacy predicted better disease-specific HRQoL. The result was 
comparable to a study by Cohen and Kimmel (2013) in which a better dialysis 
adequacy was associated with increased scores in social and emotional health-
related QoL. It was also observed that higher patients’ overall health status was 
associated with a better adequacy of dialysis.  Another study reported that a higher 
rate of dialysis adequacy was associated with better physical-health status and 
lesser bodily pain (Unruh et al., 2008). Despite the positive association between 
higher dialysis adequacy and better health outcome, several clinical and biological 
factors should be considered that could interrelate with dialysis adequacy. Lambie 
et al (2004) found that dialysis adequacy could be strongly influenced by factors 
related to dialysis procedure, such as blood-pump speed, vascular access and 
sodium-removal degree. It is likely that these factors confound with the dialysis-
adequacy measure and therefore should be noted and controlled prior to testing 
the correlation between dialysis adequacy and HRQoL.  
2.2.4. Biological function 
Higher albumin score predicted a better disease-specific HRQoL. The majority of 
studies that examined the albumin effect on patients with ESRD used the SF36 
health-status measure (Patel et al., 2002; Lopes et al., 2007). Interestingly, these 
studies did not report any significant correlation between albumin and overall 
health status. It may be that albumin is a dialysis-related health factor rather than 
an overall health-status factor. Laws et al (2000) tested the association between 
albumin and QoLI-dialysis as an outcome in ESRD patients with severe 
malnutrition and found that a low albumin level associated with poorer HRQoL. 
This possibly indicates that albumin may not lower HRQoL unless the latter is at a 
severely low level. For this population, the mean albumin level was 38.42 (SD = 
5.13), with therapeutic values around 35-48g/L according to KDOQI clinical-
practice guidelines for haemodialysis (2015), and this may reflect the clinically 
acceptable level of albumin. Hence, further exploration of the albumin relationship 
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with QoLI-dialysis is required before concluding that this variable is a reliable 
predictor of disease-specific HRQoL scores.  
2.2.5. Symptoms 
The presence of physical symptoms, as manifested by high level of fatigue, itch, 
and bodily pain, predicted poorer physical and mental health scores. This finding 
is in keeping with similar findings reported by Williams et al. (2007), Hagell et al. 
(2006), and Pakpour et al. (2010). From a behavioural perspective, physical 
symptoms could limit physical and functional activities, consequently leading to 
decreased positive reinforcement and eventual depressive symptomatology 
(Ibrahim, 2011). Dudgeon et al (2005) observed that low perceptions of control 
over physical symptoms may lead to poorer psychological health. These results 
furnish evidence that physical symptoms are associated with poor HRQoL and 
are predominant symptoms among ESRD patients, requiring clinical intervention. 
Thus, if an existing physical symptom is not effectively relieved, it may have 
detrimental effects on most aspects of HRQoL. To avoid this unpleasant cycle, 
the nephrology care practitioner should perhaps consider a comprehensive 
symptom-management programme that helps to reduce fatigue, itch and bodily-
pain impact on physical and emotional health status.  
Mood symptom, anxiety and depression, predicted low physical and mental 
health components, disease-specific HRQoL, and role-functioning scores. This 
finding is comparable to findings of studies which used HADS to measure mood 
symptom in ESRD patients (Berlim et al., 2006; Bornivelli et al., 2012; Fidan et 
al., 2013). It can be argued that the anxiety and depression symptom are the 
most important health-related variable found in this sample due to its consistent 
significance in predicting the scores of the study outcomes. Given the 
seriousness of mood symptom on HRQoL, notably, none of the studies reviewed 
used mood symptom as dependent variables. Its relative absence in the literature 
may be due to its ubiquitous nature, or to possible convergences of anxiety 
stigma with psychological disorders which hinder reporting it as a distinct 
symptom (Johnston et al., 2000). Such pitfalls in addressing anxiety as an 
important determinant of HRQoL may underestimate its prevalence. Findings, 
therefore, reveal a possible gap regarding the importance of assessing mood 
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symptom as a vital determinant of HRQoL in patients with ESRD.  Future 
research, therefore, should consider and assess anxiety and depression as a 
dependent variable. 
Gender difference in the depression mean was observed in this study. Female 
patients exhibited higher depressive symptoms compared with men.  This finding 
was comparable to studies which reported a similar result (Bornivelli et al, 2012; 
Fidan et al 2013). Although no explicit reason for gender variation has been 
identified, it may be that women are just more likely to express their feelings 
(SIMON & NATH, 2004). HADS is shown to have contested factor-structure. Also, 
studies that used HADS in patients with ESRD argue about the appropriateness 
of the predetermined cut-off score (Berlim et al., 2006; Bornivelli et al., 2012; 
Fidan et al., 2013). It is anticipated that patients’ poorer physical- and mental-
health status may reflect their responses in HADS and consequently inflate the 
scores. To overcome this, a higher cut-off score may perhaps be more 
appropriate for HADS, as well as further psychometric evaluations.  
2.2.6. Physical functional status and general health perceptions variables  
Physical functional status predicted better mental health and role-functioning. This 
finding was comparable to findings of former studies (Cleary et al., 2005; Rebollo 
et al., 1998; Santos et al., 2010). Patients with ESRD are prone to face higher 
level of debilitation and deconditioning and most of them cannot perform more 
than their daily living activities (Bonner et al., 2013). Physical functioning, 
however, is potentially modifiable.  Bayoumi et al. (2010) found that patients who 
are able to maintain independent functioning might have better HRQoL. Home 
dialysis, independent home-exercise programmes and in-centre exercise 
programmes, for instance, can maintain physical functioning (Glover et al., 2011; 
Meers et al., 1996). Although functional status seems to be an important 
dimension of HRQoL, it is a multi-dimensional domain as it may include mental-
component aspects. For that reason, when assessing functional status, it should 
be considered as a multidimensional domain. Also, studies that attempt to 
measure physical functioning status may need to consider using a multi-
dimensional functioning scales.  
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In keeping with the literature findings (Wu A et al. (2004) Cleary et al. (2005)), 
positive general health perceptions predicted better physical health, mental 
health, QoLI-dialysis and role functioning. Younger patients, for instance, in 
phase one of this study, reported uncertainty about their future, which may reflect 
a grievance caused by their health-status deterioration. It was observed, while 
collecting study data, that some patients with considerable physical weakness 
perceived their health status as better compared with some younger patients on 
haemodialysis, who seemed to be more active. Although this seems odd, it may 
be that patients evaluate their own health status by comparing it with individuals 
of a similar age (Mangione, 2002; Tovbin et al., 2001). Older patients on 
haemodialysis may perceive that individuals of the same age, who are not on 
dialysis, have different health problems; whereas younger patients on dialysis 
observe fewer health-related issues in non-dialysis individuals of a similar age. 
Patients with chronic diseases usually adjust their aims and aspirations in life to 
the demands of their new health status so that they can maintain subjective 
wellbeing (Ferrans and Powers, 1995). Such behavioural change in patients with 
long-term illness was highlighted by the Response-Shift Model (Barclay-
Goddard, 2012; Oort et al., 2005). The principle of the response-shift concept 
refers to a change in the meaning of an individual’s self-evaluation and the 
reconceptualisation that may occur due to changes in health status over time. 
2.3. Validity and reliability of the HRQoL measures 
RQ5: What are the psychometric properties of the study measures in an Omani 
context in relation to its validity and reliability? This is discussed under this 
section. A more detailed discussion can also be found in chapter seven. 
Because no studies were found that validated or explored the measures of 
HRQoL in Oman, this study explored the underlying structure of the SF36v2 and 
HADS measures using exploratory factor analysis (EFA) and confirmatory factor 
analysis (CFA). EFA was used to establish the factor structure among measures’ 
items and CFA to validate its use within this context. Surprisingly, for SF36v2, the 
original factor structure (eight-factor) was not supported within this population. 
Instead, the EFA and CFA revealed a three-factor structure for SF36v2. Likewise, 
for HADS, results did not show an exclusive factor-structure. EFA revealed a one-
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factor structure and a possible correlated two-factor structure. CFA revealed 
acceptable fit indices to study data for the one-factor, original two-factor, and 
emergent two-factor structures, though it was in favour of emergent two-factor 
structure. 
Another important observation with regard to the three-factor model of the 
SF36v2 is the combination of physical functioning, role functioning, and 
psychological functioning. The EFA result of the three-structure factor was similar 
to the findings in studies conducted in Asia such as Singapore (Thumboo et al., 
2001), Japan (Fukuhara et al., 1998) and Taiwan (Fuh JL et al., 2000). Their 
results showed that half of the items related to the vitality scale and some items 
related to bodily pain and social functioning merged into the mental-health factor 
(psychological functioning). These results are identical to the result in the current 
study, which may suggest that the standardised, original factor structure of 
SF36v2 is not reliable across different populations due to possible cultural 
influences on the structure factor of HRQoL measures. A potential explanation is 
that social, cultural and education factors play a role in how participants perceive 
different health areas. Also, the translation process of HRQoL measures from its 
origin language to Arabic or other intended languages may cause response bias. 
Despite the language equivalence of the Arabic version of HRQoL being well 
established, the response bias might change the basic nature of some of its 
items. Thus, researchers should take more cautious steps when translating 
HRQoL standard measures into Arabic. In addition, intensive psychometric 
testing should be carried out on translated measures. 
Another possible factor that influced the structure of the SF36v2 is that one or 
more of the subscales of SF36v2 have poor measurement properties in patients 
with ESRD. There are a number of indications of this. First, the internal 
consistency was relatively low in two subscales of SF36v2 (general health 
subscales α= .65, and social functioning α= .53). Second, around 220 (48.8 %) 
participants who completed the SF36v2 measure were illiterate and with low-
education level were assisted by the research assistant which may have affected 
the response to the measure items. Finally, the World Health Organization (WHO) 
defines health as a state of complete physical, mental and social well-being and 
not merely the absence of disease or infirmity.   This definition affirms the concept 
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of body-mind connection. Thus, participants may perceive the answer to the items 
of BP, Vitality, and GH subscales from a psychological perspective.    
It is worth noting that no correlation was observed between the individualised QoL 
instrument (SEiQoL-DW) and health-related QoL measures (SF36v2 and QoLI-
dialysis). This may suggest that individualised QoL measures are distinct from 
HRQoL measures and that they assess something different. HRQoL determinates 
are very much individualised and the importance of these determinates is 
influenced by several factors (Roback et al., 2011). These factors can be seen as 
patients’ expectations and ambitions, religious beliefs, culture and socio-
demographic characteristics (Chisholm et al., 2007). Thus, more attention should 
be paid to further develop the patient-generated index so that assessing HRQoL 
can be achieved.  
Although individualised measures have their limitations, a compromise can be 
used to include common factors of life that are important to renal-failure patients 
from the recently developed standardised measures that use direct weighting 
systems (Flokstra-De Blok et al., 2009). It is anticipated that identical trends might 
result in an individualised approach towards assessing patients’ quality of life. 
Nevertheless, the extent of such measures, and how sensitively they reflect the 
individualised QoL, would require further evaluation. The clinical effectiveness and 
interpretability of these measures also will also need to be evaluated and 
established (Johnson et al., 2006).    
3. Implications for Practice 
This section answers RQ5 by providing recommendations to clinicians and policy 
makers regarding concerns for augmenting QoL and HRQoL in patients with 
ESRD based on the study results.  
This study is highly important, given the number of patients in Oman with ESRD, 
the severity of their condition and the cost to the health service in providing ongoing 
support. Its findings therefore could benefit and contribute positively in improving 
patient care at different levels including clinical practice, policy development, and 
Muslim patients worldwide.  
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Nephrologists and nephrology nurses in clinical practice could benefit from the 
current study findings by the potential influence on patients’ HRQoL directly 
through facilitating supportive and educative programmes that could assist ESRD 
patients in rebalancing their lives. This can be achieved through the use of an 
integrated approach therapy that incorporates support groups and religious and 
spiritual counselling. The use of such complementary approaches may expose 
useful interventions that might influence patients’ overall QoL.  
 
The results of the current study can create an evidence base upon which current 
clinical policy and future healthcare services can be developed within the 
nephrology care services in Oman. For instance, currently, the psychological 
services available for patients with ESRD in Oman are limited. Only diagnosed 
patients with significant psychological issues are referred to psychiatry therapy. 
Patients with ESRD experience significant emotional and psychological problems, 
which untreated can have considerable negative impact on their HRQoL. Similarly, 
patients’ perceptions about their ESRD condition are extremely important in 
determining their response to management of ESRD. That is because patients are 
active participants in their own care/treatment plan and for that care providers are 
required to understand and respect the dynamic role that patients have in the 
management of their own disease. This process can be enhanced by the 
application of the Nichol’s Psychological Care Scheme (Figure one). It suggests 
that the key to a better psychological care for this group of patients is the monitoring 
of their psychological state, ensuring provision of information, emotional care, basic 
counselling and advocacy (Nichols, 1993). Given the significant proportion of 
patients with ESRD who could potentially benefit from improved support, the most 
feasible interventions are likely to be low-cost and easy to incorporate into current 
policies and everyday clinical practice. 
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Figure 1: Nichol’s Psychological Care Scheme. 
This research used highly original, patient-centred methods, testing both the 
understanding and the meaning of the concepts of QoL and HRQoL in a 
representative Islamic, Omani sample.  Participants’ reports confirmed that health 
status was an important element and that spirituality was a universal component 
of QoL and HRQoL.  The result therefore has the potential to contribute to the care 
of Muslim patients within the UK health service through understanding the possible 
influence of their religious perceptions on their treatment. It also can inform 
developing a culturally and religiously competent education toolkit tailored to their 
religious beliefs.  
Validating the HRQoL measures in an Omani population will benefit clinical 
practice as it is likely to provide clinicians with specific validated tools to assess 
their patients, which can greatly improve the integration of HRQoL data into clinical 
practice. A major benefit of integrating these measures into routine clinical practice 
is the potential for identifying symptoms and problems that may result in improved 
patient care and clinical outcomes over time. 
Assessing QoL is an important outcome measure for patients with ESRD to ensure 
that their care provides a sense of wellbeing and satisfaction with life. This cannot 
be achieved, however, without patients’ input as it is an individualised concept and 
thus their judgment on this is justifiable. This is clearly revealed by the 
individualised QoL instrument (SEiQoL-DW) in which patients nominated more 
than 14 areas that they perceived as important to their life. Besides the health-
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Information/educational 
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status measure, symptom-specific, disease-specific and spiritual-wellbeing 
measures were used to assist in quantifying the assessment of HRQoL factors. 
Although these measures were developed for research purposes, they could be 
employed in monitoring individual changes in HRQoL over time in dialysis centres 
and clinical settings.  
This study shows that HRQoL was largely not predicted by the biomedical markers 
regularly measured by the ESRD service, and that symptoms were key drivers of 
both disease specific and generic HRQoL.  Symptoms, particularly anxiety and 
depression, appeared to place a burden on dialysis patients with ESRD. A 
recommended intervention is that patients be assessed for symptoms prior to 
initiating the dialysis session. Patients should also be encouraged to discuss their 
symptoms with healthcare providers and not to consider them merely as routine, 
disease-related symptoms. The immediate tackling and managing of symptoms, 
including physical and mental symptoms, is expected to reduce their burden and 
to help in improving patients’ overall QoL (Berlim et al., 2006).  
The result of this study showed that anxiety and depression were highly dominant 
in ESRD patients including those in the Omani context. Special vigilance is 
therefore required for these two symptoms and for depression in particular. 
Depression was more prevalent, at around 43%, and assessing for symptoms 
related to depression could help in providing early interventions (Colin et al., 204).  
Some possible interventions that can be suggested to reduce the depressive 
symptoms in this group of paitnets are to use cognitive behavioural therapy (CBT) 
and exercise programmes. CBT uses well-structured techniques to support 
patients’ logical thinking and ability to recognize negative thoughts, and 
consequently mood status (Hedayati et al., 2012). Studies that used CBT as 
therapy among depressive ESRD patients reported a significant amelioration of 
depressive symptoms (Duarte et al., 2009; Weiner et al., 2010). Likewise, the use 
of physical exercise programmes associated with an improvement in self-reported 
physical functioning on the PF scale of the SF-36 and also a reduction in fatigue in 
the groups that were assigned to exercise (KOLEWASKI et al., 2005; Painter, 
2009).  
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Patients with ESRD are usually at risk of being underdiagnosed for mood 
disorders. This is due to unremarkable symptoms such as feeling tired, sometimes 
interchanged with physical symptoms such as fatigue, which can be understood 
as normal consequences of dialysis treatment. For some patients, women in 
particular, expressing these feelings with a male healthcare worker might be 
embarrassing or unimportant in relation to other existing physical symptoms. 
Emotional health, however, seems to have a large influence on HRQoL. Hence, 
consistent support and a comfortable environment should be developed with each 
patient to allow them to express their feelings. Also, a multidiscipline team should 
be involved in the patient-care plan, including a psychologist, providing social 
support as well as pharmacological interventions. Omani patients reported that 
family relationships were an important source of support, evidenced by the high 
scores on the Family subscale of QoLI-dialysis. Thus, involving family members, 
to an acceptable level, in determining care plans may enhance QoL outcomes. 
Family involvement may also help in detecting changes in behaviour that are not 
reported by the patient so as to ensure continuity of care (Bieber et al, 2014). 
Fatigue was also a significant problem in patients with ESRD on dialysis. It has a 
physical impact on patients as well as an emotional toll. Assessing fatigue levels 
in this group of patients should be carried out on a frequent basis. The challenge, 
however, may be that there is no predetermined norm level of fatigue among 
Omani patients and a further study is required to determine this.  Until then, 
screening the factors that may contribute to the intensity and type of fatigue may 
help in developing interventions for minimising post-dialysis fatigue. When fatigue 
cannot be adequately controlled, it may be that emotional support would help via 
active listening which can provide some empathetic relief.  
Assessing patients’ general health perception could be a significant way for nurses, 
as well as other healthcare providers, to gain an insight into that perception. 
General health perception is a subjective concept and might include functional 
status and physical and mental symptoms (Ferrans et al., 2005). The revised 
Wilson and Cleary model of HRQoL by Ferrans et al is comprehensive and patient-
centred and might guide healthcare providers when assessing HRQoL. According 
to the result of this study, patients’ perception of general health has a significant 
association with overall QoL and thus can be considered a unique indicator of 
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wellbeing. A high level of health perception may also provide validation that overall 
QoL is an acceptable concept. 
Of all the variables tested in this study, religion and spirituality, depression, anxiety, 
fatigue and health perception were the most important in explaining patients’ QoL 
and HRQoL. This finding shows the powerful connection between mind-body-spirit. 
This conclusion corroborates a randomised control study that examined the 
effectiveness of body-mind-spirit intervention in improving well-being, HRQoL and 
functional impairment among patients with depression. This study found that the 
intervention group had a significant improvement in wellbeing and HRQoL scores 
over a six-month period (Rentala et al., 2015). Despite the Rentala study being 
conducted exclusively among depressive patients, not ESRD patients, it is coupled 
with the findings of this study in terms of importance to provide a holistic approach 
to HRQoL. That is, HRQoL cannot be determined merely by health status.  
4. Recommendations for future research 
The majority of studies that examined HRQoL in patients with ESRD have likened 
the term to “health status”, “wellbeing” and “QoL”. This interchangeability in the 
use of this term in the literature has had mixed results. Future studies should 
clearly define the term “HRQoL” and distinguish it from other related terms. Future 
studies examining HRQoL should also consider incorporating different 
approaches of assessment, including the use of different measures to describe 
HRQoL in patients with ESRD. The factors that might possibly affect HRQoL from 
a holistic perspective need to be searched for in future studies. 
Most importantly, given that the concepts of and factors influencing the HRQoL 
are dynamic and could change over time depending on one’s perception, the use 
of an observational longitudinal design would be more useful. Longitudinal study 
would offer a better understanding of the subjective and objective factors that 
may influence one’s HRQoL, including the degree of change, over the life span 
(Bonner et al., 2013).  Special attention however should be paid to the possible 
limitations that this design may include. Repeated measures over time on the 
same patients with same chronic conditions are not independent and might cause 
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issue of withdrawals and loss of follow-up (Curran et al., 2002). HRQoL studies 
also may involve sources of bias including selection bias, heterogeneity issue, 
and confounding (Mangione, 2002).  
This study has used 23 variables representing several antecedents of QoL and 
HRQoL with the guidance of the revised Wilson and Cleary model of HRQoL 
(Ferrans et al., 2005). Five variables were important determinants of Omani 
patients’ overall wellbeing: religion and spirituality, anxiety, depression, fatigue 
and general health perception. Because only these variables were the most 
important across the regression models, other independent variables need to be 
further identified and tested, such as characteristics of the individual and clinical 
factors. Thus, the effect of these variables remains unclear. Future studies 
examining correlation or differences between the variables of the characteristics 
of the individual and HRQoL may provide additional understanding.  
Despite the clear influence of family and social support in Omani patients, marital 
status was shown to be insignificant in explaining patients’ HRQoL. Possible 
future studies looking at the broader concept of family and social support may 
provide further exploration of this aspect. Currently, in Oman, there are no 
specific centres, including dialysis settings, providing social support to ESRD 
patients. Establishing social support and rehabilitation centres within dialysis 
settings may foster patients’ perception of social support. It may also help patients 
to develop skills and strategies that help them to cope with the disease’s chronic 
nature and its related complications and then to apply specific mechanisms of 
disease management to adapt and maintain their lives.  
The sample in this study consisted of Omani Muslim patients affected by ESRD 
and this may limit the results’ generalisability in terms of non-Muslim populations. 
Regional and religious differences may play a role in influencing individuals’ 
perceptions of their health and overall QoL. Further comparative studies need to 
be conducted among ESRD patients to assess perceptions of health and HRQoL 
across different religions and cultures.     
Physical and mood symptoms associated negatively with HRQoL level. Further 
exploration of symptoms related to ESRD is required. While some symptoms may 
be tolerable, there may be a level where patients cannot manage disease-
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associated symptoms over a long period. Hence, longitudinal studies need to be 
conducted to track the full load of symptoms and their possible implications for 
patients’ HRQoL. Categorising patients on dialysis into groups based on length 
of time on dialysis would perhaps assist in exploring the threshold of symptoms 
and explaining strategies of adaptation to symptoms over time.  
Functional status was measured by the subscale of physical functioning of 
SF36v2. The findings revealed that a higher functional status variable was 
associated with better mental health and role-functioning components. Using a 
single subscale, however, to measure the relationship between functional status 
and HRQoL may not be sufficient because of the need to examine this 
relationship by stratifying dialysis patients into different functional categories to 
explore differences in HRQoL. Accordingly, intervention plans should be set and 
tailored for the patients with last stage of renal failure as the level of physical 
function differs through the disease trajectory. 
The revised Wilson and Cleary conceptual model of HRQoL (Ferrans et al., 2005) 
was used to guide this study in the selection of variables and data analyses. While 
this conceptual model provided clear conceptual and operational definitions, it 
requires further testing in ESRD patients as well as in different populations. 
Future studies using this model may assist in testing the relationship among 
HRQoL concepts using structural equation modelling (SEM). This type of formal 
testing could clarify the strength of the concepts of this conceptual model. The 
SEM type of statistical analysis allows for a non-recursive pathway (Munro, 2005) 
which might help in understanding how patients adjust to ESRD.  As formerly 
discussed, patients with ESRD may readjust their general health perception as a 
way to cope with the chronic nature of the disease. The new adjustment may 
positively influence patients’ symptom experience, which in turn may reverse the 
dominant causal flow of the model (Ferrans et al., 2005). Also, the use of SEM 
can be useful to test whether the revised Wilson and Cleary model performs 
equally in different populations. Weak correlation between the concepts of the 
model, if this becomes apparent, can then be identified for amendment. 
General health perception was shown to be an important factor determining 
patients’ HRQoL. This association, however, requires further examination by 
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future studies. An area of research in this aspect could be a comparison of the 
differences between how ESRD patients rate their health status and how 
healthcare providers rate patients’ health status. Determining the causes that 
may influence patients’ and healthcare providers’ perceptions of rating health 
status could provide an insight into the unknown factors. These factors could be 
psycho-social, spiritual, coping strategies, personal traits, or patients’ disease 
perceptions. It is recommended that future research should look for these factors 
and then examine their effects on HRQoL. Interventional programmes could then 
be identified to manage these factors to enhance patients’ HRQoL. 
5. Strengths and limitations of this study 
Several strengths can be seen in this study. First, because no studies had been 
conducted to assess QoL and HRQoL among ESRD patients in Oman, this study 
will fill this gap in the existing knowledge and help in planning appropriate 
interventions to improve patients’ HRQoL. Second, the study may guarantee new 
knowledge and expanded understanding of HRQoL among dialysis patients in 
Oman. Third, it makes a valuable contribution to the validation of HRQoL among 
ESRD patients and to international literature by adding new knowledge in this 
setting. Finally, the information generated by this study about the cultural 
relevance of HRQoL measures could help researchers aiming to standardise 
SF36v2, QoLI-dialysis, HADS, Itch-D Scale and FFS measures across cultures.  
This thesis used highly original, patient-centred methods, testing both the 
understanding and the meaning of the concepts of QoL and HRQoL in a 
representative Islamic, Omani sample.  Participants’ reports confirmed that health 
status was an important element and that spirituality was a universal component 
of QoL and HRQoL.   This study has high levels of rigour, and has, using state of 
the art psychometric approaches for the first time, validated and confirmed the 
factor structure of these key HRQoL measures, adding to our knowledge and 
understanding regarding the measurement of HRQoL in an Islamic context.  
This PhD study has many implications for clinical practice.  It has identified the 
critical importance of QoL and HRQoL as key outcomes in the care of Omani 
ESRD patients which may improve HRQoL in this patient group.  This research 
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specifies the identity and importance of key symptoms that are related to physical 
health status, mental health status and role functioning.  This study has the 
potential to contribute to Omani health policy and to the care of Muslim patients 
within the UK health service. 
Future developments include the exploration and validation of QoLID, knowledge 
mobilisation to patient, practitioner and policy maker groups. Development, 
piloting and evaluation of a patient-centred intervention to support and improve 
HRQoL in ESRD patients in Oman can build on this. 
A number of limitations in this pilot study should be acknowledged. First, although 
the sample was taken from 13 dialysis units across Oman, it may not be 
representative of the entire ESRD population within Oman as patients from 
different regions may perceive their HRQoL differently. Patients from different 
regions and rural areas may have different backgrounds and value systems. A 
larger group of patients from different regions in Oman would strengthen the 
study. Second, although this study used different methods of sampling, including 
random and opt-in sampling techniques, the results might only provide regional 
norms of the study measures, which can be used for comparison purposes until 
establishing normative values for the Omani population. Third, data are required 
on “time since patients started their dialysis” and “time needed to get to the 
dialysis unit”. Results revealed a low HRQoL level among the patients and such 
information would help in assessing the effects of these variables. Fourth, about 
30% of the patients in this study were illiterate. Although the measures were read 
to illiterate patients by trained nurses without any prompts, the answers provided 
may not reflect the true situation. Finally, because patients spend around 12-15 
hours on dialysis each week, recruitment may be enhanced by asking patients to 
participate during their regular dialysis schedule. Haemodialysis can cause 
hypotension and electrolyte imbalance and patients may not have felt at their best 
while answering the piloted measures related to their HRQoL.
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6. Summary  
The aims of this study were to explore the meaning of “QoL” to an Omani 
population, to identify factors that predicted their QoL and HRQoL and to test the 
validity and reliability of HRQoL measures within this setting. Patients nominated 
religion and spirituality, family, personal health, social life and work/occupation as 
their most valued aspects of life. These nominated aspects of ESRD patients’ 
lives could be a reliable guide to the most important priorities for medical 
interventions by neurologists and nephrology nurses, as well as policymakers 
within the healthcare system in Oman.  
Patients reported relatively moderate levels of HRQoL, considering that they 
were suffering from the burden of disease symptoms, lower functional status and 
reasonable general health perceptions. Emotional symptoms, including anxiety 
and depression, had the greatest impact on reducing their HRQoL. This may 
suggest that psychological factors may be better predictors of HRQoL than 
physiological factors. Thus, consistent clinical assessment of anxiety and 
depression symptoms is essential for these patients. Introducing interventions to 
rebalance patients’ moods and incorporate psycho-social support into routine 
care may help them to experience a higher HRQoL (Rentala et al., 2015).   
Future studies should continue to identify and examine factors that may influence 
HRQoL and determine interventions to enhance patients’ overall wellbeing. 
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research." Disability and Rehabilitation 34(13): 1131-1139. 
Carvalho, A. F., et al. (2013). "The psychological defensive profile of hemodialysis patients and its relationship to health-related quality 
of life." The Journal Of Nervous And Mental Disease 201(7): 621-628. 
Focus on psychological 
defensive profile 
Cella, D., et al. (2005). "Defining higher order dimensions of self-reported health: further evidence for a two-dimensional structure." 
Evaluation & the Health Professions 28(2): 122-141. 
General review 
Chwalisz, K. (2008). "The Future of Counseling Psychology: Improving Quality of Life for Persons With Chronic Health Issues." The 
Counseling Psychologist 36(1): 98-107. 
Focus on counselling 
Cicerchia, A. (1996). "Indicators for the measurement of the quality of urban life. What is the appropriate territorial dimension?" Social 
Indicators Research 39(3): 321-358. 
Related to environment 
Claes, C., et al. (2012). "The influence of supports strategies, environmental factors, and client characteristics on quality of life-related 
personal outcomes." Research in Developmental Disabilities 33(1): 96-103. 
Focus on intellectual 
disability 
Clark, E. H. (2002). Quality of life: psychiatric nurses hearing the voices of individuals with severe mental illness, University of Maine. 
Ph.D.: 194 p. 
Focus on mental illness 
Corcoran, M. A. (2007). "Defining and Measuring Constructs." The American Journal of Occupational Therapy 61(1). Relevant to inclusion criteria 
Cote, I., et al. (2000) Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials. 
Pharmacoeconomics 18, 435-450  
Describes the instruments of 
HRQoL 
Crosby, R. D., et al. (2003) Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology 56, 
395-407  
Clinical relevance 
Cudney, S., et al. (2003). "Management of chronic illness: voices of rural women." Journal of Advanced Nursing 44(6): 566-574. Focus on chronic illness 
management 
Curran, D., et al. (2002). "Analysing longitudinal continuous quality of life data with dropout." Statistical Methods in Medical Research 
11(1): 5-23. 
Focus on statistical issues 
Debout, C. (2011). "The concept of quality of life in healthcare, a complex definition]." Soins: La Revue de Reference Infirmiere(759): 
32-34. 
Relevant to inclusion criteria 
(article in French Language) 
Diener, E., et al. (2013). "Theory and Validity of Life Satisfaction Scales." Social Indicators Research 112(3): 497-527. Focus on satisfaction scale 
Dyess, S. M. (2011). "Faith: a concept analysis." Journal of Advanced Nursing 67(12): 2723-2731. Relevant to inclusion criteria 
Ebrahim, S. H., et al. (2007) Reporting on health-related quality of life in Cochrane reviews - a challenge for authors? [abstract]. XV 
Cochrane Colloquium; 2007 Oct 23-27; Sao Paulo, Brazil 116-117  
Relevant to inclusion criteria 
(still under review)  
Eckersley, R. (2013). "Subjective Wellbeing: Telling Only Half the Story: A Commentary on Diener et al. (2012). Theory and Validity of 
Life Satisfaction Scales. Social Indicators Research." Social Indicators Research 112(3): 529-534. 
Commentary paper 
Fang, J., et al. (2011). "The response scale for the intellectual disability module of the WHOQOL: 5-point or 3-point." Journal of 
Intellectual Disability Research 55(6): 537-549. 
Focus on disability module 
Farsides, B. and R. J. Dunlop (2001). "Is there such a thing as a life not worth living? Measuring quality of life." British Medical Journal 
322(7300): 1481-1483. 
Focus on termination of 
pregnancy 
Ferrin, J. M., et al. (2011). "Psychometric validation of the Multidimensional Acceptance of Loss Scale." Clinical Rehabilitation 25(2): 
166-174. 
Focus on loss scale 
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Fetherman, D. L., et al. (2011). "A pilot study of the application of the transtheoretical framework during strength training in older 
women." Journal of Women and Aging 23(1): 58-76. 
Focus on strength training 
Fink, A. M. (2009). "Toward a new definition of health disparity: a concept analysis." Journal of Transcultural Nursing 20(4): 349-357. Focus on health disparity 
Fleming, S. and D. S. Evans (2008). "The concept of spirituality: its role within health promotion practice in the Republic of Ireland." 
Spirituality & Health International 9(2): 79-89. 
Relevant to inclusion criteria 
Flynn, R., et al. (2005). "The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory?" 
Social Science & Medicine 60(4): 833-843. 
Focus on clinical decision 
making 
Frankel, A. (2009). "Nurses' learning styles: promoting better integration of theory into practice." Nursing times 105(2): 24-27. Relevant to inclusion criteria 
Frisch, M. B. (2013). "Evidence-Based Well-Being/Positive Psychology Assessment and Intervention with Quality of Life Therapy and 
Coaching and the Quality of Life Inventory (QOLI)." Social Indicators Research 114(2): 193-227. 
No sufficient data provided  
Gall, T. L., et al. (2011). "Spirituality and Religiousness: A Diversity of Definitions." Journal of Spirituality in Mental Health 13(3): 158-
181. 
Relevant to inclusion criteria 
Ghylin, K. M., et al. (2008). "Clarifying the dimensions of four concepts of quality." Theoretical Issues in Ergonomics Science 9(1): 73-
94. 
Focus on industry quality 
Gibson, B., et al. (2005). "Variation and change in the meaning of oral health related quality of life: a "grounded" systems approach." 
Social Science & Medicine 60(8): 1859-1868. 
Focus on oral health quality 
of life  
Gill, L., et al. (2010). "Transitional aged care and the patient's view of quality." Quality in Ageing & Older Adults 11(2): 5-18. Focus on health service 
quality 
Gillison, F. B., et al. (2006). "Relationships among adolescents' weight perceptions, exercise goals, exercise motivation, quality of life 
and leisure-time exercise behaviour: A self-determination theory approach." Health Education Research 21(6): 836-847. 
Focus on adolescent’s 
weight 
Giordano, G. N., et al. (2012). "Social capital and self-rated health – A study of temporal (causal) relationships." Social Science & 
Medicine 75(2): 340-348. 
Focus on social capital role 
González, A., et al. (2012). "Motivational and emotional profiles in university undergraduates: A self-determination theory perspective." 
Spanish Journal of Psychology 15(3): 1069-1080. 
No abstract 
Hagerty, M. R., et al. (2001). "Quality of life indexes for national policy: review for research." Social Indicators Research 55(1): 1-96. Focus on life indexes 
Hallinen, T., et al. (2009). "Costs and quality of life effects of the first year of renal replacement therapy in one Finnish treatment 
centre." Journal Of Medical Economics 12(2): 136-140. 
Focus on renal transplant 
Halvari, A. E. M., et al. (2013). "Oral health and dental well-being: Testing a self-determination theory framework." Journal of Applied 
Social Psychology 43(2): 275-292. 
Focus on oral heath 
Hanestad, B. R. (1996). "Nurses' perceptions of the content, relevance and usefulness of the quality of life concept in relation to 
nursing practice." Vard i Norden 16(1): 17-21. 
Not relevant to inclusion 
criteria 
Hawthorne, G. (2009). "Assessing utility where short measures are required: development of the short Assessment of Quality of Life-8 
(AQoL-8) instrument." Value In Health: The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 
12(6): 948-957. 
Methodological paper 
Herbert, R. J., et al. (2009). "A systematic review of questionnaires measuring health-related empowerment." Research & Theory for 
Nursing Practice 23(2): 107-132. 
focus on health related 
empowerments 
Hiemstra, M., et al. (2012). "Smoking-specific communication and children's smoking onset: An extension of the theory of planned Focus on children population 
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behaviour." Psychology and Health 27(9): 1100-1117. 
Holt, J. (2000). "Exploration of the concept of hope in the Dominican Republic." Journal of Advanced Nursing 32(5): 1116-1125. Focus on Dominican republic 
Ismael, S. T. (2002). "A PAR approach to quality of life: frameworking health through participation." Social Indicators Research 60(1-
3): 41-54. 
Focus on Canadian 
government health vision 
Jalowiec, A., et al. (2007). "Predictors of Perceived Coping Effectiveness in Patients Awaiting a Heart Transplant." Nursing Research 
56(4): 260-268. 
Focus on predictors 
Johnson, M., et al. (2012). "Professional identity and nursing: Contemporary theoretical developments and future research 
challenges." International Nursing Review 59(4): 562-569. 
Focus on professional 
identity 
Johnson, M. E., et al. (2007). "Measuring spiritual quality of life in patients with cancer." Journal of Supportive Oncology 5(9): 437-442. Focus on spiritual domain 
Julkunen, J. and R. Ahlstrom (2006). "Hostility, Anger, and Sense of Coherence As Predictors of Heath-Related Quality of Life. 
Results of an ASCOT Substudy." Journal of Psychosomatic Research 61(1): 33-39. 
Focus on predictors 
Kaasa, S. and J. H. Loge (2003). "Quality of life in palliative care: principles and practice." Palliative Medicine 17(1): 11-20. Focus on principles and 
practice 
Kemmler, G., et al. (2010) A new approach to combining clinical relevance and statistical significance for evaluation of quality of life 
changes in the individual patient. Journal of Clinical Epidemiology 63, 171-179  
Clinical relevance 
kritsonis, a. (2005). "comparison of change theories." International journal of scholarly academic intellectual diversity 8(1): 3-7. Focus on change theory 
Krueger, J. I., et al. (2013). "Comparisons in research and reasoning: Toward an integrative theory of social induction." New Ideas in 
Psychology 31(2): 73-86. 
No abstracts 
Lach, L. M., et al. (2006). "Health-related quality of life in youth with epilepsy: Theoretical framework for clinicians and researchers. 
Part I: The role of epilepsy and co-morbidity." Quality of Life Research 15(7): 1161-1171. 
Focus on youth population 
Lambiri, D., et al. (2007). "Quality of Life in the Economic and Urban Economic Literature." Social Indicators Research 84(1): 1-25. Focus on economic literature 
Lang, H.-C., et al. (2012). "Quality Of Life, Treatments, and Patients' Willingness to Pay for a Complete Remission of Cervical Cancer 
in Taiwan." Health Economics 21(10): 1217-1233. 
Focus on payment 
preferences 
La-Placa, V., et al. (2003). "Defining and using quality of life: a survey of health care professionals." Clinical Rehabilitation 17(8): 865-
870. 
Focus on health care 
professionals 
Lasseter, J. A. (2009). "Chronic Fatigue: Tired of Being Tired." Home Health Care Management & Practice 22(1): 10-15. Focus on chronic fatigue 
Lemmens, K. M. M., et al. (2008). "Designing patient-related interventions in COPD care: Empirical test of a theoretical framework." 
Patient Education and Counseling 72(2): 223-231. 
Focus on interventions 
Leung, K.-f., et al. (2005). "Development and validation of the Chinese Quality of Life Instrument." Health And Quality Of Life 
Outcomes 3: 26-26. 
Methodological study 
Lindelöf, N., et al. (2012). "Experiences of a high-intensity functional exercise programme among older people dependent in activities 
of daily living." Physiotherapy Theory and Practice 28(4): 307-316. 
Focus on exercise 
programme 
Lopez, E. D. S., et al. (2005). "Quality-of-Life Concerns of African American Breast Cancer Survivors Within Rural North Carolina: 
Blending the Techniques of Photovoice and Grounded Theory." Qualitative Health Research 15(1): 99-115. 
Describe the blended photo 
voice method 
Mandhouj, O., et al. (2012). "French-language version of the World Health Organization quality of life spirituality, religiousness and 
personal beliefs instrument." Health And Quality Of Life Outcomes 10: 39-39. 
Non-English language 
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Mann, M., et al. (1986). "OASIS: a new concept for promoting the quality of life for older adults." American Journal of Occupational 
Therapy 40(Nov 86): 784-786. 
Describes a programme 
located in stores for older 
people 
Mary, D.-W. (2011). "Using framework-based synthesis for conducting reviews of qualitative studies." BMC Medicine: 39. Focus on conducting reviews 
Mehrez, A. and A. Gafni (1990). "Evaluating health related quality of life: an indifference curve interpretation for the time trade-off 
technique." Social Science and Medicine 31(1990): 1281-1283. 
Focus on trade-off technique 
Mellon, L., et al. (2013). "Factors influencing adherence among Irish haemodialysis patients." Patient Education and Counseling 92(1): 
88-93. 
Focus on HD influencing 
technique 
Mitchell, G. J. (1990). "The lived experience of taking life day-by-day in later life: research guided by Parse's emergent method." 
Nursing Science Quarterly 3(1): 29-36. 
Focus on lived experience in 
later life 
Montpetit, M. A., et al. (2006). "Adaptive change in self-concept and well-being during conjugal loss in later life." International Journal 
of Aging & Human Development 63(3): 217-239. 
Focus on self-concept on 
conjugal loss 
Moreira-Almeida, A. and H. G. Koenig (2006). "Retaining the Meaning of the Words Religiousness and Spirituality: A Commentary on 
the WHOQOL SRPB Group's "A Cross-Cultural Study of Spirituality, Religion, and Personal Beliefs As Components of Quality of Life" 
(62: 6, 2005, 1486-1497)." Social Science & Medicine 63(4): 843-845. 
A commentary paper 
Mullaney, A. and G. Pinfield (1996). "No indication of quality or equity." Town and Country Planning 65(5): 132-133. Focus on equity 
Mystakidou, K., et al. (1999). "Quality of life as a parameter determining therapeutic choices in cancer care in a Greek sample." 
Palliative Medicine 13(5): 385-392. 
Focus on therapeutic 
choices 
Noll, H. H. (2002). "Towards a European system of social indicators: theoretical framework and system architecture." Social Indicators 
Research 58(1-3): 47-87. 
Focus on European system 
of social indicators 
O'Connell, K. A. and S. M. Skevington (2010). "Spiritual, religious, and personal beliefs are important and distinctive to assessing 
quality of life in health: A comparison of theoretical frameworks." British Journal of Health Psychology 15(4): 729-748. 
Theoretical comparison 
Painter, P., et al. (2012). "Effects of modality change on health-related quality of life." Hemodialysis International. International 
Symposium On Home Hemodialysis 16(3): 377-386. 
Focus on dialysis modality 
change on HRQOl 
Pastrana, T., et al. (2008). "A matter of definition - key elements identified in a discourse analysis of definitions of palliative care." 
Palliative Medicine 22(3): 222-232. 
Focus on palliative care 
Paterson, B. L., et al. (2001). "Critical analysis of self-care decision making in chronic illness." Journal of Advanced Nursing 35(3): 
335-341. 
Focus on self-care decision 
making 
Patrick, D., et al. (2005) Meta-analyses and systematic reviews of quality of life outcomes: preliminary results and work in progress 
[abstract]. XIII Cochrane Colloquium; 2005 Oct 22-26; Melbourne, Australia 127  
On-going study 
Perlman, R. L., et al. (2005). "Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research 
Institute-CKD study." American Journal Of Kidney Diseases: The Official Journal Of The National Kidney Foundation 45(4): 658-666. 
Comparison study between 
dialysis treatment 
Peruniak, G. S. (2008). "The Promise of Quality of Life." Journal of Employment Counseling 45(2): 50-60. General paper 
Portillo, M. C. (2009). "Understanding the practical and theoretical development of social rehabilitation through action research." 
Journal of Clinical Nursing 18(2): 234-245. 
No sufficient information 
Read, J. L., et al. (1987) Measuring overall health: an evaluation of three important approaches. Journal of Chronic Diseases 40, 7s-
26s 
General review paper 
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Reininghaus, U. and S. Priebe (2012). "Measuring patient-reported outcomes in psychosis: conceptual and methodological review." 
The British Journal of Psychiatry 201(4): 262-267. 
Focus on outcome in 
psychosis 
Roberts, J. A. and A. Clement (2007). "Materialism And Satisfaction With Over-All Quality Of Life And Eight Life Domains." Social 
Indicators Research 82(1): 79-92. 
Focus on materialism and 
satisfaction 
Royuela, V. and J. Surinach (2005). "Constituents of Quality of Life and Urban Size." Social Indicators Research 74(3): 549-572. Focus on urban size 
Sartorius, N. (1995). "Rehabilitation and quality of life." International Journal of Mental Health 24(1): 7-13. Focus on rehabilitation 
Schunemann, H. J., et al. (2006) Interpreting the results of patient reported outcome measures in clinical trials: the clinician's 
perspective. Health And Quality Of Life Outcomes 4, 62  
Focus on interpreting 
patient’s report 
Senzon, S. A. (1999). "Causation related to self-organization and health related quality of life expression based on the vertebral 
subluxation framework, the philosophy of chiropractic, and the new biology." Journal of Vertebral Subluxation Research (JVSR) 3(3): 
1-9. 
Focus on causation related 
to self-organisation 
Shaw, C., et al. (2008). "How people decide to seek health care: A qualitative study." International Journal of Nursing Studies 45(10): 
1516-524. 
Focus on service use 
Siegrist, J. (2001). "Stress, ageing and quality of life." European Review 9(4): 487-499. Focus on stress and aging 
Sirgy, M. J. (1998). "Materialism and quality of life." Social Indicators Research 43(3): 227-260. Focus on materialism 
Stuifbergen, A. K., et al. (1990). "Perceptions of health among adults with disabilities." Health Values: The Journal of Health Behavior, 
Education & Promotion 14(2): 18-26. 
Focus on health perception 
among disabilities 
Suh, E. E. (2004). "The framework of cultural competence through an evolutionary concept analysis." Journal of Transcultural Nursing 
15(2): 93-102. 
Discussion paper 
Tayeb, M. A., et al. (2010). "A "good death": perspectives of Muslim patients health care providers." Annals of Saudi Medicine 30(3): 
215-221. 
Focus on good death 
Taylor, C. L. C., et al. (2007). "A social comparison theory analysis of group composition and efficacy of cancer support group 
programs." Social Science & Medicine 65(2): 262-273. 
Focus on support group 
programme 
Thomé, B., et al. (2003). "Home care with regard to definition, care recipients, content and outcome: systematic literature review." 
Journal of Clinical Nursing 12(6): 860-872. 
Focus on definition of home 
care 
Twycross, R. G. (1987). "Quality before quantity - a note of caution." Palliative Medicine 1(1): 65-72. Focus on the aim of 
medicine from the cradle to 
grave 
Walker, H., et al. (2012). "Are they worth it? A systematic review of QOL instruments for use with mentally disordered offenders who 
have a diagnosis of psychosis." British Journal of Forensic Practice 14(4): 252-268. 
Focus on instrument specific 
to mental disorders 
Wan, C., et al. (2011). "Development and Validation of the General Module of the System of Quality of Life Instruments for Chronic 
Diseases and Its Comparison with SF-36." Journal of Pain and Symptom Management 42(1): 93-104. 
Methodological study/review 
two 
Wasserman, L. I., et al. (2002). "Concepts of rehabilitation and quality of life: their continuity and differences in modern approaches." 
International Journal of Mental Health 31(1): 24-37. 
Focus on rehabilitation 
concept in modern approach 
Weinert, C., et al. (2008). "Evolution of a Conceptual Framework for Adaptation to Chronic Illness." Journal of Nursing Scholarship 
40(4): 364-372. 
Focus on evaluation of 
conceptual framework  
Wiesmann, U., et al. (2008). "Dimensions and profiles of the generalized health-related self-concept." British Journal of Health Focused on self-concept 
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Psychology 13(Pt 4): 755-771. 
Wood, A. M., et al. (2010). "Gratitude and well-being: A review and theoretical integration." Clinical Psychology Review 30(7): 890-
905. 
Focus on gratitude. 
Yin, M. S. (2013). "Fifteen years of grey system theory research: A historical review and bibliometric analysis." Expert Systems with 
Applications 40(7): 2767-2775. 
Discussion paper 
Young, Y., et al. (2009). "Can successful aging and chronic illness coexist in the same individual? A multidimensional concept of 
successful aging." Journal of the American Medical Directors Association 10(2): 87-92. 
Focus on aging concept 
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Appendix 2.2 Critical Appraisal Checklist for Discussion Papers of Review-1: Discussion articles. (adopted from 
JBI) 
Author 
Criteria  
Yes = ✓ 
No = × 
Unclear = UN 
Yes = ✓ 
No = × 
Unclear = UN 
Yes = ✓ 
No = × 
Unclear = UN 
Yes = ✓ 
No = × 
Unclear = UN 
Yes = ✓ 
No = × 
Unclear = 
UN 
Yes = ✓ 
No = × 
Unclear = UN 
Yes = ✓ 
No = × 
Unclear = UN 
Is the source of 
opinion/discussi
on clearly 
identified? 
Does the source 
of the discussion/ 
opinion have 
standing in the 
field of expertise? 
Are the interests 
of 
patients/clients 
the central focus 
of the opinion? 
Is the 
discussion/ 
opinion’s basis 
in 
logic/experience 
clearly argued? 
Is the 
argument 
developed 
analytical? 
Is there reference 
to the extant 
literature/ evidence 
and any 
incongruence with 
it logically 
defended? 
Is the 
discussion/ 
opinion 
supported by 
peers? 
Anderson & 
Burckhardt (1998) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Camfield & 
Skevington (2013) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Carr & Higginson 
(2001) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Carr et al (2001) ✓ UN ✓ ✓ ✓ ✓ UN 
Chung et al (1997) ✓ ✓ ✓ ✓ ✓ ✓ × 
Cohen & Kimmet 
(2013) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Dijkers M (2006) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Downie R (2000) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Farquhar M (1994) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Felce (1997) ✓ ✓ ✓ ✓ ✓ ✓ UN 
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George & Bearon 
(1980) 
✓ ✓ UN ✓ ✓ ✓ ✓ 
Gill T (1995) ✓ ✓ ✓ ✓ ✓ ✓ × 
Gladis et al (1999) ✓ ✓ UN ✓ ✓ ✓ ✓ 
Gokal et al (1999) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Hagerty M (1998) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Hass B (1999) ✓ ✓ ✓ ✓ ✓ ✓ UN 
Hass et al (1999) ✓ ✓ UN ✓ ✓ ✓ × 
Hendry & McVittie 
(2004) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Holmes S (2005) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Koller et al (2005) ✓ UN ✓ ✓ ✓ ✓ × 
Meeberg (1992) ✓ ✓ UN ✓ ✓ ✓ UN 
Moons et al (2006) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Muldoon et al (1998) ✓ ✓ ✓ ✓ ✓ ✓ × 
Ravenek et al (2013) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Rebollo & Ortega 
(2002) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Schalok R (2004) ✓ ✓ ✓ ✓ ✓ ✓ UN 
Smith A (2000) ✓ ✓ ✓ ✓ ✓ ✓ UN 
Tienery et al (2007) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Ventegot et al 
(2003) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Vitterso J (2003) ✓ ✓ UN ✓ ✓ ✓ UN 
Zhan L (1991) ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
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Appendix 2.3.  A summary of the empirical studies results of Review-1. 
 
Author country 
Methodology 
Results Design/sampling 
method 
Size and 
characteristics of 
sample 
Measure 
Abdel-Kader et al 
(2009) 
USA Cross-sectional design 
151 patients 
undergoing 
peritoneal or 
haemodialysis. 
SEiQOL-DW 
Family and health were 
the most common domain 
for patients. No significant 
differences in SEiQOL-
DW scores between 
subgroups.  SEiQOL-DW 
scores correlated mental 
wellbeing (r= -.22, p 
<0.010). 
Bailey et al (2007) USA Cross-sectional 
332 psychology and 
business students 
from Baylor 
University 
Trait Hope 
Scale, and 
Quality of life 
Inventory (QOLI) 
The internal reliabilities of 
both scales were above 
0.70. Alphas for the 
scales were: Hope scale= 
0.79 and QOLI= 0.73. 
Fagerlind et al 
(2009) 
Sweden 
A phenomenograpic 
Qualitative design 
Semi structured 
interviews of 22 
patients with 
rheumatoid arthritis 
Interviews 
analysed by 
using QSR 
NUD*IST VIVO 
Two concepts ‘being 
health’ and ‘being able to 
function normally’ 
overlapped with 
respondents 
understanding of QoL. 
Garratt et al (1993) UK 
Observational study, 
postal questionnaire to 
check if SF-36 is a 
1700 patients with 
one of four conditions 
(low back pain, 
SF-36 
The SF-36 satisfied 
rigorous psychometric 
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suitable measure for 
routine use within the 
NHS. 
menorrhagia, 
suspected peptic 
ulcer, varicose veins) 
criteria for validity and 
internal consistency.  
Internal consistency 
(0.55-0.78) 
Validity (factor analysis 
identified 5 relevant 
factors with eigenvalues 
12.8 to 1.3 
Huber et al (2010) USA Cross-sectional design 
278 women with HIV 
disease 
Chronic Illness 
Quality of Life 
Ladder 
(CIQOLL) 
All internal consistency 
alpha coefficients were 
(0.91-0.95). 
Inter-item correlations 
(r=0.30-0.70). 
Kerthong et al 
(2008) 
Thailand Cross-sectional design 
A stratified four-stage 
random sampling of 
422 heart-failure 
patients 
Enhancing 
Recovery in 
Coronary Heart 
Disease Social 
Support 
Instrument; 
Cardiac 
Symptom 
Survey; the New 
York Heart 
Association 
functional 
classification 
system; and a 
100-mm 
horizontal visual 
Wilson and Cleary’s 
HRQoL fit well with the 
empirical data (X2=19.87, 
df=13, p=0.10, GFI=0.99, 
and RMSEA=0.04). 
Symptom status was the 
most influential factor 
affecting HRQoL and 
social support was the 
least influential factor 
affecting HRQoL. 
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analogue scale 
of GHP. 
Kurpas et al (2012) Poland Cross-sectional design 
131 advanced age 
patients with 
chronically ill primary 
care 
WHOQoL-bref 
Highest score was on 
social relationship (M= 
12.38 ± 2.75) and lowest 
was in the psychological 
domain (M= 12.38 ± 2.66) 
Murphy H & Murphy 
E (2006) 
UK 
Comparative 
observational study 
104 participants 
52 mental health 
service users 
20 general 
population 
WHOQOL-100 
Significant differences 
between the two groups 
in 4 domains of the 
WHOQoL (independence 
and social relationships 
t=12.150, p<0.001 and 
t=7.252, p<0.001) 
O’Boyle et al (1992) Ireland 
Prospective study (6 
months) 
20 patients 
undergoing unilateral 
hip-replacement 
SEiQOL 
Health status significantly 
improved by hip 
replacement (p<0.001) 
Prince P & Gerber 
G (2001) 
Canada Qualitative study 
Convenience sample 
of 36 patients serious 
mental illness 
SEiQOL-DW 
The SEiQOL-DW well 
accepted measure. The 
SEiQOL-DW global index 
(69.04, SD=24.58) was 
correlated with the 
satisfaction with life scale 
(SWLS) (20.97, SD= 
8.33). 
Rao et al (2008) USA Cross-sectional design 898 
Functional 
assessment of 
cancer therapy-
general (FACT-
G) 
Subscale scores: 
Physical wellbeing: 
p<0.001 
Social wellbeing: p<0.001 
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Emotional wellbeing: 
p<0.001 
Rudolf & Priebe 
(1999) 
German 
Longitudinal study. 
Interview within the 
first three weeks of 
admission 
185 women (42 
women with 
depression, 70 
women with 
alcoholism, 73 
women with 
Schizophrenia) 
SQOL 
Depressive women after 
admission express low 
SQOL ((sub-scale: 
anxiety/depression [r:-.40, 
p<0.05], activation [r:-.40, 
p<0.05], thought disorder 
[r: -.46, p<0.01] 
Saban et al (2007) USA 
Longitudinal one-group 
Pilot study 
57 patients 
undergoing elective 
lumber spinal surgery 
SF-36 
HRQoL significantly 
improved postoperatively 
(t[56] = 6.45, p<.01). 
Seongkum et al 
(2008) 
Canada Qualitative design 
Convenience sample 
of 20 patients 
Interviews 
guided by a set 
of questions to 
standardise the 
content of 
interview 
Patient’s definition of QoL 
their active pursuit of 
happiness and 
relationships with others. 
Patient’s self-evaluation 
of QoL reflected their 
adopted perception to 
their changed clinical 
condition and their 
positive outlook. 
Soaban et al (2008) USA 
Prospective 
observational study 
322 veterans 
receiving HD 
SF-6D 
KDCS 
The SF-6D correlated 
.911 (p<.05), indicating 
83% of the variance in the 
7-subscales of KDCS 
measure. 
Souse K & Kwok O 
(2006) 
USA Cross-sectional 917 HIV patients 
AIDS-specific 
symptoms scale 
The range of correlations 
(n=917) for the 
composites of each 
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domain were: symptom 
status, 0.27-0.56; 
functional health, 0.77-
0.97; general health 
perception, 0.81; and 
overall QoL, 0.70. 
Souse K & 
Williamson A (2003) 
USA 
Longitudinal design (3 
years) 
99 patients were 
presenting to the 
emergency 
department 
SF-36 
Symptom status is a key 
predictor of HRQoL. The 
baseline symptom status 
contributed 20.2% 
(p=0.001) of the variance 
explained the baseline 
physical score, and 
symptom status at follow-
up 23.2% (p= 0.001). 
symptom status explained 
the variance in baseline 
and follow-up mental 
scores (9.8%, p= 0.001 
and 29.2%, p= 0.001) 
Soyupek et al 
(2010) 
Turkey Cross-sectional design 40 patients 
Quality of Life 
Inventory (QOLI) 
Self-concept and QoL of 
these patients were lower 
(p<0.001). 
Sprangers et al 
(2002) 
Netherland Cross-sectional design 
217 consecutive 
cancer patients in the 
acute phase of their 
illness vs 192 
disease free cancer 
patients 
Activities of Daily 
Living Scale 
Patient with cancer 
reported poorer QoL 
(p<0.001). 
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Staniszewska et al 
(1999) 
UK Qualitative study 
25 ethnic group (15 
Indian patients and 
10 white patients) 
SF-36 
No differences identified 
between the two groups.  
Staniszewska S 
(1999) 
UK Qualitative study 
Semi-structured 
interviews for 33 
cardiac patients to 
explore the possibility 
of extending the 
evaluation of health 
by patient’s 
expectation concept. 
SF-36 
Comparison of the 
content of patient 
expectations with the SF-
36 found some overlap 
but indicated that patients 
seemed to adopt a 
broader approach to their 
health (internal 
consistency (0.82 and 
0.88) 
Tavernier et al 
(2011) 
USA Qualitative design 
Cognitive 
interviewing to 
explore patients with 
cancer 
understanding of PGI 
(7 men and 8 
women) 
PGI 
Interview data supported 
the content validity of the 
PGI in comprehensively 
defining and adequately 
sampling participant 
HRQoL as an 
individualised construct. 
Tokuda et al (2009) Japan Cohort study design 
3344 participants 
(53% women; 
median ager 35 
years) 
SF- 36 
One factor was retained 
(eigenvalue, 4.65; 
variance proportion 
f0.58). All item response 
category characteristic 
curves satisfied the 
monotonicity assumption 
in accurate order with 
corresponding ordinal 
responses. 
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Unruh et al (2003) USA 
Comparative study : 
self-administered vs 
interviewer-
administered surveys 
in HD patients 
978 HD patients: 
N= 427 interview 
survey 
N= 551 self-
administered 
KDQOL-SF 
The interviewer group: 
had higher scores on 
sales that measured role-
physical, role-emotional 
and effects of kidney 
disease (p<0.001). 
Verdugo et al 
(2012) 
Spain 
Analyses of the 
relationship between 
eight core QoL 
domains and 34 
articles contained in 
the Convection. 
(The concept of QoL 
and its role in 
enhancing human 
rights of persons with 
intellectual disability) 
- - 
There is a close 
relationship between the 
core QoL domains 
(independence, social 
interaction, and wellbeing) 
and the 34 articles 
contained in the 
Convection. Three 
strategies can be used to 
enhance human rights of 
persons with intellectual 
disability: employ person-
centred planning, publish 
provider profiles and 
implement as system of 
support. 
Wu. A et al (2004) USA 
Prospective cohort 
study 
Baseline: 698 HD 
230 PD 
I year: 452 HD 
133 PD 
SF-36 
Better HRQoL for PD 
patients (bodily pain, 
travel, diet restriction, and 
dialysis access [p<0.05]). 
At 1 year, SF-36 scores 
improved. HD patients 
had greater improvement 
in domains (physical 
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functioning and general 
health perception). 
Zadeh K & Unruh M 
(2005) 
USA Cohort study 
10,030 dialysis 
patients 
KDQOL-SF 
Patients in the lowest 
quintile of physical score, 
the adjusted relative risk 
(RR) of death was 93% 
higher (RR= 1.93, 
p<0.001) and the risk of 
hospitalisation was 56% 
higher (RR= 1056, 
p<0.001). 
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Appendix 2.4. Results of the articles analysed QoL concept (Review-1) 
Author (year) Category Purpose and Context 
Participant 
Characteristics 
(if any) 
Main Findings and Limitations 
(Meeberg 
1993) 
A concept 
analysis paper 
Purpose: to clarify the 
concept of QoL for further 
use. 
Context:  Health care  
Setting: - 
Country:  Canada  
- 
o A clarified definition of QoL is proposed, as “QoL 
is a feeling of overall life satisfaction, as 
determined by the mentally alert individual 
whose life is being evaluated”. 
o Individual’s living conditions should meet their 
basic life needs. 
o QoL both subjective and objective components 
(Man Cheung, 
Killingworth 
et al. 1997) 
A concept 
analysis paper 
Purpose: to examine 
briefly the concept of QoL 
by using some 
philosophical thoughts, 
particularly those from 
Ludwig Wittgenstein 
(1889-1951). 
Context:  Health care 
Setting: - 
Country:  UK 
- 
o Authors believe that QoL concept is humanly-
made arbitrary products. 
o Health care researchers should remain critical 
about the usage of QoL concepts and keep re-
examining them. This study look at such topic 
with new perspectives which generate new 
insights. 
o Philosophy has a role to play in understanding 
some issues in health care research. 
(Haas 1999) 
A concept 
analysis paper 
Purpose: to analyse how 
the concept of QoL is 
currently being defined 
and used within health 
care. 
Context:  health care 
Setting: - 
Country:  USA 
- 
o The analysis supports the theorists who 
advocate QoL’s comprising subjective and 
objective indicators.  
o Future efforts are required in developing an 
understanding of QoL to be directed towards two 
major areas: (a) the concepts of QoL must be 
further refined and opposing conceptual 
perspectives must be resolved; (b) the 
differentiation of QoL from closely related 
concepts such as well-being, life satisfaction, 
functional status and health status. 
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(Dupuis, Le 
May et al. 
2003) 
Systematic 
review paper 
Purpose: (a) to identify 
the most frequently used 
HRQoL models and (b) 
critique those models 
Context:  health care 
Setting: - 
Country:  USA 
 
 
- 
o The most frequently used HRQoL models were: 
Wilson and Cleary (16%), Ferrans and 
Colleagues (4%), or WHO (5%). Ferrans and 
colleague’s model was a revision of Wilson and 
Cleary’s model and appeared to have the 
greatest potential to guide future HRQoL 
research and practice. 
o Search strategy were limited to selected 
databases (PubMed, MEDLINE, CINAHL and 
PsychINFO) and limited time of 10 years.  
o Most of analysed articles were descriptive, 
correlational or literature reviews. 
(Schalock 
2004) 
A discussion 
paper 
Purpose: to summarise 
the current understanding 
of the construct of 
individual QoL (as spate 
from family or health 
related) as it pertains to 
persons with intellectual 
disabilities. 
Context:  health care 
Setting: - 
Country:  USA 
 
- 
o Currently, QoL is an important concept in service 
delivery principle, along with its current use and 
multidimensional nature. QoL researchers 
beginning to understand the importance of 
methodological pluralism in the assessment of 
QoL, the multiple uses of quality indicators, the 
predictors of assessed QoL, the effects of 
different data collection strategies and the etic 
(universal) and Emic (culture-bound) properties 
of the construct. Yet to understand fully the use 
of QoL-related outcomes in programme change, 
how to best evaluate the outcomes of QoL-
related services. 
(Moons, 
Budts et al. 
2006) 
A discussion 
paper 
Purpose: to present an 
overview and critique of 
different conceptualisation 
of QoL, with the ultimate 
goal of making QoL a less 
ambiguous concept. 
Context:  health care 
Setting: - 
Country:  Belgium 
- 
o Defining QoL in terms of life satisfaction is most 
appropriate because this definition successfully 
deals with all the conceptual problems discussed 
within this paper. 
o It is recommended that researchers and theorists 
can initiate conceptual debates with the aim of 
making QoL a less ambiguous concept. 
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(Camfield and 
Skevington 
2008) 
Literature 
review paper 
Purpose: to review 
literatures that could 
improve understanding 
about the relationship 
between 
conceptualisations of QoL 
and subjective well-being. 
Context:  health 
psychology 
Setting: - 
Country:  UK 
- 
o The definition of subjective well-being derived by 
an expert panel displays high convergence with 
an international definition of QoL. 
o Cross-cultural evidence showed that subjective 
well-being and QoL contained a substantial 
component of life satisfaction.  
o Increased material resources (objective factors) 
do not directly lead to improvements in 
subjective well-being, however might influence 
some of subjective factors. 
o Social capital acts as a buffer to poor QoL and 
subjective well-being in poorer communities. 
(Murphy and 
Murphy 2006) 
 
Purpose: to compare QoL 
in individuals with server 
mental illness against a 
sample of the general 
population and to 
investigate the role of 
self-esteem, self-efficacy 
and social functioning. 
Context:  mental health 
 
 
o Significant differences found between clinical 
and non-clinical groups in four domains of the 
QHOQOL-100 and in a majority of the aspects 
within domains. 
o Participants with mental illness have similar need 
to a normal population in terms of social support 
and social networks. 
o Some key variance exist between the samples in 
terms of age, employment, marital status and 
education. 
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Appendix 3.1.  Excluded articles with reasons (Review 2) 
 
Study title 
Reasons for 
exclusion 
1. Auslander, G. K., et al. (2003). "Quality of life of patients with end-stage renal disease at various stages of the 
illness." Social Work in Health Care 38(2): 1-27. 
Not related to ESRD 
1. Auzac, C. D., et al. (2004). "Do health causal attributions and coping strategies act as moderators of quality of 
life in peritoneal dialysis patients?" Journal of Psychosomatic Research 55(3): 317-322. 
Focuses on HD 
2. Avramovic, M. and V. Stefanovic (2012). "Health-Related Quality of Life in Different Stages of Renal Failure." 
Artificial Organs 36(7): 581-589. 
Discussion paper 
3. Bayoumi, M. R. N. P. and Y. El-Fouly (2010). "EFFECTS OF TEACHING PROGRAMME ON QUALITY OF 
LIFE FOR PATIENTS WITH END-STAGE RENAL DISEASE." Journal of Renal Care 36(2): 96-101. 
Not related to HD 
4. Bilgic, A., et al. (2011). "Daytime Sleepiness and Quality of Life in Peritoneal Dialysis Patients." Therapeutic 
Apheresis and Dialysis 15(6): 565-571. 
Focuses on PD 
5. Boateng, E. A. R. G. N. B. M. and L. R. N. B. M. P. East (2011). "THE IMPACT OF DIALYSIS MODALITY ON 
QUALITY OF LIFE: A SYSTEMATIC REVIEW." Journal of Renal Care 37(4): 190-200. 
Systematic review 
6. Callahan, M. B., et al. (1999). "A model for patient participation in quality of life measurement to improve 
rehabilitation outcomes." Nephrology news & issues 13(1): 33-37. 
Discussion paper 
7. Chan, R., et al. (2011). "Studying psychosocial adaptation to end-stage renal disease: The proximaladistal 
model of health-related outcomes as a base model." Journal of Psychosomatic Research 70(5): 455-464. 
Focuses on PD 
8. Chilcot, J. (2012). "The Importance of Illness Perception in End-Stage Renal Disease: Associations with 
Psychosocial and Clinical Outcomes." Seminars in Dialysis 25(1): 59-64. 
Seminar paper 
9. Cohen, S. D. (2013). "Social Support Interventions will improve the Quality of Life of ESRD Patients." 
Seminars in Dialysis 26(3): 262-265. 
Seminar paper 
10. Cohen, S. D. and P. L. Kimmel (2013). "Quality of Life and Mental Health Related to Timing, Frequency and 
Dose of Hemodialysis." Seminars in Dialysis 26(6): 697-701. 
Seminar paper 
11. Cukor, D., et al. (2013). "Anxiety and Quality of Life in ESRD." Seminars in Dialysis 26(3): 265-268. Seminar paper 
12. Danquah, F. V. N. P. R. N., et al. (2010). "Quality of Life Measures for Patients On Hemodialysis: A Review of 
Psychometric Properties." Nephrology Nursing Journal May/June 37(3): 255-269. 
Review paper 
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13. de Jonge, P., et al. (2003). "A simple risk score predicts poor quality of life and non-survival at 1 year follow-
up in dialysis patients." Nephrology Dialysis Transplantation 18(12): 2622-2628. 
14.  
No abstract 
15. Devine, E. B. P. M. B. A., et al. (2003). "Health-related quality of life assessment in chronic kidney disease." 
Expert Review of Pharmacoeconomics & Outcomes Research 3(1): 89-100. 
No abstract 
16. Diaz-Buxo, J. A., et al. (2000). "Quality-of-life evaluation using Short Form 36: comparison in hemodialysis 
and peritoneal dialysis patients." American Journal Of Kidney Diseases: The Official Journal Of The National 
Kidney Foundation 35(2): 293-300. 
No abstract 
17. Finkelstein, F. O., et al. (2002). "The treatment of depression in patients maintained on dialysis." Journal of 
Psychosomatic Research 53(4): 957-960. 
Discussion paper 
18. Fryback, D. G., et al. (2010). "Comparison of 5 health-related quality-of-life indexes using item response 
theory analysis." Medical Decision Making: An International Journal Of The Society For Medical Decision 
Making 30(1): 5-15. 
Not related to HD 
19. Fu, A. Z. and M. W. Kattan (2006). "Racial and ethnic differences in preference-based health status 
measure." Current Medical Research And Opinion 22(12): 2439-2448. 
Not related to HD 
20. Glover, C., et al. (2011). "Understanding and assessing the impact of end-stage renal disease on quality of 
life: A systematic review of the content validity of self-administered instruments used to assess health-related 
quality of life in end-stage renal disease." The Patient: Patient-Centered Outcomes Research 4(1): 19-30. 
Systematic review 
21. Gokal, R., et al. (1999). "Outcomes in peritoneal dialysis and haemodialysis-a comparative assessment of 
survival and quality of life." Nephrology Dialysis Transplantation Healthcare Systems: An International Review 
14 Supplement(6): 24-30. 
No abstract 
22. Griva, K., et al. (2012). "The impact of treatment transitions between dialysis and transplantation on illness 
cognitions and quality of life -- A prospective study." British Journal of Health Psychology 17(4): 812-827. 
Focuses on 
transplantation  
23. Gudex, C. M. (1995). "Health-related quality of life in endstage renal failure." Quality Of Life Research: An 
International Journal Of Quality Of Life Aspects Of Treatment, Care And Rehabilitation 4(4): 359-366. 
Focuses on PD 
24. Hansen, R. A. P. D. a., et al. (2009). "Predialysis chronic kidney disease: Evaluation of quality of life in clinic 
patients receiving comprehensive anemia care." Research In Social & Administrative Pharmacy 5(2): 143-
153. 
Not related to HD 
25. Hawthorne, G., et al. (1999). "The Assessment of Quality of Life (AQoL) instrument: a psychometric measure 
of health-related quality of life." Quality Of Life Research: An International Journal Of Quality Of Life Aspects 
Of Treatment, Care And Rehabilitation 8(3): 209-224. 
Discussion paper 
26. Hays, R. D., et al. (2005). "Evaluating the statistical significance of health-related quality-of-life change in 
individual patients." Evaluation & The Health Professions 28(2): 160-171. 
Not related to HD 
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27. Hsieh, R.-L., et al. (2007). "Quality of life and its correlates in ambulatory hemodialysis patients." Journal of 
Nephrology 20(6): 731-738. 
No abstract 
28. Hutchinson, T. A. (2005). "Transitions in the lives of patients with End Stage Renal Disease: a cause of 
suffering and an opportunity for healing." Palliative Medicine 19(4): 270-277. 
Discussion paper 
29. Jablonski, A. (2007). "The Multidimensional Characteristics of Symptoms Reported by Patients on 
Hemodialysis." Nephrology Nursing Journal January/February 34(1): 29-37. 
Not related to QoL 
30. Kalantar-Zadeh, K. and M. Unruh (2005). "Health related quality of life in patients with chronic kidney 
disease." International Urology and Nephrology 37(2): 367-378. 
Not related to HD 
31. Kinchen, K. S. and N. R. Powe (2001). "Measuring and Managing Health Outcomes and Quality of Care in 
End-Stage Renal Disease." Disease Management & Health Outcomes 9(9): 483-493. 
No abstract 
32. Kolewaski, C. D. M. B. O. T. O. T. R. M. C., et al. (2005). "Quality of life and exercise rehabilitation in end 
stage renal disease." CANNT Journal October/November/December 15(4): 22-29. 
No abstract 
33. Kring, D. L. and P. B. Crane (2009). "Factors Affecting Quality of Life In Persons on Haemodialysis." 
Nephrology Nursing Journal January/February 36(1): 15-24. 
No abstract 
34. Kusztal, M., et al. (2003). "[Evaluation of health-related quality of life in dialysis patients. Personal experience 
using questionnaire SF-36]." Polski Merkuriusz Lekarski 14(80): 113-117. 
Non-English language 
35. Kutner, N. G. and S. V. Jassal (2002). "Quality of Life and Rehabilitation of Elderly Dialysis Patients." 
Seminars in Dialysis 15(2): 107-112. 
No abstract 
36. Lausevic, M., et al. (2007). "Health-related Quality of Life in Patients on Peritoneal Dialysis in Serbia: 
Comparison with Hemodialysis." Artificial Organs 31(12): 901-910. 
Focuses on PD 
37. Leao, R., et al. (2010). "Sexual dysfunction in uraemic patients undergoing haemodialysis: predisposing and 
related conditions." Andrologia 42(3): 166-175. 
38.  
Not related to QoL 
39. Lee, C. P., et al. (2009). "An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-
Effectiveness Standard." Value in Health 12(1): 80-87. 
Focuses on cost 
effectiveness 
40. Li, I. C. and S.-F. Niu (2005). "Quality of life of patients having renal replacement therapy." Journal of 
Advanced Nursing 51(1): 15-21. 
Not related to HD 
41. Liem, Y. S. M. D. M., et al. (2008). "Preference-Based Quality of Life of Patients on Renal Replacement 
Therapy: A Systematic Review and Meta-Analysis." Value in Health July/August 11(4): 733-741 
Systematic review 
42. Lin, P.-F., et al. (2003). "Acupoints massage in improving the quality of sleep and quality of life in patients with 
end-stage renal disease." Journal of Advanced Nursing 42(2): 134-142 
Not related to HD 
43. Lindqvist, R. R. N. and P.-O. P. Sjoden (1998). "Coping strategies and quality of life among patients on 
continuous ambulatory peritoneal dialysis (CAPD)." Journal of Advanced Nursing 27(2): 312-319. 
Focuses on PD 
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44. Lindqvist, R., et al. (2000). "Coping strategies and health-related quality of life among spouses of continuous 
ambulatory peritoneal dialysis, haemodialysis, and transplant patients." Journal of Advanced Nursing 31(6): 
1398-1408. 
Focuses on PD 
45. Martin, C. R. and D. R. Thompson (2000). "Prediction of quality of life in patients with end-stage renal 
disease." British Journal of Health Psychology 5(1): 41-55 
No abstract 
46. Meers, C., et al. (1996). "Self-delivery of hemodialysis care: a therapy in itself." American Journal Of Kidney 
Diseases: The Official Journal Of The National Kidney Foundation 27(6): 844-847. 
Review paper 
47. Mozes, B. and E. Shabtai (1996). "The contribution of personal rating to the clinimetric functioning of a 
generic quality of life instrument." Journal of Clinical Epidemiology 49(12): 1419-1422. 
Not related to HD 
48. Murray, M. A., et al. (2009). "Review: A systematic review of factors influencing decision-making in adults 
living with chronic kidney disease." Patient Education and Counseling 76(2): 149-158. 
Review paper 
49. Naik, N., et al. (2012). "Measurement of Health-Related Quality of Life in the Care of Patients with ESRD: 
Isn’t This the Metric That Matters?" Seminars in Dialysis 25(4): 439-444. 
 
Seminar paper 
50. Pai, A. B., et al. (2009). "Health-related quality of life is maintained in hemodialysis patients receiving 
pharmaceutical care: A 2-year randomized, controlled study." Hemodialysis International 13(1): 72-79. 
 
Related to 
pharmaceutical care 
51. Painter, P., et al. (2012). "Effects of modality change on health-related quality of life." Hemodialysis 
International 16(3): 377-386 
Focuses on modality 
changes 
52. Patel, S. S. (2013). "Treating Pain to Improve Quality of Life in End-Stage Renal Disease." Seminars in 
Dialysis 26(3): 268-273. 
No abstract 
53. Rebollo, P., et al. (2000). "[Factors associated with health related quality of life in patients undergoing renal 
replacement therapy]." Nefrología: Publicación Oficial De La Sociedad Española Nefrologia 20(2): 171-181 
Non-English language 
54. Romney, D. M. and D. R. Evans (1996). "Toward a general model of health-related quality of life." Quality Of 
Life Research: An International Journal Of Quality Of Life Aspects Of Treatment, Care And Rehabilitation 
5(2): 235-241. 
 
Not related to HD 
55. Santos, P. R. and L. R. Pontes (2007). "[Change in the level of quality of life in end-stage kidney patients 
during a 12 months follow-up]." Revista Da Associacao Medica Brasileira 53(4): 329-334. 
Non-English language 
56. Schell, J. O. a. b., et al. (2013). "Recent insights into life expectancy with and without dialysis." Current 
Opinion in Nephrology & Hypertension 22(2): 185-192. 
No abstract 
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57. Schneider, R. A. (2004). "Chronic renal failure: assessing the fatigue severity scale for use among 
caregivers." Journal of Clinical Nursing 13(2): 219-225. 
Focuses on caregivers 
58. Shayamsunder, A. K., et al. (2005). "PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY 
DISEASE: Sleepiness, Sleeplessness, and Pain in End-Stage Renal Disease: Distressing Symptoms for 
Patients." Seminars in Dialysis 18(2): 109-118. 
Seminar paper 
59. Son, Y.-J., et al. (2012). "Influence of Type D personality on health-related quality of life among Korean 
patients with end-stage renal disease." International Journal of Nursing Practice 18(3): 260-267. 
Not related to HD 
60. Symister, P. (2011). "Beyond social support: Using family expectations to predict psychological adjustment in 
end-stage renal disease patients." Journal of Health Psychology 16(7): 1015-1026. 
Patients is not the 
focus 
61. Tayeb, M. A., et al. (2010). "A "good death": perspectives of Muslim patients and health care providers." 
Annals of Saudi Medicine 30(3): 215-221. 
 
Not related to HD 
62. Taylor, C. L. C., et al. (2007). "A social comparison theory analysis of group composition and efficacy of 
cancer support group programs." Social Science & Medicine 65(2): 262-273. 
 
Related to cancer 
63. Terada, I. and C. Hyde (2002). "The SF-36: an instrument for measuring quality of life in ESRD patients." 
Edtna-Erca Journal 28(2): 73-76, 83. 
Review paper 
64. Tierney, D. K., et al. (2007). "Response shift: A theoretical exploration of quality of life following hematopoietic 
cell transplantation." Cancer Nursing 30(2): 125-138 
 
Not related to HD 
65. Tobita, I. and C. Hyde (2007). "QUALITY OF LIFE RESEARCH: A VALUABLE TOOL FOR NEPHROLOGY 
NURSES." Journal of Renal Care 33(1): 25-29. 
No abstract 
66. Tokuda, Y., et al. (2009). "Assessing Items on the SF-8 Japanese Version for Health-Related Quality of Life: 
A Psychometric Analysis Based on the Nominal Categories Model of Item Response Theory." Value in Health 
12(4): 568-573. 
 
Not related to HD 
67. Twycross, R. G. (1987). "Quality before quantity - a note of caution." Palliative Medicine 1(1): 65-72. 
 
Not related to HD 
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68. Verdugo, M. A., et al. (2012). "The concept of quality of life and its role in enhancing human rights in the field 
of intellectual disability." Journal of Intellectual Disability Research 56(11): 1036-1045. 
 
Not related to HD 
69. Vitterso, J. (2004). "Subjective well-being VERSUS self-actualization: using the flow-simplex to promote a 
conceptual clarification of subjective quality of life." Social Indicators Research 65(3): 299-331. 
 
Not related to HD 
70. Walker, H., et al. (2012). "Are they worth it? A systematic review of QOL instruments for use with mentally 
disordered offenders who have a diagnosis of psychosis." British Journal of Forensic Practice 14(4): 252-268. 
Systematic review 
71. Wan, C., et al. (2011). "Development and Validation of the General Module of the System of Quality of Life 
Instruments for Chronic Diseases and Its Comparison with SF-36." Journal of Pain and Symptom 
Management 42(1): 93-104. 
 
Not related to HD 
72. Wasserman, L. I., et al. (2002). "Concepts of rehabilitation and quality of life: their continuity and differences 
in modern approaches." International Journal of Mental Health 31(1): 24-37. 
 
Not related to HD 
73. Weinert, C., et al. (2008). "Evolution of a Conceptual Model for Adaptation to Chronic Illness." Journal of 
Nursing Scholarship 40(4): 364-372. 
 
Not related to HD 
74. White, C. and H. McDonnell (2014). "PSYCHOSOCIAL DISTRESS IN PATIENTS WITH END-STAGE 
KIDNEY DISEASE." Journal of Renal Care 40(1): 74-81. 
Continuing Education 
(CE) series  
75. Wiesmann, U., et al. (2008). "Dimensions and profiles of the generalized health-related self-concept." British 
Journal of Health Psychology 13(Pt 4): 755-771. 
Not related to HD 
76. Wood, A. M., et al. (2010). "Gratitude and well-being: A review and theoretical integration." Clinical 
Psychology Review 30(7): 890-905. 
Not related to HD 
77. Yamamoto-Mitani, N., et al. (2002). "Development of a Japanese quality of life instrument for older adults 
experiencing dementia (QLDJ)." International Journal of Aging and Human Development 55(1): 71-95. 
Not related to HD 
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Study 
Reporting 
External validity 
(Generalisability) 
Internal validity 
Yes = ✓ 
No = × 
Unclear = UN 
Yes = ✓ 
No = × 
Unclear = UN 
Yes = ✓ 
No = × 
Unclear = UN 
Clearly 
described 
the study 
aim, 
hypothese
s or 
research 
questions 
Clearly 
described 
the main 
outcome 
Clearly 
described 
participants 
characteristic
s 
Clearly 
describe
d the 
key 
findings 
Participants 
are 
representativ
e of the 
entire 
population 
Healthcare 
resources 
in setting or 
data 
collection 
representati
ve of 
intervention 
that 
majority of 
patients 
receive  
Used valid 
and reliable 
measureme
nt 
Used 
appropriat
e 
statistical 
data 
analysis 
Recruite
d study 
and 
control 
from the 
same 
populati
on 
Used 
appropriat
e 
sampling 
method 
Reported 
number 
and 
characteri
stics who 
lost 
during 
study 
Reporter 
method of 
sample 
calculatio
n 
Abd 
Elhafeez 
et al 
(2012) 
✓ ✓ ✓ ✓ ✓ 
× 
 
✓ ✓ ✓ ✓ ✓ ✓ 
Berlim et 
al (2006) 
✓ UN ✓ ✓ ✓ ✓ ✓ ✓ ✓ UN ✓ UN 
Bohlke et 
al (2008) ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
✓ ✓ 
Bonner 
et al 
(2013) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Brekke 
et al 
(2014) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Cheung 
et al 
(2012) 
✓ ✓ ✓ ✓ ✓ 
× 
 
✓ ✓ ✓ ✓ UN ✓ 
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Cleary & 
Drennan 
(2004) 
✓ ✓ UN ✓ ✓ ✓ ✓ ✓ ✓ UN ✓ ✓ 
Davison 
et al 
(2010) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Ferri & 
Pruchno 
et al 
(2009) 
✓ UN ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
× 
 
Fidan et 
al (2013) ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
Green  et 
al(2001) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Griva et 
al (2009) ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
✓ 
Hayashin
o et al 
(2009) 
✓ ✓ ✓ ✓ ✓ UN ✓ ✓ ✓ ✓ 
× 
 
✓ 
Ibrahim 
et al 
(2011) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Jablonski 
A (2007) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Kao et al 
(2009) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Kovacs 
et al 
(2010) 
✓ ✓ ✓ ✓ UN ✓ ✓ ✓ ✓ ✓ UN UN 
Lee et al 
(2004) 
 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
✓ 
Liu et al 
(2014) 
✓ ✓ UN ✓ ✓ ✓ ✓ ✓ ✓ UN UN ✓ 
Loos et 
al (2003) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UN ✓ ✓ 
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Loos-
Ayav et 
al (2007) 
✓ ✓ UN ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
✓ 
Merkus 
et al 
(1999) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
✓ ✓ 
Morsch 
et al 
(2005 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
× 
 
Morsch 
et al 
(2005) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ × × 
Mujais et 
al (2009) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UN UN 
Nejad & 
Khani 
(2013) 
✓ ✓ UN UN ✓ ✓ ✓ ✓ ✓ ✓ UN ✓ 
Neto et 
al (2000) ✓ ✓ 
 
UN 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
✓ 
Oren & 
Enc 
(2012) 
✓ ✓ UN ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
Pakpour 
et al 
(2010)  
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UN ✓ 
Poppe et 
al (2012) ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
× 
 
Rambod 
& Rafii 
(2001) 
✓ ✓ UN ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
× 
 
Ramirez 
et al 
(2012) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Rebollo 
et al 
(1998) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
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Saban et 
al (2008) 
✓ ✓ ✓ ✓ ✓ UN ✓ ✓ ✓ ✓ ✓ ✓ 
saffari et 
al (2013) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UN UN 
Saini et 
al (2006) ✓ ✓ 
× 
 
✓ ✓ ✓ ✓ ✓ ✓ UN UN ✓ 
Santos S 
(2010) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UN 
Tovbin et 
al (2003) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UN UN ✓ × 
Tsai et al 
(2010) 
✓ ✓ ✓ ✓ ✓ UN ✓ ✓ ✓ ✓ ✓ UN 
Unruh et 
al (2002) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Unruh et 
al (2008) 
✓ ✓ ✓ ✓ ✓ UN ✓ ✓ ✓ ✓ ✓ UN 
Vasilieva 
I (2006) ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
× 
 
✓ ✓ 
Vazquez 
et al 
(2005) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UN ✓ 
Yong et 
al (2009) 
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
353 
 
Appendix 3.3.  Summary of Data Extraction of Review 2 (Adopted From JBI) 
 
Author 
Countr
y 
Study aim 
Methodology  
Results  
QoL 
& 
HRQ
oL 
Mode
l 
used 
Strength and Limitations 
Study 
design/ 
population 
Sample 
size 
Instrume
nt 
Abd 
ElHafeez 
et al 
(2012) 
Egypt 
Present an Arabic 
translation, 
adaptation and the 
subsequent 
validation of the 
Kidney Disease 
Quality of Life 
Questionnaire in 
Egyptian ESRD 
patients. 
Cross-
sectional 
design 
 
100 
patients 
with 
ESRD 
KDQOL-
SF 
All items of the 
questionnaire met the 
criterion for internal 
consistency of α≥ 0.7. 
Three dimensions were < 
α0.7 (Social interaction 
[0.23], work status [0.23], 
and cognitive function 
[0.60]. 
- 
Rigors translation process followed 
by validation stage with adequate 
sample size. 
Neto et al 
(2000) 
Brazil 
Evaluate the 
construct validity of 
the SF-36 and to 
assess the QoL of 
patients with ESRD 
at the initiation of 
maintenance 
dialysis treatment 
Cross-
sectional 
design 
80 ESRD 
patients 
at the 
initiation 
of dialysis 
treatment 
SF-36 
SF-36 dimensions 
correlated significantly with 
those of the kidney 
disease questionnaire 
(correlation coefficients 
ranging from 0.23 to 0.68. 
- 
Health status of ESRD patients 
changes rapidly at the stage of 
initiating dialysis. This could 
confound with the results. 
Brekke et 
al (2014) 
Norway 
Examine the 
association 
between sleep 
quality, daytime 
sleepiness and 
mortality in dialysis 
patients. 
Cross-
sectional 
design 
 
160 HD 
patients. 
KDQOL-
SF 
 
Pittsburgh 
Sleep 
Quality 
Index 
 
Daytime sleepiness was 
not related to mortality (HR 
1.01. CI 0.95-1.08, p= 
0.751). Higher 
consumption of 
antidepressants reduce 
HRQoL (mental 
component summary: 
45.4±11.0 vs 50.0± 10.4, p< 
0.001. physical component 
- 
Principal study which attempted to 
examine the association between 
sleep quality and morality in HD 
patients. A chance for selection 
bias might exist because of the 
exclusion of fragile and hospitalised 
patients. 
Data on urea removal rate were 
scarce which might masked a 
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summary score: 35.0±9.9 vs 
38.5± 10.5, p= 0.004) 
possible association between 
dialysis efficiency and QoL.  
Cheung 
et al 
(2012) 
Singapo
re 
Examine the 
measurement 
properties of the 
Chines version of 
the KDQoL-SF in 
ethnic Chinese 
ESRD patients who 
live in Singapore. 
Cross-
sectional 
design. 
 
78 
Chines-
speaking 
patients 
HD 
KDQOL-
SF 
 
Majority of the scales in 
the Chinese version of the 
KDQOL-SF were valid and 
have achieved internal 
consistency reliability 
(alpha= 0.97), except for 
the ‘work status scale’ 
(alpha= 0.32). 
- 
Low sample size. 
 
Cleary et 
al (2005) 
Ireland 
Measure the 
overall QoL of 
people receiving 
HD and compare 
their QoL with that 
of the general 
population and 
identify any 
differences 
between the QoL in 
relation to 
adequately 
dialysed and those 
inadequately 
dialysed.  
Cross-
sectional 
design 
 
Non-
probability 
sample of 
97 
patients 
SF-36 
 
Patients with HD have 
number of factors affecting 
their QoL: vitality score 
was the lowest (mean= 
44.97, SD= 27.24). 
General health scale 
(mean= 50.87, SD= 
26.96), physical 
functioning (mean= 53.40, 
SD= 27.23), role 
functioning-physical 
(mean= 54.19, SD= 
32.15), role functioning-
emotional (mean= 69.85, 
SD= 31.61). 
- 
Examined QoL among two sub-
groups (adequately dialysed and 
inadequately dialysed) as dialysis 
might contribute significantly on 
improving patients QoL. The use of 
only one clinical site. 
Small sample size 
Jamaiyah 
et al 
(2010) 
Malaysi
a 
Investigate the 
reliability and 
validity of EQ-5D in 
the Malaysian 
dialysis population 
Cross-
sectional, 
survey 
686 
dialysis 
patients 
EQ-5D 
Majority of patients 
reported no problems with 
their health in terms of 
mobility (82.42%), pain 
(64.53%), and anxiety 
(77.22%).  
EQ-5D was able to 
demonstrate moderate 
convergent validity 
between study population 
of 0.45 (p<0.05). Age 
groups vs mobility was 
- 
Large sample size.  
This study reported opposite effect 
in terms of the influence of age 
compared to other studies used 
EQ-5D, e.g. similar study in the UK 
found differences in anxiety among 
males vs females. 
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found to be statistically 
significant at the p<0.05. 
Statistically significant 
difference was found 
comparing modality vs 
usual activity (p<0.05). 
Fidan et 
al (2013) 
Turkey 
Assess the HRQoL 
in patients with HD 
using KDQOL and 
determine its 
relationship with 
conventional 
clinical measures, 
musculoskeletal 
problems, hand 
disability and 
depression 
Cross-
sectional 
design 
 
50 HD 
patients 
KDQOL-
SF 
 
Beck 
Depressio
n 
Inventory 
(BDI) 
Patients aged ≥ 65 had 
poorer KDQoL subgroups 
scores for physical 
component scale (p= 
0.000), and for symptom 
list (p= 0.007). they also 
had poorer BDI scores (p< 
0.05). 
- 
A primary study on physical 
functioning specific to hand 
disability and pain in HD patients 
Use of four relevant measures.  
Relatively small sample size 
.   
Ferri & 
Pruchno 
(2009) 
USA 
Examine 
similarities and 
differences in 
spouse and patient 
ratings of the QoL 
of patients with 
ESRD 
Prospective 
study 
design 
315 
couples 
Quality of 
Life Index 
HD patients and their 
spouses perceive QoL and 
predictors of patients QoL 
differently as spouses 
rated all patients QoL 
characteristics wore than 
patients did. The mean 
rating of QoL by the 
patients is significantly 
higher than mean rating by 
the spouse (baseline: M 
paitnet= 3.35, M spouse= 
2.90, t (313)= 6.29, 
p<0.000; Follow-up: M 
paitnet= 3.30, M spouse= 
2.98, t (202)= 3.37, 
p<0.001. 
- 
Provide a rational of why proxy 
ratings are consistently lower than 
patient rating. Use of signal-item to 
assess QoL. 
Rebollo et 
al (1998) 
Asturias 
Assess HRQoL of 
elderly patients on 
renal replacement 
therapy and to 
identify socio-
Cross-
sectional 
design 
124 
dialysis 
patients 
SF-36 
PF (47.8±25.6) 
RP (63.8±45.6) 
BP (66.6±31.6) 
GH (36.3±19.8) 
SF (80±25) 
- 
This study would be better if 
designed in longitudinal design 
especially if assessing clinical 
variables with ESRD patients, such 
anaemia. 
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demographic and 
clinical variables 
that influence 
HRQoL 
MH (76.4±88.6) 
HCT (30.1±5) 
g/dl (9.9±5)) 
Albumin (3.7±0.4) 
Green et 
al (2001) 
Japan 
Translation, 
cultural adaptation 
and initial reliability 
and multi-trait 
testing of the 
Kidney Disease 
Quality of Life 
Instrument 
(KDQOL) 
Cross-
sectional 
design into 
stage: 
focus-group 
and survey. 
 
930 HD 
patients. 
SF-36 
 
SF-36 scales are internally 
consist and their scores 
are reproducible 
(Cronbach’s α ranged from 
0.73 to 0.92). Interclass 
correlation between test 
and retest scores ranged 
from 0.60 to 0.82. 
- 
A comparison of two QoL 
instruments used. The KDQOL 
instrument initially subjected to a 
focus group validation before field 
test. Focus-group: patients were 
asked only to state whether the 
items were difficult to understand. It 
would be more useful if they were 
asked to describe it by their own 
words what the questions meant. 
Griva et al 
(2009) 
UK 
Assess the illness 
representation and 
treatment 
disruption beliefs of 
patients with ESRD 
and to determine 
whether beliefs 
about illness and 
treatment differ 
between different 
renal therapy; and 
whether these 
beliefs are 
associated with 
HRQoL. 
Cross-
sectional 
design. 
 
262 
ESRD 
patients. 
ESRD-SI 
 
Illness 
perceptio
ns 
questionn
aire (IPQ) 
 
36-SF 
HD patients, in comparison 
with other renal 
replacement therapy, 
reported lower control 
beliefs and more illness 
and treatment 
disruptiveness which 
inversely associated with 
HRQoL. HRQOL scores 
was higher in transplant 
patients (p< .001), 
stronger chronic timeline 
beliefs (p< .001), lower 
control beliefs (p <.05) 
- 
It is the first empirical study that 
attempt to investigate the extended 
common sense model (CSM) in 
ESRD patients. The tight inclusion 
criteria that was applied to rule out 
potential confounders has affected 
results in terms of recruiting 
patients who are young and free of 
comorbid conditions. 
Hayashin
o et al 
(2009) 
Japan 
Investigate the 
impact of HRQoL 
on mortality risk in 
patients with 
diabetes on HD. 
Cross-
sectional 
design 
 
527 
diabetic 
patients 
on HD. 
SF-36 
 
The mortality age-adjusted 
hazard ratio of having a 
physical component score 
greater than or equal to 
the median was 0.27 [95% 
confidence interval (CI) 
0.08-0.96]. The 
multivariable-adjusted 
mortality hazard ratio of 
having mental component 
- 
Large sample of diabetes patients 
on HD. 
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score greater than or equal 
to the median was 1.21 
(95% CI 0.44-3.35). 
Poppe et 
al (2012) 
Belgium 
Investigate whether 
acceptance of the 
disease contributes 
in a better physical 
and mental 
HRQoL. 
Cross-
sectional 
design 
 
155 
dialysis 
patients 
SF-36 
Disease acceptance was 
positively correlated with 
MH QoL (r= 0.56, p< 0.01) 
and positively correlated 
with PH QoL (r= 0.45, p< 
0.01). Neuroticism showed 
negative correlation with 
acceptance (r= -0.49, p< 
0.01) and with MH QoL (r= 
-0.52, p< 0.01) 
- 
The sample size is relatively small 
and consisted nearly completely of 
Caucasians patients from a single 
region which might limit its results 
generalisability. 
Kao et al 
(2009) 
Taiwan 
Examine the 
associations 
between economic, 
social, 
psychological 
factors, and 
HRQoL of HD 
patients. 
Cross-
sectional 
design 
 
861 HD 
patients 
Short 
Forum-36 
 
Beck 
Depressio
n 
Inventory  
(BDI) 
High monthly income was 
positively associated with 
role emotional and mental 
health (p <0.05). 
Increased frequency of 
social activities with social 
functioning (p <0.05). 
Higher depression scores 
were associated with lower 
scores of all SF-36 
dimensions (p <0.01) 
Revis
ed 
Wilso
n and 
Clear
y 
HRQo
L 
model 
The presentation of the statistical 
parameters is comprehensive and 
clear. Patients who were too sick 
were excluded from study which 
might miss valuable information 
about this subgroup. 
Cross-sectional design which 
cannot differentiate the exact 
causal relationship between various 
factors and HRQoL. 
Mujais et 
al (2009) 
USA 
Investigate the 
determinants of 
HRQoL in chronic 
kidney disease 
(CKD) patients. 
A 
prospective 
design 
study 
1189 
patients 
with CKD 
KDQoL-
SF 
Baseline measures of 
HRQoL were reduces in 
these patients. Physical 
functioning score declined 
progressively with more 
advance stage of CKD. 
Female gender and a 
history of cardiovascular 
co-morbidities were also 
associated with reduced 
HRQoL (PCS score: male: 
41.0±10.2; female: 
37.7±10.8; p< .001; diabetic: 
41.6±10.2, p< .001; history of 
- 
Factors affecting completion of the 
questionnaire were not explored 
prospectively. 
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congestive heart failure, yes: 
35.4±9.7; no: 40.3±10.6; p< 
0.0001; history of myocardial 
infraction, yes: 36.12±10.0; 
no: 40.2±10.6; p<0.0001). 
Albumin lower than 35g/l was 
associated with a significant 
decline in sexual function 
(albumin≤35 g/l= -8.48, 
albumin >35g/l= -0.8, p<0.05) 
Lee et al 
(2004) 
Republi
c of 
Korea 
Examined the 
putative 
association 
between the levels 
of HCT and 
improvement of 
cognitive function 
and QoL in ESRD 
patients 
Comparativ
e study 
56 
patients 
(group A- 
28) 
 
(group B- 
28) 
SF-36 
 
HCT level 
Patients with higher HCT 
level scores better in the 
neurocognitive function 
test (p= .034). QoL was 
not any better than those 
with lower HCT level. 
- 
Underlying disease was not 
completely excluded. Medication 
could confound the result of the 
study particularly Iron supplements. 
Bohlke et 
al (2008) 
Brazil 
Examine the 
predictors of 
HRQoL in a 
sample of patients 
undergoing dialysis 
in southern brazil. 
Cross-
sectional 
design 
 
140 
patients: 
94 HD 
46 PD 
SF-36 
 
The predictors of better 
physical component 
summary were; younger 
age (β-0.16; 95% 
confidence interval, CI: -
0.27 to -0.05), shorter time 
on dialysis (β-0.06; 95% 
CI: -0.09 to -0.02). the 
predictors of higher mental 
component summery 
were: being married of 
having a marriage-like 
relationship (β4.56; 95% 
CI:0.9-8.2), being on PD 
(β4.9; 95% CI: 0.9-8.8) 
and not having BP (β3.9; 
95% CI:0.3-7.6) 
- 
This study shows that most of the 
associations detected have also 
been described in pervious studies 
involving similar populations. 
Liu et al 
(2013) 
Malaysi
a 
Evaluate the QoL 
among dialysis 
patients using 
WHOQOL-BREEF 
Cross-
sectional 
design 
 
1332 
ESRD 
patients 
WHOQOL
-BREEF 
(English-
PD patients achieve higher 
combined overall QoL that 
HD patients (63.0 vs 60.0, 
p< 0.001).  
- 
Sample size had adequate number 
of both HD & PD from various 
dialysis institutions. 
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and examine 
significant factors 
that affect QoL 
scores. 
Malay-
Chinese) 
Mean (SD) transformed 
QoL scores were 56.2 
(physical 15.8), 
psychological 59.8 (16.8), 
social relations 58.2 (18.5), 
environmental domains 
59.5 (14.6), and combined 
overall QoL 61.0 (18.5). 
The use of three translations of 
WHOQOL-BREEF facilitated 
inclusion of ethnic origin. 
Participants from big urban dialysis 
centres with experienced staff and 
patients from rural areas usually 
have different socioeconomic-
cultural profile. 
The WHOQOL-BREEF version 
does not explore issues related to 
spirituality or religiosity compared 
with the full version. 
Loos et al 
(2003) 
French 
Assess the effect 
of ESRD on QoL of 
older patients 
Cross-
sectional 
design 
 
169 
(mean 
age 76.2) 
with 
ESRD 
SF-36 
 
Older patients undergoing 
HD have lower QoL 
scores. Physical 
functioning dimension had 
fewer points (p= .014).  
 
- 
Co-morbid diseases in older patient 
might affect overall QoL. The use of 
one measurement tool of QoL could 
be considered as limit in this study. 
Loos-
Ayav et al 
(2008) 
French 
Assess the 
changes of HRQoL 
during the first year 
of dialysis by 
comparing 
independent 
dialysis patient with 
patients on in-
centre dialysis. 
Cross-
sectional 
design 
 
In-centre 
dialysis 
patients: 
195 pts in 
HD 
 
147 
Autonomo
us 
patients. 
 
KDQOL-
SF 
Independent patients 
showed improved HRQoL 
when compared with in-
centre dialysis patients. 
Several dimensions of 
HRQoL were significantly 
higher in autonomous pats 
(physical functioning [60.4 
vs 50.7], work status [30.9 
vs 18.4]. 
- 
The age of independent patients 
were younger compared to the age 
of in-centre dialysis patients. 
Morsch et 
al (2006) 
Brazil 
Examine the 
association 
between QoL and 
morbidity, mortality 
and clinical 
indicators in HD 
patients 
Descriptive 
cohort 
design 
40 HD 
patients 
followed 
for 12 
months 
SF-36 
Men patients presented 
higher HRQoL scores in 
the energy and fatigue 
component (p=0.04). 
Patients treated for over 
one year (p<0.05). 
Patients with diabetes 
perceived their physical 
functioning more 
negatively (p= 0.045). a 
- 
Prospective design (40 patients 
followed for 12 months). Age factor 
was not measured as independent 
variable as it might associate with 
different diseases. 
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correlation were found 
between physical 
functioning and serum 
albumin (r= 0.341, p<0.05) 
and physical functioning 
and haematocrit (r= 0.317, 
p<0.05). 
Oren 
(2013) 
Turkey 
Quality of life in 
chronic 
haemodialysis and 
peritoneal dialysis 
patients in Turkey 
and related factors 
Cross-
sectional 
deign 
 
175 HD 
patients 
 
125 PD 
patients 
SF-36 
The QoL values in PD is 
higher than those of HD 
(P< 0.05). Both groups 
affected by varies factors: 
significant relationship 
between age and 
functionality (p<0.01); 
wellbeing (p<0.05) and 
overall QoL (p<0.05). 
There was statistically 
significant relationship 
between educational 
status and functionality 
(P<0.05). No QoL 
subscale scores difference 
between both groups due 
to employment status 
(<0.05). 
- 
Inclusion of samples from two 
different health sectors (private and 
university hospital) 
Nejad and 
Khani 
(2013) 
Iran 
Examine the QoL 
and sleep in HD 
patients 
Cross-
sectional 
deign 
 
115 HD 
patients 
SF-36 
 
Pittsburgh 
Sleep 
Quality 
Index 
(PSQI) 
There was a negative 
relationship between the 
quality of sleep and MCS 
scores (r= -0.222; p<0.01), 
and the global SF-36 (r= -
0.227; p>0.05) show that 
as the quality of sleep 
worsened, the QoL 
decreased. 
There was no correlation 
between PCS and the 
global PSQI (r= -0.159; p= 
0.090).  
- 
Because of the absence of 
polysomnographic data it was not 
possible to determine the exact 
cause of insomnia and sleep 
disturbance. 
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The correlation between 
total SF-36 score and 
global PSQI was 
statistically significant (r= -
0.227, p<0.05). 
Pakpour 
et al 
(2010)  
Iran 
Compare HRQoL 
in Iranian patients 
with ESRD on HD 
with healthy 
population and 
compare study 
data with data from 
similar studies that 
were conducted in 
Asia, West, and 
East European. 
Cross-
sectional. 
 
250 
patients 
with 
ESRD on 
HD were 
recruited 
based on 
convenien
ce 
sampling 
method. 
SF-36 
Iranian HD patients 
reported lower HRQoL 
compared to other five 
nations. 
Subs
cale 
Irania
n 
sampl
e 
Gener
al 
popul
ation 
PF 41.6± 
30.2 
85.3±2
0.8 
RP 30.8± 
32.5 
70.0± 
38.0 
BP 43.9± 
28.0 
79.4± 
25.1 
Vitalit
y 
46.3± 
23.9 
65.8± 
17.3 
SF 44.1± 
25.7 
76.0± 
24.4 
MH 56.7± 
22.4 
67.0± 
18.0 
 
- 
Variation in sample size (Iranian 
n=250 vs general cohort n=1997). 
Cultural and socio-environmental 
variation. 
Rambod 
et al 
(2010) 
Iran 
Examine the 
relationship 
between perceived 
social support and 
the QoL in HD 
patients from an 
Islamic cultural 
background 
Cross-
sectional 
design 
 
202 HD 
patients 
Ferrans 
and 
Powers 
Quality of 
Life 
Index-
Dialysis 
Significant relationship 
were found between 
perceived social support 
and health-functioning (r= 
.65, p≤.05) socioeconomic 
(r= .67, ≤.05), 
psychological-spiritual (r= 
.63, p≤ .05) and family 
subscales of QoL (r=.51, 
p≤ .05). Total QoL also 
found to be significant 
correlated with perceived 
social support (r= 0.27, p= 
.00). 
- 
Patients usually defined Social 
support based on the context of the 
demands of their illness and study 
design could be a limitation in this 
context. 
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Ramirez 
et al 
(2012) 
Brazil 
Assessed whether 
positive religious 
coping or religious 
struggle was 
independently 
associated with 
psychological 
distress and 
HRQoL in HD 
patients. 
Cross-
sectional 
design. 
170 HD 
patients 
 
Anxiety 
and 
Depressio
n Scale 
(HADS) 
 
Current 
Psychom
etric 
Status of 
a Short 
Measure 
of 
Religious 
Coping 
World 
Health 
Organisati
on Quality 
of Life 
Instrumen
t-
Abbreviat
ed 
Version 
(WHOQO
L-BEEF) 
Religious struggle was 
independently associated 
with greater psychological 
distress and impaired 
HRQoL (r=0.43; p< .0001) 
and anxiety (r= 0.32; P< 
.0001).  
- 
Was able to demonstrate the 
independent association of religious 
coping strategies with HRQoL and 
psychological distress in HD 
patients. The sample of the study 
was only limited to participants with 
Christian which limits the 
generalizability of the results. 
The design of the study (cross-
sectional) could not establish a 
causal relationship between 
religious coping, psychological 
distress and HRQoL in HD patients. 
Saban et 
al (2008) 
USA 
Examine the 
measurement 
invariance of the 
KDQOL-SF across 
veterans and non-
veterans with 
ESRD. 
Prospective 
observation
al design 
 
Veterans: 
314 
patients 
Non-
veterans: 
3300 
KDQOL-
SF 
 
KDCS 
The SF-6D correlated .911 
(p<.05), indicating 83% of 
the variance in the 7-
subscales of KDCS 
measure. 
- 
First study to examine QoL in 
Veterans group. Large variation in 
the number of participants groups 
Demographic data were not control 
which could interfere with the 
results 
Saffari et 
al (2013) 
Iran 
Examine the 
relationship 
between 
spiritual/religious, 
demographic and 
Cross-
sectional. 
 
362 
patients 
on HD. 
Spiritual 
coping 
strategy 
(SCS) 
 
Religious/ spirituality is an 
important factor in the QoL 
in patients with ESRD on 
HD. Correlations between 
spiritual coping score with 
- 
Large sample size. Face to face 
data collection conducted to collect 
more completed data. Convenience 
sampling method which can reduce 
findings generalizability. Use of 
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clinical variables 
and QoL among 
Iranian Muslims. 
EQ-5D 
 
EQ-5D index score was 
(r=0.182, p< 0.001) and 
EQ-VAS scores (r= 0.131, 
p= 0.012).  
There is a significant 
difference of QoL between 
male and female (p= 
0.005), but not health 
status. 
Married patients reported 
better health status than 
unmarried (p= 0.005) 
Self-report which might present 
reporting and recall biases. 
Santos et 
al (2010) 
Brazil 
Analysed the 
correlation 
between coping 
style and QoL in 
HD patients. 
Cross-
sectional 
 
166 HD 
patients 
SF-36 
 
QoL dimensions: 
Physical functioning 
(55.4±25.5) 
General health (46.1±21.3) 
Social functioning (69.2± 
30.3) 
Mental health (64.2 ± 22.0) 
Problem-oriented coping 
(51.4± 8.4) 
Emotion-oriented coping 
(68.1± 9.6) 
- 
Use of appropriate tools for 
comparison between problem-
oriented coping and emotional-
oriented coping. Considering the 
nature of coping behaviour, 
longitudinal design would fit more 
the aim of this study. 
Results can be compared with a 
transversal study to identify if the 
low QoL makes patients coping 
low. 
Sample was limited to one area 
which increase homogeneity rate 
and therefore might affects study 
results. 
Tasi et al 
(2010) 
Taiwan 
Examine the 
relationship 
between QoL and 
risk of ESRD and 
mortality in CKD 
patients 
Prospective 
design (12 
months) 
 
423 
patients 
WHOQOL
- bref 
 
Beck 
Depressio
n 
Inventory 
Physical, psychological 
and overall QoL correlate 
with increased risks of 
ESRD and death. The total 
scores and scores of both 
physical and psychological 
domains predicted dialysis 
and mortality (every 1 
point decrease hazard 
ratio (HR): 1.050, 95% CI: 
1.008-1.095, p= 0.020; 
HR: 1.179, CI: 1.033-
WHO
QoL 
model 
One of the first study to evaluate 
the association between all 
components of QoL and the 
adverse outcome in ESRD patients 
with WHOQOL-BREEF tool. 
Comorbidity histories was not 
considered as a confounder which 
can confound with the study results 
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1.346, p= 0.014; HR: 
1.167, CI: 1.016-1.339, p= 
0.028) 
Tovbin et 
al (2002) 
USA 
Examine the 
interrelation 
between 
psychosocial 
factors and 
individualised QoL 
of HD patients 
Cross-
sectional 
 
48 HD 
patients 
SEiQOL 
Scale 
 
Perceived-control is 
mediated by clinical 
variable such as albumin, 
hostility and moderated by 
social-support. QoL was 
significantly correlated with 
physical component (r= 
0.65) and social support 
(r= 0.38), and inversely 
correlated with hostility (r= 
-0.31), diabetes and 
hypoalbuminemia 
(p<0.05). 
- 
The use of SEiQOL as a self-rating 
scale allowed to include patients 
with relatively ill and cognitively 
limitations. Small sample size 
Use of cross-sectional design 
doesn’t permit to interpret 
compensating effects of causal 
relationship. 
Unruh et 
al (2003) 
USA 
Examine the 
relationship of 
patient-reported 
HRQoL to the 
mode of survey 
administration in 
HD patients. 
Cross-
sectional 
design 
975 patients 
Interview: 
427 
Self-
administere
d: 551 
978 HD 
patients: 
N= 427 
interview 
survey 
N= 551 
self-
administe
red 
KDQOL-
LF 
Patients in the interviewer-
administered group 
reported higher scores on 
scales that measured 
Role-Physical, Role-
Emotional and Effects of 
Kidney Disease. 
- 
The interviewer group: had higher 
scores on sales that measured role-
physical, role-emotional and effects 
of kidney disease (p<0.001). 
Unruh et 
al (2008) 
USA 
Assess the extent 
to which persons 
aged 70 and older 
undergoing HD had 
greater changes in 
HRQoL over 3 
years than younger 
patients 
undergoing HD 
Longitudinal 
study 
design over 
3 years 
 
Secondar
y analysis 
of the 
HEMO 
study 
(1,813 HD 
patients) 
KDQOL-
LF 
HRQoL scores at baseline 
reflected a better-
preserved 
multidimensional QoL in 
patients with age 70 and 
older: physical component 
summary (34.4 ±9.8) and 
mental component 
summary (50.2±10.9). No 
substantial relationship 
reported between age and 
average decline in HRQoL 
- 
Study population was large 
Multicentre HD  
 
Instruments measured 
multidimensional aspects of life. 
Patients who had been in HD for 
less than 3 months were excluded 
from study. 
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score over 3 years in 
participants.  
Vasilieva 
and Irina 
(2006) 
Russia 
Compare HRQoL 
of Russian HD 
patients with the 
general population 
and international 
data. 
Cross-
sectional 
design 
 
1047 HD 
patients 
SF-36 
 
Russian HD patients had 
significantly lower scores 
on the majority of SF-36 
measure: 
sc
ale 
HD 
patients 
General 
pop 
PF 61.2±25.
8 
79.6±22.
0 
BP 55.6±28.
8 
66.4±25.
0 
Vit
alit
y 
49.3±19.
8 
56.2±18.
2 
M
H 
61.3±17.
9 
58.0±16.
4 
 
- 
Results were compared with an 
international data. 
Large sample size. Study design 
limit determining the causality 
relationship between different QoL 
factors..  
Vázquez 
et al 
(2005) 
Spain 
Examine the 
relationship 
between 
psychosocial status 
and KDQOL-SF by 
controlling 
sociodemographic 
and clinical 
variables. 
Cross-
sectional 
design 
 
194 HD 
patients 
KDQOL-
SF 
 
Trait anxiety and 
depressive symptoms 
found to increase the 
proportion of explained 
variability with highest 
standardised regression 
coefficients observed for 
most KDQOL scales 
(emotional wellbeing 
R2=0.556; mental 
component summary  
R2=0.505; physical 
functioning R2=0.456) 
- 
Use of different measures. Study 
participants were relatively young 
(mean age= 48.5±16.06 years) 
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Appendix 3.4.  Psychometric Properties of the instruments of QoL and HRQoL in ESRD 
Instrument 
Test-
retest 
reliability 
Internal 
consistenc
y 
Conte
nt 
validity 
Construct 
validity 
Responsivene
ss 
Interpretabili
ty 
Precisio
n 
Acceptabilit
y 
Feasibility 
Cultural 
and 
language 
adaptation 
Health and Generic measures 
SF-36v2 
 
ID 
Physical 
summary 
(alpha = 
0.88) and 
mental 
summary 
(alpha = 
0.82) 
✓ 
Physical 
summary 
(F-ratio = 
6.09, p < 
0.001) 
 
Mental 
summary 
(F-ratio = 
2.37, p < 
0.001) 
80% ID ID ✓ 
Easy to 
administer 
and can be 
used by 
patients with 
different 
conditions. 
Translated 
into 
different 
internation
al 
languages 
including 
Arabic. 
Quality of 
Life Scale 
r = 0.78 
to 0.84) 
 = .82 to 
.92 
✓ 
Correlates 
with The 
Life 
Satisfactio
n Index (r= 
0.67 to 
0.75) 
60% ID ID ✓ 
Easy to 
administer 
and can be 
used by 
patients with 
different 
conditions. 
Used 
across 
different 
cultures 
and 
translated 
into 
different 
languages 
including 
Arabic. 
EQ-5D 
 
(r = 0.69 
to 0.94) 
ID ✓ ✓ 
Small 
treatment 
effect: 0.10 
ID ID ✓ 
Easy to 
administer 
(self-
administratio
n, through a 
proxy, or can 
be 
administered 
Translated 
into 
different 
languages 
including 
Arabic. 
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in a postal 
survey form). 
WHOQoL-
Bref 
 
ID 
α 0.66 
α 0.97 
✓ ✓ ID ID ID ✓ 
Easy to 
administer.  
A valuable 
tool for 
clinical 
practice and 
international 
studies.  
Used 
cross-
culturally 
and 
translated 
into 40 
different 
languages. 
Disease-specific measures 
KDQoL-SF 
 
ID α 0.80 ✓ ✓ ✓ ID ID ✓ 
Self-
reported. 
Consists of 
SF-36 items 
and kidney 
disease-
specific 
items. 
Used on a 
worldwide 
basis and 
has been 
translated 
into many 
different 
languages 
including 
Arabic. 
ESRD-SI 
 
ID α 0.92 ✓ ✓ ID ID ID ✓ 
Easy to 
administer. 
ID 
QoLI-
Dialysis 
 
ID α 0.91 ✓ ✓ 
46 % (394 HD 
patients) 
ID ID ✓ 
Can be 
administered 
via post and 
by interview. 
ID 
Symptom measures 
Memorial 
Symptom 
Assessment 
Scale Short 
Form 
(MSAS-SF)  
ID α 0.80 ✓ 
Correlate 
with FACT 
measure 
(r=-.035 to 
-0.54) 
(t-test, P 
<0.05) 
 
60% 
ID ID ✓ 
Easy to 
administer 
and can be 
used by 
patients with 
different 
conditions. 
Used 
across 
different 
cultures 
and 
translated 
into 
different 
languages 
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including 
Arabic 
Revised 
Illness 
Perception 
Questionnair
e (IPQ) 
ID ID ID 
(r= .47, P 
< .001) 
ID ID ID ✓ 
Easy to 
administer 
and can be 
used by 
patients with 
different 
conditions. 
Used 
across 
different 
cultures 
and 
translated 
into 
different 
languages 
including 
Arabic. 
5-D Itch 
Scale 
Correlatio
n at 
baseline 
r= .727 to 
r= .892 at 
6-week 
r= .734, 
p< .001 
✓ 
Correlated 
strongly 
with the 
VAS (r= 
.862) 
50% HIV Pts 
48% ESRD 
Pts 
50% Liver 
disease Pts 
 
ID ID ✓ 
Easy to 
administer 
(5-8 
minutes). 
Used by 
patients with 
different 
conditions 
e.g. HIV, 
ESRD, Burn. 
Used 
across 
different 
cultures 
and 
translated 
into 
different 
languages 
including 
Arabic. 
The fatigue 
severity 
scale 
(ICC= 
0.91) 
α 0.86 – 
0.94 
ID 
Correlates 
with 
functional 
assessme
nt (r=-
0.77). 
 
Correlates 
with the 
Nottingha
m Health 
Profile 
(r= 0.62) 
 
P <0.04 ID ID ✓ 
Easy to 
administer 
and can be 
used by 
patients with 
different 
conditions. 
Used 
across 
different 
cultures 
and 
translated 
into 
different 
languages 
including 
Arabic. 
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Note: r = test-retest; internal consistency: Cronbach’s alpha ( );✓ = qualitative evidence exists; ID = indeterminate. 
 
 
Correlates 
with 
Parkinson’
s Fatigue 
Scale 
(r= 0.84) 
 
Individualised measures 
(SEiQoL-
DW) Scale 
0.70 ID ✓ ✓ ✓ ID ID ✓ 
Easy to 
administer 
and can be 
used by 
patients with 
different 
conditions. 
Used 
across 
different 
cultures 
and 
translated 
into 
different 
languages 
including 
Arabic. 
Patient-
generated 
index (PGI) 
ID ID ✓ ✓ ✓ ID ID ✓ 
Easy to 
administer 
and can be 
used by 
patients with 
different 
conditions. 
Used 
across 
different 
cultures 
and 
translated 
into 
different 
languages 
including 
Arabic. 
370 | P a g e  
 
Appendix 4.1. a  University Research Ethical Committee (UREC)
  
 
 
371 
 
 
 
 
372 
 
Appendix 4.1.b.   Directorate of Research and Ethical Review and Approve 
Committee, Oman 
 
373 
 
Appendix 4.2.a (Demographical questions) 
 استبيان البيانات الديموجرافية و الطبية
 البيانات الديموجرافية  
   ......................... .  :✓)) العمر
 :✓))الجنس 
 
 الحالة الاجتماعية والاقتصادية: 
 الحالة الاجتماعية: 
 
 مستوى التعليم : 
  أكملت الدراسة اللإبتدائية  غير متعلم )لم ألتحق بمدرسة(
 
 العمل:
  عن عملة /باحث  ربة منزل  عمل حر  قطاع خاص  خاص حكومي  حكومي
 مستوى الدخل: 
  ريالا عمانيا 1500-1000بين   ريالا عمانيا 600-250بين   ريالا عمانيا 250أقل من 
 
  ريالا عمانيا 1500أكثر من   ريالا عمانيا 1000-600 بين
 البيانات الطبية )تعبأ من قبل الطاقم الطبي(
 % ..................  (:Hematocritمعدل الهيموكريت ) ......................... :Hb)معدل الهيموغلوبين )
 ..................... (:cholesterolمعدل الكلسترول ) ........................... :(Albumin)معدل الزلال 
 Kt/V ....................التخليص/كفاية الغسيل الدموي: 
 ساعة  ....................... فى الشهر:  عدد ساعات الغسيل
 سنة ...........................المدة على الغسيل الدموى بالسنوات:  
ساعة ...................... الوقت المستغرق للوصول إلى وحدة الغسيل:  
  ىأنث   ذكر
  أعزب   أرمل   مطلق   متزوج
  جامعي  أكملت الدراسة الثانوية  أكملت الدراسة الإعدادية )المتوسطة(
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Appendix 4.2.b (SF36v2) 
 
 صحتك ورفاهيتكإستبيان 
 
ستساعد هذه المعلومات في تتبع شعورك وكيف  .يسأل هذا االستبيان عن وجهة نظرك حول صحتك
 !شكرا إلكمالك هذا االستبيان  .قادرا على القيام بنشاطاتك االعتيادية بشكل جيد تكن
 .يصف بأفضل شكل إجابتك في المربع الذي  الرجاء وضع إشارة في كل واحد من األسئلة التالية،
 بشكل عام، تود أن تقول أن صحتك... .1
 ضعيفة معتدلة جيّدة جيّدة جدا ممتازة
     
 1      2      3      4     5     
 ؟بشكل عام اآلنم صحتك كيف تقي   بالمقارنة مع السنة الماضية، .2
أفضل بكثير اآلن 
بالمقارنة مع العام 
 الماضي
أفضل نوعا ما اآلن 
بالمقارنة مع العام 
 الماضي
تقريبا نفس العام 
 الماضي
أسوأ نوعا ما اآلن 
بالمقارنة مع العام 
 الماضي
أسوا بكثير اآلن 
بالمقارنة مع العام 
 الماضي
     
 1      2      3       4     5     
 
 
هل تقيدك . نشاطات من الممكن أن تقوم بها خالل يوم عادي لاألسئلة التالية تدور حو .3
 أي مدى؟ ىكانت كذلك، فإلإذا   صحتك اآلن في النشاطات التالية؟
 
  دنيتقيّ نعم،   
 كثيرا
  دنيتقيّ  ،نعم
 قليال
على دني تقيّ  ال، ال
 اإلطالق
    
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 ، مثل الركض، رفع أشياء ثقيلة، النشاطات القوية ا. 
  1 ..................  2 ................. 3 .................................................. المشاركة في رياضة شاقة
 دفع مكنسة  ،تحريك طاولة مثل ،النشاطات معتدلة الشدة .ب 
  1 ..................  2 ................. 3 ....................................  السباحة أو ركوب الدراجة ،كهربائية
  1 ..................  2 ................. 3 ..................................................... رفع أو حمل مواد البقالة .ج 
  1 ..................  2 ................. 3 ................................................... طوابق عدةصعود الدرج  .د 
  1 ..................  2 ................. 3 ................................................... واحدصعود الدرج طابق  .ه 
  1 ..................  2 ................. 3 ............................ االنحناء، الّركوع، أو طأطأة الرأس والكتفين .و 
  1 ..................  2 ................. 3 .............................................. واحد أكثر من كيلومتر المشي .ز 
  1 ..................  2 ................. 3 ............................................... عدة مئات من األمتارالمشي  .ح 
  1 ..................  2 ................. 3 ................................................................ مئة مترالمشي  .ط 
  1 ..................  2 ................. 3 ............................................... االستحمام أو ارتداء المالبس .ي 
 
 
 
، كم من الوقت واجهت أيا من المشاكل التالية في عملك أو األسابيع األربعة الماضيةخالل  .4
 ؟الجسديةنتيجة لصحتك نشاطاتك اليومية االعتيادية األخرى 
وال في أي  قليل من الوقت بعض الوقت معظم الوقت كّل الوقت 
 وقت
 
  الذي قضيته في كمية الوقتانخفاض في  ا. 
   1 ............   2 ............   3 .............   4 ...........   5 ....................... العمل أو النشاطات األخرى
   1  ............  2  ............  3  .............  4  ...........  5 ................................ مما تريد أنجزت أقل ب. 
 العمل أو النشاطات نوع دا/ة فيكنت مقيّ  ج. 
   1 ............   2 ............   3 .............   4 ...........   5 ............................................... األخرى
 في أداء عملك أو النشاطات صعوبةواجهت  د. 
   1 ............   2 ............   3 .............   4 ...........   5 ...... منك جهدا إضافيا(. تاألخرى )مثال، أخذ
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واجهت أيا من الصعوبات التالية أثناء قيامك  كم من الوقت، األربعة الماضية أسابيعخالل  .5
)مثل اإلحساس  مشاكل متعلقة بالعاطفةبعملك أو بأنشطتك العادية اليومية األخرى بسبب أي 
 باإلكتئاب أو القلق(؟
وال في أي  قليل من الوقت بعض الوقت معظم الوقت كّل الوقت 
 وقت
 
 الذي قضيته في  كمية الوقتانخفاض في  ا. 
   1 ............   2 ............   3 .............   4 ...........   5 ....................... العمل أو النشاطات األخرى
   1  ............  2  ............  3  .............  4  ...........  5 ....................... مما كنت ترغبأنجزت أقل  ب. 
 بحذر أقل قمت بعمل أو نشاطات أخرى  ج. 
   1  ............  2  ............  3  .............  4  ...........  5 ............................................ من المعتاد
 
 
الجسدية أو العاطفية في إلى أي مدى تدخلت مشاكلك ، األسابيع األربعة الماضيةخالل  .6
 نشاطاتك االجتماعية االعتيادية مع العائلة، األصدقاء، الجيران، أو المجموعات؟
 ةبشد كثيرا بشكل معتدل قليال ال على اإلطالق
     
 1      2      3      4     5     
 ؟األسابيع األربعة الماضيةعانيت خالل  الجسديكم من األلم  .7
 شديد جدا شديد متوسط خفيف خفيف جدا ال شيء
      
 1       2       3       4      5     6     
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بعملك االعتيادي )بما فيه العمل  األلم، إلى أي مدى تدخل ةاألسابيع األربعة الماضيخالل  .8
 خارج البيت أو العمل البيتي(؟
 ةبشد كثيرا بشكل معتدل قليال ال على اإلطالق
     
 1       2       3       4      5     
 
 
كل ل . األسابيع األربعة الماضيةهذه األسئلة تستفسر عن شعورك وكيف سارت األمور معك خالل  7
األسابيع كم من الوقت خالل  .الجواب األقرب إلى الطريقة التي شعرت بهاسؤال، الرجاء إعطاء 
 ...األربعة الماضية
 
 
تك الجسدي ة أو، كم من الوقت تدخلت األسابيع األربعة الماضيةخالل  8 في نشاطاتك االجتماعية )مثل  العاطفية مشاكلك صح 
 القيام بزيارات لألصدقاء، األقارب، الخ.(؟
 وال في أي وقت قليل من الوقت بعض الوقت الوقتمعظم  كّل الوقت
     
وال في أي  قليل من الوقت بعض الوقت معظم الوقت كّل الوقت 
 وقت
 
  1 .............  2 .............  3 .............  4 .............  5 .................................. ؟ شعرت بالحيوية  ا. 
  1 .............  2 .............  3 .............  4 .............  5 ....................... شعرت بأنك عصبّي/ة جداً؟ ب. 
 جدا بحيث انه ل ة/شعرت بأنك محبط ج. 
  1 .............  2 .............  3 .............  4 .............  5 .............................. ا شيء يمكنه إسعادك؟
  1 .............  2 .............  3 .............  4 .............  5 ....................... شعرت بالهدوء والطمأنينة؟ د. 
  1 .............  2 .............  3 .............  4 .............  5 ............................ كانت لديك طاقة كبيرة؟ .ه 
  1 .............  2 .............  3 .............  4 .............  5 ................. ؟شعرت بأنك حزين/ة ومكتئب/ة .و 
  1 .............  2 .............  3 .............  4 .............  5 ............................... ة؟/شعرت بأنك منهك .ز 
  1 .............  2 .............  3 .............  4 .............  5 .................................... شعرت بالسعادة؟ .ح 
  1 .............  2 .............  3 .............  4 .............  5 ...................................... شعرت بالتعب؟ ط. 
378 
 
 1       2       3       4      5     
 
 
 
 من العبارات اآلتية بالنسبة لك؟ كلما مدى صحة أو خطأ  9
بشكل مطلق  
 صحيحة
على األغلب 
 صحيحة
على األغلب  ال أعرف
 خاطئة
 بشكل مطلق
 خاطئة
      
 يبدو أنّي أكثر سهولة في التعّرض للمرض ا. 
  1 ...........  2 ............  3 ............  4 ..........  5 ..................................... من أشخاص آخرين.
 بنفس قدر السالمة التي يتمتّع بها  ة/أنا سليم .ب 
  1 ...........  2 ............  3 ............  4 ..........  5 ......................................... أي شخص أعرفه
  1 ...........  2 ............  3 ............  4 ..........  5 .......................... أتوقع أن تزداد صحتي سوءا. .ج 
  1 ...........  2 ............  3 ............  4 ..........  5 ........................................... صّحتي ممتازة. .د 
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Quality of Life Inde 
Dialysis Version III 
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Appendix 4.2.d (HADS) 
 
 
 
  (HADS)واالكتئاب الخاص بالمستشفيات والمرا كز الصحيةقلق مقياس ال
 
 
ا
طو
هنا
ي 
 
 __________: التاريخ ________________________________________________ :االسم
 يعرف األطباء أن المشاعر تلعب دوراً هاماً في ُمعظم األمراض. فإذا عرف طبيبك عن هذه المشاعر، سيستطيع أن يساعدك أكثر.
اإلجابة األقرب إلى ما كنت تشعر به  وضع خطاً أسفل هذا االستبيان ُمصمم لمساعدة طبيبك في معرفة ما تشعر به. إقرأ كل بند في المقطع التالي
رد فعلك الفوري لكل بند سيكون  ال تفكر طوياًل في اإلجابات، إذ أن طراف االستبيان.أعلي  رقام المطبوعةخالل االيام السبعة الماضية. تجاهل األ
 غالباً أدق مما لو فكرت طوياًل.
ا
طو
ي هنا
 
 
 
كل االسئلة ىجابة علإلنك قد قمت باأن تحقق من اآل    
  D A 
 
   
       المجموع   
 
HADS copyright © R.P. Snaith and A.S. Zigmond, 1983, 1992, 1994.  
Record form items originally published in Acta Psychiatrica Scandinavica, 67, 361–70,  
copyright © Munksgaard International Publishers Ltd, Copenhagen, 1983. 
This edition first published in 1994 by nferNelson Publishing Company Ltd,  
389 Chiswick High Road, 9th Floor East, London, W4 4AL. GL Assessment is part of the Granada Group 
This form may not be reproduced by any means without first obtaining permission from the publisher.  
Email: permissions@gl-assessment.co.uk 
 
 D A   
ءيبط يأشعر كأن      
طول الوقتتقريباً    ٣   
اً جد اً كثير   ٢   
 ١    ً  أحيانا
ً مطلق   ٠  ا  
مثل شعور غريب فى المعدة خوفنوع من الشعور بال يينتابن      
ً مطلق  ٠   ا  
ً أحيان  ١   ا  
إلى حد ما اً كثير  ٢    
اً جد اً كثير  ٣    
 
  
 لقد فقدت االهتمام بمظهري 
 بالتأكيد   ٣ 
ينبغيلم أعد أهتم بالقدر الذى    ٢   
 ربما ال أهتم بنفس القدر   ١ 
ً أهتم  بنفس القدر كما كنت دائم   ٠  ا  
 أشعر بعدم اإلستقرار وكأني يجب أن أتحرك طول الوقت    
اً جد اً كثير  ٣    
اً كثير  ٢    
اً ليس كثير  ١    
ً مطلق  ٠   ا  
 أتطلع إلى األمور باستمتاع    
ً بنفس القدر كما كنت دائم   ٠  ا  
 أقل نوعا ما مما كنت من قبل   ١ 
 بالتأكيد أقل مما كنت من قبل   ٢ 
ً يكاد يكون مطلق   ٣  ا  
 تنتابني مشاعر مفاجئة بالذعر    
 في أحيان كثيرة جداً   ٣  
 في أحيان كثيرة  ٢  
 ليس كثيراً   ١  
ً مطلق  ٠   ا  
تليفزيونيأستطيع أن أستمتع بكتاب جيد أو الراديو أو برنامج       
 كثيراً    ٠ 
 ١    ً  أحيانا
 ليس كثيراً    ٢ 
اً نادراً جد   ٣   
  D A  
"مشدود"وأأشعر بأني متوتر   
    
  ٣   معظم الوقت
من الوقت اً كثير    ٢  
ً أحيان ً ا    ١  
اً مطلق    ٠  
 ما زلت أستمتع باألمور التي كنت أستمتع بها من قبل
    
   ٠  بالتأكيد بنفس القدر
   ١  ليس بنفس القدر
فقط قليالً    ٢   
ً يكاد يكون مطلق ا   ٣   
وكأن شيئاً فظيعاً على وشك الحدوث خوفينتابنى نوع من الشعور بال  
    
  ٣   بالتأكيد وبدرجة سيئة
  ٢   نعم، ولكن ليس بدرجة سيئة
، ولكن ال يقلقنىقليالً     ١  
اً مطلق    ٠  
الجانب الفكاهي في األمورأستطيع أن أضحك وأن أرى   
    
 ً    ٠  بنفس القدر كما كنت دائما
   ١  ليس بنفس القدر اآلن 
   ٢  بالتأكيد ليس بنفس القدر اآلن 
اً مطلق   ٣   
 تمر بذهني أفكار ُمقلقة
    
من الوقت اً جد اً كثير    ٣  
من الوقت اً كثير    ٢  
  ١   ليس كثيراً 
جداً  قليالً     ٠  
بالمرحأشعر   
    
اً مطلق   ٣   
   ٢  ليس كثيراً 
   ١  أحياناً 
   ٠  ُمعظم الوقت 
 أستطيع أن أجلس بأمان وأن أشعر باالسترخاء
    
  ٠   بالتأكيد
  ١   عادةً 
  ٢   ليس كثيراً 
  ٣    اً مطلق
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Appendix 4.2.f (FATIGUE SEVERITY SCALE) 
 مقياس شدة التعب
 
 خالل اإلسبوع الماضي وجدت أن:
 أوافق ال
 تماما
 
 
 أوافق ال
 أرفض وال
 
 أوافق
 تماما
 أشعر حينما أقل تكون ءاألشيا لعمل دافعيتى .1
  ّءباإلعيا
1 2 3 4 5 6 7 
 يسبب ط، بنشا أقوم أو الرياضة أمارس حينما .2
 ءباإلعيا شعورا ذلك
1 2 3 4 5 6 7 
 7 6 5 4 3 2 1 بسهولة ءباإلعيا أصاب .3
 لوظائفي ممارستي طريق في يقف ءاإلعيا .4
 الجسدية
1 2 3 4 5 6 7 
 7 6 5 4 3 2 1 ومتكررة عديدة مشاكل لي يسبب ءاإلعيا .5
 وظائفي عمل في االستمرار من يمنعني ءاإلعيا .6
 الجسدية
1 2 3 4 5 6 7 
 7 6 5 4 3 2 1 مىومها لواجباتي تأديتي طريق في يقف ءاإلعيا .7
 7 6 5 4 3 2 1 إعاقتي في تتسبب أعراض ثالثة أهم من ءاإلعيا .8
العملية، حياتي  سلبا ويؤثر يضايقني ءاإلعيا .9
 االجتماعيةأو  العائلية
1 2 3 4 5 6 7 
 
 (التالية الصفحة إلى الذهاب يرجى)
© Copyright 1984 & 1998 Carol Estwing Ferrans and Marjorie J. Powers 
Copyright Arabic translation: Jehad O. Halabi (1995, 2004), University of Jordan, Amman, 
dr_jehadhalabi@yahoo.com 
 
Appendix 4.2.g (5D Itching Scale) 
 مقياس الحكة
 
 في أخر اسبوعين, كم عدد الساعات التي شعرت خاللها بالحكة؟   .1
 
 كيف تقيم شدة الحكة في أخر أسبوعين؟   .2
 
 
 خالل األسبوعين الماضيين, هل تحسنت الحكة أم ساءت مقارتناً بالشهر الماضي؟   .3
 
 
 قيم تأثير الحكة على النشاطات التالية خالل أخر أسبوعين؟     .4
a.  تأثير الحكة على النوم    
 
1 2 3 4 5 
ال توثر على 
 النوم
 تؤخر النوم كثيرا تؤخر النوم نادراً 
تؤخر النوم وتسبب 
 اليقظة
تؤخر النوم وتسبب 
 اليقظة كثيراً 
  
b.  لديك؟ماهو مدى تأثر الحكة على نشاطات التواصل االجتماعي 
 
1 2 3 4 5 
ً  كثيراً  أحيانا قليالً  ال تؤثر  دائما
 
c. ماهو مدى تأثير الحكة على نشاطك اليومي؟ 
 
1 2 3 4 5 
ً  كثيراً  أحيانا قليالً  ال تؤثر  دائما
 
d. ما مدى تأثير الحكة على عملك؟ 
 
1 2 3 4 5 
ً  كثيراً  أحيانا قليالً  ال تؤثر  دائما
 
1 2 3 4 5 
ساعات 6أقل من  ساعة 6-12  ساعة 12-18  ساعة 18-23   طول اليوم 
1 2 3 4 5 
 اليحتمل قوي متوسط خفيف اليوجد
1 2 3 4 5 
تحسنت كثيراً لكن  انتهت الحكـة
 يوجد حكة
تحسنت قليالً مع وجود 
 حكة
 ساءت لم تتغير
 (التالية الصفحة إلى الذهاب يرجى)
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األكثر تأثرا بالحكة خالل األسبوعين الماضين )إذا لم يكن العضو المتأثر أي من أعضاء الجسم التالية  .5
 من ضمن القائمة فباإلمكان وضع عالمة بالعضو األقرب للموضع(؟
 
 العضو الجسدي ال توجد حكة توجد حكة
  a. فروة الرأس 
  b. الوجه 
  c. منطقة الصدر 
  d. منطقة البطن 
  e. منطقة الظهر 
  f. المؤخرة 
  g. الفخذين 
  h. األرجل 
  i. بطن القدم 
  j. بطن الكف 
  k. اليدين واألصابع 
  l. الكتفين 
  m. أعلى اليدين 
  n.  األماكن المالمسة
 للمالبس
  o. بين الفخذين 
  p. أعلى أصابع القدمين 
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Appendix 4.2.h (Spritual Wellbeing Scale) 
 مقيياسس االصحة االرووحانيية
كل عباررةة٬ ) ( ضع إإشاررةة تك لمضمونن  ف ل ا لى ددررجهه مواافقتك أأوو مخ لى ع ث  ،لالختييارر االداالل بصوررةة م
تك االشخصي بر  وواالمعبر عن خ
   أأوواافق بشدهه ال أأوواافق باعتداالل الأأوواافقأأوواافق أأوواافق اعتداالل   أأوواافق بشدهه
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: The original English Spiritual Well-Being Scale (SWBS) is in the Journal of 
Psychology and Theology, 1983, 11(4), p. 340. English SWBS © 1982 & Arabic SWBS © 
2010 by C. W. Ellison & R. F. Paloutzian. All rights reserved. Translation courtesy of 
Ahmad S. Musa. Layout by John Thibdeau. Not to be duplicated unless expressed 
written permission is granted by copyright holder or Life Advance: 
www.lifeadvance.com. 
احح       ي ي ت ارر ب ثر  ك أأ تي  ا اج ن في م لي  توس لى هللا وو إإ  ال 
 أأشعر
يريي       ي يكونن مص ي ا س يت٬ م ي ت أأ أأوو، ا٬  ن أأ ين من  ي أأ أأوو،من   
لم ااع  ال 
أأنن       ني  يحفظ ي تهه وو ي ي ا برع أأؤؤمن  ني  ب يح ي  هللا 
اؤؤلل       ف ت ل ل تدعو  أأنن  ةة  ا ي ي لح اا  أأررىى 
أأمورر       ية . ي يوم ي ل اا أأنن  تي  ا ي ي قد ح ت ااع يرعى  ي  هللا 
لى أأشعر       لق ع ق ل ا ب لي  ب ق ت  مس
ا       ب ني  بط تر قة . ي قة عمي  )عال
ةة       ا ي ي لح اا في  اء  ف ت االك ب أأشعر  ا  لرض اا  وو
ين من وو       ي ي ي ف ا لك اا نهه  ا بح لى) هللا (س ا تع بر وو لص اا  
لعونن اا تمد  أأس  ال 
لذيي       اا تي  ا ي ي بهه ح امم  ت ل اا ير  ي تس هه  ا تج اال ب  
احح ي ي ت االرر ب  أأشعر 
أأنن       د  ق ت ااع ني  ا يرع ي  في ھھھھمومي هللا 
 أأحب االحيياةة      
ني       ل تص قة ال  ا( عال ب ية.  ي  مرض
لي ااستبشر       ب ق ت  بمس
ةة       د لوح ا ب عورر  لش اا ا2  ب تي  ل ني ص فع ع د  ت
اتت       قض ا ن ت ل ا ب آسي  لم اا ةة وو ا ي ي لح اا أأررىى  لهه  ق ث  أأنن م
كونن       أأ ا  دم ن لهه ع لى ص اتت ع ددررج نة  ي ي ن أ لطم اا أأشعر   
لى أع  ب
ا ب نة  ي ي ت  !م
ةة       ا ي ي لح اا تحمل  ير  ي ث لك اا نى  لمع اا  ال من 
تي       ل ني ص تشعر ا-  ب احح  ي ي ت االرر  ب
اةة       ي لحي اا في  لوجودديي  أأنن  يهه  ي د مج ية  ي ا اكك غ ن د ھھھھ ق ت  ااع
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Appendix 4.3.  Lesson Plan for Questionnaire Administration Procedure 
 
Lesson Title: Principles of self-administered questionnaire related to a pilot study  
Date: 2nd week of October 2015 
Presenter: Waleed Al Rajhi 
 
Rationale:   
This is a 2-3 hours session is designed for the key individuals (nephrology nurses) from 
haemodialysis units, Oman, whom agreed to assist in conducting the pilot study which 
is a part of main study of Quality of Life and Health Related Quality of Life in Individuals 
with End Stage Renal Disease: meaning, level and predictors within an Omani Context. 
It is presented very much as a practical introduction to the assistants and consists of a 
mixture of a series of short lectures interspersed with practical activities. The areas of 
discussion will include: aims and objectives of study, consent form, and principles and 
procedure of administering the questionnaire. 
 
Prescribed Learning Outcome(s):  
Attendants will be able to: 
1. Administer effectively the study questionnaire pertaining to phase 2 of Quality of 
Life and Health Related Quality of Life in Individuals with End Stage Renal 
Disease: meaning, level and predictors within an Omani Context. 
2. Maintain confidentiality and sounds ethical principles throughout the process of 
administering, following-up, and collecting back the questionnaires. 
3. Respond to participant’s enquiries that might arise related to study 
questionnaire. 
 
Instructional Objective(s):  
At the end of this session, attendants will be able to: 
1. Gain an insight into the aims and objectives of the pilot study 
2. Understand and practice the method for obtaining consent form related to the 
pilot study 
3. Understand and practice the method of self-administered questionnaire 
4. Understand and practice the method of following-up and handling questionnaire 
after completion by participants 
5. Recognise and discuss the special issues that might arise in self-administered 
questionnaire. 
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Prerequisite Concepts and Skills: 
It is essential for nurses who will assist in administering the study questionnaire that 
have/are: self-interest to assist; qualified nephrology nurses registered at Ministry of 
Health, Oman; permitted by authorities of HD unit; and their participation would not 
negatively affect their clinical role and tasks. 
Materials and Resources: 
Presenter  Attendant  
Sample of the study questionnaire 
Flip chart 
Laptop 
Overhead projector 
Note book and pencil  
 
Lesson Activities: 
Presenter Activities Attendant Activities Time Venue 
 
1. Introduction to the 
study aims and 
objectives 
2. Discussion on ethical 
principles applied to the 
study 
3. Demonstration for 
obtaining consent form 
4. Demonstration of 
questionnaire 
administration 
5. Discussion and 
distribution of the key 
instructions to 
administer a 
questionnaire 
6. Wrap-up 
 
1. In all the activities, 
attendants are 
expected to engage in 
discussion and 
enquire about aspects 
that are not clear. 
 
 
09-12 
am 
 
Dialysis 
unit: 
Seminar 
room, 
meeting 
room. 
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Key Instructions to Administering Pilot Study Questionnaire 
 
1. Participant should complete the questionnaire independently without 
assistance from health professionals or family members.  If the patient is 
unable to complete/read the questionnaire themselves, the questions can 
be read out for them and/or their responses recorded. The questionnaire 
is designed to assess the patient’s perception so their answers should not 
be influenced in any way.    
2. Ensure that consent form has been signed and handed over along the 
questionnaire. 
3. Express the importance of the research that they are contributing to, and 
that the answers they give on the questionnaires may be an important 
contribution to the health of others. 
4. Emphasise that the questionnaire’s scientific value is contingent on 
carefully and thoughtfully given answers.   
5. The questionnaire must be completed with a dark blue or black pen.   
6. Tell the participant that if they have any uncertainty about how to answer 
a question, they should select what they think is the most appropriate 
answer.  
7. Remind the participant to answer all of the questions.   
8. Instruct the participant on how to correct mistakes, if necessary, by 
crossing out the wrong answer, filling in the correct answer, and circling 
the correct answer. 
9. Thank the participant for completing the questionnaires.  
10. REMEMBER:  confidentiality is vital throughout the process.  
Quality assurance of the self-administered questionnaires   
Before participant leaves the HD unit, a quality assurance check of the 
questionnaire must be done.  Remind the participant with the following items:   
1. Completeness: that all questions have been answered.   
2. Accurate identification: make sure that the questionnaire has a printed 
code on the cover page.   
3. Coherence: that only one answer is given for each question. If the 
participant has made any corrections on the questionnaire, to sure that the 
intended answer is clearly marked.  
Resources for additional information   
If you have questions related to this or during the questionnaire administration, 
please contact Waleed Khalid Alrajhi, Researcher, in any of the following ways:  
Telephone: 00968 99636344 OR Email:  wkalrajhi@dundee.ac.uk. Alternatively, 
you can contact Dr Abdullah Al Battashi on 00968 99885711 (Study supervisor). 
 (التالية الصفحة إلى الذهاب يرجى)
© Copyright 1984 & 1998 Carol Estwing Ferrans and Marjorie J. Powers 
Copyright Arabic translation: Jehad O. Halabi (1995, 2004), University of Jordan, Amman, 
dr_jehadhalabi@yahoo.com 
 
Appendix 4.3.a.  Participant information sheet– Phase 1 
 
 
 
PARTICIPANT INFORMATION SHEET – PHASE 1 
 
Quality of Life and Health Related Quality of Life in Individuals with End Stage 
Renal Disease: Meaning, level and predictors within an Omani Context. 
 
You are being invited to take part in a research study that will assess quality of life 
(QoL) and health related quality of life (HRQoL) in patients with end stage renal 
disease (ESRD) in an Omani context. Before you decide to take part, it is important 
that you understand firstly why the research is being done and what it will involve. 
Please take time to read the following information, and carefully consider whether 
you want to take part. Please ask the researcher or nurse involved in this study if 
there is anything that is not clear or if you would like more information. 
 
Aim 
The aims of this phase are to explore your thoughts about quality of life, and to identify 
the areas of life which are most important to you and rate your level of satisfaction with 
each of them. This phase of the study will help the researcher to explore the 
understanding of the meaning of quality of life in an Omani context. This will then inform 
the next phase of the study in terms of ensuring that we use the appropriate study 
questionnaires suitable to Omani patients.  
 
Why have I been invited? 
You are being asked to participate as you are an adult with ESRD and on haemodialysis 
therapy on a regular basis. Your dialysis nurse has identified that you are eligible to 
participate in this study. I hope that 12 patients will agree to take part in this study. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will 
be given this information sheet to keep and be asked to sign a consent form. If you decide 
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to take part you are still free to withdraw at any time and without giving a reason. A 
decision to withdraw at any time, or a decision not to take part, will not affect your medical 
or nursing care. 
 
What will happen if I agree to help? 
If you agree to take part in this study, it will involve you completing two questionnaires 
related to quality of life during an interview while your presence in dialysis unit for your 
regular haemodialysis sessions. You are required to think out loud while completing the 
questionnaires, and following the completion of items/questions, I will explore the basis 
of your answers. I might also ask you to nominate the areas of life which are most 
important, rate your level of satisfaction with each, and indicate the relative importance 
of each to your overall quality of life. 
The time is expected to finish the interview around one hour. The interview will take place 
in the dialysis unit, pre-dialysis waiting room, or a place you prefer. There will be a private 
room for conducting the interview to maintain privacy.  If you like, you can ask a relative 
or friend to be present during the interview but not contribute.  
With your permission, I would like to audio record this interview so that I have an accurate 
account of what was said. You can ask me to stop to take a rest at any point during the 
interview.    
 
We do not anticipate that there will be any disadvantages or risks if you choose to 
participate in the study. The information will be gathered may not benefit you directly, but 
I hope that it will help individuals with the same condition in the future. 
 
What if there is a problem? 
If you have a concern about any aspects of the study, you should speak to the researcher 
who will do his best to answer your questions. The contact details are listed below. If you 
believe that you have been harmed in any way by taking part in this study, you have the 
right to pursue a complaint to the Dialysis Unit In-charge or to the Call Centre, Ministry 
of Health. To do so, you can phone the Ministry of Health Call Centre on number 
24441999. Working hours: 7:30am to 9.30pm, and during public holidays: 9:30am until 
4:30pm. 
Who will disclose, use and/or receive my health information? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. Any information about you (name, address, phone number, direct 
quotes and locations) that is obtained from you either during the interview or through the 
questionnaires will be anonymised for publication purposes (e.g. trial report, research 
paper, conference presentation) so that you cannot be recognised from it. All study data 
will be kept separately from the consent forms and personal contact information so that 
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no connection can be made between the data and your identify. Personal contact 
information (e.g. name, phone number, etc.) will be stored as a hard copy separately in 
a secure location for at least 5 years after the study has ended. All study data will be 
stored safely and securely either on a password protected file, on a secure, password 
protected PC within the university or in a locked filing cabinet in a locked room at the 
University of Dundee, Scotland, UK. If you decide to withdraw from the study, all 
identifiable data will be withdrawn; however, any unidentifiable data already collected 
prior to your withdrawal will be retained and used in the study. 
 
The Ethical Committee on Medical Research at Ministry of Health, Oman, which has 
responsibility for scrutinizing all proposals for medical research on humans, has 
examined the proposal and has raised no objections from the point of view of medical 
ethics. It is a requirement that your records in this research, together with any relevant 
medical records, be made available for scrutiny by monitors from Ethical Committee, 
Ministry of Health, Oman, whose role is to check that research is properly conducted and 
the interests of those taking part are adequately protected. Once the results are ready I 
hope to publish them in a medical journal so that other healthcare professionals can 
benefit from the results. At the end of the study, results will be disseminated to the key 
stakeholders. 
 
The study has been organised and supervised by the School of Nursing and Midwifery, 
University of Dundee, Scotland, UK. 
 
Contact 
Thank you for taking time to consider taking part in this study. If you would like to find 
out more about it, please contact:  
Waleed Khalid Alrajhi, Researcher, Department of Nursing and Midwifery, University of 
Dundee – Scotland. I can be contacted in any of the following ways:  Telephone: 00968 
99636344 OR Email:  wkalrajhi@dundee.ac.uk 
 
Alternatively, 
Dr. Abdullah Al Battashi on 00968 99885711 (Dean of Nursing Institute, Ibri) who will be 
happy to discuss it with you.  
 
Thank you for taking the time to consider taking part in this study. 
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Appendix 4.3.b. PARTICIPANT INFORMED CONSENT FORM-PHASE 1 
 
 
PARTICIPANT INFORMED CONSENT FORM-PHASE 1 
Please take some time to read the following statements. If you agree with the 
statements, please put your initials in each box, thus indicating your consent to 
take part in the study. Thank you. 
STUDY TITLE 
Quality of Life and Health Related Quality of Life in Individuals with End Stage 
Renal Disease: meaning, level and predictors within an Omani Context. 
Statement 
Initial 
each box 
1.  
I confirm that I have read and understood the patient 
information sheet dated 15 March 2015 (final version 1.0) 
for the above study. I have had the opportunity to consider 
the information, ask questions and have had these 
answered satisfactorily. 
 
2.  
I understand that my participation is voluntary and that I 
am free to withdraw at any time without giving any reason, 
without any medical care or legal rights being affected. 
 
3.  
I understand that data collected during the study may be 
looked at by the study supervisors, where it is relevant to 
my taking part in this research. I give permission for them 
to have access to these data. 
 
4.  
I give permission that personal information (e.g. telephone 
number) will be used by the researcher only to contact me 
during this study. 
 
5.  
I understand that if I choose to withdraw from the study, 
any information provided till this moment will be included in 
the study, with my personal data remaining confidential. 
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6.  
I give permission for all the information I provide during the 
study to be used for research purposes (including reports, 
publications and presentation), with strict preservation of 
anonymity. 
 
7.  
I understand that any information I provide will be treated 
in strict confidence. The information will be held securely 
for at least 5 years and will only be available to the 
research team. The information will be destroyed 
thereafter. 
 
8.  
I agree that personal contact information (e.g. name, 
phone number) will be stored as hard copy separately in a 
secure location for at least 5 years after the study has 
ended. 
 
9.  
I give permission for the researcher to audio record the 
interview for the purpose of study only. 
 
10.  I agree to take part in this study. 
 
 
______________________  _______________________ 
 ________________ 
Name of participant   Date     Signature 
 
______________________  ___________________ 
 _________________ 
Name of person taking consent Date     Signature 
 
 
When complete, 1 for participant; 1 for researcher site file; 1 (original) to be kept in 
medical notes 
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Appendix 4.4  Coding Form for Cognitive Interviews (adopted 
from Willis, 2005) 
 
QUESTION APPRAISAL SYSTEM: CODING FORM 
INSTRUCTIONS. Use one form for EACH question to be reviewed. In reviewing each 
question:  
1. WRITE OR TYPE IN QUESTION NUMBER. ATTACH QUESTION. 
2. Proceed through the form - Circle or highlight YES or NO for each Problem 
Type. 
3. Whenever a YES is circled, write detailed notes on this form that describe the 
problem. 
STEP 1 - READING: Determine if it is difficult for the interviewers to read the question 
uniformly to all respondents. 
1a. WHAT TO READ: Interviewer may have difficulty determining what parts 
of the question should be read.  
YES       NO 
1b. MISSING INFORMATION: Information the interviewer needs to 
administer the question is not contained in the question.  
YES       NO 
1c. HOW TO READ: Question is not fully scripted and therefore difficult to 
read. 
YES       NO 
STEP 2 - INSTRUCTIONS: Look for problems with any introductions, instructions, or 
explanations from the respondent’s point of view. 
2a. CONFLICTING OR INACCURATE INSTRUCTIONS, introductions, or 
explanations.  
YES       NO 
2b. COMPLICATED INSTRUCTIONS, introductions, or explanations.  YES       NO 
STEP 3 - CLARITY: Identify problems related to communicating the intent or meaning of the 
question to the respondent. 
3a. WORDING: Question is lengthy, awkward, ungrammatical, or contains 
complicated syntax.  
YES       NO 
3b. TECHNICAL TERM(S) are undefined, unclear, or complex. YES       NO 
3c. VAGUE: There are multiple ways to interpret the question or to decide 
what is to be included or excluded.  
YES       NO 
3d. REFERENCE PERIODS are missing, not well specified, or in conflict. YES       NO 
STEP 4 - ASSUMPTIONS: Determine if there are problems with assumptions made or the 
underlying logic. 
4a. INAPPROPRIATE ASSUMPTIONS are made about the respondent or 
about his/her living situation.  
YES       NO 
4b. ASSUMES CONSTANT BEHAVIOR or experience for situations that 
vary. 
YES       NO 
4c. DOUBLE-BARRELED: Contains more than one implicit question. YES       NO 
STEP 5 - KNOWLEDGE/MEMORY: Check whether respondents are likely to not know or 
have trouble remembering information. 
5a. KNOWLEDGE may not exist: Respondent is unlikely to know the answer 
to a factual question.  
YES       NO 
5b. ATTITUDE may not exist: Respondent is unlikely to have formed the 
attitude being asked about. 
YES       NO 
5c. RECALL failure: Respondent may not remember the information asked 
for. 
YES       NO 
5d. COMPUTATION problem: The question requires a difficult mental 
calculation. 
YES       NO 
STEP 6 - SENSITIVITY/BIAS: Assess questions for sensitive nature or wording, and for bias. 
Question number or question here: 
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6a. SENSITIVE CONTENT (general): The question asks about a topic that is 
embarrassing, very private, or that involves illegal behaviour.  
YES       NO 
6b. SENSITIVE WORDING (specific): Given that the general topic is 
sensitive, the wording should be improved to minimize sensitivity.  
YES       NO 
6c. SOCIALLY ACCEPTABLE response is implied by the question. YES       NO 
STEP 7 - RESPONSE CATEGORIES: Assess the adequacy of the range of responses to be 
recorded. 
7a. OPEN-ENDED QUESTION that is inappropriate or difficult. YES       NO 
7b. MISMATCH between question and response categories. YES       NO 
7c. TECHNICAL TERM(S) are undefined, unclear, or complex. YES       NO 
7d. VAGUE response categories are subject to multiple interpretations. YES       NO 
7e. OVERLAPPING response categories. YES       NO 
7f. MISSING eligible responses in response categories. YES       NO 
7g. ILLOGICAL ORDER of response categories. YES       NO 
STEP 8 - OTHER PROBLEMS: Look for problems not identified in Steps 1 - 7. 
8. Other problems not previously identified. YES       NO 
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Appendix 4.5.a. Participants information sheet-phase 2 & 3 
 
  
 
     
Quality of Life and Health Related Quality of Life in Individuals with End Stage 
Renal Disease: an Omani Context. 
You are being invited to take part in a research study that will assess quality of life (QoL) 
and health related quality of life (HRQoL) in patients with end stage renal disease 
(ESRD) in an Omani context. Before you decide to take part, it is important that you 
understand firstly why the research is being done and what it will involve. Please take 
time to read the following information, and carefully consider whether you want to take 
part. Please ask the researcher or nurse involved in this study if there is anything that is 
not clear or if you would like more information. 
Aim 
The aims of this study are to identify the level of quality of life for patients with end stage 
renal disease on dialysis by using a number of questionnaires.  These will tell us how 
well these questionnaires are accepted by Omanis; and to what extant disease 
symptoms, social spiritual factors affect quality of life in Omani patients. The findings 
from the present study will improve our understanding of the ESRD patients’ perceptions 
about their disease, which can be then incorporated into their future medical and nursing 
care. 
Why have I been invited? 
You are being asked to participate as you are an adult who has been diagnosed with 
ESRD and on haemodialysis therapy on a regular basis. Your dialysis nurse has 
identified that you are eligible to participate in this study. I hope that 400 patients will 
agree to take part in this study. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will 
be given this information sheet to keep and be asked to sign a consent form. If you decide 
to take part you are still free to withdraw at any time and without giving a reason. A 
decision to withdraw at any time, or a decision not to take part, will not affect your medical 
or nursing care. 
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What will happen if I agree to help? 
If you agree to take part in this study, it will involve you completing 6 questionnaires 
during your presence in dialysis unit for your regular haemodialysis sessions. The 
estimated time to complete these questionnaires will be around 30-40 minutes, but it may 
take less or more time for some individuals.  
The questionnaires to fill out are:  
a) Three questionnaires to assess your experience with three symptoms 
associated with your ESRD disease and how these may affect your 
everyday activities.  
b) A questionnaire to assess what you think about your health status. 
c) A questionnaire to assess the impact of ESRD on your socio-economic 
activates. 
d) A questionnaire to assess the impact of ESRD on your spiritual aspects. 
You will also be asked some background questions related to your age, gender, 
education level, marital status, monthly income. 
 
A clinical data will be collected from your medical record (e.g. total hours of 
haemodialysis per week; malnutrition status, anaemia status) to examine its impact and 
association with your level of QoL. 
Once you have finished completing the questionnaires, you will hand it over to your 
nurse who in turn will seal it and hand it over to the researcher.  
 We do not anticipate that there will be any disadvantages or risks if you choose to 
participate in the study. The information will be gathered may not benefit you directly, 
but I hope that it will help individuals with the same condition in the future. 
What if there is a problem? 
If you have a concern about any aspects of the study, you should speak to the researcher 
who will do his best to answer your questions. The contact details are listed below. If you 
believe that you have been harmed in any way by taking part in this study, you have the 
right to pursue a complaint to the Dialysis Unit In-charge or to the Call Centre, Ministry 
of Health. To do so, you can phone the Ministry of Health Call Centre on number 
24441999. Working hours: 7:30am to 9.30pm, and during public holidays: 9:30am until 
4:30pm. 
Who will disclose, use and/or receive my health information? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. Any information about you (name, address, phone number, direct 
quotes and locations) that is obtained from you either during the interview or through the 
questionnaires will be anonymised for publication purposes (e.g. trial report, research 
paper, conference presentation) so that you cannot be recognised from it. All study data 
will be kept separately from the consent forms and personal contact information so that 
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no connection can be made between the data and your identify. Personal contact 
information (e.g. name, phone number, etc.) will be stored as a hard copy separately in 
a secure location for at least 5 years after the study has ended. All study data will be 
stored safely and securely either on a password protected file, on a secure, password 
protected PC within the university or in a locked filing cabinet in a locked room at the 
University of Dundee, Scotland, UK. If you decide to withdraw from the study, all 
identifiable data will be withdrawn; however, any unidentifiable data already collected 
prior to your withdrawal will be retained and used in the study. 
The Ethical Committee on Medical Research at Ministry of Health, Oman, which has 
responsibility for scrutinizing all proposals for medical research on humans, has 
examined the proposal and has raised no objections from the point of view of medical 
ethics. It is a requirement that your records in this research, together with any relevant 
medical records, be made available for scrutiny by monitors from Ethical Committee, 
Ministry of Health, Oman, whose role is to check that research is properly conducted and 
the interests of those taking part are adequately protected. Once the results are ready I 
hope to publish them in a medical journal so that other healthcare professionals can 
benefit from the results. At the end of the study, results will be disseminated to the key 
stakeholders. 
The study has been organised and supervised by the School of Nursing and Midwifery, 
University of Dundee, Scotland, UK. 
Contact 
Thank you for taking time to consider taking part in this study. If you would like to find 
out more about it, please contact:  
Waleed Khalid Alrajhi, Researcher, Department of Nursing and Midwifery, University of 
Dundee – Scotland. I can be contacted in any of the following ways:  Telephone: 00968 
99636344 OR Email:  wkalrajhi@dundee.ac.uk 
 
Alternatively, 
Dr. Abdullah Al Battashi on 00968 99885711 (Dean of Nursing Institute, Ibri) who will be 
happy to discuss it with you.  
 
Thank you for taking the time to consider taking part in this study. 
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Appendix 4.5.b.   participant information consent form-phase 2 & 3  
 
              
 
PARTICIPANT INFORMED CONSENT FORM-PHASE 2 and 3 
 
Please take some time to read the following statements. If you agree with the 
statements, please put your initials in each box, thus indicating your consent to take 
part in the study. Thank you. 
STUDY TITLE 
Quality of Life and Health Related Quality of Life in Individuals with End Stage Renal 
Disease: an Omani Context. 
 
Statement 
Initial 
each box 
1.  
I confirm that I have read and understood the patient 
information sheet dated 15 March 2015 (final version 1.0) for 
the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered 
satisfactorily. 
 
2.  
I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
any medical care or legal rights being affected. 
 
3.  
I understand that data collected during the study may be 
looked at by the study supervisors, where it is relevant to my 
taking part in this research. I give permission for them to have 
access to these data. 
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4.  
I give permission that personal information (e.g. telephone 
number) will be used by the researcher only to contact me 
during this study. 
 
5.  
I understand that if I choose to withdraw from the study, any 
information provided till this moment will be included in the 
study, with my personal data remaining confidential. 
 
6.  
I give permission for all the information I provide during the 
study to be used for research purposes (including reports, 
publications and presentation), with strict preservation of 
anonymity. 
 
7.  
I understand that any information I provide will be treated in 
strict confidence. The information will be held securely for at 
least 5 years and will only be available to the research team. 
The information will be destroyed thereafter. 
 
8.  
I agree that personal contact information (e.g. name, phone 
number) will be stored as hard copy separately in a secure 
location for at least 5 years after the study has ended. 
 
9.  I agree to take part in this study. 
 
 
 
______________________  _______________________ 
 ________________ 
Name of participant   Date     Signature 
_____________________ ______________________  _________________ 
Name of person taking consent Date     Signature 
 
 
When complete, 1 for participant; 1 for researcher site file; 1 (original) to be kept in medical 
notes 
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Appendix 4.6. Risk assessment plan 
 
Risk Action to prevent Action to manage 
University and Ministry 
of Health, Oman, 
ethics approval takes 
longer than anticipated 
Study documentation is 
prepared as early as possible. 
Check slots for ethics review as 
early as possible. 
Engage in discussion with Research 
office and Directorate of Research, 
Oman. 
Recruitment to 
cognitive interviews 
proves challenging 
Patients are invited to take part 
when next in clinic. Flexibility in 
dates is allowed. 
A minimum of 3 interviews is allowed. 
An extra month of recruitment is 
allowed. 
Attendance of patient 
to cognitive interview 
proves challenging and 
creates delay 
Patients are invited to take part 
when next in clinic. Patients are 
given the option to participate at 
different times and dates. 
An extra month of recruitment is 
considered. 
Responses to pilot 
study survey are fewer 
than required 
Oversampling technique is 
pursued. Two weekly reminders 
are sent by the researcher. 
Additional 2 reminders will be sent if 
required. Additional invitations are 
sent by the researcher. 
Responses to main 
study survey are fewer 
than required 
Oversampling technique is 
pursued. Two weekly reminders 
are sent. 
Additional reminders are sent if 
required. Additional invitations are 
sent. 
Nephrology nurses or 
clinical site is not 
engaging as planned 
Ensure involvement of clinicians 
in planning discussions. Identify 
clinicians who show interest in 
research. Regular contact and 
updates sent to clinicians. 
Engage in discussion and negotiation 
with clinicians. Identify source of sub-
optimal engagement. Examine 
alternatives to increase engagement. 
Nephrology nurses or 
clinical site withdraws 
early 
Ensure involvement of clinicians 
in planning discussions. Identify 
clinicians who show interest in 
research. Regular contact and 
updates sent to clinicians. 
Start negotiations with another clinical 
site. Inform other clinical sites about 
development and request support 
with recruitment until a new clinical 
site comes on board. 
Recruitment to main 
study survey proves 
challenging 
Ensure involvement of clinicians 
in planning discussions. Identify 
clinicians who show interest in 
research. Regular contact and 
updates sent to clinicians. 
Offer to support clinicians during 
recruitment. Consider adding a new 
clinical site. 
Patient withdraws early Ensure patient fully 
understands the purpose and 
procedures of the study. 
Replace patients who withdraw. 
Intensify recruitment. Set minimum 
number of patients required. 
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Risk Action to prevent Action to manage 
Recruiting clinicians for 
the study proves 
challenging 
Set intense recruitment 
strategy, ensuring study 
advertisements are widely 
available. 
Relax requirements set in the job 
description. An additional month of 
recruitment is allowed. Explore 
possible availability within research 
group. 
Data collection rates 
are lower than 
expected 
Ensure that questionnaires 
have been adequately 
prepared. Ensure that 
participants fully understand 
procedures. 
Administering questionnaires as an 
interview base. 
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Appendix 5.1. SEIQoL-DW interview record form (IRF) 
 
Respond
ent  
Interview Record Form (IRF) 
Time 
taken 
to 
comple
te 
(minute
s: 
second
s) 
Understanding of method Fatigue/Boredom 
Overall validity of 
information 
Not 
understo
od 
Poor/Uncert
ain 
Understandi
ng 
understoo
d 
Non
e 
Som
e  
A 
lot 
Definit
ely 
Invalid 
Uncerta
in 
Vali
d  
01 21 - - ✓ - - - - - ✓ 
02 15 - - ✓ - - - - - ✓ 
03 12 - - ✓ - - - - - ✓ 
04 15 - - ✓ - - - - - ✓ 
05 15 - - ✓ - - - - - ✓ 
06 16 - - ✓ - - - - - ✓ 
07 14 - - ✓ - - - - - ✓ 
08 13 - - ✓ - - - - - ✓ 
09 18 - - ✓ - - - - - ✓ 
10 21 - - ✓ - - - - - ✓ 
11 14 - - ✓ - - - - - ✓ 
12 19 - - ✓ - - - - - ✓ 
 
 
 
 
 
 
 
 
 
 
Appendix 5.2.   Summary of cues definitions and categorisation of cues 
Participants Description of Cue Cue Label 
Categorisation of QoL cues 
Researcher Reviewer 1 Reviewer 2 Agreed category 
Participant 
001 
“…mixing up with people 
and sitting with them. Sitting 
with friends, hanging out 
with them..”. 
Socialisation Social life Social life 
Social life/ enjoying 
life 
Social life 
“physical activity, ability to 
go to shopping and get 
groceries. Ability to climb up 
the stairs”. 
Physical activity Living conditions Independence Role functioning Role functioning 
“transportation. Able to 
drive to places of interest is 
highly important to me. Also 
ability to bank up the money 
required to this”.  
Mobility/money Finances Enjoying life 
Autonomy/ 
Independence 
 
Autonomy/ 
Independence 
 
“I am youth and my future is 
not clear; the job as well!! I 
don’t know if I will find a job 
that suits my health 
condition and how my future 
will be?” 
Future Role functioning Work 
Autonomy/ 
Independence 
 
Role functioning  
“going to mosque and 
praying to Allah ‘God’, 
fasting and being able to 
fast is highly important to 
me”. 
Religion Religion/spiritual life Religion 
Religion/spiritual life 
 
Religion/ spiritual 
life 
Participant 
002 
“family life and specifically 
children are important to 
me. They make up my life”. 
Family Family  Family Family Family  
“diabetic was a cause to 
amputate my leg. I wish to 
have it back so that I can 
walk and looks normal; 
having good health 
extremity is what I want”.  
Body image Health  Not sure Health 
Personal and family 
health 
 
“mobility, walking and 
meeting my needs”. 
Mobility Living conditions 
 
Autonomy/ 
Independence 
Role functioning Role functioning  
“I wish to study; learning is 
important”. 
Self-development 
Autonomy/ 
independence 
 
Attitudes to life 
Autonomy/ 
Independence 
 
Autonomy/ 
independence  
“religion is very important; in 
fact it is on top of this list”. 
Religion Religion/spiritual life Religion Religion/spiritual life 
Religion/ spiritual 
life 
Participant 
003 
“praying five time a day; 
and being fasting is crucial 
to me. I don’t want to feel 
delinquent at this part” 
Religion Religion/spiritual life Religion Religion/spiritual life 
Religion/ spiritual 
life 
“health and being able to 
move and live in normal 
life”. 
Health Health Personal health Health 
Personal and family 
health 
“work. I work in army and 
such type of job demands 
you to be active most of 
time”. 
Job Work/occupation Work 
Work/occupation 
 
Work/ occupation 
“sport and mobility. As 
being in army, sport 
become part of my life”. 
Sport 
Leisure 
activities/hobbies 
Leisure 
activities 
Leisure activities/ 
Hobbies 
Leisure activities 
“my family and close 
relatives are important to 
me. I am the only one who 
looks after them”.  
Family Family Family Family Family  
Participant 
004 
“my presence at home is 
very important to care for 
my wife and children. They 
are taking most of my time”. 
Family Family Family Family Family  
“going out from home and 
coming for dialysis; also 
getting groceries to home is 
important. These are all my 
responsibilities”. 
Mobility Role functioning  
 
Autonomy/Inde
pendence 
Autonomy/ 
Independence 
Autonomy/ 
Independence 
“it is important to me to care 
for my wife. Sexual life, for 
Wife/sexual ability Sexuality  Relationships Sexuality Sexuality  
 
instance, I consider it as an 
important aspect in my life”. 
“diseases; allergies from 
medications and secondary 
diseases. Basically, my 
health”. 
Health Health Personal health Health 
Personal and family 
health 
“being on time for prayers, 
going to mosque; as well as 
going to Hajj are important 
to me”. 
Religion/worship Religion/spiritual life Religion 
Religion/spiritual life 
 
Religion/spiritual life 
Participant 
005 
“reading Quran (holy book), 
prying and going to Hajj. 
These on top of the 
important list in my life” 
Worship Religion/spiritual life Religion Religion/spiritual life Religion/spiritual life 
“looking after my family and 
caring for my children 
comes after worship”. 
Family Family Family Family Family  
“practical life, living in good 
condition and with sufficient 
money are also important to 
me”. 
Wealth Finances  Finances Living conditions Finances  
“herbal remedy, using 
‘Quran recitation’ in treating 
myself can improves my 
health condition” 
Health Health Personal Health Religion/spiritual life 
Personal and family 
health 
“neighbourhood and 
neighbours, sitting with my 
friend and going out with 
me makes me feel good”. 
Social life Social life Social Life Relationships Social life 
Participant 
006 
“I am from Al-Jabal Al-
Akhdar (called the ‘Green 
Mountain’ in Arabic. 
Located at 2,000 metres 
above sea level). Driving up 
and down is important to 
me so that I can come for 
dialysis”. 
Health Health 
 
Personal Health 
Living conditions 
Personal and family 
health 
 
“raising children is a huge 
responsibility and I devote it 
a lot of time”. 
Children Family Family Family Family  
“overall responsibilities that 
I have and the provision of 
food to my family are 
important”. 
Responsibility Role functioning Family Role functioning Role functioning 
“worship and praying. It is 
obligatory to perform 
prayers in congregation”. 
Prayer Religion/spiritual life Religion 
Religion/spiritual life 
 
Religion/spiritual life 
“visiting relatives and 
friends and sitting with 
them. I would say family 
gathering is important to 
me”. 
Family gathering Social life Social life Family Social life 
Participant 
007 
“I am 31 years old; not yet 
married. Marriage and 
engagement something 
important to me”. 
Marriage Partnership  Relationships Relationships Relationships  
“I usually spend most of 
time doing sport. Sport and 
physical activity are 
dominating most of my 
time”. 
Sport 
Leisure activities/ 
hobbies 
Leisure 
activities 
Leisure activities/ 
Hobbies 
Leisure activities/ 
Hobbies 
“travelling and sightseeing 
is my favourite. I have been 
to different places.. I like 
seeing new places”. 
Entertainment 
Leisure activities/ 
hobbies 
Attitudes to life 
Leisure activities/ 
Hobbies 
Leisure activities/ 
Hobbies 
“the relationship with people 
and specifically with my 
colleagues at work, and 
neighbours are important”.   
Social life Social life Social life Relationships Social life 
“spirituality; praying and 
going to places of worship 
are also important to me”. 
Spirituality Religion/spiritual life Religion Religion/spiritual life Religion/spiritual life 
Participant 
008 
“looking and caring after my 
young children something I 
would rank it as very 
Family Family Family Family Family  
 
important. Their study as 
well is very important” . 
“religious issues, like prayer 
and fasting something 
obligatory in this life. I am 
delinquent in this aspect”. 
Religion Religion/spiritual life Religion 
Religion/spiritual life 
 
Religion/spiritual life 
“connecting with people and 
friends something that I like. 
Especially when I site with 
them I feel the joy”. 
Social interaction Social life Social Life Social life Social life 
“my job. I have my own 
small business and I devote 
it much of my time”. 
Job Work/occupation 
Work 
 
Work/occupation Work/occupation 
“tourism was my profession. 
Till today, sightseeing and 
tourism are very important 
to me”. 
Tourism 
Leisure activities/ 
hobbies 
Enjoying life Work/occupation Enjoying life 
Participant 
009 
“family. my family is my 
main responsibility. I have 
to keep them happy and 
provide them with whatever 
required to live happily”. 
Family Family Family Family Family  
“worship, going to mosque 
and Hajj (Makha). I have 
never been there and it is 
my dream. It is something 
important to me”. 
Worship Religion/spiritual life Religion Religion/spiritual life Religion/spiritual life 
“work, active, earning 
money and settling a 
business”. 
Job Finances 
Autonomy/Inde
pendence 
Work/occupation Work/occupation 
“can’t believe that I am 
away from agriculture. It is 
my hoppy and it is important 
to me”.  
Agriculture 
Leisure activities/ 
hobbies 
Leisure 
activities 
Leisure activities/ 
Hobbies 
Leisure activities/ 
Hobbies 
Participant 
010 
“I would say my children, 
my children and my 
children. The greatest 
Children Family Family Family Family  
 
interest in my life is my 
children”. 
“the trip to dialysis unit is 
very important to me. It is 
what it keeps me alive”. 
Health Health 
 
Personal health 
Quality of life 
Personal and family 
health 
“my prayers and fasting. 
Although my health 
deteriorated, but these are 
of something that I have to 
do”. 
Worship Religion/spiritual life Religion Social life Religion/spiritual life 
“”I work on trading. It keeps 
me busy and gives me a 
secured wealth”. 
Business Finances Work Work/occupation Work/ occupation 
“I have had kidney 
transplantation. 
Unfortunately it failed and to 
have another one is crucial 
to me”. 
Kidney transplant 
Kidney transplant/ 
health 
Personal Health Quality of care 
Personal and family 
health 
Participant 
011 
“socialisation and staying 
connected with people. This 
what I would say”. 
Social life Social life Social Life Social life Social life 
“my job. I would say my job 
is something very important 
in my life”. 
Job Work/occupation Work Work/occupation Work/ occupation 
“you might not believe this!, 
kitchen and cooking. It is 
always of my interest.. 
maybe it is a matter of self-
esteem.. I don’t know”. 
Cooking 
Leisure activities/ 
hobbies 
Autonomy/Inde
pendence 
Leisure activities/ 
Hobbies 
 
Leisure activities/ 
Hobbies 
“the difficulties that I face in 
praying, fasting and going 
to ‘Makah’ is bothering me. 
Worship is important”. 
Worship Religion/spiritual life Religion Religion/spiritual life Religion/spiritual life 
“I am a young girl, and my 
future is vague to me. I wish 
to marry and have children”.  
Future Role functioning 
 
Other – not sure 
Role functioning Role functioning 
Participant 
012 
“my health is the most 
important aspect in my life. 
Health Health 
 
Personal Health 
Health 
Personal and family 
health   
 
How can I mobilise when I 
am ill?” 
“the healthcare that I 
receive from the medical 
team at dialysis unit is very 
important to me”. 
Healthcare Quality of care Quality of care Quality of care Quality of care 
“fasting. I can’t fast and my 
health condition doesn’t 
really support me to fast. 
Another ‘Ramadan-fasting 
month- will be coming and I 
didn’t fast. I wish to do this”. 
Fasting Religion/spiritual life Religion Religion/spiritual life Religion/spiritual life 
“currently, I look after my 
grandchildren. My children 
have a busy life, and I enjoy 
looking after my 
grandchildren”. 
Grandchildren Family Family Family Family  
“I have a small garden; I like 
agriculture. I spend free 
time there. It also keeps me 
busy and active”. 
Garden/agriculture 
Leisure activities/ 
hobbies 
Leisure 
activities 
Work/occupation 
 
Leisure activities/ 
hobbies 
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Appendix 5.3. Cues, the levels and weights reported per 
participants 
 
R
e
s
p
o
n
d
e
n
t 
1
 Deriving 
SEiQOL 
outcome data 
Cues category  
Social life 
Physical 
movement 
Future  Money  Religion 
Cues levels 54 48 10 12 63 
Cues weights 15 10 15 15 45 
SEiQOL index 8.1 4.8 1.5 1.8 28.35 
Overall SEiQOL-DW 
score 
44.55 
 
R
e
s
p
o
n
d
e
n
t 
2
 Deriving 
SEiQOL 
outcome data 
Cues category  
Family 
Body 
image 
Mobility 
Self-
development 
Religion 
Cues levels 98 28 20 53 32 
Cues weights 30 15 15 15 25 
SEiQOL index 29.4 4.2 3 7.95 8 
Overall SEiQOL-DW 
score 
52.55 
 
R
e
s
p
o
n
d
e
n
t 
3
 
Deriving 
SEiQOL 
outcome data 
Cues category  
Religion Health Job Sport Family 
Cues levels 88 52 87 60 97 
Cues weights 30 30 05 05 30 
SEiQOL index 26.4 15.6 4.35 3 29.1 
Overall SEiQOL-DW 
score 
78.45 
 
R
e
s
p
o
n
d
e
n
t 
4
 
Deriving SEiQOL 
outcome data 
Cues category  
Family Mobility 
Sexual 
relationship 
Health 
Religion 
& worship 
Cues levels 95 37 97 58 90 
Cues weights 20 13 22 20 25 
SEiQOL index 19 4.81 21.34 11.6 22.5 
 (التالية الصفحة إلى الذهاب يرجى)
© Copyright 1984 & 1998 Carol Estwing Ferrans and Marjorie J. Powers 
Copyright Arabic translation: Jehad O. Halabi (1995, 2004), University of Jordan, Amman, 
dr_jehadhalabi@yahoo.com 
 
Overall SEiQOL-DW score 79.25 
 
R
e
s
p
o
n
d
e
n
t 
5
 Deriving SEiQOL 
outcome data 
Cues category  
Worship Family Wealth Health 
Social 
life 
Cues levels 71 69 36 40 71 
Cues weights 26 20 15 24 15 
SEiQOL index 18.46 13.8 5.4 9.6 10.65 
Overall SEiQOL-DW score 57.91 
 
R
e
s
p
o
n
d
e
n
t 
6
 
Deriving 
SEiQOL 
outcome 
data 
Cues category  
Health Family Responsibility Prayer 
Social 
gathering  
Cues levels 42 75 65 59 86 
Cues weights 20 26 14 30 10 
SEiQOL 
index 
8.4 19.5 9.1 17.7 8.6 
Overall SEiQOL-
DW score 
63.3 
 
R
e
s
p
o
n
d
e
n
t 
7
 
Deriving 
SEiQOL 
outcome data 
Cues category  
Marriage Sport  Entrainment  
Social 
life 
Religion 
Cues levels 07 62 58 38 60 
Cues weights 27 22 15 15 21 
SEiQOL index 1.89 13.64 8.7 5.7 12.6 
Overall SEiQOL-DW 
score 
42.53 
 
R e s p o n d e n
t 8
 Cues category  
 (التالية الصفحة إلى الذهاب يرجى)
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Copyright Arabic translation: Jehad O. Halabi (1995, 2004), University of Jordan, Amman, 
dr_jehadhalabi@yahoo.com 
 
Deriving 
SEiQOL 
outcome data 
Family Worship 
Social 
interaction 
Job Tourism 
Cues levels 77 39 50 40 62 
Cues weights 33 30 5 23 9 
SEiQOL index 25.41 11.7 2.5 9.2 5.58 
Overall SEiQOL-DW 
score 
54.39 
 
R
e
s
p
o
n
d
e
n
t 
9
 
Deriving 
SEiQOL 
outcome data 
Cues category  
Family Worship Job Agriculture  
Cues levels 60 70 40 33 
Cues weights 39 38 14 9 
SEiQOL index 23.4 26.6 5.6 2.97 
Overall SEiQOL-DW 
score 
58.57 
 
R
e
s
p
o
n
d
e
n
t 
1
0
 
Deriving 
SEiQOL 
outcome 
data 
Cues category  
Children  Health Worship Business 
Kidney 
transplant 
Cues levels 77 57 52 43 19 
Cues weights 31 28 21 08 12 
SEiQOL 
index 
23.87 15.96 10.92 3.44 2.28 
Overall SEiQOL-DW 
score 
56.47 
 
R
e
s
p
o
n
d
e
n
t 
1
1
 Deriving 
SEiQOL 
outcome data 
Cues category  
Social life Job Cooking Worship Future 
Cues levels 26 6 13 38 74 
Cues weights 28 19 16 11 26 
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SEiQOL index 7.28 1.14 2.08 4.18 19.24 
Overall SEiQOL-DW 
score 
33.92 
 
R
e
s
p
o
n
d
e
n
t 
1
2
 
Deriving 
SEiQOL 
outcome 
data 
Cues category  
Health 
Health 
care 
Fasting 
(spiritual) 
Grandchildren  Agriculture 
Cues levels 34 68 25 68 30 
Cues 
weights 
20 18 27 24 11 
SEiQOL 
index 
6.8 12.24 6.75 16.32 3.3 
Overall SEiQOL-
DW score 
45.41 
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Appendix 5.4 Findings of the Cognitive interviewing of SF-36 
across participants 
SF-36 items Participants 
0
1 
02 0
3 
04 0
5 
06 0
7 
0
8 
09 1
0 
11 12 
1.General 
health 
            
2.Health 
compared to 
1 year ago 
            
3(a) 
Limitations of 
activities 
(Vigorous 
activities) 
            
3 (b) 
Moderate 
activities 
            
3 (c) Lifting or 
carrying 
groceries 
            
3(d) Climbing 
several flights 
of stairs 
            
3(e) Climbing 
one flight of 
stairs 
            
3(f) Bending, 
kneeling, or 
stooping 
            
3(g) Walking 
more than a 
mile 
            
3(h) Walking 
several 
blocks 
            
3(i) Walking 
one block 
            
3(j) Bathing 
or dressing 
yourself 
            
4(a) Physical 
health 
problems 
(time you 
spent on 
work) 
            
4(b) 
Accomplishe
d less than 
you would 
like 
     Question 
is 
undefined
, unclear, 
or 
complex. 
      
4(c) limited in 
the kind of 
work 
            
4(d)  limited 
in the kind of 
work 
            
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 = item probed what was intended and participant was able to find his/her answer 
5(a) 
emotional 
health (cut 
down amount 
of work) 
 Questio
n is 
contains 
complic
ated 
syntax. 
 Question 
is lengthy 
and 
contains 
complicat
ed syntax. 
    Question 
is 
awkward, 
or 
contains 
complicat
ed syntax. 
 Questio
n is 
lengthy. 
Questio
n is 
lengthy, 
awkwar
d. 
5(b) 
Accomplishe
d less than 
you would 
like 
            
5(c) Didn't do 
work or other 
activities as 
carefully as 
usual 
            
6 (social 
activities) 
            
7. bodily pain 
during the 
past 4 weeks 
            
8. pain 
interference 
with normal 
work 
            
9(a) energy 
and emotions 
            
9(b) Have you 
been nervous 
person 
            
9(c) Have you 
felt so down 
            
9(d) Have you 
felt calm and 
peaceful 
            
9(e) Did you 
have a lot of 
energy 
            
9(f) Have you 
felt 
downhearted 
            
9(g) Did you 
feel worn out 
            
9(h) Have you 
been a happy 
person 
            
9(i) Did you 
feel tired 
            
10.Social 
activities 
            
11(a) General 
health 
            
11(b) I am as 
healthy as 
anybody I 
know 
            
11(c) I expect 
my health to 
get worse 
            
11(d) My 
health is 
excellent 
            
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Appendix 5.5 Findings of the Cognitive interviewing of QOLI-D 
across participants 
QOLI-D 
items 
Participants 
0
1 
02 0
3 
04 0
5 
06 0
7 
0
8 
09 10 11 12 
Part 1 (how satisfied are you with) 
1- Health              
2-Health 
care 
            
3-Energy 
for 
everyday 
activities 
            
4-Self-
care 
            
5-
Chance 
to get 
Kidney 
transpla
nt 
            
6-
Changes 
due 
ESRD 
            
7-Control 
on life 
            
8-
Chance 
to live 
long 
 Clarity
: not 
clear  
        Clarity: 
not clear   
 Clarity: 
not 
clear 
9-Family 
health 
            
10-
Children 
            
11-
Family 
happines
s 
            
12-Your 
sexual 
life 
     Sensitivit
y:  The 
question 
asks 
about a 
topic that 
is 
embarras
sing and 
very 
private    
   Sensitivit
y:  The 
question 
asks 
about a 
topic that 
is 
embarras
sing and 
very 
private   
Sensitivit
y:  The 
question 
asks 
about a 
topic that 
is 
embarras
sing and 
very 
private   
Sensitivi
ty:  The 
question 
asks 
about a 
topic 
that is 
embarra
ssing 
and 
very 
private   
13- 
partners
hip 
            
14-
Friendsh
ip  
            
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15-
Emotion
al 
support 
from 
family 
            
16-
Emotion
al 
support 
from 
others 
            
17-
Ability to 
look 
after 
family 
            
18-
Usefulne
ss to 
others 
            
19-
Worries 
in life 
            
20-
Neighbo
urhood 
            
21-Place 
where 
you live 
            
22-Job (if 
employe
e) 
            
23-Not 
having a 
job (if 
unemplo
yed) 
            
24-
Educatio
n 
            
25-
Financial 
needs 
            
26-
Entertain
ment 
            
27-
Chances 
for 
Happy 
future 
   Clarity: 
not 
clear 
    Clarit
y: 
not 
clear 
   
28-Peace 
of mind 
            
29-Faith 
in God 
            
30-
Achieve
ment of 
personal 
goals  
            
31-
Happine
ss in 
general 
            
32-Life in 
general  
            
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33-
Personal 
appearan
ce 
            
34Yours
elf in 
general  
            
Part 2 (how important to you is) 
1- Health              
2-Health 
care 
            
3-Energy 
for 
everyday 
activities 
            
4-Self-
care 
            
5-
Chance 
to get 
Kidney 
transpla
nt 
            
6-
Changes 
due 
ESRD 
            
7-Control 
on life 
            
8-
Chance 
to live 
long 
            
9-Family 
health 
            
10-
Children 
            
11-
Family 
happines
s 
            
12-Your 
sexual 
life 
     Sensitivit
y:  The 
question 
asks 
about a 
topic that 
is 
embarras
sing and 
very 
private    
   Sensitivit
y:  The 
question 
asks 
about a 
topic that 
is 
embarras
sing and 
very 
private    
Sensitivit
y:  The 
question 
asks 
about a 
topic that 
is 
embarras
sing and 
very 
private    
Sensitivi
ty:  The 
question 
asks 
about a 
topic 
that is 
embarra
ssing 
and 
very 
private    
13- 
partners
hip 
            
14-
Friendsh
ip  
            
15-
Emotion
al 
support 
from 
family 
            
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16-
Emotion
al 
support 
from 
others 
            
17-
Ability to 
look 
after 
family 
            
18-
Usefulne
ss to 
others 
            
19-
Worries 
in life 
            
20-
Neighbo
urhood 
            
21-Place 
where 
you live 
            
22-Job (if 
employe
e) 
            
23-Not 
having a 
job (if 
unemplo
yed) 
            
24-
Educatio
n 
            
25-
Financial 
needs 
            
26-
Entertain
ment 
            
27-
Chances 
for 
Happy 
future 
            
28-Peace 
of mind 
            
29-Faith 
in God 
            
30-
Achieve
ment of 
personal 
goals  
            
31-
Happine
ss in 
general 
            
32-Life in 
general  
            
33-
Personal 
appearan
ce 
            
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 = item probed what was intended and participant was able to find his/her answer 
34-
Yourself 
in 
general  
            
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Appendix 6.1 Summary of the variables against outliers, skewness and kurtosis 
values, distribution, and tests of normality 
 
Variable 
Outlier 
skewne
ss 
Z 
score 
kurtosi
s 
Z 
score 
Tests of normality (p 
value) 
Upper 
end 
Lower 
end 
Kolmogoro
v-Smirnov 
Shapiro-
Wilk 
Pt age - - .497 1.392 .133 0.189 .001 .002 
Hb level 2 2 .546 0.194 1.225 1.745 .200* .340 
HCT 2 - .730 2.044 .651 0.927 .200* .112 
Albumin - 2 -.987 -2.764 1.578 2.247 .200* .026 
HD hours - - .106 0.296 .322 0.458 .000 .000 
HD 
adequacy 
- - -.142 -0.397 .002 0.002 .200* .267 
SF36- PF - - .029 0.08 -.923 -1.31 .200* .193 
SF36-RP - - .154 0.43 -.769 -1.09 .200* .094 
SF36-BP - - .211 0.59 -.613 -0.87 .060 .081 
SF36-GH - - .049 0.13 -.917 -1.30 .200* .340 
SF36-
vitality 
- - .100 0.28 0.49 0.698 .124 .340 
SF36-SF - - 0.096 0.26 -.752 -1.07 .010 .048 
SF36-RE - - -.021 -0.05 -1.060 -1.51 .062 .017 
SF36-MH - - -.056 -0.15 -.537 -0.76 .200* .274 
SF36-PCS - - -.012 -0.03 -.947 -1.34 .120 .353 
SF36-MCS - - .081 0.22 -.460 -0.65 .200* .908 
QOLI-D- 
total 
- - -.342 -0.957 -.841 -0.00 .200* .530 
QOLI-D-
health & 
functioning 
- - -.394 -1.10 -.264 -0.37 .200* .607 
QOLI-D- 
social & 
economic 
- 1 -.407 -1.14 -.193 -0.27 .200* .240 
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QOLI-D- 
psychologic
al/ spiritual 
- - -.809 -2.26 -.013 -0.01 .036 .001 
QOLI-D-
family 
 3 -1.489 -4.17 3.656 5.65 .002 .000 
HADS- 
anxiety 
- - .300 0.84 -.592 -0.84 .200* .189 
HADS- 
depression 
- - .067 0.18 -.963 -1.37 .200* .151 
HADS- total - - .119 0.33 -.664 -0.94 .200* .510 
Itch-5D - - .432 1.21 -.140 -0.19 .200* .216 
FSS - - -.317 -0.88 -1.171 -1.66 .019 .007 
SWB- 
religious 
- - -1.547 -4.33 3.38 4.82 .041 .002 
SWB- 
existential 
 2 -.567 -1.58 .344 0.49 .200* .107 
SWB- total - 1 -1.273 -3.56 2.44 3.48 .075 .129 
 
Multivariate normality, linearity, and homoscedasticity 
SF-36 (PCS) 
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SF-36 (MCS) 
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QOLI-D 
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Appendix 7.1 standarised factor structure of the SF36 V2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Hypothesised by Ware et al., 1993) 
Vigorous activities (PF01) 
Moderate activities (PF02) 
Lift, carry groceries (PF03) 
Climbing several flights (PF04) 
Climbing one flight (PF05)  
Bend, kneel (PF06) 
Walk mile (PF07) 
Walk several blocks (PF08) 
Walking one block (PF09) 
Bathe, dress (PF10) 
 
Cut down time (RF01) 
Accomplished less (RF02) 
Limited in kind (RF03) 
Had difficulty (RF04) 
 
Pain-magnitude (BP01) 
Pain-interfere (BP02) 
 
EVGFP rating (GH1) 
Sick easier (GH02) 
As healthy (GH03) 
Health to get worse (GH04) 
Health excellent (GH05) 
 
Pep/Life (VT01) 
Energy (VT02) 
Worn out (VT03) 
Tired (VT04) 
 
Social-extent (SF01) 
Social-time (SF02) 
 
Physical 
component 
scale 
General 
health 
Bodily 
pain 
Role 
functioning 
– physical  
Physical 
functioning 
Role 
functioning 
– emotional  
Mental 
health 
Social 
functioning  
Mental 
component 
scale 
Vitality  
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Appendix 7.2 SF36v2 underlying factor structures 4-8  
SF36v2  4-Factor structure 
Item Factor 1 Factor 2 Factor 3 Factor 4 
Vigorous activities (PF01) 0.56 0.26 0.01 0.03 
Moderate activities (PF02) 0.27 0.62 -0.08 0.01 
Lift, carry groceries (PF03) 0.18 0.65 0.09 -0.00 
Climbing several flights 
(PF04) 
0.35 0.67 -0.08 0.02 
Climbing one flight (PF05) -0.04 0.73 -0.01 0.01 
Bend, kneel (PF06) -0.14 0.70 0.03 0.01 
Walk mile (PF07) 0.12 0.76 0.01 0.08 
Walk several blocks (PF08) -0.01 0.78 0.03 -0.00 
Walking one block (PF09) -0.16 0.70 0.02 0.01 
Bathe, dress (PF10) -0.33 0.63 -0.03 0.09 
Cut down time (RF01) 0.03 0.02 -0.10 0.79 
Accomplished less (RF02) 0.07 -0.05 -0.01 0.80 
Limited in kind (RF03) 0.05 0.09 -0.14 0.71 
Had difficulty (RF04) 0.04 0.11 0.07 0.70 
Pain-magnitude (BP01) 0.09 0.11 0.69 0.01 
Pain-interfere (BP02) 0.04 0.12 0.68 0.04 
EVGFP rating (GH1) 0.24 0.04 0.47 0.01 
Sick easier (GH02) -0.07 0.11 0.33 0.09 
As healthy (GH03) 0.17 -0.13 0.42 0.05 
Health to get worse (GH04) -0.01 0.09 0.39 0.02 
Health excellent (GH05) 0.22 0.02 0.61 0.07 
Pep/Life (VT01) 0.36 -0.11 0.70 -0.00 
Energy (VT02) 0.38 0.01 0.63 -0.10 
Worn out (VT03) -0.16 0.02 0.70 -0.04 
Tired (VT04) -0.15 -0.05 0.68 0.04 
Social-extent (SF01) -0.09 0.08 0.63 0.03 
Social-time (SF02) -0.07 0.16 0.36 0.07 
Cut down time (RE01) -0.12 -0.02 0.13 0.77 
Accomplished less (RE02) -0.14 -0.01 0.04 0.84 
Not careful (RE03) -0.05 0.02 0.06 0.67 
Nervous (MH01) -0.39 0.08 0.49 -0.03 
Down in dumps (MH02) -0.30 -0.03 0.65 0.03 
Peaceful (MH03) -0.05 -0.01 0.58 0.02 
Blue/sad (MH04) -0.38 -0.02 0.58 0.06 
Happy (MH05) 0.12 -0.07 0.61 0.01
9 
Bold values indicate that item loading on a factor is ≥ .30
431 | P a g e  
 
SF36v2  5-Factor structure 
Item               Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 
Vigorous activities (PF01) 0.77 0.05 0.05 0.10 -0.08 
Moderate activities (PF02) 0.43 0.52 0.02 0.01 -0.01 
Lift, carry groceries (PF03) 0.28 0.59 0.01 0.12 -0.01 
Climbing several flights 
(PF04) 
0.49 0.54 0.03 0.05 -0.06 
Climbing one flight (PF05) 0.09 0.72 0.01 -0.04 0.02 
Bend, kneel (PF06) -0.07 0.74 0.01 0.03 0.01 
Walk mile (PF07) 0.33 0.69 0.01 -0.02 0.05 
Walk several blocks 
(PF08) 
0.16 0.76 -0.01 -0.04 0.06 
Walking one block (PF09) -0.07 0.73 0.01 -0.01 0.04 
Bathe, dress (PF10) -0.38 0.75 0.01 -0.01 -0.04 
Cut down time (RF01) 0.03 -0.03 0.83 -0.15 0.01 
Accomplished less (RF02) 0.07 -0.13 0.84 -0.01 0.04 
Limited in kind (RF03) 0.10 0.01 0.75 -0.20 0.01 
Had difficulty (RF04) 0.04 0.06 0.73 0.01 0.07 
Pain-magnitude (BP01) -0.02 0.13 -0.01 0.57 0.24 
Pain-interfere (BP02) -0.07 0.15 0.03 0.53 0.26 
EVGFP rating (GH1) 0.02 0.04 0.01 0.56 -0.03 
Sick easier (GH02) -0.03 0.12 0.09 0.16 0.23 
As healthy (GH03) -0.04 -0.12 0.06 0.47 0.01 
Health to get worse 
(GH04) 
0.03 0.08 0.02 0.23 0.23 
Health excellent (GH05) 0.04 0.01 0.07 0.59 0.10 
Pep/Life (VT01) 0.05 -0.12 0.01 0.79 0.01 
Energy (VT02) 0.13 -0.01 -0.10 0.75 -0.02 
Worn out (VT03) 0.15 -0.01 -0.04 0.20 0.64 
Tired (VT04) 0.04 -0.06 0.05 0.26 0.56 
Social-extent (SF01) -0.04 0.10 0.03 0.33 0.42 
Social-time (SF02) -0.06 0.19 0.06 0.22 0.21 
Cut down time (RE01) -0.23 0.01 0.79 0.07 0.07 
Accomplished less (RE02) -0.34 0.02 0.87 0.07 -0.06 
Not careful (RE03) -0.23 0.06 0.68 0.13 -0.08 
Nervous (MH01) -0.03 0.09 -0.04 -0.07 0.68 
Down in dumps (MH02) -0.06 -0.01 0.04 0.15 0.64 
Peaceful (MH03) -0.01 -0.01 0.01 0.38 0.31 
Blue/sad (MH04) 0.01 -0.01 0.01 -0.04 0.76 
Happy (MH05) 0.12 -0.11 0.02 0.44 0.28 
Bold values indicate that item loading on a factor is ≥ .30
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SF36v2  6-Factor structure 
Item               Factor 1 Factor 2  Factor 3 Factor 4 Factor 5 Factor 6 
Vigorous activities (PF01) 0.83 -0.66 0.03 0.04         -0.02 -
0.01 
Moderate activities (PF02) 0.70 0.01 0.01 -0.01         -
0.01 
0.01 
Lift, carry groceries 
(PF03) 
0.60 0.17 -0.01 0.08         -0.01 0.05 
Climbing several flights 
(PF04) 
0.79 -0.05 0.01 0.01         -0.03 -0.01 
Climbing one flight (PF05) 0.49 0.41 0.01 -
0.06          
0.01 0.01 
Bend, kneel (PF06) 0.33 0.55 0.01 0.0
1         
-0.01 0.04 
Walk mile (PF07) 0.72 0.17 -0.01 -0.08          0.08 0.02 
Walk several blocks 
(PF08) 
0.55 0.41 0.01 -
0.01          
0.05 0.07 
Walking one block (PF09) 0.26 0.65 0.04 0.0
7         
-0.01 
-0.01 
Bathe, dress (PF10) 0.01 0.86 0.01 0.04         -0.11   -0.26 
Cut down time (RF01) 0.02 0.03 0.77 -0.01         -0.04 -0.28 
Accomplished less (RF02) -0.01 -0.04 0.80 0.07         -0.01 0.01 
Limited in kind (RF03) 0.13 0.01 0.71        -
0.07         
-0.03 -0.03 
Had difficulty (RF04) 0.11 0.04 0.69         0.08         0.04  -0.07 
Pain-magnitude (BP01) 0.05 0.08 -0.03 0.50         0.25 -0.06 
Pain-interfere (BP02) -0.01 0.18 0.02 0.49         0.27 0.03 
EVGFP rating (GH1) 0.03 0.04 0.01 0.57  -0.04 0.20 
Sick easier (GH02) 0.08 0.03 0.05 0.07         0.26 0.11 
As healthy (GH03) -0.12 -0.01 0.05 0.49        -0.01 0.04 
Health to get worse 
(GH04) 
0.09 -0.01 0.01 0.16 0.26 0.26 
Health excellent (GH05) 0.01 0.03 0.07 0.61         0.09 0.03 
Pep/Life (VT01) -0.03 -0.08 -0.01 0.79         0.02         0.14 
Energy (VT02) 0.10 -0.06 -0.10 0.74        -0.01 -
0.02 
Worn out (VT03) 0.14 -0.17 -0.05 0.07          0.72     -0.03 
Tired (VT04) 0.02 -0.13 0.03 0.14         0.62 -0.05 
Social-extent (SF01) -0.01 0.11 0.03 0.27         0.45        0.04 
Social-time (SF02) 0.07 0.12 0.04 0.14         0.24           0.09 
Cut down time (RE01) -0.01 -0.01 0.71 -0.01          0.14          0.01 
Accomplished less (RE02) -0.04 0.02 0.77 -0.02          0.02          
0.20 
Not careful (RE03) 0.03 -0.01 0.59 0.03        -0.01 0.38 
Nervous (MH01) -0.01 0.08 -0.03 -0.18 0.73 0.48 
Down in dumps (MH02) -0.06 0.01 0.03          0.03          0.71 0.47 
Peaceful (MH03) -0.07 0.09 0.03          0.37         0.33 -0.05 
Blue/sad (MH04) -0.01 -0.01 0.02         -0.16         0.83 0.01 
Happy (MH05) -0.01 -0.06 0.04          0.4
6         
0.30 -0.19 
Bold values indicate that item loading on a factor is ≥ .30 
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SF36v2  7-Factor structure 
      Item Factor 1 Factor 
2 
Factor3 Factor 
4 
Factor 5 Factor 
6 
Factor 
7 
Vigorous activities (PF01)  0.83         -0.67         0.03         0.05          -0.04   -0.03 -0.03 
Moderate activities (PF02) 0.71  -0.01           0.02          -0.01           0.01    -0.02 -0.01 
Lift, carry groceries (PF03)  0.60          0.18         -0.05           0.11           0.04   -0.14 -0.01 
Climbing several flights 
(PF04) 
 0.79         -0.09           0.08          -0.06          -0.06  0.04 0.10 
Climbing one flight (PF05)  0.49          0.39          0.01          -0.05          0.04  0.01 0.02 
Bend, kneel (PF06)  0.33          0.56         0.01           0.03           0.03   -0.08 0.04 
Walk mile (PF07)  0.72          0.12          -0.05                  -0.10  0.05 0.11 0.09 
Walk several blocks (PF08)  0.56          0.31          0.05          -0.04           0.01  0.34 -0.02 
Walking one block (PF09)  0.27          0.55          0.03           0.03         -0.05  0.44 -0.01 
Bathe, dress (PF10)  0.01           0.89         0.02  0.07         -0.06   -0.07 0.01 
Cut down time (RF01)  0.04           0.01           0.73          0.01         -0.02 0.14 0.01 
Accomplished less (RF02)  0.01          -0.04           0.76          0.11         0.02 0.09 -0.06 
Limited in kind (RF03)  0.14          0.01           0.68         -0.01           0.03  -0.02 -0.11 
Had difficulty (RF04)  0.11          0.04           0.66          0.11          0.06    0.03 0.04 
Pain-magnitude (BP01)  0.06          -0.03         -0.039           0.37          0.129   0.22 0.43 
Pain-interfere (BP02)  0.01           0.03           0.01           0.36          0.12 0.39 0.41 
EVGFP rating (GH1)  0.02           0.04           0.04           0.55         -0.06  0.01 0.12 
Sick easier (GH02) 0.06   0.06           0.05           0.05           0.26 -0.19 0.24 
As healthy (GH03)  -0.10          0.01           0.05           0.48         -0.02  -0.05 0.05 
Health to get worse (GH04)  0.08           0.09           0.01           0.19          0.34  -0.36 0.02 
Health excellent (GH05)  0.03           0.08           0.07           0.63          0.12 -0.09 -0.02 
Pep/Life (VT01)  -0.04          -0.06          -0.03           0.77         -0.01  0.04 0.07 
Energy (VT02)  0.08          -0.01          -0.09          0.76         -0.06  -0.07 -0.02 
Worn out (VT03)  0.13        -0.16        -0.05           0.05           0.70   -0.05 0.09 
Tired (VT04)  0.01         -0.15       0.03      0.09           0.57 0.04 0.20 
Social-extent (SF01)  0.01           0.06                 0.02    0.16           0.36 0.32 0.24 
Social-time (SF02)  0.07           0.06           0.02           0.06          0.15 0.12 0.35 
Cut down time (RE01)  -0.02          -0.03           0.66         -0.04           0.07  0.08 0.44 
Accomplished less (RE02)  -0.06           0.03           0.72         -0.03          -0.03 -0.07 0.49 
Not careful (RE03)  0.01          -0.01           0.55          0.01         -0.08  -0.09 0.49 
Nervous (MH01)  -0.05           0.07          -0.02          -0.19         0.73 0.03 0.01 
Down in dumps (MH02)  -0.08           0.02           0.03           0.02           0.70  -0.03 0.06 
Peaceful (MH03)  -0.07           0.05           0.03           0.34          0.31 0.21 -0.04 
Blue/sad (MH04)  -0.02         -0.03           0.02         -0.16          0.85  -0.09 -0.08 
Happy (MH05)  -0.03          -0.05           0.05           0.48          0.34   0.07 -0.23 
Bold values indicate that item loading on a factor is ≥ .30 
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SF36v2  8-Factor structure 
Item Factor 
1 
Factor 2 Factor 
3 
Factor 
4 
Factor 5 Factor 6 Factor 7 Factor 8 
Vigorous activities 
(PF01) 
0.84 0.03 0.05 -0.02 -0.05 0.15 -0.05 -0.02 
Moderate activities 
(PF02) 
0.36 0.50 0.02 0.09 -0.01 -0.01 -0.03 -0.03 
Lift, carry groceries 
(PF03) 
0.19 0.58 -0.01 0.25 0.01 0.01 -0.12 -0.03 
Climbing several 
flights (PF04) 
0.46 0.50 0.01 0.12 -0.08 -0.03 0.07 0.03 
Climbing one flight 
(PF05) 
-0.07 0.71 0.01 0.08 0.02 -0.09 0.01 0.01 
Bend, kneel (PF06) -0.20 0.76 0.01 0.04 0.04 0.03 -0.08 0.08 
Walk mile (PF07) 0.27 0.70 0.01 -0.13 0.08 0.02 0.08 0.10 
Walk several blocks 
(PF08) 
0.06 0.75 0.01 -0.10 0.03 0.01 0.26 -0.13 
Walking one block 
(PF09) 
-0.23 0.75 0.03 -0.04 -0.04 0.01 0.38 -0.17 
Bathe, dress (PF10) -0.57 0.79 0.01 0.04 -0.05 0.01 -0.01 0.03 
Cut down time 
(RF01) 
0.01 0.01 0.78 0.02 -0.04 -0.07 0.07 -0.01 
Accomplished less 
(RF02) 
0.02 -0.06 0.81 0.01 0.01 0.04 0.01 -0.05 
Limited in kind 
(RF03) 
0.05 0.08 0.72 -0.02 0.01 -0.04 -0.10 -0.05 
Had difficulty (RF04) 0.02 0.10 0.70 0.08 0.05 0.03 -0.01 0.04 
Pain-magnitude 
(BP01) 
0.08 -0.01 -0.03 0.60 0.06 0.01 0.40 0.09 
Pain-interfere (BP02) -0.01 0.02 0.01 0.51 0.06 0.01 0.57 0.02 
EVGFP rating (GH1) 0.01 0.02 0.01 0.42 -0.10 0.29 0.10 -0.03 
Sick easier (GH02) 0.01 0.05 0.05 0.36 0.21 -0.12 -0.07 0.18 
As healthy (GH03) -0.05 -0.14 0.05 0.44 -0.05 0.20 0.04 -0.09 
Health to get worse 
(GH04) 
0.01 0.07 0.01 0.34 0.29 0.04 -0.29 0.03 
Health excellent 
(GH05) 
-0.03 0.01 0.06 0.61 0.05 0.28 -0.02 -0.21 
Pep/Life (VT01) 0.01 -0.03 0.01 0.08 0.01 0.72 0.13 0.07 
Energy (VT02) 0.03 0.13 -0.10 -0.01 0.04 0.80 -0.05 0.06 
Worn out (VT03) 0.16 -0.02 -0.05 0.07 0.67 0.07 0.01 0.06 
Tired (VT04) 0.10 -0.09 0.03 0.04 0.55 0.10 0.13 0.14 
Social-extent (SF01) -0.01 0.04 0.02 0.17 0.33 0.04 0.41 0.02 
Social-time (SF02) -0.01 0.13 0.02 0.12 0.14 0.01 0.24 0.25 
Cut down time 
(RE01) 
0.01 -0.03 0.71 0.02 0.08 -0.03 0.07 0.42 
Accomplished less 
(RE02) 
-0.07 0.01 0.77 -0.06 0.01 0.04 -0.01 0.52 
Not careful (RE03) 0.01 0.03 0.59 0.02 -0.05 0.04 -0.01 0.50 
Nervous (MH01) -0.05 0.06 -0.03 0.03 0.70 -0.19 0.04 -0.06 
Down in dumps 
(MH02) 
-0.06 -0.01 0.03 0.01 0.69 0.06 0.01 0.05 
Peaceful (MH03) -0.08 0.04 0.03 -0.01 0.32 0.31 0.22 -0.13 
Blue/sad (MH04) -0.01 0.01 0.03 -0.09 0.84 -0.07 -0.03 -0.08 
Happy (MH05) 0.02 -0.02 0.06 0.03 0.34 0.44 0.02 -0.27 
Bold values indicate that item loading on a factor is ≥ .30 
 (التالية الصفحة إلى الذهاب يرجى)
© Copyright 1984 & 1998 Carol Estwing Ferrans and Marjorie J. Powers 
Copyright Arabic translation: Jehad O. Halabi (1995, 2004), University of Jordan, Amman, 
dr_jehadhalabi@yahoo.com 
 
Appendix 9.1.  Number of patients nominating category and their 
percentages 
 
Phase Two n= 12  
Phase Four n= 45 
Category 
# of patients 
nominating 
categories 
(%) 
Category 
# of patients 
nominating 
categories (%) 
Religion/Spiritual Life 12 (100) Religion/spiritual life 36 (80%) 
Family  9 (75) Family 35 (77.7%) 
Personal Health  6 (50) Personal health 31 (68.8%) 
Social Life 6 (50) Social life 17 (37.7%) 
Leisure Activities 6 (50) Work/occupation 15 (33.3%) 
Work/Occupation 5 (41.6) Leisure activities/hobbies 14 (31.1%) 
Role Functioning 5 (41.6) Autonomy/independence 12 (26.6%) 
Autonomy/Independence 3 (25) Role functioning 9 (20%) 
Family Health 1 (8.3) Living conditions 9 (20%) 
Sexuality  1 (8.3) Peace and contentment 7 (15.5%) 
Finances  1 (8.3) Finance 7 (15.5%) 
Relationships 1 (8.3) Family health 6 (13.3%) 
Enjoying Life 1 (8.3) Quality of care 5 (11.1%) 
Quality of Care 1 (8.3) Sexual life 4 (8.8%) 
  Enjoying life 4 (8.8%) 
  Relationships 4 (8.8%) 
  Coping  3 (6.6%) 
  Emotional well-being 2 (4.4%) 
  Exercise/mobility 1 (2.2%) 
 
